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There has been a growing acknowledgement of the involvement of the gut 
microbiome - the collection of microbes that reside in our gut - in regulating our 
mood and behaviour. This phenomenon is referred to as the microbiota-gut-brain 
axis. While our techniques to measure the presence and abundance of these 
microbes has been steadily improving, there are many factors that prevent us from 
understanding what aspects of the gut microbiome specifically influence the 
microbiota-gut-brain axis. In this thesis, we set out to identify and investigate aspects 
of the microbiome that are informative to gut-brain communication. We do this by 
investigating the state of the gut microbiome in both health and disease, as well as 
after supplementing or perturbing it.  
While all of the work presented here is based on real data from real experiments, the 
thesis has a strong bioinformatics focus, that means that while the physiological 
background and interpretation are important, my role in these projects has been to 
bioinformatically and statistically zoom in on the features of the microbiome that are 
the most informative to our questions. As such, all results will be discussed from a 
primarily bioinformatics point of view.  
Two main aspects of the gut microbiome came out as the most promising features 
to measure, namely functional capacity and volatility. Traditionally, the microbiome 
is thought of as a collection of microbes and most analysis is done on the taxonomical 
level. However, we find that by investigating microbial function - as defined by the 
genes that are found or associated in the detected microbes -  rather than taxonomy, 
we are able to perform more sensitive analysis and that our results are more easily 
interpretable. Second, microbiome studies are typically conducted using a single 
sample per subject. We find that the degree of change in the microbial ecosystem, 
called volatility, is an important feature of the microbiome and that is linked to 
severity of stress response. While volatility was coined before in the context of the 
microbiome, this was only in passing.  We were the first to investigate volatility as a 
feature of the microbiome.  
xi 
 
Our research in this thesis reconfirms the existence of the microbiota-gut-brain axis 
and demonstrates novel metrics that can be used to interrogate the microbiome. We 
utilize mathematical frameworks originally from geology and classical ecology to 
bolster our analysis. We show that considering the microbiome as an ecosystem is a 
powerful model that can help us better formulate our scientific questions and 
interpret our findings. We argue for strategies to unify bioinformatics methodology 





Chapter 1 Introduction 
Two published manuscripts and one manuscript in preparation were used for this 
chapter.  
Chapter 1.1 largely consists of the following published manuscripts: 
Making Sense of … the Microbiome in Psychiatry 
Thomaz F S Bastiaanssen, Caitlin S M Cowan, Marcus J Claesson, Timothy G Dinan, 
John F Cryan 
Published in the International Journal of Neuropsychopharmacology, 2019 
DOI: 10.1093/ijnp/pyy067 
 
Gutted! Unraveling the Role of the Microbiome in Major Depressive Disorder 
Thomaz F S Bastiaanssen, Sofia Cussotto, Marcus J Claesson, Gerard Clarke, Timothy 
G Dinan, John F Cryan 
Published in Harvard Review of Psychiatry, 2020 
DOI: 10.1097/HRP.0000000000000243 
 
Chapter 1.2 largely consists of parts of the following manuscript (in preparation, 
tentative title) 
Dealing with Bugs and Features: A field guide to the statistical analysis of host-
microbiome experiments 
Thomaz F.S. Bastiaanssen, Thomas P. Quinn, Amy Loughman, John F. Cryan 




1.1 Introduction to the Microbiota-Gut-Brain Axis  
1.1.1 Introduction 
When the Dutchman Antonie van Leeuwenhoek peered through his home-made 
microscope in the seventeenth century, he dubbed the kleine diertjens (tiny animals) 
he found there animalcules (Lane, 2015). The discovery that microorganisms are 
residing practically everywhere, including in and on humans, had a profound impact 
on medical knowledge. A short time later, the link between these small, bloodless 
animals and a diarrhea epidemic was suggested by Valk (Valk, 1745). In 1890, Robert 
Koch published his famous postulates in an attempt to formulate criteria that would 
establish whether a given microbe causes a given disease (Koch, 1876). Up until 
recently in medicine, we have regarded microorganisms as undesirable germs to be 
kept at bay. They were thought to range from pathogenic to harmless to humans and 
relevant to almost all areas of medicine.  
Nonetheless, the disciplines of Microbiology and Psychiatry evolved along distinct 
trajectories with only a few notable exceptions. Infamously, the psychiatrist Henry 
Cotton had the teeth of psychiatric patients in his care removed, believing microbes 
on their teeth to be the source of their illness (Anderson et al., 2017). There is also a 
report in the British Journal of Psychiatry in 1910 of the successful treatment of 
melancholia with Lactic acid bacillus in 1910 (Phillips, 1910). An early adopter of the 
idea of microorganisms as beneficial was the 1908 winner of the Nobel Prize in 
Physiology and Medicine, Metchnikoff. He was convinced of the beneficial effects of 
fermented milk for “autointoxication” (a rather broad term encompassing a range of 
negative health outcomes, including fatigue and melancholia; Bested et al., 2013), so 
much so that it has been reported that he drank fermented milk daily. Despite 
Metchnikoff’s early hypotheses regarding the potential health benefits of certain 
bacterial strains, these ideas were largely ignored for the better part of a century.  
However, in the last decade, developments in sequencing technology and 
bioinformatics have allowed in-depth investigations into the composition of complex 
microbial ecosystems as well as the metabolic and metagenomic potential of such 
systems. Ventures like MetaHIT (Qin et al., 2010), the Human Microbiome Project 
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(Methé et al., 2012), the ELDERMET study (Claesson et al., 2012), the Belgian Flemish 
Gut Flora Project (Falony et al., 2016) and The Dutch LifeLines-DEEP (Tigchelaar et al., 
2015) have shed light on the bidirectional relationship between microorganisms and 
their hosts. This marks a pivotal change in our view of microbes. Not only do we now 
view microorganisms as a cause of disease, they are also increasingly seen as a cause 
of health (Bloomfield et al., 2016).  
 
The largest population of microorganisms on the human body resides in the 
gastrointestinal tract. Known as the gut microbiota, this complex ecosystem is 
comprised of microorganisms including bacteria, fungi and archaea from over 60 
genera (Falony et al., 2016). Recent estimates put the total bacterial count on an 
average human at around 3.0 x 10¹³, which is just more than the estimates of human 
cells in the body (Sender et al., 2016). In a 70 kg individual, the human gut microbiota 
would weigh in at an impressive 0.2 kg (Sender et al., 2016). The total genetic 
material of this mass is known as the microbiome. In terms of genes we are more 
than 99% microbial, meaning the vast majority of both genes and DNA found in a 
human originates from microbes (Qin et al., 2010). Perhaps the most surprising 
development to arise from this field has been the realization that the microbiome 
plays a key role in the programming of all major body systems, including the brain 
(Round and Mazmanian, 2009; Diaz Heijtz et al., 2011; Collins et al., 2012; Cryan and 
Dinan, 2012; Foster et al., 2016; Kundu et al., 2017).  
 
1.1.2 The “Healthy” Microbiome 
It is worth reminding ourselves that we are living in a microbial world; microbes were 
here first and there has never been a time when the brain existed without microbes 
(Stilling et al., 2014). It makes sense to consider the human host in the context of its 
environment. While scientific reductionism is a powerful tool, a more holistic systems 
biology approach has enabled us to more accurately understand complex 
interactions (Sugihara et al., 2012). In this spirit, the term holobiont, describing the 
totality of the host and its microorganisms, has gained increasing traction in the field 
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(Bordenstein and Theis, 2015; Theis et al., 2016). By blurring the borders between 
otherwise clearly defined organ systems, the holobiont provides a useful concept for 
understanding the many levels of interaction between the host and its microbiome. 
 
1.1.3 Where it began... 
The composition of the microbiome is not only unique to each individual but is also 
known to differ drastically throughout the host's lifespan. For the most part, 
colonization of the human gut microbiome is thought to begin at birth, although this 
notion has become subject to debate based on recent reports of microbial DNA in 
the placenta and meconium (Stout et al., 2013; Aagaard et al., 2014). While these 
reports remain controversial (Perez-Muñoz et al., 2017), what is clear is that the 
neonate is exposed to the vaginal microbiome of the mother during delivery through 
the birth canal. In contrast, when the newborn is delivered via Caesarean section (C-
section), it is exposed to the skin microbiome rather than the vaginal microbiome 
(Chu et al., 2017). Consequently, the microbiome of children delivered via C-section 
differs significantly from that of children delivered vaginally (Dominguez-Bello et al., 
2010; Dominguez-Bello et al., 2016). Other factors, such as prematurity, 
breastfeeding, the presence of pets, parental smoking, maternal age, weight 
(especially obesity), and race are also known to impact the developing microbiome 
(Borre et al., 2014; Bokulich et al., 2016; Levin et al., 2016).  
1.1.4 The ageing microbiome  
Just as development in early life has been found to parallel gut microbiome 
development, several age-related diseases have been similarly linked to the state of 
the microbiome in both animals (Scott et al., 2017) and humans (Claesson et al., 
2012). In a study in elderly Koreans, administration of Lactobacillus helveticus 
IDCC3801 improved performance in cognitive fatigue tests (Chung et al., 2014). A 
decline in microbial diversity is associated with a concomitant increase in microglial 
activation correlated to brain mass differences in the mouse (Von Bernhardi et al., 
2015). This contributes to an age-associated inflammatory response known as 
“inflammageing”, which in turn has been associated with neurodegenerative 
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diseases such as Alzheimer’s and Parkinson’s disease (Franceschi et al., 2007). During 
ageing, the stability of the microbiome deteriorates (Claesson et al., 2011); however, 
it is worth noting that we still lack an exact characterisation of the ageing gut 
microbiome. Decreasing diversity of the gut microbiota has been linked to ageing 
(Biagi et al., 2010) and age-related impairments like frailty in humans (Claesson et al., 
2012; Jackson et al., 2016). In contrast, aged (24-month old) mice exhibit increased 
microbial diversity compared to younger adult mice (Scott et al., 2017). Intriguingly, 
the aged gut microbiota composition can also contribute to “inflammageing” 
(Thevaranjan et al., 2017), the heightened proinflammatory status and decline in 
adaptive immunity progressively observed in older age (Franceschi et al., 2000). 
Given the high prevalence of MDD in ageing (Charlton et al., 2018; Beutel et al., 
2019), it is tempting to speculate that the microbiome might be at the intersection 
of ageing and mood, however, this hypothesis needs to be further verified in targeted 
and large population-based studies (Prenderville et al., 2015). Interventions targeting 
the microbiome have been found to protect against physiological and neuroimmune 
changes due to ageing (Boehme et al 2019) and behavioural and cognitive effects of 
stress (Burokas et al 2017, O'Mahony et al 2019, Provensi et al 2019).  
 
1.1.5 They are what you eat 
As the infant develops it seems that some of these early factors become less 
influential. For example, the microbiota of infants born by C-section or natural 
delivery converges over time, becoming indistinguishable by six weeks of age (Chu et 
al., 2017; Hill et al., 2017). However, one factor that continues to have a significant 
impact on microbiota composition throughout the lifespan is the diet of the host 
(David et al., 2014; Sandhu et al., 2017). In particular, the research shows a stark 
contrast between the Western diet, with its high sugar, animal fat, and carbohydrate 
content, in comparison to a Mediterranean diet, which is characterized by increased 
variety of foods and higher fiber content. The microbiota profile of individuals with 
these different diets is drastically different (Wu et al., 2011; De Filippis et al., 2016). 
Although previous studies have segregated different mammalian gut microbiomes 
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based on their compositions, known as enterotypes, this concept has been 
challenged and is still in the process of being refined (Costea et al., 2018). While there 
is still debate over the canonical number of enterotypes in humans, there is a general 
consensus that a division can be made between an enterotype enriched at the genus 
level in Prevotella and one enriched in Bacteroides. Strikingly, this difference can be 
related to dietary intake. Specifically, fiber-rich diets are associated with the 
Prevotella enterotype, reflecting the role of Prevotella species in production of 
hydrolases specialized for plant fiber degradation (Purushe et al., 2010). Bacteroides, 
on the other hand, are associated with the Western diet (Costea et al., 2018). Specific 
dietary compounds such as polyphenols, which are known to affect brain chemistry, 
are also known to influence the microbiome (Filosa et al., 2018; Matarazzo et al., 
2018; Donoso et al., 2020).  
 
1.1.6 The microbiota-gut-brain axis  
The gut microbiota is known to interact with the brain indirectly, in a bidirectional 
manner, most likely through a variety of pathways including vagal nerve stimulation, 
interaction with the immune system and microbial production of human 
neurotransmitters (see Figure 1; Cryan and Dinan, 2012; Lyte, 2014; Yano et al., 2015; 
Schirmer et al., 2016; Kennedy et al., 2017). While the precise mechanism of action 
remains unknown, evidence for bidirectional communication between the 




Figure 1.1-1. The microbiota-gut-brain axis Pathways of communication between 
the gut microbiome and the brain, include vagal nerve stimulation, interaction with 
short-chain fatty acids, immunoregulatory elements and tryptophan metabolism. In 
addition, certain microbes are known to produce and secrete human 




Besides regulating brain function, the microbiome has also been shown to regulate 
the physical development of the brain (Dinan and Cryan, 2017). For instance, 
hypermyelination of prefrontal cortex neurons has been observed in the brains of 
germ-free mice (Hoban et al., 2016). Moreover, the dendrites of neurons in the 
amygdala and hippocampus of germ-free mice are morphologically distinct to those 
in control mice (Luczynski et al., 2016). In a recent study, mouse pups born from 
germ-free mothers were either colonized with microbiota from slow or fast growing 
human infants (Lu et al., 2018). Pups with microbiota from fast-growing infants 
showed an accelerated neuronal differentiation when compared to slow-growing 
humanized and germ-free pups. In addition, slow-growing humanized mice were 
found to exhibit more signs of neuroinflammation. Finally, the microbiota-derived 
molecule Pglyrp2, which was determined to cross the blood-brain barrier, has been 
shown to influence the protein expression profile in the germ-free mouse model 
(Arentsen et al., 2017).  
 
Completing the circle, not only does targeting the gut microbiome influence the 
brain, there is research that suggests targeting the brain also influences the gut 
microbiome. There have been several recent studies indicating that certain 
pharmaceuticals, especially psychotropic agents, can shape the microbiome (Davey 
et al., 2012; Davey et al., 2013; Kao et al., 2018; Maier et al., 2018). The best evidence 
for psychotropic effects on the microbiota have been observed with antipsychotic 
drugs (Davey et al., 2012; Davey et al., 2013; Kao et al., 2018). In addition, most 
classes of antidepressants, including the widely-used selective serotonin receptor 
inhibitors (SSRIs), have also been shown to impact the microbiota, exhibiting 
antimicrobial activity in vitro (Munoz-Bellido et al., 2000; Macedo et al., 2017). These 
findings are suggestive of a potential whole microbiota-gut-brain axis effect of 
certain psychotropics, consistent with the effects of stress and psychological state on 
this axis (Cryan and Dinan, 2012; Moloney et al., 2014; Foster et al., 2017). However, 
it is difficult to disentangle whether such effects are mediated by changes in 
signalling from the brain to the gut microbiota or, alternatively, via direct actions of 
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the drugs on the microbiota. Other tools and models such as brain stimulation and 
traumatic brain injury are now being used to establish brain to microbiota influences 
more directly. Brain stimulation research is still very much in the preliminary stages; 
only one conference abstract has been published, which reported that deep 
transcranial magnetic stimulation (dTMS) improves symptoms of obesity by 
modulating gut microbiota (FERRULLI et al., 2018). In a controlled experimental 
model of stroke in mice, changes in the cecal microbiota were observed within 72 
hours after brain damage was induced (Houlden et al., 2016). This work replicates 
clinical findings from a patient population of Chinese stroke victims who exhibited 
altered microbiota composition compared to asymptomatic controls (Yin et al., 
2015). Together, these studies highlight the substantial influence of the brain over 
the microbiota, which we are only just beginning to understand. 
 
1.1.7 Tools to Interrogate the Microbiome 
Over the years, a plethora of different experimental models have been utilized to 
investigate the microbiome and its interactions with the host. Here, some of the most 
common will be discussed. For the most part, mice and rats are used as hosts when 
modelling the microbiome. While both animals have distinct features when 
compared to humans, there are many similarities and advantages, making them the 
preferred models in most studies (Nguyen et al., 2015). However, many other species 
from drosophila (Leitão-Gonçalves et al., 2017) to zebrafish (Borrelli et al., 2016) and 
up to primates (Bailey and Coe, 1999; McKenney et al., 2015; Amaral et al., 2017) 
have also been used to investigate the microbiome. As the field of microbiota-brain 
interactions matures we can expect that more studies will be carried out in healthy 
humans and clinical populations, which will further strengthen the conclusions that 
can be drawn from this line of research.  
 
1.1.7.1 Microbiota depletion: Germ-free animals & antibiotics 
As in all aspects of science and engineering, one of the main ways to confirm the 
importance of a specific process is to remove it and study the consequences. Germ-
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free animals represent our best available model for complete removal of all 
microorganisms. This method has been instrumental in linking the microbiome to 
many key brain processes and behaviors (Diaz Heijtz et al., 2011; Luczynski et al., 
2016; Luczynski et al., 2016). However, given that germ-free animals exhibit such 
dramatically abnormal neurodevelopment, it is difficult to determine the precise role 
of the microbiome in said processes (Al-Asmakh and Zadjali, 2015; Luczynski et al., 
2016). Moreover, this is an extreme model with limited clinical translation. 
 
While on first glance similar to the germ-free model, antibiotics represent an 
alternative distinct model to investigate the microbiome (Lundberg et al., 2016). 
Antibiotics have the advantage that they can be used to knock out/down the 
microbiota for specified timeframes without affecting neurodevelopmental 
programming per se. However, as antibiotic treatments can negatively impact the 
animals’ health, it is sometimes hard to distinguish the side-effects of the antibiotics 
from the microbiome-driven effects (Luczynski et al., 2016). Moreover, many 
antibiotics can cross the blood brain barrier (Nau et al., 2010) and caution is therefore 
required when interpreting studies of antibiotic-induced microbiota depletion.   
 
1.1.7.2 “Friends with benefits”: Prebiotics, probiotics, synbiotics & psychobiotics 
While disruption of the microbiome can have a negative effect on the host, 
supplementing the microbiome has been used as a strategy to optimize host 
performance. Introducing probiotic microbes that are known or suspected to be 
beneficial is an intuitive way to investigate the relationship between the host and the 
microbiome. Here, it is important to note that it is likely not just specific microbes 
that may be beneficial, but the collateral effects of that strain on the microbial 
ecosystem in given niches (Duran-Pinedo and Frias-Lopez, 2015). Although the term 
probiotic has gained substantial public attention and become part of the wider 
vocabulary, it is important to clarify that many commercially available strains 
marketed as probiotics have never been tested in clinical trials and therefore by 




Prebiotics represent a more general way to alter microbiome composition, 
essentially providing nutrients to encourage the growth of beneficial microorganisms 
(Gibson et al., 2017). However, prebiotics are considered less specific than probiotics 
as there is little control over which microorganisms will metabolize the prebiotics and 
which will proliferate. A growing body of work is now focused on combining 
prebiotics and probiotics to develop synbiotics (Ford et al., 2014). Finally, and most 
recently, the term psychobiotics has been introduced to describe targeted 
microbiome interventions with a beneficial effect on mental health, which are of 
particular interest to the study of psychiatric disorders (Dinan et al., 2013; Sarkar et 
al., 2016; Anderson et al., 2017). Overall, these approaches are appealing because 
they can be introduced in food and drink and therefore provide a relatively non-
invasive method of manipulating the microbiota. While these studies show the 
potential of probiotics, negative studies have demonstrated that similar probiotic 
treatments can vary in effectiveness, suggesting that there are more factors at play 
than just the specific probiotic strain used (Hojsak et al., 2015 ; Mazurak et al., 2015). 
This conforms with the understanding that the behavior of a microbial strain is 
dependent on its metabolic, microbial and host environment (Succurro et al., 2018).   
 
1.1.7.3 Fecal microbiota transplantation (FMT) 
The concept of fecal microbiome transplantation (FMT) as a therapeutic intervention 
is disrupting Western medicine completely. The procedure involves introducing fecal 
microbiota from a selected donor to the gastrointestinal tract of the recipient, with 
the aim of making the recipient microbiome more similar to the donor (Borody and 
Khoruts, 2012). When used as a therapeutic intervention, donors must be screened 
to ensure they are healthy, as phenotypes like obesity and depression have been 
shown to be transferable via FMT, at least in rodents (Turnbaugh et al., 2006; Kelly 
et al., 2016). FMT used in a preclinical setting can involve deliberately unhealthy 
donor phenotypes. The realization that patients with recurrent Clostridium difficile 
infection have a good chance to recover after FMT treatment represents an arguably 
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non-invasive and cheap approach to an otherwise difficult to treat disease (Gianotti 
and Moss, 2017). Moreover, the potential of FMT as a clinical and experimental tool 
is reflected in the application of this approach to treat a wide variety of diseases (e.g. 
irritable bowel syndrome, steatohepatitis, ulcerative colitis, and even autism Pinn et 
al., 2015; Ren et al., 2015; Kang et al., 2017; Zhou et al., 2017) and investigations of 
the effects of inter-species FMT from specific clinical populations to experimental 
rodents (Arrieta et al., 2016). Intriguingly, FMT from young donors to middle-aged 
recipients has even been used to extend the lifespan of killifish (Smith et al., 2017). 
 
1.1.7.4 Cross-sectional studies 
One of the most widely used methods to study the microbiome in humans is to assess 
microbiome composition across cohorts of clinical patients and matched controls. 
Thanks to the increasing number of such studies including the microbiome in their 
measurements, there are a large number of databases available for interrogation, 
such as the Human Pan Microbial Communities Database (HPMCD; Forster et al., 
2016) and the NIH Human Microbiome Project (HMP; The N. I. H. H. M. P. Working 
Group et al., 2009). Here, it is important to note that it is often problematic to pool 
measurements from different databases together because the exact techniques used 
for extraction and processing of microbial genetic material account for a large part 
of the variation between samples (Clooney et al., 2016).  
 
1.1.8 Linking the Microbiome to Psychiatric Disorders 
Given the many modes of communication between the brain and the gut 
microbiome, it is not difficult to imagine the impact the gut microbiome has on host 
mental health and illness. Here, we first discuss the role of the gut microbiome in 
stress regulation, as stress is one of the most potent risk factors for psychiatric illness. 
We then briefly discuss the current state of the evidence linking the microbiome to 




1.1.8.1 The microbiome and stress 
There is a robust association between stress, which is associated with activation of 
the hypothalamus-pituitary-adrenal (HPA) axis, and the state of the microbiome (for 
reviews, see Moloney et al., 2014; Gur et al., 2015; de Weerth, 2017; Foster et al., 
2017; Bastiaanssen et al., 2018; Cryan et al., 2019). A number of studies have 
demonstrated that stress alters the composition of the microbiota in a range of 
different hosts, from rats and mice (Gareau et al., 2007; O'Mahony et al., 2011; 
Golubeva et al., 2015; Bharwani et al., 2016; Burokas et al., 2017) to Syrian hamsters 
(Partrick et al., 2018), pigs (Mudd et al., 2017) and non-human primates (Bailey and 
Coe, 1999; Bailey et al., 2011). 
 
In the other direction, the gut microbiome also regulates the stress response. In a 
seminal study, Sudo et al. (2004) elegantly demonstrated that germ-free mice exhibit 
elevated HPA axis responses to stress as measured by adrenocorticotropic hormone 
and corticosterone. The HPA axis response was found to be normalized by 
colonization with a probiotic species but exaggerated by colonization with an 
enteropathogen in the same study. Similarly, probiotics have been shown to reverse 
stress effects in many studies using various animal models (Gareau et al., 2007; 
Desbonnet et al., 2010; Bravo et al., 2011; Ait-Belgnaoui et al., 2012; Barouei et al., 
2012; Liang et al., 2015; Cowan et al., 2016; Bharwani et al., 2017; Callaghan, 2017). 
Promisingly, there is analogous evidence that probiotics promote stress resilience or 
reduce stress-induced physical symptoms and cognitive deficits in humans (Diop et 
al., 2008; Langkamp-Henken et al., 2015; Kato-Kataoka et al., 2016; Allen et al., 2017; 
Wang, 2017; Papalini et al., 2018). Finally, certain prebiotics have also been shown 
to protect against stress-induced effects on the microbiome, physiology and behavior 
(Tarr et al., 2015; Burokas et al., 2017; Provensi et al., 2019). 
1.1.8.2 Major depression 
There is  strong (and continually mounting) evidence that the microbiome plays a 
role in major depression (Foster and McVey Neufeld, 2013; Dash et al., 2015). Germ-
free mice display reduced depressive-like behavior; in the forced swim test of 
behavioral despair, germ-free mice will continue swimming or attempting to escape 
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an inescapable pool for longer than control mice (Zheng et al., 2016), while both 
probiotic and prebiotic treatments have been shown to reduce depressive-like 
behavior in rodent models (Desbonnet et al., 2010; Bravo et al., 2011; Burokas et al., 
2017). These studies seem to hold translational value, with several systematic 
reviews indicating that probiotics effectively improve mood in humans (Huang et al., 
2016; Pirbaglou et al., 2016; Wallace and Milev, 2017). It is worth noting though that 
one such systematic review found that benefits were limited to those with mild to 
moderate depression (i.e. healthy individuals did not significantly benefit; Ng et al., 
2018) which, alongside probiotic strain differences, may explain some of the 
conflicting findings in the attempts to translate probiotic effects to humans (Allen et 
al., 2016; Kelly et al., 2017).  
 
Clinically, several studies have found an altered microbial composition in patients 
with major depression (Naseribafrouei et al., 2014; Jiang et al., 2015; Kelly et al., 
2016; Zheng et al., 2016). Of note, two studies reported a reduction in the relative 
abundance of Faecalibacterium (Jiang et al., 2015; Zheng et al., 2016), mirroring the 
results described earlier for bipolar disorder (Evans et al., 2017). Jiang et al. (2015) 
went further to identify a negative correlation between the severity of depression 
and the prevalence of Faecalibacterium. Another study reported lower levels of 
Bifidobacterium and Lactobacillus in depressed patients (Aizawa et al., 2016). 
Strikingly, when the gut microbiome of depressed humans has been transferred to 
either rats or mice via FMT the recipient animals exhibit greater depressive- and 
anxiety-like behavior compared to those that received FMT from healthy humans 
(Kelly et al., 2016; Zheng et al., 2016). 
 
1.1.8.3 Anxiety disorders 
There is clear preclinical evidence to support a link between anxiety and the 
microbiome (Foster and McVey Neufeld, 2013; Malan-Muller et al., 2018). Germ-free 
mice and zebrafish exhibit reduced anxiety-like behavior (Diaz Heijtz et al., 2011; 
Neufeld et al., 2011; Clarke et al., 2013; Davis et al., 2016), although germ-free rats 
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exhibit more anxiety-like behavior compared to conventionally colonized controls 
(Crumeyrolle-Arias et al., 2014). Anxiety-associated microbiome differences have 
also been observed between strains of mice, with the anxious BALB/c having a 
distinct microbiome profile compared to the more resilient Swiss Webster strain 
(Bercik et al., 2011). Furthermore, FMT from one mouse strain to the other was 
sufficient to partially transfer the respective behavioral phenotypes (i.e., BALB/c mice 
given NIH Swiss microbiota became less anxious, whereas NIH Swiss mice given 
BALB/c microbiota became more so).  
 
Additional preclinical studies have shown that probiotic and prebiotic treatments can 
reduce anxiety-like behaviours in rodents (e.g. Bravo et al., 2011; Burokas et al., 
2017). Unfortunately, very few studies have examined the relationship between 
anxiety and the microbiome in clinical populations. A single, small study of a South 
African population revealed specific phylum-level differences in the microbiome for 
those diagnosed with post-traumatic stress disorder (PTSD) in comparison to trauma-
exposed controls (Hemmings et al., 2017). Aside from this correlational study, there 
have been two small intervention studies showing that probiotics reduce self-
reported anxiety in healthy individuals (Messaoudi et al., 2011) and in a clinical group 
presenting with chronic fatigue syndrome (Rao et al., 2009).  
1.1.8.4 Obsessive-compulsive disorders (OCD)  
While there have been no direct investigations (as of yet) into the microbiome in 
obsessive-compulsive disorder (OCD) patients, several researchers have speculated 
that there may be a link (Rees, 2014; Turna et al., 2016). This hypothesis is based on 
two lines of observation. First, it has been noted that many of the risk factors for 
onset of OCD are also known to disrupt the microbiome, including stress, pregnancy 
and antibiotic use (Rees, 2014). Second, there is preclinical evidence that OCD-like 
behavior in rodents (frequently measured using the marble burying test, which aims 
to assess repetitive, compulsive behaviors, one of the core symptoms of OCD) can be 
modified by microbial treatments, including germ-free environments and probiotic 
treatments (Nishino et al., 2013; Kantak et al., 2014; Savignac et al., 2014). Notably, 
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the deer mouse, or Peromyscus maniculatus, is used as an animal model for OCD. 
The deer mouse is a nest builder. Naturally, a large proportion of deer mice will 
display a behaviour where they build abnormally large nests (Wolmarans et al., 
2016). Indeed, large nest building deer mice have been shown to respond to selective 
serotonin reuptake inhibitors (SSRIs), which are commonly prescribed for OCD. 
Recently, the large nestbuilding phenotype was shown to have a differing 
microbiome composition compared to its normal nestbuilding counterpart 
(Scheepers et al., 2020).  
 
1.1.8.5 Eating disorders 
The gut microbiome has also been linked to diet-induced obesity (Torres-Fuentes et 
al.). Obese individuals exhibit differences in microbiota composition (Ley et al., 2005; 
Turnbaugh et al., 2006; but see also Sze and Schloss, 2016). Importantly, a causal 
contribution of the microbiome to diet-induced weight gain has been demonstrated 
using mice with a humanized microbiome (Turnbaugh et al., 2009). In these mice, 
switching from a plant-based diet to a Western-style diet caused rapid shifts in the 
microbiome composition (within 24 hours) and subsequent weight gain. 
Furthermore, the increased adiposity associated with the Western diet could then be 
transferred to naïve mice via FMT. Offering hope that we might utilize the 
microbiome to enact positive weight changes as well, it has been hypothesized that 
the microbiome may contribute to weight loss following bariatric surgery, based on 
evidence that such surgeries induce microbiome alterations in both humans and 
rodents (Peat et al., 2015; Torres-Fuentes et al., 2017). 
 
In patients suffering from disorders that are associated with altered eating habits, it 
will continue to be difficult to disentangle the direction of microbiome-mental health 
relationships. It is intriguing to consider this problem; is eating behavior 
“manipulated” by an altered microbiome (as has been suggested by some, e.g. Alcock 
et al., 2014), does eating behavior drive microbiome changes and thereby alter gut-
brain communication, or both? When considering this question, it is worth noting 
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that changes in eating habits are not limited to eating disorders but are observed 
across a variety of psychiatric disorders (including anxiety, ADHD, ASD, depression; 
Yannakoulia et al., 2008; Ptacek et al., 2014), while epidemiological studies show that 
healthy dietary patterns are associated with better mental health (O’Neil et al., 
2014). It is therefore an important question that deserves ongoing attention. 
Regardless of the initial cause of these disruptions, the opportunity to utilize dietary 
or other microbiome-targeting interventions to improve mental health holds great 
appeal and scientific potential. 
 
1.1.9 Linking the Microbiome to Neurological Disorders 
1.1.9.1 Alzheimer’s disease (AD) 
In addition to being involved in the general phenomenon of inflammaging, the gut 
microbiome has also been found to be involved in specific age-related illnesses. In 
patients with Alzheimer’s disease (AD), Hill et al. (2014) reported a correlation 
between colonization of certain pathogenic microbes such as Toxoplasma and 
Clamydophila pneumoniae and progression of the disease. Furthermore, patients 
suffering from AD were shown to have a less diverse microbiome with distinct 
compositional differences when compared to the healthy microbiome (Vogt et al., 
2017). In the same study, the researchers theorize about the high prevalence of pro-
inflammatory lipopolysaccharide producing gram-negative bacteria such as 
Bacteroides in AD patients and their role in pathogenesis (Cattaneo et al., 2017). In a 
large Chinese cohort, patients with mild cognitive decline had a distinct microbiome 
from patients suffering from AD (Liu et al., 2019). Promisingly, a modified ketogenic 
diet targeting the microbiome has been shown to ameliorate some of the mild 
cognitive decline effect of AD (Nagpal et al., 2019). Finally, germ free or antibiotic-
treated transgenic AD mouse models fail to develop plaques (Harach et al., 2017; 




1.1.9.2 Parkinson’s disease (PD) 
There is a growing emphasis on the role of the gut-brain axis in the onset of 
Parkinson’s disease (PD; Dinan and Cryan, 2017; Perez-Pardo et al., 2017; Elfil et al., 
2020). A number of studies have shown alterations in the microbiome in PD 
(Scheperjans et al., 2014; Keshavarzian et al., 2015; Heintz-Buschart et al., 2018; Qian 
et al., 2018; Sun et al., 2018). When mice were colonized with the microbiota of PD 
patients via FMT, they developed motor deficits and neuroinflammation, two 
hallmark symptoms of PD (Sampson et al., 2016). Additionally, symptoms improved 
when the mice were treated with antibiotics. In rats, overexpression of alpha-
synuclein cooccurred with alterations in the gut microbiome (O’Donovan et al., 
2020). Large-scale investigations using the extensive patient records in Denmark and 
Sweden have shown that vagotomy (or more specifically truncal vagotomy), which 
removes one of the major routes for microbiota to brain communication, is 










With the advent of high-throughput sequencing, the gut microbiome has become a 
popular subject of investigation. As part of these investigative efforts, it has become 
increasingly clear that the microbiome is in constant bidirectional communication 
with the host, and that both systems influence each other on multiple levels. For 
instance, the human gut microbiome has been shown to differ between individuals 
on the basis of dietary factors, physical health, age, medications, and even 
psychological health (Consortium, 2012; Cryan et al., 2019; Vujkovic-Cvijin et al., 
2020). Analysing and interpreting microbiome experiments can be challenging for 
various reasons. Some factors include the vast range of scientific fields relevant to 
the microbiome--each with their own unique research culture and norms--and the 
sheer number of specialist software tools needed to pre-process and analyse the 
associated data. In this section, we present an overview of the various methods used 
to analyse, interpret, and visualise microbiome studies. Figure 1.2-1 shows a 




     
 
Figure 1.2-1. From Stool to Story. Overview of what a typical gut microbiome 
analysis may look like. A) Shows the pre-digital part of the pipeline. Genetic material 
is isolated and digitized, either using the 16S or shotgun sequencing approach. In B) 
the digitized reads are annotated and based on taxonomy and/or function. In C), the 
features are tallied up into count tables. In D), mesoscale patterns, or patterns within 
the data that are larger than features but smaller than the whole such as functional 
modules, are identified. In E) features of the microbiome are assessed statistically. 





1.2.2 16S amplicon vs. shotgun sequencing 
Generally speaking, two methods of microbiome sequencing are widely used: (1) 16S 
or amplicon sequencing, which includes methods where an evolutionarily preserved 
genomic sequence is targeted and sequenced, and (2) whole genome shotgun 
sequencing, where all genetic material in a sample is targeted and sequenced.  
1.2.2.1 Pre-processing 16S sequencing data 
The analysis of 16S sequencing typically begins by trimming reads, filtering them for 
quality based on a threshold, and removing chimera sequences. Then, a table of 
either operational taxonomic units (OTUs) or amplicon sequence variants (ASVs) is 
generated. The philosophy and process behind these two units differ meaningfully, 
and this has been comprehensively written about elsewhere (Callahan et al., 2016). 
For all but the most theoretical purposes, both OTUs and ASVs can be seen as the 
highest taxonomic resolution that a specific method can distinguish. Roughly 
speaking, they can be viewed as analogous to species or genera. Although OTUs and 
ASVs are technically distinct, the two are interchangeable concepts when it comes to 
downstream statistical analysis. 
After generating a table of OTUs or ASVs, the next step is to assign taxonomy. In most 
cases, this is done by use of a reference database. Several such databases exist, and 
some are better curated than others. At time of writing, the SILVA database is widely 
regarded as the most accurate and extensive (Quast et al., 2012). Although the 
Greengenes database is still often used, it has not been updated since 2013.  
 
1.2.2.2 Pre-processing shotgun sequencing data 
In the case of shotgun sequencing, it is also common to filter and trim reads in a 
fashion analogous to 16S data. Apart from this, non-microbial genetic material needs 
to be filtered out. This is often done by removing all reads that map to a reference 
genome of the host organism, as well as any other genomes that may be 
contaminants (e.g., plant genetic material from diet).  
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1.2.2.3 The count table 
Although 16S/amplicon and shotgun sequencing differ widely in execution, the type 
of data that is obtained tends to converge downstream in the analysis. After pre-
processing, both 16S and shotgun sequencing methodologies yield a count table. A 
count table shows how many observations (i.e., counts) there were for each feature 
(e.g., microbe, function, gene, etc.) per sample. By convention, a count table will have 
features as columns and samples as rows. Although many software tools assume this 
organisation, there are notable exceptions, so it is always worth checking the 
software before proceeding with an analysis. It is tempting to directly correspond a 
count to a biological instance of a feature in a sample, but due to biases inherent to 
metagenomic sequencing (McLaren et al., 2019), raw counts should not be used with 
initial pre-processing (e.g., normalization). The remainder of this guide assumes the 
use of a count table, though some of the methods presented -- notably, log-ratio 
transformation-based methods -- will perform identically for counts and proportions. 
 
1.2.2.4 Rare features and Rarefaction 
Before the microbiome analysis starts, it is common to filter out rare features. 
Commonly, features that are only detected in a certain percentage of samples are 
removed. This is referred to as prevalence filtering. Similarly, features that are only 
detected in low levels can be dropped here. This is referred to as abundance filtering. 
In rare cases, features can be filtered out based on other metrics, such as variance 
(Guyon and Elisseeff, 2003). Importantly, features should not be filtered based on 
their association with a phenotype, as this could bias the p-value estimates of 
downstream statistical tests. 
The total number of observations recorded for each sample in a count table depends 
on the sequencing depth of the assay. Rarefaction is the practice of randomly 
removing observations from a sample until all samples have the same number of 
observations. However, it has been described as an unnecessary and potentially 
counterproductive measure (McMurdie and Holmes, 2014). It is more conventional 
now to address inter-sample differences in sequencing depth through effective 
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library size normalization or log-ratio transformation (Gloor et al., 2017). One notable 
exception is alpha diversity analysis, as discussed below. 
 
1.2.3 Linking the microbiome to host features 
1.2.3.1 Diversity indices 
The microbiome is a complex ecosystem. The analysis and visualisation of the 
microbiome can be qualitatively distinct from other high-throughput sequencing 
data. Although the data arise from a molecular biology assay, several of the statistical 
approaches used in microbiome analysis originate from other fields, such as ecology. 
This makes microbiome science a clear beneficiary of interdisciplinary research. 
Diversity, as popularized in ecology, is a way to quantify and understand variation in 
microbiome samples. Classically, diversity is separated into three related types: 
Alpha, Beta, and Gamma diversity (Hsieh et al., 2016). Alpha diversity refers to the 
degree of variation within a sample. Beta diversity refers to the degree of variation 
between samples. Gamma diversity refers to the total diversity in all samples (which 
can be thought of as the Alpha diversity of all samples combined). In practice, Gamma 
diversity is rarely used.  
1.2.3.2 Alpha diversity – the diversity within samples 
There are many measures of alpha diversity, which can make alpha diversity 
confusing to understand. It is helpful to classify alpha diversity measures along two 
axes: the Hill number (0, 1, or 2) and whether it is phylogenetic (yes or no).  
Regarding the first axis, alpha diversity measures can be understood as being the 
result of a unifying equation in which a single parameter--called the Hill number--acts 
to vary the meaning for the equation, and thus define the alpha diversity measures.  
Every number gives a different alpha diversity metric. In practice, three Hill numbers 
are most often used: 0, 1 and 2. The number 0 defines Richness, or how many 
different features a sample has. The number 1 defines Evenness, or how equally the 
features in a sample are represented (equivalent to Shannon entropy). The number 
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2 defines Simpson’s Index, or the probability that two features picked at random do 
not have the same name (as a probability it is bounded by 0 and 1).  
Regarding the second axis, other phylogenetic diversity (PD) measures, like Faith’s 
PD, extend alpha diversity by taking into account the coverage of all features (e.g., 
bacteria) on a phylogenetic tree. Typically, the more of the tree that is represented 
in a sample, the higher the diversity. Figure 1.2-2  illustrates a classification of several 
popular alpha diversity measures. 
 
     
 
Figure 1.2-2. Alpha Diversity metrics are related to each other. Commonly used 
alpha diversity metrics in the microbiome field can be mapped on two axes. Here, we 
show the hill number used on the x-axis and whether the index considers phylogeny 
on the y-axis.  
 
1.2.3.3 Statistical considerations with Alpha diversity 
Alpha diversity is used to summarize the entire microbiome composition as a single 
number (Hsieh et al., 2016; Hsieh and Chao, 2017). It is common to model alpha 
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diversity as a dependent variable, using sample meta-data as the predictors. When 
this is done, the literature has shown that a lower Alpha diversity is often associated 
with  worse host health outcomes (Ma, 2020). However, it should by no means be 
taken as principle that a higher Alpha diversity is strictly “better”, as there are many 
examples where elevated Alpha diversity indicates an abnormal or even unhealthy 
host state. For instance, in infants there is a high selection pressure on certain 
microbes, such as numerous species in the genera Bifidobacterium and Lactobacillus 
(Yang et al., 2019). Here, an increased Alpha diversity could indicate a lowered 
selection pressure, which could be indicative of health issues (Hill et al., 2017).  
There are at least 3 issues to consider when using alpha diversity for microbiome data 
analysis. First, all alpha diversity measures are sensitive to transcript-level 
measurement biases such as PCR bias (McLaren et al., 2019). This is recognized as a 
critical limitation of alpha diversity that cannot be resolved unless the PCR bias 
factors are already known a priori (McLaren et al., 2019). Second, some alpha 
diversity measures will change depending on the total number of observations (i.e., 
counts) recorded for a sample. It is often appropriate to “normalize” away 
differences in sequencing depth before comparing alpha diversity between samples. 
This can be done by dividing out total counts to get proportions (e.g., in the case of 
Shannon entropy), or by performing rarefaction (no longer recommended, as 
discussed above). Both procedures will equalise the number of observations 
between samples, so that they can be compared fairly. In fact, many alpha diversity 
software tools will perform this “normalization” step automatically. Third, all alpha 
diversity measures are sensitive to the number of rare taxa that get observed in 
samples, and thus are sensitive to sequencing depth. Failure to record the presence 
of a rare taxa, when it is in fact present, can make a sample appear less diverse than 
it is. 
 
It is important to keep in mind these 3 issues when interpreting the results from an 
alpha diversity analysis. For example, in the case of very low microbial load due to, 
say, an antibiotics course, alpha diversity may appear higher than expected (Elokil et 
al., 2020). This seemingly paradoxical phenomenon can be better understood when 
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considering that there is a limited amount of sequencing material during the 
sequencing process, regardless of method used. In the case of an abundance of 
microbes, the most prevalent ones will use up most of the sequencing reagents, 
leaving little for the rarer taxa to be sequenced. In the case of a low bacterial load, 
there are no prevalent microbes to take up most of the material and thus the rarer 
taxa that happen to be in the sample will have a much higher likelihood to be 
sequenced, thus inflating the calculated diversity.  
1.2.3.4 Beta diversity – the diversity between samples 
Beta diversity refers to the degree of difference between two microbiomes (Goodrich 
et al., 2014; Bastiaanssen et al., 2021). It is worth appreciating the assumptions and 
limitations that come with describing the total difference between two complex 
ecosystems as a single number. There are many ways to measure the “difference” 
between two samples, and each one imparts a unique perspective on the data. In 
principle, one could use any dissimilarity or distance measure. Three common 
difference measures are: 
1.2.3.4.1 Jaccard’s Index 
This is a similarity measure that simply describes the proportion of all features that 
are shared between two samples, without taking abundance into account. As such, 
one could interpret Jaccard’s Index as the fraction of unique taxa (not abundances) 
shared by two samples. If two samples have exactly the same microbe taxa, the 
Jaccard index will be 1. In the case that two samples share no microbe taxa, the 
Jaccard index will be 0. Subtracting Jaccard’s index from 1 makes it the Jaccard 
Distance measure.  
1.2.3.4.2 Euclidean Distance  
This is the geometric distance derived by applying the Pythagorean theorem, using 
every microbe as a separate dimension. It is computed by taking (the square root of) 
the sum of the squared differences in bacteria abundance. As in geometry, the 
minimum Euclidean distance is 0 while the maximum is unbounded.  Euclidean 
Distance satisfies the triangle inequality, making it useful for certain geometric 
analyses, such as volatility analysis as discussed below. A related measure called 
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Aitchison Distance is the Euclidean distance between log-ratio transformed data. This 
distance has a favorable property known as sub-compositional dominance (i.e., the 
removal of a taxa feature will never make two samples appear further apart), and is 
also equivalent to taking the Euclidean distance between all pairwise log-ratios 
(Aitchison et al., 2000). 
1.2.3.4.3 Bray-Curtis Dissimilarity 
This dissimilarity measure is similar to Jaccard’s Index in that it ranges from 0-to-1, 
while also being similar to Euclidean distance in that it is computed from the 
differences between abundances. Bray-Curtis is calculated by summing the 
difference in abundance between each bacteria taxa, and dividing it by the total 
microbial abundance of the two samples. Thus, one could interpret Bray-Curtis as the 
fraction of abundances (not unique taxa) unshared by two samples. 
The three common difference measures listed above make use of bacteria presence 
or abundance without considering the phylogenetic relationship between the 
bacteria. Just as we can make alpha diversity phylogenetic, we can do the same with 
beta diversity.  
1.2.3.4.4 UniFrac  
This distance makes use of phylogenetic information to measure the difference 
between samples. There are (at least) two types. The Unweighted UniFrac Distance 
considers the branch lengths of the phylogenetic tree along with bacteria presence, 
and is defined as the sum of branch lengths unshared between the samples divided 
by the sum of branch lengths present in either sample. This measure has some 
analogy to Jaccard Distance in that an unweighted UniFrac distance of 1 means the 
two samples share no bacteria taxa in common. The Weighted UniFrac Distance 
further considers bacteria abundance, and weighs each branch length in the 
Unweighted UniFrac formula by per-sample proportional abundances. 
1.2.3.4.5 PhILR 
This method uses a log-ratio transformation called the isometric log-ratio (ILR) 
transformation which uses a phylogenetic tree to recast the microbiome variables as 
a series of log-contrasts called “balances” (Silverman et al., 2017). PhILR offers 2 
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weighting options called taxon weighting and branch weighting. When both are 
disabled, the PhILR beta diversity is equivalent to Aitchison distance, although its use 
of phylogeny-based coordinates may yield a more interpretable ordination of the 
data (for example, via a principal coordinates plot). The taxon weighting provides a 
compositionally robust alternative to weighted Jaccard or Bray-Curtis measures, 
while the branch weighting provides a compositionally robust alternative to UniFrac 
measures. 
Figure 1.2-3 illustrates a decision tree that we the authors use when selecting a beta 
diversity measure. As with alpha diversity, it is sometimes helpful to compare and 
contrast the results from multiple measures of beta diversity. 
 
 
Figure 1.2-3. Decision tree featuring common Beta diversity indices. Different Beta 
diversity indices are more suitable depending on the needs of the researcher. This 
decision tree recommends an index based on three common criteria: The need to 
consider abundance, phylogeny and whether it needs to be a true distance metric (i.e. 




1.2.3.5 Statistical considerations with Beta diversity 
There are two general strategies used to assess beta diversity: 
(1) Qualitative – visualization of samples plotted across an ordination of the data, 
such as a principal components analysis (PCA) or principal coordinates analysis 
(PCoA) 
(2) Quantitative – explicit modelling of PCA/PcoA axes as a dependent variable, using 
the sample meta-data as the predictors, or some other formal comparison between 
the group centroids 
When discussing Beta diversity, it is important to consider that microbiome data are 
compositional. This is because some common difference measures can have an 
irregular behavior when applied to compositional data (most notably, Euclidean 
distances). Fortunately, the study of compositional data has allowed for the 
development of tools and transformations that enable us to work with compositional 
data in virtually the same manner as regular data. In the case of Beta diversity, the 
alternative to Euclidean distance is Aitchison distance (Aitchison et al., 2000). One 
clear advantage of Aitchison distance, which applies to the unweighted PhILR 
distance too, is that -- unlike alpha diversity and other beta diversities -- it is 
unaffected by PCR bias (McLaren et al., 2019). 
We note here that there is an interesting parallel between compositional data and 
the probability vectors routinely studied in information theory. Similar to how 
Shannon entropy can be used to measure alpha diversity, other informatic metrics 
like Kullback-Leibler divergence could feasibly be used to measure beta diversity (Erb 
and Ay, 2020). Although these metrics are not commonplace in microbiome analysis, 
they are often used in machine learning, and may be more robust for the analysis of 
amalgamated data, for example genus-level or family-level counts (Quinn and Erb, 
2020).  
1.2.3.6 Volatility 
The microbiome is a dynamic ecosystem and undergoes constant change. The degree 
of change in the microbiome over time is called volatility, which is inversely related 
to stability. It can be helpful to think of volatility as a change in sample diversity (alpha 
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or beta) over time. In a neutral setting, without intervention, a higher volatility is 
generally considered to be associated with negative health outcomes (Bastiaanssen 
et al., 2021). The term was first coined in the context of the microbiome in a study 
noting that the microbiome of patients with inflammatory bowel disease tend to 
change more over time than those of healthy controls (Halfvarson et al., 2017). One 
way to calculate volatility is to measure the beta diversity between two or more time 
points corresponding to the same host. When measuring volatility in this fashion, it 
is especially useful to choose a beta diversity metric that is also a distance (i.e., 
follows triangle inequality, like PhiLR or Aitchison distance).   
 
1.2.3.7 Differential feature abundance 
1.2.3.7.1 Taxa and Genes 
Differential abundance (DA) analysis is perhaps one of the most popular microbiome 
analyses. Like alpha and beta diversities, there are many approaches to measuring 
DA. Most methods follow the same general pattern: (a) applying a normalization to 
correct for variation in sequencing depth; (b) performing a univariate statistical test 
for each taxa as a dependent variable with the sample meta-data as predictors; and 
(c) adjusting the p-values for multiple testing, for example using Bonferroni, Storey’s 
q-value or Benjamini-Hochberg. 
1.2.3.7.2  Functions 
Another line of investigation that starts at this point is functional inference. There 
are two general strategies to measuring whether the functions of the measured taxa 
(or genes) associate with the sample meta-data. Both approaches require some 
external database that assigns functions to the taxa (or genes), which we will term a 
functional database.  
(1) Primary analysis: In this approach, the functional database is used to score each 
function based on the taxa or gene abundances. This produces a functional count 
table, which is simply a count table tallying the occurrence of functions rather than 
taxa or any other feature. Then, one could proceed with a routine statistical analysis 
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that uses the functional scores as a dependent variable, as one would for a microbial 
count table.  
(2) Secondary analysis: In this approach, a DA analysis is first performed on the taxa 
or genes, and then the functional database is used to summarize the DA results. In 
the simplest case, the DA results can be dichotomized into significant or non-
significant, and functional status can be dichotomized as present or absent. For each 
function, one could perform a Fisher exact test (or similar) to measure whether that 
function is over-enriched among the significant taxa or genes (Irizarry et al., 2009). 
Gene set enrichment analysis (GSEA) is a popular generalization of this concept, and 
is commonplace in gene expression analysis (Irizarry et al., 2009; Chong et al., 2018). 
The way in which one gets to the functional count table depends on the type of 
sequencing. In the case of 16S, Piphillin and PICRUSt2 are available. Both of these 
tools infer what the metagenome of a sample might look like by comparing all input 
16S sequences to a functional database (currently KEGG and MetaCyc) of fully 
sequenced microbial genomes and building a functional count table based on the 
functions present in these reference genomes. While these methods remain 
inferential, they do provide a reasonably accurate view of the functional potential of 
a microbiome. In the case of shotgun sequencing we still infer function, but since we 
do so from evidence from the genetic sequences in our sample, we only need to 
identify genes and annotate them, often by using a database. Tools like HUMAnN2 
in the biobakery suite are typically used to generate a functional count table for 
shotgun data. 16S functional inference can be thought of as a bigger inferential leap 
than with shotgun, as with 16S we guess the entire genomic content and thus 
function based on a single sequence rather than directly inferring function from the 
detected genes as is the case in shotgun sequencing.  In both cases, a functional 
analysis is limited by the validity and completeness of the functional database used 
to assign functional importance to the taxa or genes. The number of functional 
databases is currently quite limited, with KEGG, UniRef90 and MetaCyc being among 
the most common. Like taxonomic databases, functional databases are updated 
frequently and results may be affected as a consequence. In general, the functional 
microbiome is known to be more consistent between hosts than the taxonomic 
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microbiome, making it a method to reduce inter-subject variance worth 
consideration (Mehta et al., 2018).  
1.2.4 Exploring the mesoscale 
1.2.4.1 Mesoscale features 
Mesoscale features of the microbiome are features that do not necessarily contain 
information about its smallest parts, the microscale, like microbial taxa, nor about 
the whole system, the macroscale, like alpha diversity, but rather contain 
information about patterns within parts of a microbiome that can be seen across 
samples. Mesoscale analysis focuses on identifying community-level patterns that 
define the ecosystem(s) under study. The mesoscale is an important object of study 
in theoretical ecology (Hogeweg, 2010). Here, some of the more common types of 
mesoscale features will be discussed.  
1.2.4.1.1 Ecological Guilds 
Ecological guilds are taxonomically unrelated but functionally related clusters of 
microbes that fulfil a certain function in the microbiome (e.g., occupy a common 
niche). For example, microbial communities across a wide span of environments 
including soil, the ocean, and the human gut can be modelled as being organised in 
trophic groups that feed on one set of substrates and subsequently pass on 
metabolites to another trophic group. While ecological guilds are a promising 
concept in microbiome science, to our knowledge there are currently no 
standardized pipelines or databases that can be used to detect and compare 
ecological guilds across cohorts and experiments. Such tools would be welcome 
additions to the field (Lam et al., 2018; Zhao et al., 2018).  
1.2.4.1.2 Functional Modules  
Functional modules are a list of curated metabolic pathways encoding for processes 
that are related to a specific aspect of the microbiome. As of now, there exist two 
classes of functional modules. Gut-Brain modules cover pathways that are related to 
gut-brain communication, such as serotonin degradation or histamine production. 
The complete list of Gut-Brain Modules can be accessed as a table in the 
supplementary files of the paper that introduced them (Valles-Colomer et al., 2019) 
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as well as online (http://raeslab.org/software/gbms.html). Gut-Metabolic Modules 
cover metabolic processes in the microbiome. Changes in Gut-Metabolic Modules 
can indicate a shift in the microbial metabolic environment and thereby in the fitness 
landscape, thus allowing for microbes with different metabolic features to thrive. The 
complete list of Gut-Metabolic Modules can be accessed as a table in the 
supplementary files of the paper that introduced them (Vieira-Silva et al., 2016) as 
well as on GitHub (https://github.com/raeslab/GMMs). Functional modules are 
especially useful because they can be very easy to interpret and sometimes allow for 
clear hypothesis development for future experiments.  
1.2.5 A word on compositional data 
It may seem tempting to directly treat count data, such as from the microbiome, as 
one would normally treat other types of measurements, perhaps converting the 
count data to percentages or even performing a logarithm, or square root 
transformation to normalize the data. Indeed, up until recently most microbiome 
studies were conducted in this manner. In the past few years, more and higher 
impact microbiome studies employing compositional data analysis (CoDa) have been 
published, indicating that this approach is gaining traction (Johnson et al., 2019; 
Valles-Colomer et al., 2019; Martino et al., 2020).  
Microbiome datasets are compositional, which comes with a set of properties that, 
if ignored, will lead to an underpowered analysis and numerous spurious results. 
There are excellent reviews on CoDa in general and how it relates to the microbiome 
in particular that we encourage our audience to read (Aitchison, 1982; Gloor et al., 
2017).   
 
1.2.5.1 A straightforward and solid approach to account for compositionality in 
microbiome data 
In this guidebook, we will recommend performing a centered log-ratio (CLR) 
transformation on the count data before performing any plotting or statistical 
analysis like normal, with three exceptions. First, alpha diversity should not be done 
on transformed data. Second, stacked bar plots should rather be generated using 
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counts normalized to 1 or to percentages. Third, correlating taxa or other features to 
each other, for example with the intent of performing a network analysis, warrants 
more attention and will be covered in its own paragraph.  
Because microbiome count data is typically zero-inflated and, as the name implies, a 
centered log-ratio transformation involves taking a logarithm and, as is well-known, 
the logarithm of zero is undefined, the zeroes in microbiome count data must first 
be dealt with. Several good solutions have been proposed and in practice the exact 
method chosen from these solutions is of little consequence. In the chapters found 
in this thesis, I employ an approach derived from the ALDEx2 framework (Fernandes 
et al., 2013). In short, we take the median of the CLR-transformed Monte Carlo 
samples of the Dirichlet distribution for each sample as an estimate for what the 
theoretical CLR-transformed values would be. After the CLR-transformation, the 
values of features will have a domain of ℝ, rather than count data, which cannot be 
negative. From this point onwards, classical statistical approaches can be applied as 
normal.  
 
1.2.5.2 Compositions and correlations between microbiome features 
One of the properties of compositional data is that features are innately negatively 
correlated, rendering popular methods to assess correlations, like Pearson’s r, 
Spearman’s ρ or even Kendall’s τ unreliable. Indeed, Karl Pearson warned against 
applying his namesake Pearson’s correlation coefficient on compositional data 
(Pearson, 1897). Effective and compositionally appropriate alternatives exist. Here, 
we recommend the ϕ and ρ metrics found in the propr library in R (Quinn et al., 
2017). In a nutshell, these metrics assess proportionality; if the ratio between two 
features remains constant through many observations, this is an indication that the 





1.3 Specific Aims and Hypotheses 
1.3.1 General aim 
In this thesis I set out to investigate what features in the microbiome are most 
informative in regard to gut-brain communication. Given the highly complex nature 
of the microbiome and the quite specific ways in which we can practically measure 
the microbiome (i.e. mostly metagenomics and sometimes metabolomics), finding 
helpful and informative features that to measure is crucial when conducting a 
microbiome study. There is a consensus that diversity and differential taxon 
abundance should be considered, but other than this, there are few concrete 
guidelines to follow. In order to find and apply informative metrics, we set out to 
investigate the interplay between the microbiome and brain and behaviour in 
different settings.  
 
1.3.2 Sub-aims 
The figure below shows the aspects of the microbiome-gut-brain axis that we set out 
to investigate to identify our metrics of interest.  
1.3.2.1 Neurobehavioural phenotype 
Defining experimental groups based on neurobehavioural differences is a classic 
approach in the microbiome-gut-brain axis field. In chapter 5.1, we investigate the 
differences in microbiome composition between deer mice that build large nest and 
those that build normal nests. A proportion of deer mice will naturally exhibit large 
nest building behaviour and they are used as an animal model for OCD. Indeed, large 
nest building deer mice have been shown to respond to SSRIs, which are commonly 
prescribed for OCD.  
1.3.2.2 Stress 
It is well known that stress affects the microbiome, though the specific taxa that are 
altered by stress seem to differ between studies. Stress and the microbiome 
represent a major aspect of this thesis and their interplay is investigated in chapters 
36 
 
3.1, 3.2 and most notably in 5.1, which focuses on the effects of chronic stress on the 
microbiome in both mice and humans.  
1.3.2.3 Critical windows 
When Paracelsus famously claimed that dosis sola facit venenum (only the dose 
makes the poison), he unfortunately missed that timing is also important. It is evident 
that timing is crucial when it comes to the microbiome. Microbiome perturbations 
during colonization at early life are known to have consequences for the host later in 
life. In chapters 3.3, 3.5, 4.2 and 4.4, we study animal models of the microbiome 
undergoing early life adverse events and perturbations. In a category on its own, we 
studied the feasibility of targeting the microbiome during adolescence to cushion the 
symptoms of ageing in chapter 3.1. 
1.3.2.4 Diet 
Diet is known to be one of the major factors shaping the microbiome. It is also known 
to play a role in modulating brain and behaviour. In all subchapters of chapter 3, we 
investigate the effects of diet on the microbiome in animal models. Furthermore, 
chapter 7.3 features an observational study where we follow 24 human participants 
during a 12 week course where they all eat from the same diet rich in unpasteurized 
diary.  
1.3.2.5 Perturbation 
Perturbation of the microbiome is a broad term, but it captures an important aspect 
of my fascination with the microbiome. Here, perturbation is used to indicate 
alterations in the microbiome due to factors that are generally thought of as harmful, 
such as antibiotics or even host stress. In all subchapters of chapter 4 we investigate 
the dynamics of perturbation, robustness and recovery. Furthermore, we zoom in on 
the volatile nature of the microbiome in rest and during stress in chapter 6.1, on 
volatility.   
1.3.2.6 Psychobiotic Intervention 
A psychobiotic intervention will on first glance mean the administration of pre- or 
probiotics. However, in can be interpreted as any treatment that targets the 
microbiome composition with the goal to positively influence host mental health and 
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cognition. As such, I invite the reader to also think of FMT and certain dietary 
interventions as psychobiotic. Psychobiotic interventions are the most common 
theme in this thesis, but they can be found in particular in chapter 4.1 and 4.3, which 




Figure 1.3-1 summarising the aspects of the microbiota-gut-brain axis that have been 




1.4 Summary of the Presented Papers and 
Manuscripts by subchapter 
Here, I will give a heavily abridged summary of every manuscript presented in this 
thesis, as to help remind the reader what the general subject and findings of a given 
manuscript were. For the published work, I will also provide the DOI on the title page 
of the subchapter. Supplementary figures and some tables have been omitted from 
this thesis and are all available online.  
 
Chapter 2 Targeting the Microbiome-Gut-Brain Axis with Diet 
2.1 Mid-Life Microbiota Crises: Middle Age is Associated with Pervasive 
Neuroimmune Alterations that are Reversed by Targeting the Gut Microbiome  
Ageing comes with a host of physiological and behavioural changes including 
cognitive decline. FOS-Inulin supplementation counteracted the neuroinflammatroy 
phenotype normally found in middle-aged mice after stress. Notable, both ageing 
and prebiotics supplementation showed their own signature in the microbiome. 
2.2 Preventing adolescent stress-induced cognitive and microbiome changes 
by diet  
Stress impacts the host in many ways, including behaviour and the microbiome. By 
supplementing rats with a diet rich in omega-3 fatty acids and vitamin A, these 
changes in both the microbiome and in behaviour were decreased. Notably, the 
effect of the enriched diet remained visible in adulthood.  
2.3 Polyphenols selectively reverse early-life stress-induced behavioural, 
neurochemical and microbiota changes in the rat  
Early life stress is known to promote anxiety and depressive-like behaviour later in 
life. Polyphenol supplementation rescued these early life stress effects and changed 
the microbiome, including its functional potential.  
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2.4 Prebiotic administration modulates gut microbiota and faecal short-chain 
fatty acid concentrations but does not prevent chronic intermittent hypoxia-
induced apnoea and hypertension in adult rats  
Hypoxia can promote cardiorespiratory morbidity and also affects the microbiome. 
Prebiotic (FOS/GOS) supplementation did not rescue cardiorespiratory effects of 
hypoxia, but affected the microbiome strongly, both in terms of taxonomy as in 
function.  
2.5 Adolescent Dietary Manipulations Differentially Affect Gut Microbiota 
Composition and Amygdala Neuroimmune Gene Expression in Male Mice in 
Adulthood  
Poor diets such as high fat or even cafeteria diet in adolescence affect the host during 
adulthood in many ways, including in terms of neuroimmunity. In adult mice, the 
effects of these diets are still visible in the microbiome, both in terms of differential 
taxa abundance as in beta diversity.  
 
Chapter 3 Targeting the Microbiome with Perturbations and 
Psychobiotics 
3.1 Microbiota from Young Mice Selectively Counteracts the Effects of Aging 
Across the Microbiome-Gut-Immune-Brain Axis 
In addition to impacting host physiology, immune system brain and behaviour, 
ageing impacts the host microbiome in specific manners. We show that Faecal 
Microbiota Transplantation (FMT) from young to aged mice counteracts some, but 
not all, of these age-induced changes.  
3.2 Enduring neurobehavioral effects induced by microbiota depletion during 
the adolescent period 
Antibiotics perturbation of the microbiome during adolescence can have long lasting 
consequences with regards to brain and behaviour. While the effects of antibiotics 
were no longer detectable in the microbiome in adulthood, a behavioural phenotype 
persists. This suggests some sort of critical window where adolescent mice are 
susceptible to antibiotics perturbation.  
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3.3 Strategies for effective gut microbiota recovery after chronic broad-
spectrum antibiotic administration in adult male rats. 
The way in which the microbiome restores itself after antibiotics depletion remains 
unclear. Strikingly, the genus Blautia was only able to colonize after ABX perturbation 
followed by prebiotics supplementation, but not after just ABX or just prebiotics 
alone. This colonization of Blautia was linked back to changes in functional capacity.  
3.4 Enduring behavioral effects induced by birth by caesarean section in the 
mouse 
C-section alters the starting state of the microbiome, as the offspring is never in 
contact with the birth canal, where microbiome colonisation is thought to typically 
take place. In early life, the microbiome of mice delivered by c-section is clearly 
different from that of naturally born animals. In adulthood, these changes can no 
longer be detected in the microbiome, but a signature remains in brain gene 
expression and in behaviour.  
Chapter 4 
4.1 Natural compulsive-like behaviour in the deer mouse (Peromyscus 
maniculatus bairdii) is associated with altered gut microbiota composition 
The deer mouse builds nests. Naturally, a proportion of deer mice builds much larger 
nests than the rest. The deer mouse is used as a model organism for OCD. We find 
that microbiome composition, but not any specific microbial genera, is associated 
with nest builder status. This in turn has implications for OCD being partially 
modulated by the microbiome.  
Chapter 5 
5.1 Volatility as a Concept to Understand the Impact of Stress on the 
Microbiome 
We find that degree of change in the microbiome after a stressor is correlated with 
severity of the stress response, both in mice and in students undergoing academic 
stress. Furthermore, we find that, while which genera are altered due to stress is 
dependent on the cohort, functional changes are consistent between cohorts and 





Chapter 6 Human Microbiome-Gut-Brain Axis Studies 
6.1 A specific dietary fibre supplementation improves cognitive 
performance—an exploratory randomised, placebo-controlled, crossover study 
The prebiotic polydextrose improved scores in cognitive tasks. In the microbiome, it 
specifically increased relative abundance of the genus Ruminiclostridium but did not 
alter the microbiome composition detectably on a beta diversity level.  
6.2 Bifidobacterium longum Counters the Effects of Obesity: Partial Successful 
Translation from Rodent to Human 
In this translational study, the probiotic Bifidobacterium longum APC1472 was shown 
to have anti-obesity effects in mice but these were not replicated in humans. In a 
longitudinal cohort of obese and overweight (human) participants, recipients 
showed an improvement in other measurements, including higher ghrelin levels and 
reduced cortisol awakening response.  
6.3 Recipe for a Healthy Gut: Intake of Unpasteurised Milk Is Associated with 
Increased Lactobacillus Abundance in the Human Gut Microbiome 
After a 12-week residential cookery course where students have an increased intake 
in unpasteurized dairy, we find that milk-fermenting bacteria are strongly increased 
in the gut microbiome. We also find an increase in neuroactive gut-brain modules, as 
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Male middle age is a transitional period where many physiological and psychological 
changes occur leading to cognitive and behavioural alterations, and a deterioration 
of brain function. However, the mechanisms underpinning such changes are unclear. 
The gut microbiome has been implicated as a key mediator in the communication 
between the gut and the brain, and in the regulation of brain homeostasis including 
brain immune cell function. Thus, we tested whether targeting the gut microbiome 
by prebiotic supplementation, may alter microglia activation and brain function in 
ageing. Male young adult (eight weeks) and middle-aged C57BL/6J mice (ten months) 
received diet enriched with a prebiotic (10% oligofructose-enriched inulin (FOS-
Inulin)) or control chow for 14 weeks. Prebiotic supplementation differentially 
altered the gut microbiota profile in young and middle-aged mice with changes 
correlating with faecal metabolites. Functionally, this translated into a reversal of 
stress-induced immune priming in middle-aged mice. In addition, a reduction in 
ageing-induced infiltration of Ly-6Chi-monocytes into the brain coupled with a 
reversal in ageing-related increases in a subset of activated microglia (Ly-6C+) was 
observed. Taken together, these data highlight a potential pathway by which 
targeting the gut microbiome with prebiotics can modulate the peripheral immune 
response and alter neuroinflammation in middle age. Our data highlight a novel 
strategy for the amelioration of age-related neuroinflammatory pathologies and 




We have trillions of microbes in our gastrointestinal tract, and a growing body of 
evidence supports a role for them in maintaining health across the lifespan (Lynch 
and Pedersen, 2016; Fung et al., 2017; Miquel et al., 2018). Indeed, microbiota has 
been implicated as a key mediator in the communication between the gut and the 
brain and regulating brain homeostasis. Diet has been shown to be one of the most 
important factors in modifying the gut microbiota composition (David et al., 2014; 
Sandhu et al., 2017). However, the ability of nutritional interventions that target the 
microbiome to alter brain function has not received much attention (Donovan, 2017; 
Sandhu et al., 2017; Miquel et al., 2018). 
 
Ageing is defined as a process involving slow deterioration of various homeostatic 
functions throughout the lifespan. Middle age in particular is a life period where 
many physiological and psychological changes occur, leading to first cognitive 
impairments and behavioural alterations, and a deterioration of brain function 
(Francia et al., 2006; Ennaceur et al., 2008; Duarte et al., 2014; Bensalem et al., 2016; 
Shoji et al., 2016). In rodents, increased anxiety-like behaviour occurs in middle-age 
(Ennaceur et al., 2008; Shoji et al., 2016). A few studies reported cognitive decline in 
middle-aged rodents (Bensalem et al., 2016; Shoji et al., 2016), with variable 
definitions of “middle-age“ highlighting the need for greater specification 
(Prenderville et al., 2015). Moreover, the levels of neurotransmitters (Duarte et al., 
2014) and neurotrophins (Francia et al., 2006) were shown to decline with age, which 
may possibly contribute to altered behaviour and brain homeostasis.  
 
Increased age is associated with a shift towards a pro-inflammatory state and 
inflammageing (Sparkman and Johnson, 2008; Franceschi et al., 2017). This, in turn, 
can make the ageing brain more vulnerable to various intrinsic and extrinsic 
disruptive effects including stress, disease and infection (Norden and Godbout, 2013; 
Prenderville et al., 2015). Moreover, this vulnerability may result in cognitive 
alterations (Miquel et al., 2018). However, it remains unclear to what extent an 
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altered brain immune system can contribute to alterations in cognitive functions in 
middle-aged subjects.  
 
Microglia are the major immune cells in the brain and have been shown to be a key 
player in neuropsychological and neurodegenerative conditions (Tay et al., 2017; 
Hickman et al., 2018). Increased activation of microglia in the aged brain has been 
suggested to be indicative of enhanced inflammation and heightened reactivity in 
the rodent and the human brain (Perry et al., 2003; Streit et al., 2004; Sparkman and 
Johnson, 2008). Following an immune stimulus, which is exaggerated in ageing, 
microglia are referred to as “primed“ due to their rapid induction and increased 
cytokine release upon activation (Perry et al., 2003; Sparkman and Johnson, 2008). 
Microglia are specialised cells continuously monitoring their environment 
(Nimmerjahn et al., 2005) and can sense changes in the brain’s milieu (Hickman et 
al., 2013). In addition, microglia play a crucial role in synaptic plasticity, brain function 
and cognition across the lifespan (Tay et al., 2017).  
 
Numerous studies have shown shifts in the composition of the intestinal microbiota 
with age in rodent models (Scott et al., 2017; van der Lugt et al., 2018) and in humans, 
including extreme ageing (Biagi et al., 2010; Biagi et al., 2016). Previous research 
utilizing pre-clinical models implicated a role of microbiota from aged mice in driving 
systemic immunity (Fransen et al., 2017; Thevaranjan et al., 2017). However, the 
effect on neuro-immunity and subsequent brain function and behaviour remains 
unaddressed. Interestingly, the transfer of gut microbiota from young-to-aged might 
influence healthy ageing as shown in the short-lived killifish model, which exhibited 
an increase in lifespan and motor behaviour (Smith et al., 2017). It has been shown 
that the administration of prebiotics (a substrate that is selectively utilized by host 
microorganisms conferring a health benefit (Gibson et al., 2017)) results in an 
increase in the number of beneficial intestinal bacterial species with a reduction in 
systemic inflammation in rodents (Burokas et al., 2017) and humans (Schiffrin et al., 
2007; Vulevic et al., 2008). Moreover, that prebiotics may alter microglia activation 
47 
 
in the aged brain (Matt et al., 2018) which would have important implications for the 
healthcare system. It however remains unclear what is driving these changes and 
what is the impact on brain function and behaviour, i.e. cognitive behaviour. 
Therapeutic interventions aim to delay ageing, decrease pro-ageing factors, reduce 
microglia activation and ultimately improve cognition during ageing. 
 
We hypothesise that there is a dysregulation in the communication between the gut 
microbiota and the brain during middle age, which is critical in mediating age-related 
functional decline. Thus, targeting the gut microbiota with prebiotics may alter 
microglia activation state and brain function in ageing. To this end, we hypothesised 
that targeting the gut microbiome by dietary intervention with a complex short- and 
long-chain prebiotic, oligofructose-enriched inulin (FOS-Inulin), would have selective 
effects on (neuro-) immune profile and behaviour in middle-aged male compared to 




2.1.3.1  Animals 
Male young adult C57BL/6J mice (n = 60; Harlan, Cambridgeshire, UK; 2 months) and 
middle-aged C57BL/6J mice (n = 48; 10 months) were used in this study. All 
experiments were conducted in accordance with European Directive 86/609/EEC, 
Recommendation 2007/526/65/EC, and approved by the Animal Experimentation 
Ethics Committee of University College Cork (B100/3774). Animals were habituated 
to the animal facility for two weeks before experiments started and kept under a 12-
hour light/dark cycle, with a temperature of 21 ± 1 °C and humidity of 55 ± 10%. Food 
and water were given ad libitum. 
2.1.3.2 Prebiotic administration 
Mice received chow (ssniff-Spezialdiäten GmbH, Soest, Germany) enriched with 10% 
Oligofructose-enriched inulin (FOS-Inulin: mixture of 92±2% Inulin and 8±2% 
Fructooligosaccharide, Orafti®Synergy1; BENEO-Orafti N.V., Tienen, Belgium) or 
control chow for 3.5 weeks (microglia cohort) and 14 weeks (behavioural cohort). 
The dosage of FOS-Inulin supplementation was chosen based on previous studies in 
rodents (Messaoudi et al., 2005; Rault-Nania et al., 2006; Rozan et al., 2008). 
Duration of prebiotic intervention was chosen according to previous studies in 
rodents showing effects on brain and behaviour (Savignac et al., 2015; Burokas et al., 
2017).  
 
2.1.3.3 Study design and experimental timeline 
Two separate cohorts of animals were used (see Supplementary Figure S1).  
Cohort one investigated the effects of FOS-Inulin on behaviour including cognitive 
(spontaneous alternation behaviour, Morris water maze, fear conditioning), anxiety-
like (open field, elevated-plus maze, marble burying), social (three-chamber social 
interaction test) and depressive-like behaviour (forced swim test). Following a three-
week lead-in of diet, mice (n=8-10 per group) underwent behavioural assessment 
while continuing dietary supplementation for a total of 14 weeks. In addition, 
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peripheral immune cell activation (pre-/post stress) was assessed in blood by using 
flow cytometry. To correlate the changes in behaviour with specific neuroimmune 
targets, we subsequently analysed targets in the brain at the end of the study.   
To characterize the neuroimmune status in the brain at a time point that coincided 
with that before animals were tested behaviourally, cohort two (young adult: n=14-
16, middle-aged: n=8-10) investigated if a dietary lead-in phase of 3.5 weeks with 
FOS-Inulin can alter monocyte infiltration and subsequent microglia activation in the 
brain, key mediators influencing cognition and anxiety-like behaviour.  
 
2.1.3.4 Behaviour 
2.1.3.4.1  Spontaneous alternation in the Y-Maze 
Spontaneous alternation behaviour in the Y-maze tests hippocampal-dependent 
spatial memory and exploration exploratory activity and was carried out as 
previously described (Scott et al., 2017). Behaviour was assessed for five minutes. 
 
2.1.3.4.2  Morris water maze 
The Morris water maze represents a robust and reliable test for spatial learning that 
strongly correlates with hippocampal synaptic plasticity (Vorhees and Williams, 
2006). Briefly, mice were trained over five days (four trials per day, two minutes each) 
to spatially locate the submerged platform. On day six, the platform was removed 
and a probe trial lasting 30s conducted.  
 
2.1.3.4.3 Fear conditioning 
Fear conditioning was conducted as previously described (Izquierdo et al., 2006), 
over three consecutive days (day 1: conditioning by three pairings with variable inter-
pairing interval; day 2: conditioned stimulus recall and extinction in a novel context; 




2.1.3.4.4 Open field 
The open field is a widely used test to assess approach-avoidance behaviour, 
locomotor activity and the behavioural response to a novel context, and was 
conducted as previously described (Burokas et al., 2017). Briefly, a test mouse was 
placed into an open arena with 60 lux lighting and allowed to explore the context for 
ten minutes.  
 
2.1.3.4.5 Marble burying test 
The marble burying test assesses compulsive, repetitive and anxiety-like behaviour, 
and was conducted as previously described (Burokas et al., 2017). Briefly, mice were 
tested for 30 min and the number of buried marbles was recorded.  
 
2.1.3.4.6  Elevated-plus maze 
The Elevated-plus Maze test was used to assess anxiety-like behaviour and was 
conducted as previously described (Burokas et al., 2017). Mice were allowed to 
explore the maze for five minutes; the time spent in the open arms, as well as number 
of entries into the open arms was analysed.  
 
2.1.3.4.7 Three-chamber social interaction test 
Sociability and social novelty were assessed in a three-chamber apparatus as 
previously described (Desbonnet et al., 2012). The test consists of three sequential 
ten minute trials: (1) habituation; (2) sociability (the analysis of time a test mouse 
spends in the chamber with the conspecific mouse or with the object).  (3) social 
novelty preference (the analysis of time a test mouse spends in the chamber with the 
novel or in the chamber with the familiar mouse).   
 
2.1.3.4.8 Forced swim test 
The forced swim test was used to assess depressive-like or despair-like behaviour 
(Porsolt et al., 1977; Cryan and Mombereau, 2004). Mice were individually placed in 
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a transparent glass cylinder for six minutes. Time spent immobile was defined as no 
movements apart from breathing and considered as depressive-like behaviour. 
Behaviour was analysed during the last 4 minutes of the test which represents the 
most common protocol to use in analysing FST in the mouse and accounts for the 
fact that most mice struggle heavily during the first two minutes as they habituate to 
the water situation (Porsolt et al., 1977; Cryan and Mombereau, 2004).  
 
2.1.3.5 Plasma collection and corticosterone analysis 
To investigate the endocrine and immune response to stress, we collected blood 
samples prior to and following the forced swim test session. Approximately 60 μl of 
blood per mouse were collected by tail tipping using Lithium-Heparin-coated 
capillaries (Sigma-Aldrich, St. Louis, Missouri, United States). Blood was centrifuged 
at 3500 g at 4 °C for 15 min. Plasma was aspirated and stored at −80°C. Blood was 
taken immediately before the forced swim test (baseline), as well as 15 min, 45 min 
and 120 min after the baseline. Baseline samples and samples at 120 min post-stress 
time point were used for flow cytometry (see 2.7). 
Plasma corticosterone levels were measured in duplicates by ELISA (ENZO 
Corticosterone ELISA, Enzo Life Sciences, Exeter, UK) as previously described (Scott 
et al., 2017). Data were expressed in ng/ml. Only data derived from duplicates with 
< 15% coefficient of variation (CV) were included in the analysis. 
 
2.1.3.6 Blood stimulation cytokine assay 
To assess if a prebiotic-enriched diet alters systemic immunity, 100 μl of trunk blood 
was obtained at the end of the study using Lithium-Heparin-coated tubes (Greiner 
Bio-One, Kremsmünster, Austria). Blood cells from each mouse were stimulated with 
lipopolysaccharide (LPS-2 μg/ml) or Concanavalin A (ConA-2.5 μg/ml) for 24 h or left 
unstimulated as control. Following 24 h-incubation, samples were taken and stored 
at -80°C. The levels of secreted IL-1β, IL-4, IL-6, IL-10, TNFα and CXCL1 were analysed 
with the Proinflammatory Panel 1 (mouse) V-PLEX Kit and the MESO QuickPlex SQ 
120, SECTOR Imager 2400 (Meso Scale Discovery, Maryland, USA). Only data derived 
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from duplicates with < 15% CV were included in the analysis. Concentrations of 
cytokines were expressed in pg/ml. 
 
2.1.3.7 Flow cytometry 
To assess stress-induced immune priming, blood was collected from young adult and 
middle-aged mice by tail tipping (60 μl) at baseline and 120 min after acute stress 
(cohort one). Staining was performed using CD11b-VioBright FITC, Ly-6C-PE, LY-6G-
PerCP-Vio700 and MHC-II-PE (all Miltenyi Biotec, Bergisch Gladbach, Germany) to 
assess inflammatory monocytes (CD11b+, SSClow, LY-6Chi) and MHC-II+-neutrophils 
(CD11b+, LY-6G+, MHC-II+). Inflammatory monocyte and MHC-II+-neutrophil counts 
were normalized to the amount of peripheral blood mononuclear cell (PBMC). Gating 
strategy is depicted in Supplementary Figure S2a. 
Cohort two investigated if the diet lead-in phase with FOS-Inulin modulates 
monocyte infiltration and subsequent microglia activation in the brain. Following 
perfusion with ice-cold PBS for five min, brains were carefully dissected, 
enzymatically digested using the neural dissociation kit (P), followed by incubation in 
myelin-removal beads and magnetic separation using LS columns (Miltenyi Biotec). 
Cells were stained using CD11b-Viobright FITC, CD45-APC and Ly-6C-PE (all Miltenyi 
Biotec). Gating strategy is depicted in Supplementary Figure S2b. Monocyte counts 
were normalized to CD11b+ cells, microglia to CD11b+, CD45low.  
 
2.1.3.8 Analysis of gene expression levels in the brain tissues (RT-qPCR) 
To assess gene expression brain areas associated with cognition, the right 
hemisphere of both, the hippocampus and the prefrontal cortex were used 
(Schellekens et al., 2012). Total RNA was extracted using the mirVana™ miRNA 
Isolation Kit (Ambion, Life technologies, Waltham, MA, US), followed by DNase 
treatment using the TURBO DNA-free™ Kit (Thermo Fisher Scientific Inc., Waltham, 
Massachusetts, USA) according to the manufacturer’s instructions. RNA was 
quantified using the NanoDrop™ spectrophotometer (Thermo Fisher Scientific Inc., 
Waltham, Massachusetts, USA).  
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RNA was reverse transcribed to cDNA using the Applied Biosystems High Capacity 
cDNA kit (Applied Biosystems, Warrington, UK). Ccl2 and Tnf genes were amplified 
with probes designed by Integrated DNA Technologies (Coralville, IA, US) (Table S1). 
PCR was run in triplicates on a LightCycler®480 (Roche). Data were analysed with the 
comparative cycle threshold (Ct) method. Data were normalized using Actb as 
endogenous control and transformed using the 2−ΔΔCT method (Livak and Schmittgen, 
2001). We confirmed beforehand that the housekeeper Actb is neither changed by 
age nor by prebiotic treatment. 
 
2.1.3.9 Caecal microbiota composition (16S rRNA gene sequencing) and short-chain 
fatty acid analysis 
Caecum was harvested, snap frozen and stored at -80°C prior to the analysis. DNA 
from caecal content was extracted using the Qiagen QIAmp Fast DNA Stool Mini Kit 
coupled with an initial bead-beating step, as previously described . The V3-V4 
hypervariable region of the 16S rRNA gene was amplified and prepared for 
sequencing as outlined in the Illumina 16S Metagenomic Sequencing Library 
Protocol. Samples were sequenced at Teagasc Sequencing Facility on the Illumina 
MiSeq platform using a 2 × 250 bp kit.  
FLASH was used to assemble paired-end reads. Further processing of paired-end 
reads including quality filtering based on a quality score of > 25 and removal of 
mismatched barcodes and sequences below length thresholds was completed using 
QIIME (version 1.9.0). Denoising, chimera detection and clustering into operational 
taxonomic unit (OTU) grouping were performed using USEARCH v7 (64-bit) (Edgar, 
2010).  OTUs were aligned using PyNAST (and taxonomy was assigned using BLAST 
against the SILVA SSURef database release 123. Alpha and beta diversities were 
generated in QIIME (Caporaso et al., 2010). 
Short chain fatty acids (SCFAs) were measured by gas chromatography, using a Varian 
3500 GC flame-ionization system fitted with a ZB-FFAP column as previously 




2.1.3.10 Metabolomics from faecal water 
Faecal pellets were collected at the end of cohort one. Faecal material were freshly 
collected with sterilized tools to ensure no cross contamination within a time-
window of 10 minutes’ maximum to ensure least oxygen exposure of the faeces as 
possible. Subsequently, pellets were directly snap freeze to ensure optimal DNA 
integrity. Faecal water was prepared by homogenising faecal samples (20-50 mg) 
with 4x wt/volume sterile PBS followed by vortexing for 20 minutes. Samples were 
centrifuged at 16000 g for 30 minutes; the supernatant was transferred in a new 2 
mL micro centrifuge tube and centrifuged for further 30 minutes. This step was 
repeated one more time before filtering the supernatant through Costar Spin-X 
centrifuge filters 0.2 µM at 10000 g. Faecal water samples were stored at -20°C. 
Subsequently, samples were derivatized with methyl chloroformate as previously 
described (Smart et al., 2010) and processed by MS-Omics (Copenhagen, Denmark) 
using Gas Chromatography – Mass Spectometry (GC-MS). Raw data was converted 
to netCDF format using ChemStation (Agilent technologies) and processed in Matlab 
R2014b (Mathworks, Inc., Natick, MA, USA) using the PARADISe software described 
by (Johnsen et al., 2017). 
 
2.1.3.11 Statistical analysis 
Statistical analyses were conducted using SPSS 24 (IBM Corp., Armonk, NY, USA) and 
Graphpad Prism 7 (GraphPad Software, Inc., La Jolla, CA, USA). Data were analysed 
for normality using the Shapiro-Wilk test and for equality of variances using the 
Levene's test. Non-parametric data were analysed with Kruskal-Wallis test followed 
by post-hoc Dunn‘s, and are depicted as median with inter-quartile ranges (IQR) and 
min/max values as error bars. Parametric data were analysed using two-way analysis 
of variance (ANOVA) post-hoc Holm-Sidak, and are shown as mean ± SEM. Changes 
in corticosterone response, Morris Water Maze learning and fear conditioning were 
analysed using two-way-repeated measurement (RM)-ANOVA post-hoc Sidak. 
Correlation analyses were performed using Spearman correlations for non-
parametric data. Outliers were excluded using the Grubbs test. Statistical significance 
was set at p ≤ 0.05.  
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Statistical analysis of microbiota data was performed in an R software environment. 
For Principal Component Analysis (PCA), Permutational multivariate analysis of 
variance (PERMANOVA) was used to identify relationships of significance between 
variables the Adonis function from the vegan package on Aitchison distance matrices 
calculated with the ALDEx2 package. ALDEx2 was also used to calculate pairwise 
differential abundance. Hierarchical All-against-All significance (HAllA) was used to 
investigate between-dataset covariance. For all tests, a Benjamini-Hochberg post-
hoc test was performed to correct for multiple comparisons with a conservative q-




2.1.4.1 Prebiotic supplementation reversed stress-induced immune priming in 
ageing 
To assess if ageing triggers stress-induced immune priming in middle-aged mice, and 
whether age-associated changes are alleviated following prebiotic supplementation, 
mice were exposed to an acute stress (forced swim test), and blood samples were 
taken at baseline and 2 hours after stress exposure. We focused on neutrophils, 
which act as the first responders to any immune challenge and can trigger adaptive 
immunity, including T-cell priming via expression of major histocompatibility 
complexes (MHC), a classical activation marker. 
In middle-aged mice, acute stress caused a long-lasting increase of the MHC-II+ 
neutrophil population (p=0.0280, Kruskal-Wallis post-hoc Dunn’s; Figure 2.1-1a); the 
response being absent in young adult animals. Strikingly, prebiotic supplementation 
prevented the development of the age-associated phenotype and restored the levels 
of MHC-II+ neutrophils in stressed aged animals to young levels (p=0.011).  
Since acute stress is known to affect peripheral innate immunity through 
corticosterone (Dhabhar et al., 2012), we investigated whether these changes in 
neutrophil activation status were associated with altered stress axis activity. For this, 
we measured plasma release of corticosterone (as an indicator of endocrine 
reactivity to stress) in the same animals, prior to and at different time points 
following the forced swim stress exposure. Two-way RM-ANOVA revealed an overall 
effect of age on the corticosterone response (F (1, 28) = 10.825, p=0.003; Figure 2.1-
1b). In particular, middle-aged mice exhibited lower plasma corticosterone levels at 
baseline (F (1, 29) = 16.68, p<0.001, Figure 2.1-1c) and at T15 (F (1, 34) = 24.65, p<0.001). 
Calculation of area-under-the-curve (AUC) for corticosterone response confirmed 
that middle-aged mice exhibited a blunted stress axis reactivity (F (1, 28) = 5.207, 
p=0.03, Figure 2.1-1d). However, we did not observe any modulation on 
corticosterone response neither at baseline nor following stress in neither young 
adult nor middle-aged mice by prebiotic supplementation suggesting that the 




Figure 2.1-1. Prebiotic supplementation reversed stress-induced immune priming in 
middle-aged mice. (a) MHC-II+ neutrophils at baseline and 2h after acute stress. (b) 
Plasma Corticosterone (Cort) response curve at baseline, immediately before 
exposure to acute stress, and 15, 45 and 120 min after exposure to acute stress. (c) 
Plasma corticosterone at baseline. (d) Area-under-the-curve (AUC) of corticosterone 
response. Mean ± SEM. n = 8-10. vs. control young adult * p < 0.05, ** p < 0.01, *** 
p < 0.001, vs. control middle-aged # p < 0.05, ## p < 0.01, vs. prebiotic middle-aged 





2.1.4.2 Effect of prebiotic supplementation on systemic inflammation and immune 
cell priming 
To investigate if systemic inflammation and immune cell priming is altered in middle-
aged mice and counteracted by prebiotic supplementation, whole blood was taken 
after 14 weeks of prebiotic intervention and stimulated with LPS or ConA. Following 
ConA-stimulation, middle-aged control mice exhibited a trend towards increased IL-
1β and IL-10 cytokine release (p=0.089 and p=0.069, respectively, Supplementary 
Figure S3b+e), while prebiotic-treated middle-aged mice showed similar levels as in 
young controls. Moreover, prebiotic supplementation decreased TNFα in middle-
aged mice following ConA-stimulation (p=0.014, Kruskal-Wallis post-hoc Dunn‘s; 
S3a). No changes were observed at baseline or in response to LPS stimulation. 
2.1.4.3 Pervasive neuroimmune alterations in middle-aged mice were alleviated by 
prebiotic supplementation 
Given the decline of cognitive function in middle-aged mice (Prenderville et al., 2015; 
Shoji et al., 2016), we investigated whether the middle-aged brain is more vulnerable 
to peripheral immune cell trafficking and subsequent microglial activation, and this 
status can be targeted by prebiotic supplementation, we investigated brain immunity 
by flow cytometry. Two-way ANOVA revealed an effect of age (F (1, 41) = 11.94, 
p=0.001; Figure 2.1-2a) and prebiotic treatment (F (1, 41) = 7.88, p=0.008) as well as an 
interaction of both (F (1, 41) = 6.01, p=0.019) on trafficking of inflammatory monocytes 
(Ly-6Chi) into the brain. Specifically, middle-aged control mice showed an increase in 
Ly-6Chi monocytes compared to young controls (p<0.001), which was alleviated by 
prebiotic supplementation (p=0.007). We in addition investigated if these changes in 
infiltrating monocytes are also systemically reflected in the blood. We didn’t find any 
differences (see Supplementary Figure S7) suggesting that the brain becomes 
particularly vulnerable in middle-aged mice as inflammatory monocytes traffic to 
inflamed tissue. Furthermore, we investigated whether the observed increase in 
monocyte trafficking was associated with microglia activation. Two-way ANOVA 
revealed an effect not only of age (F (1, 43) = 10.75, p=0.002; Figure 2.1-2b), but also 
prebiotic treatment (F (1, 43) = 10.95, p=0.002) and an interaction of both (F (1, 43) = 
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13.81, p<0.001) on Ly-6C+ microglia. Middle-aged controls showed a higher 
percentage of Ly-6C+ microglia compared to young controls (p<0.001), which was 
reversed by prebiotic supplementation to young control levels (p<0.001).  
In agreement with these findings, the gene expression of Ccl2 and Tnf were up-
regulated in the hippocampus of middle-aged mice (F (1, 35) = 13.60, F (1, 35) = 15.79, 
p<0.001; Figure 2.1-2c-d). Ccl2 and Tnf encode for pro-inflammatory cytokines which 
are secreted from activated microglia and associated with monocyte infiltration. This 
supports the observation of microglia activation in the middle-aged brain, including 
the hippocampus, a key region controlling learning and memory. In contrast, both, 
Ccl2 and Tnf, were not found to be upregulated in middle-aged mice following 
prebiotic supplementation. Furthermore, we investigated this phenomenon in 
another cognition-related brain region, the prefrontal cortex. In contrast to the 
hippocampus, no effect of age or prebiotic supplementation on Ccl2 and Tnf gene 
expression was found (Supplementary Figure S4), suggesting a non-universal effect 





Figure 2.1-2. Middle-aged mice exhibited elevated infiltration of Ly-6Chi monocytes 
into the brain and increased microglia activation; the phenotype was reversed by 
prebiotic supplementation. (a) Monocyte infiltration in the brain. (b) Microglia 
expression pattern in the brain. (c-d) Pro-inflammatory cytokine expression in the 
hippocampus. Mean ± SEM. n = 7-16 (Flow Cytometry), n = 9-10 (Gene expression 
Hippocampus). vs. control young adult * p < 0.05, *** p < 0.001, vs. control middle-
aged ## p < 0.01, ### p < 0.001. 
 
2.1.4.4 Prebiotic intervention improved learning and reduced anxiety-like 
behaviour in young adult mice 
To assess if prebiotic intervention improves spatial learning and memory, mice were 
trained over five consecutive days to find a hidden platform in the Morris water maze 
(MWM). Middle-aged mice displayed an impairment in learning (F (1, 35) = 8.653, 
p=0.006; Figure 2.1-3a). However, prebiotic supplementation modulated learning (F 
(1, 35) = 10.252, p=0.003), the improvement was only evident in young adult mice (F (1, 
18) = 10.897, p=0.004). We did not identify an interaction (F (1, 35) = 2.073, p=0.159) 
suggesting that the prebiotic effects were specific to young adult mice. Although, the 
average between day four to five is visually different, both days are not statistically 
different from each other (p=0.19) and mostly explained by a much greater variation 
compared to day four. Similarly, area-under-the-curve (AUC) analysis confirmed the 
improved learning in prebiotic-treated young mice (p=0.005). Both, age (F (1, 34) = 
13.10, p=0.001) and prebiotic supplementation (F (1, 34) = 12.89, p=0.001) had a 
modulatory impact on spatial learning. To assess spatial long-term memory, a probe 
trial was performed on day six. A trend towards decreased time spent in the target 
quadrant with age (F (1, 35) = 3.442, p=0.072) was found, however, no improvement 
by prebiotic supplementation was observed (Figure 2.1-3a). Neither age or prebiotic 
exposure affected swim speed, or total distance respectively (data not shown). 
We further tested the effect on short-term memory by assessing spontaneous 
alternation behaviour in the Y-maze. Middle-aged mice showed a decrease in 
spontaneous alternations (F (1, 35) = 10.66, p=0.003) and total number of alternations 




Next, we tested if prebiotic supplementation can modulate amygdala-dependent 
learning and memory. For this, mice were tested in a fear conditioning task (Figure 
3c). On day one, mice were conditioned to three cued-shock pairings with a variable 
inter-pairing interval. Middle-aged mice displayed an impaired acquisition (F (1, 36) = 
4.842, p=0.034, Figure 2.1-3c). 24h later, CS recall and extinction learning were 
assessed. Middle-aged mice showed increased freezing during habituation to the 
new context (F (1, 35) = 6.702, p=0.014) suggesting anxiety-like behaviour. Although 
statistically not significant, the changes in extinction in the prebiotic-treated young 
adult mice compared to the other groups are explained by the less freezing across 
the cue-shock pairings during acquisition. Similarly, to deficiencies in acquisition, 
middle-aged mice showed impairments in extinction learning (F (1, 36) = 4.898, 
p=0.034). In contrast, no impact of age nor of prebiotic supplementation on context 
recall was found (Figure 2.1-3c). 
Next, we analysed anxiety-like behaviour in the elevated plus maze and the open 
field, as changes in anxiety levels are known to affect cognitive performance. Overall, 
middle-aged mice displayed increased anxiety-like behaviour, as shown by less time 
spent in the aversive open arms of the elevated plus maze (F (1,33) = 18.31 p<0.001; 
Figure 2.1-3d), the central zone of the open field arena (F (1, 34) = 7.337, p=0.011; 
Figure 2.1-3e) as well as decreased number of centre visits (F (1, 34) = 14.69, p<0.001). 
The locomotor activity was also marginally reduced in middle-aged mice (F (1,33) = 
4.538, p=0.041; Figure 2.1-3c). Prebiotic supplementation did not affect anxiety 
levels in middle-aged mice. However, a significant increase in the time spent in the 
open arms of the elevated plus maze was observed in young adult prebiotic-treated 
mice (p=0.027). This suggests that prebiotic supplementation did have an anxiolytic-
like effect, but in young animals only. The observed changes in anxiety-like 
behaviour, i.e. increased anxiety levels in aged mice and selective anxiolytic effect in 
prebiotic-treated young mice, had a similar pattern seen in the spatial recognition in 
the MWM. This suggests that impaired cognitive performance in middle-aged mice, 
as well as improved learning of prebiotic-treated young adults could may be partially 
mediated by changes in anxiety levels. 
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Interestingly, learning performance in the Morris water maze correlated with the 
relative abundance of the Verrucomicrobiaceae family (r (38) = -0.369, p=0.023; Figure 
2.1-3f); wherein the association is mainly driven by Akkermansia, the predominant 
genus within the Verrucomicrobiaceae (r (38) = -0.323, p=0.048; Figure 2.1-3f). 
Moreover, we identified a significant correlation between hippocampal Ccl2 
expression (as a readout of microglia activation linked to monocyte trafficking) and 
learning performance (AUC) in the MWM task (r (39) = 0.349, p=0.03; Figure 2.1-3g). 
To emphasize these correlations further, we indicated which data points relates to 




Figure 2.1-3. Prebiotic supplementation improved learning and reduced anxiety-
like behaviour in young adult mice. (a) Learning and memory in Morris water maze 
(MWM). Latency-to-find platform over five training days. Summarized as area-under-
the-curve (AUC), as well as the probe trial 24h after the last training day is depicted. 
(b) Short-term memory assessed by Spontaneous Alternation Behaviour (Y-Maze). (c) 
Fear Conditioning: Conditioning (Acquisition, day 1) including AUC. Extinction (day 2) 
– two consecutive cue presentations were depicted as one trial block. AUC for trial 
block 1-20 is depicted. Context recall (day 3). (d) Time spent in open arms in elevated-
plus maze. (e) Behaviour in open field. (f) Spearman correlation analysis of learning 
efficacy in Morris water maze (AUC) vs. relative abundance of bacteria from the 
Verrucomicrobiaceae family and Akkermansia genus (g) Spearman correlation 
learning in Morris water maze vs. hippocampal Ccl2 expression. Mean ± SEM. n = 9-
10. vs. control young adult * p < 0.05, ** p < 0.01, *** p < 0.001, vs. control middle-






Figure 2.1-4. Middle age and prebiotic treatment have distinct effects on the gut 
microbiota composition accompanied with changes in short-chain fatty acid (SCFA) 
profile. (a) PCA plot. (b) Alpha-diversity Indices (Chao1, Simpson, Shannon). (c) Heat 
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map representing differentially abundant taxa (genus with higher hierarchy family 
name). Microbes are sorted taxonomically; therefore, genetically closer microbes are 
closer together. Heat map represents all taxa which reach a Benjamini-Hochberg FDR 
q value < 0.2 at least once. Asterisks in the heat map represent the following q values: 
* <0.1, ** < 0.01, *** < 0.001. (d) Hierarchical All-against-All significance testing 
(HAllA) representing the 100 strongest significant correlations (q<0.2) between gut 
microbiota composition and faecal metabolomics. Numbers (1-100) indicate the 




2.1.4.5 Effect of age and prebiotic supplementation on gut microbiota composition 
and short-chain fatty acid profile in the gut 
Principal Component Analysis (PCA) analysis identified structural differences in 
microbiota across all four groups (PERMANOVA, p<0.001; Figure 2.1-4a). The 
composition of caecal microbiota was significantly affected by age and by prebiotic 
supplementation (all p<0.05, pairwise PERMANOVA). Interestingly, no interaction 
between age and prebiotic was observed, i.e. marked differences between middle-
aged and young mice were evident in both control and prebiotic-treated groups, as 
well as prebiotic supplementation effectively shifted microbiota composition in both 
young adult and middle-aged animals.  
When we looked at structural properties of microbial communities at the genus level, 
we observed multiple changes in the relative abundance of individual bacterial taxa 
(Figure 2.1-4b). In particular, middle-aged mice displayed an increase in Clostridum 
sensu stricto 1, Delftia, Salmonella, Enterococcus, Turibacter (q < 0.1).  In contrast, 
Parabacteroides (q < 0.01) was decreased in middle-aged control mice. Interestingly, 
prebiotic supplementation not only increased the abundance of Bifidobacterium in 
young adult but also middle-aged mice (q < 0.1 and q < 0.01, respectively). In 
contrast, Akkermansia was only increased in middle-aged prebiotic-treated mice (q 
< 0.1). Moreover, prebiotic supplementation increased the abundance of 
Prevotellaceae UCG-001 and Bacteroides not only in young adult mice but even more 
pronounced in middle-aged mice (q < 0.01, respectively), while Lactobacillus and 
Roseburia were decreased in prebiotic-treated middle-aged mice (q < 0.1). 
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The Chao1 index was increased in middle-aged compared to young adult control 
mice, indicating an increase in overall richness of bacterial species associated with 
age (p=0.028; Kruskal-Wallis post-hoc Dunn’s; Figure 2.1-4c). However, the Shannon 
and the Simpson indices, which take into account the evenness of species 
abundance, were not affected by age but were reduced following prebiotic 
supplementation in young adult mice (p=0.010 and p=0.016, respectively). This 
suggest that prebiotic supplementation favoured the selective expansion of certain 
bacterial taxa in young adult animals only. 
To identify if changes in gut microbiota composition correlated with faecal 
metabolomics, we utilized Hierarchical All-against-All significance testing (HAllA). 
Among others, HAllA identified a negative association between the relative 
abundance of Akkermansia, which was significantly over-represented in prebiotic-
treated middle-aged mice, and several amino acids including leucine (ρ=-0.63, 
p<0.001, FDR corrected, Figure 2.1-4d), valine and isoleucine (ρ=-0.60, p<0.001, 
respectively). Similarly, between Bifidobacterium, which was significantly over-
represented in prebiotic-treated young and middle-aged mice, and the respective 
amino acids (ρ=-0.55, p=0.001).  
Prebiotic supplementation increased caecum weight (F (1, 35) = 88.95, p<0.001; 
Supplementary Figure S6b) in both young adult and middle-aged mice. Among short-
chain fatty acids (SCFAs), caecal butyrate, propionate and valerate levels were 
affected by either age or prebiotic supplementation. No effect was found on acetate 
and total-SCFA levels (data not shown). Middle-aged mice exhibited higher butyrate 
levels than young mice (F (1, 35) = 16.74, p<0.001; Figure S6c). Prebiotic 
supplementation increased propionate independent of age (F (1, 35) = 8.75, p<0.001), 
with a more pronounced increase seen in middle-aged mice (p=0.035). While 
valerate was increased in middle-aged compared to young controls (p<0.001), 
prebiotic supplementation reduced valerate in both, young adult (p=0.021) and 





There is a growing appreciation of the role of the gut microbiota in regulating 
neuroinflammatory responses. The middle-aged brain remains completely 
understudied regarding this interrelationship. Our data show that middle age is 
already associated with pervasive alterations in systemic and brain immunity. 
Targeting the gut microbiome by prebiotic intervention (FOS-Inulin) reversed many 
of these age-associated neuroinflammatory impairments.  
 
To our knowledge, this is the first study demonstrating the presence of a strong basal 
and stress-induced (neuro-) inflammatory profile in middle-aged mice (11 months 
old), although an exaggerated inflammatory response has been previously reported 
in middle-aged rodents following immune stimulation (Bardou et al., 2013; Lee et al., 
2013; Nikodemova et al., 2016). Moreover, our study implicates the gut microbiome 
in such processes as dietary targeting with prebiotic supplementation counteracted 
stress-induced peripheral immune cell activation. Following acute stress, we 
investigated a subtype of neutrophils that express MHC-II, which plays a role in 
priming of T-cells and therefore provides a link between the innate and the adaptive 
immune system (Culshaw et al., 2008; Vono et al., 2017). Further research is 
warranted on the functional characterization of these neutrophils and their impact 
on the brain in ageing particularly following acute stress. 
 
The gut microbiome has emerged as being essential for brain health in ageing and as 
a key player in the bidirectional communication across the gut–brain axis (Leung and 
Thuret, 2015; Dinan and Cryan, 2017). Previous research points out a role of aged 
microbiota in driving systemic immunity (Fransen et al., 2017; Thevaranjan et al., 
2017). In addition, key metabolites which are produced by the gut microbiota 
following i.e. a prebiotic-enriched diet such as short-chain fatty acids (SCFAs) has 
been implicated in alleviating stress-induced alteration (van de Wouw et al., 2018). 
In addition, we show that prebiotic supplementation is capable of dampening age-
associated systemic inflammation, particularly TNFα, following stimulation with 
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Concanavalin A. As ConA stimulates both, T- and NK-cells, it seems that both cell 
types are in particular sensible to prebiotic treatment in middle-aged mice compared 
to LPS stimulation which unspecifically stimulates immune cells. We previously 
showed that prebiotic treatment rescues immune alteration induced by chronic 
psychosocial stress following ConA stimulation exclusively (Burokas et al., 2017) 
suggesting that prebiotics might have specific effects on immune priming on T- and 
NK-cells systemically, and may influence brain function and behaviour as recent 
research showed a role of T-cell activation in regulating behaviour, anxiety-like and 
fear-related behaviour (Miyajima et al., 2017), cognition (Derecki et al., 2010) and 
sociability (Filiano et al., 2016). A critical factor for T-cell activation is the availability 
of specific amino acids such as leucine (Sinclair et al., 2013). By using HAIIA, we 
identified strong correlations between prebiotic-driven changes in gut microbiota, 
Bifidobacterium and Akkermansia with several amino acids in faecal water, including 
valine, leucine and isoleucine amongst others. In fact the gut microbiome has been 
implicated in regulating amino acid availability (Lin et al., 2017). Interestingly, a 
recent study in a Chinese cohort of middle-aged to elderly individuals found a 
correlation between Akkermansia and CD8+ as well as CD4+ T cells (Shen et al., 2018).  
 
A bidirectional relationship between the brain and the peripheral immune system 
exists (Varvel et al., 2016), which can promote neuroinflammation and exacerbate 
neuronal damage in the hippocampus. Recent studies suggest a constant influx of 
immune cells, inflammatory monocytes (Ly-6Chi-monocytes), into the brain even 
under steady-state conditions (Möhle et al., 2016; Korin et al., 2017; Mrdjen et al., 
2018). Previously these cells were thought to only play a role in inflammatory 
conditions such as following viral infection and associated encephalitis (Getts et al., 
2008) or after social defeat stress (Wohleb et al., 2013; Sawicki et al., 2015). 
However, recent research suggests that trafficking of Ly-6Chi-monocytes into the 
brain is crucial for brain plasticity and influence cognitive behaviour (Möhle et al., 
2016). This link was mediated by the gut microbiome as antibiotic depletion and 
subsequent reconstitution of the gut microbiome restored the antibiotic-induced 
deficits in brain plasticity and cognitive behaviour (Möhle et al., 2016). To 
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characterize if these Ly-6Chi-monocytes also affect the brain in middle-aged mice 
before animals were tested behaviourally, we assessed their neuroimmune status in 
cohort two. Here we show that middle-aged mice exhibited an increased influx of 
inflammatory monocytes into the brain. To correlate the changes in behaviour with 
specific neuroimmune markers which link monocyte trafficking to microglia 
activation, we subsequently analysed targets in the brain at the end of the study. Ly-
6Chi-monocytes are hereby recruited to the brain in a CCL2-dependent manner 
(Mildner et al., 2007; Getts et al., 2008; Sawicki et al., 2015). We show that Ccl2 is 
specifically upregulated in the hippocampus of middle-aged mice, but not present 
following prebiotic supplementation suggesting that this is may be a potential 
pathway in which gut-microbiota-immune-brain communication can affect brain 
function and behavioural traits in this key region for learning and memory. However, 
despite these changes in neuro-immunity, we have not identified any overt cognitive 
impairments in middle-aged control mice. Although it is worth noting that the 
dynamics of hippocampal Ccl2 expression correlated with cognitive behaviour 
assessed in the Morris water maze paradigm. Interestingly, prebiotic-driven changes 
in the neuroinflammatory profile are not universal across brain regions as there were 
no changes in the prefrontal cortex. This is in line with previous findings that there 
are marked regional differences in microglia activation across brain regions (Grabert 
et al., 2016). Interestingly, we found that middle-aged mice exhibited increased 
microglia activation under basal conditions before animals were behaviourally 
assessed. This subset of inflammatory activated microglia expressed Ly-6C (Mildner 
et al., 2007; Stirling et al., 2014; Mrdjen et al., 2018) and have been suggested to 
arise from Ly-6Chi-monocytes (Getts et al., 2008). Recent work has demonstrated a 
modulatory effect of the gut microbiota on microglia function (Erny et al., 2015; Rea 
et al., 2016; Vuong et al., 2017). Of note, germ-free mice exhibited deficits in 
microglia maturation and function while addition of SCFAs rescued these deficits. 
However, the short-chain fatty acid receptor FFAR2 is actually not present on 
microglia (Erny et al., 2015), but on monocytes (Ang et al., 2016). Future studies are 
needed to investigate the mechanistic relationship between these receptors and 




Microglia activation has been shown to alter cognitive and anxiety-like behaviour 
(Wohleb et al., 2014; Tay et al., 2017). Here, we show that prebiotic supplementation 
improves anxiety-like behaviour and cognition in young adult mice. This is in 
accordance with previous studies which targeted the gut microbiome by dietary 
interventions in rodents (Savignac et al., 2015; Tarr et al., 2015; Vazquez et al., 2015; 
Burokas et al., 2017; Mika et al., 2018). Interestingly, studies using a probiotic mix 
(VSL#3) failed to show improvements in anxiety-related behaviour (Beilharz et al., 
2017) suggesting that strain selection is very important and that prebiotics might be 
a better approach to improve behaviour. Moreover, we show that middle-aged 
control mice showed a decreased number of centre visits in the open field suggesting 
increased anxiety-like behaviour (Ennaceur et al., 2008), which may have influenced 
cognitive performance (Shoji et al., 2016). Middle-aged mice displayed mild cognitive 
impairments, which were not present following prebiotic supplementation. It is 
worth noting that neuroinflammation at this stage was not significant enough to 
manifest in major cognitive impairments. However, our data imply that prebiotic 
intervention may have some potential to counteract cognitive decline. As the impact 
of prebiotic supplementation on behaviour, particularly the cognitive tests, is clearly 
stronger in adult subjects, the data suggests that prebiotics may be less effective as 
we age. On the other side, a much longer exposure to prebiotics might be needed to 
achieve significant effects suggesting that supplementation may have to start earlier 
to be effectively preventative before alterations in the brain occur. This is particularly 
evident for the behaviour. On the other side, particularly in light of the stress-induced 
peripheral immune data, the system may need to be challenged to potentially exert 
negative behavioural effects (Fonken et al., 2018) before prebiotic supplementation 
can act beneficially (Burokas et al., 2017). Future studies focused on long-term effects 
of this mid-life microbiota manipulation are now warranted.  
 
We hypothesized that the dysregulated gut-microbiome-brain axis in middle-aged 
mice can be ameliorated by targeting the gut microbiome with prebiotics known to 
promote beneficial bacteria like Bifidobacteria. It was previously shown that the 
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prebiotic, inulin, can alter the microbiome composition under pathophysiological 
conditions such as following high-fat diet (Zhang et al., 2017) or in extreme ageing 
(Matt et al., 2018); however, its effects remained unexplored in healthy 
ageing/middle age. In fact, by utilizing FOS-Inulin, we show a profound yet 
differential alteration of the gut microbiota composition in both young adult but also 
in middle-aged mice. This was concomitant with a change in short-chain fatty acids 
with propionate increased in prebiotic-treated middle-aged mice while prebiotic 
supplementation decreased valerate in both, young adult and middle-aged mice.  
 
Previous research has shown that diet-driven modulation of the gut microbiota by 
administration of prebiotics can modulate peripheral immune response in the serum 
of naïve mice (Burokas et al., 2017) and we recently showed that SCFAs attenuate 
the effect of chronic stress (van de Wouw et al., 2018). It was shown previously that 
propionate can inhibit the production of pro-inflammatory cytokines (Vinolo et al., 
2011). Moreover, in-vitro experiments suggests pro-inflammatory capabilities of 
valerate while it enhanced LPS-induced inflammatory response in a murine N9 
microglial cell line (Huuskonen et al., 2004). Although the effects on SCFA levels is 
relatively modest it is possible that some of the anti-inflammatory effects of prebiotic 
supplementation might have been mediated by the changes observed in SCFA 
concentrations. 
 
We have previously reported a shift in microbial composition by prebiotics in adult 
mice (Burokas et al., 2017) but the impact on middle-aged remained unexplored. 
Interestingly, we found an increase in species richness in middle-aged mice, which is 
in line with previous findings in rodents (Scott et al., 2017) and humans (Odamaki et 
al., 2016). In fact, it has been shown in humans that the gut microbiota remarkably 
changes with ageing not only in diversity but also representation of specific taxa 




Prebiotic supplementation increased the relative abundance of Bifidobacterium, 
which is in accordance with previous studies in humans (Gibson et al., 1995). 
Interestingly, Bifidobacteria has been reported to be reduced in the elderly (Hopkins 
et al., 2001). In addition, supplementation increased the relative abundance of 
Akkermansia in middle-aged mice suggesting that prebiotics might promote a young 
microbiota phenotype, compared to a previous study where Akkermansia abundance 
strongly declined in 12- vs. 4-months-old control mice (van der Lugt et al., 2018). 
When transferring faecal matter from old mice to young germ-free (GF) mice, 
Akkermansia was lower abundant in those recipients than in GF mice that received 
young microbiota (Fransen et al., 2017). Interestingly, Akkermansia has been 
associated with immune modulation (Fransen et al., 2017), has shown to protect 
against inflammation and promote gut health in diet-induced obesity (Everard et al., 
2013), and restored intestinal permeability and subsequent immunomodulation in 
aged mice (Bodogai et al., 2018). Moreover, Akkermansia has been found to be 
enriched in super-centenarians (Biagi et al., 2016). Together with Bifidobacterium, 
Akkermansia are claimed as longevity-adapted and possibly health-promoting taxa 
and therefore might be involved in healthy ageing (Biagi et al., 2016). It is worth 
noting that learning performance strongly correlated with the abundance of 
Akkermansia suggesting a link between microbiota and cognitive performance. 
Future studies are warranted to investigate the potential beneficial impact of 
Akkermansia on cognitive performance and healthy ageing. 
 
In conclusion, the present study identified a strong neuroimmune phenotype in 
middle-aged mice. Moreover, prebiotic-driven changes in gut microbiota 
composition are beneficial for host health and associated well-being in middle-aged 
mice (Figure 5). Prebiotic supplementation is capable of altering age-induced 
changes in brain homeostasis, particularly alleviation of microglia activation, 
suggesting a preventative strategy towards preservation of cognitive health in 
ageing.  Taken together, the modulatory effects of prebiotic supplementation on 
monocyte infiltration into the brain and accompanied regulation of age-related 
microglia activation highlight a potential pathway by which prebiotics can modulate 
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peripheral immune response and alter neuroinflammation in ageing. Our data thus 
suggest a novel strategy for the amelioration of age-related neuroinflammatory 
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2.2.1 Abstract  
Psychological stress during adolescence may cause enduring cognitive deficits and 
anxiety, both in humans and animals that are accompanied by a rearrangement of a 
multitude of brain structures and functions. A healthy diet is essential for proper 
brain development and for the maintenance of optimal cognitive functions during 
adulthood. Furthermore, nutritional components profoundly affect the intestinal 
community of microbes that may impact on gut to brain communication. We 
adopted a relatively mild stress protocol, the social instability stress that when 
repeatedly administered to juvenile rats, modifies cognitive behaviors and plasticity 
markers in the brain. We then tested the preventive effect of a prolonged diet 
enriched with the -3 polyunsaturated fatty acids eicosapentaenoic, 
docosahexaenoic, docosapentaenoic acid, and vitamin A. Our study highlighted the 
beneficial effect of the enriched diet on cognitive memory impairment induced by 
social instability stress, as rats fed the enriched diet exhibited performance in both 
emotional and reference memory test indistinguishable from non-stressed rats. 
Furthermore, the decline of brain derived neurotrophic factor (BDNF) expression in 
the hippocampus and shifts in microbiota composition of stressed rats were 
normalized by the enriched diet. The detrimental behavioral and neurochemical 
effects of adolescent stress as well as the protective effect of the enriched diet were 
maintained through adulthood, long after the exposure to the stressful environment 
was terminated. Taken together, our results strongly suggest a beneficial role of 
nutritional components to ameliorate stress-related behaviors and associated 




In rodents, as in humans, adolescence is a time of developmental changes and 
reorganization in the brain and stress systems, marked by cognitive maturation and 
behavioral changes (Spear, 2000). Interactions with age-matched conspecifics during 
adolescence are important for appropriate rodent neurodevelopment and any 
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alteration to such adolescent social experiences can result in neurobehavioral 
measurements relevant to anxiety, depression, and substance of abuse (Burke et al., 
2017). Preclinical research has focused on earlier and later periods of development, 
as several reports have demonstrated that early-life stress in rodents as well as in 
humans represents a neurodevelopmental risk with implications to subsequent 
cognitive abilities during adulthood (Kaplan et al., 2001; Oomen et al., 2011). Given 
the paucity of data on the key factors that contribute to the detrimental effects of 
adolescence stress, no effective strategies have been developed to prevent or cure 
these problems. In this respect, nutrition is one of the key lifestyle factors that 
contributes to mental health, and has far-reaching consequences on cognitive 
functions that extend late in life (Laus et al., 2011; Prado and Dewey, 2014). Among 
the nutritional components associated with optimal brain functioning, the -3 
polyunsaturated fatty acids (-3 PUFAs) play a critical role in the development and 
function of the central nervous system (CNS). In animal studies, prenatal deficiency 
of brain -3 PUFAs is associated with enduring neuroanatomical and 
neurotransmitters alterations, neurocognitive deficits, elevated behavioral indices of 
anxiety, aggression, and depression (reviewed in (McNamara and Carlson, 2006)) and 
increased vulnerability to the effect of inflammatory events (Delpech et al., 2015; 
Labrousse et al., 2018). Recent studies have proven the long lasting, beneficial 
cognitive effects of a diet supplemented with the -3 PUFAs eicosapentaenoic acid 
(EPA), docosahexaenoic acid (DHA) on early stressful events such as maternal 
separation (Mathieu et al., 2011; Pusceddu et al., 2015), or following -3 PUFAs 
deficiency during the perinatal period (Lozada et al., 2017; Robertson et al., 2017). 
Also, supplementation with -3 PUFAs prevented the emotional and neuronal 
impairments induced by chronic social defeat in adult mice (Larrieu et al., 2014) and 
ameliorated memory performance in aged animals (Denis et al., 2013). Another 
essential nutrient is vitamin A, that through its active metabolite retinoic acid, plays 
a key role in cognitive functions in adult (Olson and Mello, 2010) and aged rats 
(Bonhomme et al., 2014). Vitamin A deficiency increased hypothalamus-pituitary-
adrenal axis activity and vitamin A-deficient rats showed a delayed and heightened 
corticosterone response to restraint stress (Marissal-Arvy et al., 2013). On the 
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contrary, vitamin A supplementation to adult rats prevented age-associated spatial 
memory decline (Touyarot et al., 2013). A vast literature indicates that -3 PUFAs 
and retinoic acid signaling pathways may act together to modulate memory and 
synaptic plasticity and indeed, a combined diet enriched with EPA-DHA and Vitamin 
A had synergistic behavioral and neurochemical effects in middle-aged rats (Letondor 
et al., 2016). However, the long-lasting effects of a prolonged diet enriched with 
these micronutrients on the detrimental consequences of adolescence stress is a 
fairly unexplored field.  
The gut microbiota has emerged as one of the key regulators of brain health across 
the lifespan including adolescence (McVey Neufeld et al., 2016; McVey Neufeld et 
al., 2016; Dinan and Cryan, 2017). Stress and other insults can seriously impact the 
composition of the microbiome (Foster et al., 2017) and dietary interventions have 
been shown to normalize such effects (Pusceddu et al., 2015). Moreover, -3 PUFAs 
deficiency or supplementation have been shown to differentially modulate 
microbiome composition (Pusceddu et al., 2015; Robertson et al., 2017; Robertson 
et al., 2017).  
In the current study, we hypothesized that a diet enriched in -3 PUFAs and Vitamin 
A may prevent immediate and long-lasting behavioral deficit, neurochemical and 
intestinal microbiota changes induced by stress during adolescence. We used the 
social instability stress, a well validated animal model of social stress that produces 
long-lasting effects on cognitive and emotional responses that may persist for the 
entire life (McCormick et al., 2015; Burke et al., 2017). We then adopted a multilevel 
approach at two different ages (immediately after completion of the social instability 
stress procedure and at adulthood) using a battery of behavioral tests 
comprehensive of several domains potentially affected by chronic stress: cognition 
pertaining to emotional and recognition memory, anxiety-like and anhedonia-like 
responses. We also measured the expression of Brain Derived Neurotrophic Factor 
(BDNF) that promotes neuronal survival, regulates nerve cells differentiation and 
may influence cognitive impairment (Buchman et al., 2016), and of synaptophysin, 
an abundant synaptic vesicle-associated protein involved in synaptic formation 
(Tarsa and Goda, 2002) in the hippocampus and frontal cortex of adult and 
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adolescent rats. These brain regions are particularly vulnerable to the negative 
impact of stress, especially during early-life (Bennett and Lagopoulos, 2014).  
In addition, we investigated the short and long-term impact of social instability stress 
and the dietetic intervention on caecal microbiota composition and short chain fatty 
acids (SCFA) production. Our findings revealed that the -3 PUFAs/Vitamin A 
enriched diet prevented adolescent stress-induced cognitive and microbiome 
changes.  
2.2.3 Materials and Methods 
2.2.3.1 Social Instability stress.  
Male Wistar rats arrived to our animal facility at PND 25 and were randomly assigned 
to three experimental groups: a group of non-stressed animals fed with the control 
diet (NSCD), a second group subjected to social instability protocol and fed with the 
control diet (SCD), and a third group also submitted to stressful manipulation and fed 
with the enriched diet (SED). The social instability stress involves changing the social 
housing conditions of adolescent rats according to (McCormick et al., 2015). In brief, 
on each day from postnatal days (PND) 30 to 45, rats were isolated for 1 h in 
ventilated, round small plastic containers (10 cm in diameter), akin to restraint. After 
isolation, rats were housed with a new partner undergoing the same procedure in a 
new cage. The stress regimen occurred at various times during the light cycle to 
decrease the predictability of the event. After the last isolation on PND 45, rats were 
returned to their original cage partner. Non-stressed rats were not disturbed except 
for regular cage maintenance and to be weighed. The consequences of the social 
instability stress procedure were assessed during adolescence (PND 46-51) and 
during adulthood (PND 70-76) using a battery of tests comprehensive of several 
domains affected by chronic stress: cognition (novel object recognition and 
contextual fear conditioning), anhedonia-like behavior (sucrose preference), anxiety-
like behavior (elevated plus maze). Locomotor activity was measured in an open field 
arena. One day after the end of the behavioral tests, the brains and caecal content 
were collected for neurochemical determinations and metagenomics analysis, 
respectively. Different cohorts of animals were used at the two time points. The 
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experimental timeline is depicted in Fig. 1A. Details of the behavioral tests, western 
blot and metagenomics analysis are provided in the Supplementary Information. 
Previous reports indicate that while adult rats readily habituate to this procedure, 
adolescents show increased corticosterone release in response to repeated changes 
of cage partners. Consistently, the long-lasting cognitive and emotional alterations 
observed in adolescent rats subjected to the social instability procedure were not 
found in adults rats, suggesting that this model may capture adolescent-specific 
stress reactivity (Hodges and McCormick, 2015; McCormick et al., 2015). 
2.2.3.2 Diets composition.  
Diets were matched for macronutrients content and the detailed composition is 
shown in SI Table S1. To prevent oxidation of PUFAs, diets were maintained in air-
sealed bags at 4 oC in the dark. Food was changed and weighted every day.  
 
2.2.4 Results 
We adopted the social instability protocol (McCormick et al., 2015) consisting of daily 
isolation followed by change of cage partners from PNDs 30 to 45 (Fig. 2.2-1A). In 
rodents adolescence is defined by the time elapsed between weaning at PND 21 and 
the firsts signs of puberty that in males coincides with preputial separation occurring 
around PND 42±3 (Spear, 2000). To assess if social instability stress cause acute and 
long-lasting deficits and if an -3 PUFAs/Vitamin A enriched diet (SI Table S1) could 
ameliorate stress-induced deficits we utilized a battery of measurements and 
behavioral tests, that were performed starting on the day after completion of the 





Figure 2.2-1. (A) Time line for the adolescent social instability stress experiment. 
Adolescent rats were randomly assigned to three experimental groups: NSCD, SCD, 
and SED. (B and C) Effects of stress and enriched diet on body weight at PND 45 on 
completion of the stress procedure (B) and at PND 70 (C). n = 18–24 rats/group. ***P 
< 0.001, *P < 0.05 vs. NSCD rats; ##P < 0.01, #P < 0.05 vs. NSCD by one-way ANOVA 
and the Bonferroni test. 
2.2.4.1 Effect of stress and enriched diet on body weight and food consumption  
As shown in Fig. 1B, adolescent stressed gained less weight than non-stressed rats 
(F(2,61)=9.950; P<0.001), an effect that lasted until adulthood (F(2,59)=5.262; P<0.01; Fig 
2.2-1C) as previously reported (Hodges and McCormick, 2015). This effect was 
counteracted by -3 PUFAs/Vitamin A enriched diet. At both ages, rats ate 
comparable amounts of food independently of stress and diet (SI Fig. 1S A, B). 
2.2.4.2 Enriched diet prevented the cognitive impairments induced by Social 
Instability Stress.  
Two weeks of social instability stress had a negative impact on recognition memory 
that lasted until adulthood. For short-term memory (1 hr after training), adolescent 
rats spent significantly more time exploring the novel object regardless of stress or 
diet (objects F(1,34)=62.88, P<0.001; condition F(2,34)=0.0, P>0.05; interaction 
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F(2,34)=4.43, P>0.05; Fig. 2.2-2A). Regarding long-term memory (4 hrs after training), 
Stressed rats fed with Control Diet (SCD) did not discriminate between the two 
objects (Fig. 2B). The enriched diet fully prevented the stress-induced impairment of 
object discrimination (objects F(1,30)=59.11, P<0.001; condition F(2,30)=0, P>0.05; 
interaction F (2, 30)=15.01, P<0.01). The cognitive impairment induced by the social 
instability stress persisted into adulthood and was prevented by the enriched diet 
administered since adolescence (F(1,30)=67.45, P<0.001; conditions F(2,30)=0, P>0.05; 
interaction F(2, 30)=14.08, P<0.001; Fig. 2.2-2D).  
 
Figure 2.2-2. The enriched diet prevented stress-induced cognitive impairment in 
the novel object recognition test. (A and C) Stress did not affect the performance of 
either adolescent or adult rats when the test was performed at 1 h after training. (B 
and D) Adolescent and adult stressed rats showed memory impairment when tested 
at 4 h after training, which was prevented by dietary supplementation with ω-3 
PUFA/vitamin A. n = 6–8 rats/group. ***P < 0.001; **P < 0.01; *P < 0.05 vs. familiar 
object within each experimental group by two-way ANOVA and the Bonferroni test. 
 
 
Furthermore, we tested rats with an emotional arousing training experience that 
engages both contextual and emotional memory processing: the contextual fear 
conditioning paradigm. Freezing time obtained during a 3 min re-exposure of rats to 
the conditioning apparatus 24 hrs after acquisition was used as an index of memory 
of the aversive experience. As shown in Fig. 2.2-3A, social instability stress did not 
affect acquisition of fear memory irrespective of diet, whereas SCD adolescent rats 
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froze less during context retrieval than did Non-Stressed rats fed with Control Diet 
(NSCD; F(5, 55)=22.77, P<0.001). The enriched diet restored contextual fear memory 
expression, as SED rats spent significantly more time freezing at recall than SCD rats 
which were indistinguishable from NSCD rats. The emotional memory deficit and 
beneficial effects of the enriched diet were long lasting, as adult Stressed rats fed 
with Enriched Diet (SED) froze significantly more than SCD rats (F(5, 55)=47.95, 
P<0.001; Fig. 2.2-3B) 
 
Fig 2.2-3. The enriched diet prevented immediate (A) and long-term (B) stress-
induced cognitive impairment in the contextual fear conditioning test. Rat freezing 
time did not differ at training regardless of treatment condition. When tested at 24 h 
after training, the SCD rats showed a lower freezing time than the NSCD rats, and the 
SED rats showed no stress-induced cognitive impairment. n = 9–10 rats/group. ***P 
< 0.001, **P < 0.01 vs. respective training; ###P < 0.001, #P < 0.05 vs. SCD by one-




2.2.4.3 Enriched diet prevented short and long-term effects of social stress on the 
expression of BDNF.  
To investigate the effect of stress and diet on brain plasticity, we assessed the 
expression of BDNF in the brain. We found significant differences in BDNF protein 
levels in the hippocampus of adolescent rats (F(2,27)=10.33, P<0.001; Fig. 2.2-4A). 
BDNF expression was decreased in SCD compared to NSCD rats and this effect was 
prevented by the enriched diet. In the frontal cortex of adolescent rats, stress did not 
significantly modify BDNF, whereas the enriched diet increased BDNF levels 
(F(2,27)=5.808, P<0.01; Fig. 2.2-4B). Interestingly, social instability stress led to long-
lasting decrease of hippocampal BDNF while enriched diet prevented the effect of 
social instability stress (F(2,28)=6.896, P<0.01; Fig. 2.2-4C). Similar to adolescent rats, 
BDNF levels were significantly increased following enriched diet in the frontal cortex 
of adult rats (F(2,24)=3.680, P<0.05; Fig. 2.2-4D). 
In addition, we used Western blot analysis to detect synaptophysin (a glycoprotein 
associated with presynaptic vesicles) as a marker of synaptic density. Synaptophysin 
expression of adolescent and adult rats was not significantly affected by stress (SI Fig. 
S2), in agreement with a previous report (McCormick et al., 2012). In adolescent rats, 
the enriched diet did not significantly affect synaptophysin expression in the 
hippocampus (F(2,28)=2.121, P>0.05), nor in the cortex (F(2,29)=2.727, P>0.05). In adult 
rats, though, we observed a significant, diet-induced increase of synaptophysin 
expression both in the hippocampus (F(2,26) =8.858, P<0.001) and frontal cortex 
(F(2,27)=3.705, P<0.05) which is consistent with the previous observation that long 
exposure to -3 PUFAs increase hippocampal synaptophysin expression (Venna et 




Fig. 2.2-4 The enriched diet restored BDNF expression in the brain of stressed rats. 
(A and B) Stress decreased BDNF levels in the hippocampus in both adolescent (A) and 
adult (B) rats. The enriched diet restored BDNF expression to control levels. (C and D) 
In the prefrontal cortex of stressed rats, the BDNF decrease did not reach statistical 
significance in either adolescence (C) or adulthood (D); nonetheless, the enriched diet 
augmented BDNF expression compared with stressed and control rats. (Insets) 
Representative immunoblots for each experimental group. n = 8–10 rats/group. **P 
< 0.01; *P < 0.05 vs. NSCD; ###P < 0.001, ##P < 0.01, #P < 0.05 vs. SCD by one-way 
ANOVA and Bonferroni’s test. 
 
2.2.4.4 Anhedonia-like behavior.  
In agreement with recent data (Marcolin et al., 2018) no differences were observed 
between stressed and control animals fed with the control diet in terms of 
preference towards the consumption of a sweetened solution when evaluated at 
different time points (SI Fig. S3). Neither stress nor the enriched diet had an effect 
on anhedonia-like behavior, as the preference for a sucrose sweetened drink was not 
affected by any of the experimental manipulations at any age tested.  
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2.2.4.5 Locomotor activity and anxiety-related behaviors.  
Locomotor activity measured as the distance travelled and time spent moving in an 
open field was comparable among the groups within each age, although adult rats 
were less active then adolescents (SI Table S2). Neither stress nor diet affected the 
number of entries and time spent in the center or periphery of the open field (SI 
Table S2). Treatment conditions did not affect other exploratory behaviors such as 
climbing, rearing, grooming indicative of a non-distressed state. Accordingly, there 
was no effect of treatment conditions on the number of entries and percentage of 
time spent by adolescent or adult rats in the open arms of the elevated plus maze (SI 
Table S3).  
2.2.4.6 Enriched diet prevented acute stress-induced changes in caecal microbiota 
composition of adolescent rats. 
The enriched diet increased alpha diversity (Chao1) of caecal microbiota of 
adolescent SED rats compared to both SCD (P<0.05; SI Fig. S4B) and NSCD rats 
(P<0.01). Consequently, significant differences were found in observed species 
(P<0.05 and P<0.01, respectively) indicating that the dietary intervention acutely 
increased microbiota diversity in adolescence irrespective of stress exposure. This 
was restricted to adolescence as there was no long-lasting effect of diet on diversity 
into adulthood. Principle Component Analysis (PCA) identified structural differences 
(beta-diversity) between adolescent NSCD and SCD rats (pairwise PERMANOVA, 
P<0.05; Fig. 2.2-5A) indicating a shift of the microbiome composition following social 
instability stress that was almost entirely prevented when stressed rats were fed the 
-3 PUFAs/Vitamin A enriched diet (pairwise PERMANOVA, P<0.1; Fig. 2.2-5A). No 
long-lasting impact of stress on the composition of the gut microbiota was identified 
in adult rats (Fig 2.2-5B). However, stressed rats exposed to an -3 PUFAs/Vitamin A 
enriched diet displayed a long-lasting shift in the gut microbiota composition 
(pairwise PERMANOVA, P<0.05; Fig. 2.2-5B). Compared to adolescent rats, adult rats 
exhibit a shift in the gut microbiota composition in all three treatment groups 
(pairwise PERMANOVA, P<0.05; Fig. 2.2-5C-E)   
Social instability stress during adolescence significantly modulated a multitude of 
taxa that were normalized by -3 PUFAs/Vitamin A enriched diet (Fig. 2.2-5F). Among 
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these, SCD rats had a decreased relative abundance of genera of the Lachnospiraceae 
family (in particular Acetatifactor, Anaerostipes and Lachnospiraceae NK4A136 
group) and several family members in the Ruminococcaceae family (in particular 
Ruminococcus 1), whereas the relative abundance of the Eubacterium genus as well 
as family members from Coriobacteriaceae were increased. These changes were 
largely counterbalanced by the -3 PUFAs/Vitamin A enriched diet. Independent of 
social instability stress, -3 PUFAs/Vitamin A enriched diet showed a long-lasting 
impact only on a few taxa into adulthood (Fig. 2.2-5F).  
Social instability stress reduced the concentration of the short-chain fatty acids 
(SCFAs), butyrate (P<0.05), valerate (P<0.05) and isobutyrate (P<0.05) in adolescent 
rats (SI Fig. S6). In contrast, SED rats exhibited an increase in isobutyrate (P<0.001) 
and isovalerate (P<0.05) that led to an overall increase in branched-chain fatty acids 
(BCFAs; P<0.001). In adult rats, the enriched diet decreased butyrate compared to 




Fig. 2.2-5 Social instability stress shapes the gut microbiome in adolescence. (A and 
B) PCA plots displaying beta diversity of the gut microbiome in adolescent (A) and 
adult (B) rats. (C–E) PCA plots comparing beta diversity of the gut microbiome for 
each treatment between adulthood and adolescence. (F) Changes in gut microbiome 
composition (genera) in adolescence (T1) and adulthood (T2). Changes in genera in 
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each age group are depicted as follows: (i) SCD vs. NSCD, (ii) SED vs. SCD, (iii) SED vs. 
NSCD. *P < 0.1, **P < 0.01, post hoc Benjamini–Hochberg test. 
 
2.2.5 Discussion 
Nutrition has a fundamental role in maintaining brain health and behavior at critical 
time periods, especially adolescence (Hueston et al., 2017). In rodents, appropriate 
essential micronutrient supplementation protects against cognitive decline 
associated with early life stress (Naninck et al., 2015). Our study corroborates the 
notion that dietary intervention affects neurobehavioral development (Robertson et 
al., 2017) by demonstrating for the first time, to the best of our knowledge, that a 
diet supplemented with the -3 PUFAs and vitamin A prevented the deleterious 
cognitive decline induced by social instability stress during adolescence, and the 
amelioration was maintained in adulthood. The rational for using a combination of 
-3 PUFAs and vitamin A stems from recent findings demonstrating a beneficial, 
synergistic effect of vitamin A and EPA/DHA on behavioral and neurobiological 
markers of aged rats (Letondor et al., 2016). Multiple levels of interactions occur 
between -3 PUFAs and retinoid signaling, as retinoic acid, the active metabolite of 
vitamin A, and DHA may bind to common nuclear receptors (de Urquiza et al., 2000). 
Furthermore, retinoic acid and -3 PUFAs have common intracellular signaling 
pathways such as AKT and ERK1/2 (Masia et al., 2007; Rao et al., 2007), that are 
known to be activated in several neuronal functions (Tang and Yasuda, 2017).  
We found that social instability stress during adolescence caused emotional and 
recognition memory impairments that were retained until adulthood. These 
behavioral changes were closely associated with alterations in BDNF expression in 
the hippocampus and the frontal cortex. Dietary -3 PUFAs/Vitamin A exposure from 
adolescence to adulthood was sufficient to prevent such alterations, and the 
beneficial outcomes were maintained through adulthood. 
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2.2.5.1 Enriched diet prevents memory and brain BDNF decline induced by social 
stress.  
Social instability stress in adolescence exerted long lasting effects on aversive and 
recognition memory. This is in line with previous reports that describe enduring 
deficits in contextual fear memory in response to adolescence stress (Morrissey et 
al., 2011). Indeed, the hippocampus is one of the brain structures crucially involved 
in regulation of stress responses (Reul and de Kloet, 1985). We found that social 
instability impaired contextual fear memory, a predominantly hippocampus-
dependent form of aversive memory (reviewed in (Kim and Diamond, 2002)) in both 
adolescent and adult rats.  
In the novel object recognition test as well, adolescent stressed rats showed long-
lasting memory impairments, an effect not previously observed (McCormick et al., 
2012). Infact, in McCormick’s study (McCormick et al., 2012), stressed rats had 
hippocampal-dependent spatial recognition impairment, but no reference memory 
deficit when tested 4 hs after training.  
We found a good correspondence between rats’ memory performance and BDNF 
expression in the hippocampus, as both were significantly decreased in stressed 
adolescent as well as adult rats and the enriched diet prevented both effects. Our 
results are in agreement with recent observations that -3 PUFAs induce BDNF 
increase in rat hippocampus (Vines et al., 2012). Unequivocal evidence suggests a key 
role for BDNF in the initiation of fear memory consolidation. Importantly, BDNF 
enhances and antibodies against BDNF impair fear memory when administered into 
the CA1 region of the hippocampus (reviewed in (Izquierdo et al., 2016)). Hence, 
BDNF expression and activity in the hippocampus is required to ensure successful 
storage for associative memory persistence over days (Bekinschtein et al., 2007). Our 
behavioral results are in accordance with these observations, as social instability 
stress reduced hippocampal BDNF and impaired contextual fear memory.  
In this regard, we cannot exclude that in our study BDNF modulation in the 
hippocampus affects also object memory. Although canonically the novel object 
recognition task is assumed to be largely independent of the hippocampus, some 
findings are challenging this theory (Clark et al., 2000; Cohen et al., 2013) pointing to 
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a temporal specificity for hippocampal involvement in object recognition memory 
(Hammond et al., 2004; Cohen and Stackman, 2015). Nonetheless, our results do not 
exclude that stressed-rats’ cognitive deficit is a global impairment in learning and 
memory function, rather than being specific to hippocampal responses. 
In the frontal cortex BDNF expression is required for fear memory consolidation and 
expression (reviewed in (Bekinschtein et al., 2014)). Social instability stress did not 
affect BDNF level significantly in the cortex, of adolescent and adult rats, though the 
enriched diet augmented BDNF level, presumably concurring in maintaining long-
term memory. 
2.2.5.2 Enriched diet does not affect behaviors relevant to anxiety and anhedonia.  
Social instability  administered during adolescence modifies several social behaviors, 
as stressed rats spend less time in social interactions with another male, have 
reduced sexual performance, longer latency to enter the center of an open arena 
(Green et al., 2013), all validated measures of anxiety-like behavior. Furthermore, the 
modified social repertoire is evident in adulthood weeks after the end of the stressful 
procedure (Burke et al., 2017). In our study, we found no difference between 
stressed and non-stressed rats in the latency to enter the center of the arena or in 
the number of entries, nor they showed behavioral differences in the elevated plus 
maze during adolescence or adulthood. One factor contributing to these 
discrepancies may be strain differences, which are known to be responsible for the 
anxiety profile (Ramos et al., 1997). In fact, Wistar rats used in our experiments 
appeared more resilient to the ones commonly used for anxiety-like tests. Other 
behavioral signs of stress, such as modified grooming, rearing or climbing (Kruk et al., 
1998; Fuzesi et al., 2016) were not affected by stress, nor by diet supplementation. 
Confirming recent data regarding the consumption of natural rewards (Marcolin et 
al., 2018), neither adolescent nor adult stressed rats did manifest anhedonia-like 
behavior in the sucrose preference test. 
2.2.5.3 Social instability stress during adolescence dramatically altered the gut 
microbiome which was reversed by -3 PUFAs/Vitamin A enriched diet.  
Increasing evidence shows that intestinal microbiota influences behaviors relevant 
to mood and cognitive functions. One of the ways that are proposed for such effects 
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is by producing metabolites with central effects, among which SCFAs are the most 
important (Bercik et al., 2011; Bravo et al., 2011; de Lartigue et al., 2011).  -3 PUFAs 
are known to have a positive action on the intestinal microbiota increasing the 
production of SCFAs (reviewed in (Costantini et al., 2017)). Moreover, perturbations 
of the microbiota during adolescence have been shown to result in enduring social 
and cognitive deficits (Desbonnet et al., 2015). 
Psychological stress (ranging from restraint stress to maternal separation and 
overcrowding) has been shown to alter microbiota composition (O'Mahony et al., 
2009; Bailey et al., 2011; Hsiao et al., 2013; De Palma et al., 2014; Bharwani et al., 
2017). Social instability stress induced striking differences in the gut microbiome 
composition of adolescent rats which were partially reversed by an -3 
PUFAs/Vitamin A enriched diet. Adolescence stress resulted in a decreased 
abundance of several genera within the Ruminococcaceae and the Lachnospiraceae 
family. The functional consequences of such changes are not clear at this stage but it 
is worth noting that both, Ruminococcaceae and Lachnospiraceae, were found to be 
decreased in patients with depressive disorders  (Jiang et al., 2015). In contrast, the 
Eubacterium genus was increased in stressed rats fed with control diet. 
Eubacteriaceae were found to be increased in rats with experimental colitis and 
when additionally exposed to stress (Konturek et al.) conditions where 
Lachnospiraceae were decreased (66). Coriobacteriaceae, in particular 
Enterorhabdus, were increased in SCD rats. This is in line with studies implicating 
Coriobacteriaceae with colonic health and inflammation (Morgan et al., 2012). 
Nonetheless, the enriched diet was sufficient to prevent such modifications. 
However, despite the stress-induced changes and independently of the diet, the 
intestinal microbiota during adulthood recovered the core microbiota composition 
characteristic of adult animals (Flemer et al., 2017).  Interestingly, no long-lasting 
impact of stress was identified in adult rats. However, stressed rats exposed to an -
3 PUFAs/Vitamin A enriched diet displayed a long-lasting shift in the gut microbiota 
composition. A limitation of our current study is that we cannot definitely prove a 
causal correlation between changes in microbiota and cognitive performance at this 
juncture. However, given that the microbiome has been implicated as a conduit for 
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the positive effects of nutrition on host health, modulation of the microbiota is a 
plausible mechanism as to how nutritional interventions may reduce the effects of 
stress (Sandhu et al., 2017), as we found that both diet and stress induced effects on 
both the microbiome and behavioral/neurochemical measures of cognitive 
functions. We also found that the enriched diet increased the production of branched 
SCFA whereas unbranched SCFA were unchanged. It was previously shown that SCFA 
levels strongly correlated with improvement in tests of anxiety- and depression-like 
behaviors induced by prebiotic diet (Burokas et al., 2017) and that SCFAs can reverse 
the enduring effects of social stress in adulthood .  
 
2.2.5.4 Conclusion 
Stress, emotional instability, impulsivity are all enhanced during adolescence and 
inadequate nutrition may exacerbate such conditions. Moreover, there is a growing 
link between changes in gut microbial composition and brain health in adolescence.  
Clinical studies have shown that young adults who endured environmental or 
psychosocial stressors during development or have low blood -3 PUFAs levels are 
often diagnosed with psychiatric disorders or cognitive impairments (Espejo et al., 
2007; Heim et al., 2008; Kuratko et al., 2013; Montgomery et al., 2013; Joffre et al., 
2014). Our study thus provides the first preclinical evidence that -3 PUFAs and 
vitamin A supplementation is sufficient to prevent long-lasting cognitive disturbances 
and modulate microbiota composition that accompany repeated, prolonged stressful 
stimuli during adolescence. Optimization of dietary components that affect brain 
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There is a growing emphasis on the role of the microbiota-gut-brain axis as 
modulator of host behaviour and as therapeutic target for neuropsychiatric 
disorders. In addition, accumulating evidence suggests that early-life stress can exert 
long-lasting changes on the brain and microbiota, and this early adversity is 
associated with increased risk for developing depression in later life. The maternal 
separation (MS) model in rats is a robust paradigm to study the effects of early-life 
stress on the microbiota-gut-brain axis. Recently, we have shown that   polyphenols, 
naturally occurring compounds associated with several health benefits, have anti-
stress effects in in vitro models. In this study, we assess the therapeutic potential of 
a variety of both flavonoid and non-flavonoid polyphenols in reversing the impact of 
MS on behaviour and the microbiota-gut-brain axis. 
Rats underwent a dietary intervention with the naturally-derived polyphenols 
xanthohumol and quercetin, as well as with a phlorotannin extract for 8 weeks. 
Treatment with polyphenols prevented the depressive and anxiety-like behaviours 
induced by MS, where xanthohumol effects were correlated with rescue of BDNF 
plasma levels. In addition, MS resulted in altered brain levels of 5-
hydroxyindoleacetic acid (5-HIAA) and dopamine, accompanied by abnormal 
elevation of plasma corticosterone. Although polyphenols did not reverse 
neurotransmitter imbalance, xanthohumol normalised corticosterone levels in MS 
rats. Finally, we explored the impact of MS and polyphenolic diets on the gut 
microbiota. We observed profound changes in microbial composition and diversity 
produced by MS condition and by xanthohumol treatment. Moreover, functional 
prediction analysis revealed that MS results in altered enrichment of pathways 
associated with microbiota-brain interactions that are significantly reversed by 
xanthohumol treatment. These results suggest that naturally-derived polyphenols 
exert antidepressant-like effects in MS rats, which mechanisms could be potentially 





Stress-related psychiatric disorders including depression and anxiety are currently a 
major public health concern. Indeed, the World Health Organisation (WHO) has 
predicted that depression will be the second largest cause of disability by 2020 
(Johnston et al., 2019). On the other hand, major depressive disorder is thought to 
result from the complex interplay of multiple inherited genetic factors and 
subsequent exposure to a wide range of environmental variables throughout life (aan 
het Rot et al., 2009); therefore, the search for adequate treatments is a great 
challenge as no established mechanisms have yet been determined (Berton and 
Nestler, 2006). Based on these observations and considering that depression has an 
inconsistent response to treatment, the development of new antidepressant 
strategies is increasingly being considered as a critical focus of research. 
It is well known that stressful events in early life can exert long-lasting changes in 
brain structure and function later on (Cryan and Dinan, 2013) and accumulating 
evidence indicates that this early life adversity is associated with an increased risk for 
developing depression (Chapman et al., 2004; Heim and Binder, 2012). For instance, 
inadequate maternal care has been linked to developmental, emotional and social 
deficits in humans (Field, 1998). In rodents, the maternal separation (MS) model is a 
well-described paradigm used to investigate the neurobiological and behavioural 
consequences of early life stress (O'Mahony et al., 2011; Nishi et al., 2014; Rincel and 
Darnaudery, 2019). For this reason, the MS model has been used to study various 
psychiatric conditions, especially depression (Meaney et al., 1996; Vetulani, 2013) 
(Wieck et al., 2013). 
The microbiota-gut-brain axis describes the complex bidirectional communication 
system that exists between the central nervous system (CNS) and enteric microbiota; 
involving endocrine, immune and neural pathways (Rhee et al., 2009; Foster et al., 
2017; Cryan et al., 2019). Accumulating research has focused on the impact of the 
microbiota on CNS function and stress perception, and its consequences for 
behaviour (Cryan and Dinan, 2012). Indeed, top down activation of the CNS can 
influence gut neuromotor and secretory function, immunity and microbiota 
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composition during stress (De Palma et al., 2014; Foster et al., 2017). In this regard, 
early-life stress models such as MS have long-term impact on the gut microbiota, 
which correlate with increased HPA axis activity and behaviour (Bailey and Coe, 1999; 
O'Mahony et al., 2009). Moreover, the MS model is sensitive to reversal treatments 
that target the gut microbiota (Gareau et al., 2007; Fukui et al., 2018; Cowan et al., 
2019; McVey Neufeld et al., 2019; O'Mahony et al., 2019). 
The emerging and compelling evidence for nutrition as a crucial factor in the high 
prevalence and incidence of mental disorders suggests that changes in diet are a 
viable strategy for improving mental health and treatment of psychiatric disorders 
including anxiety and depression (Jacka et al., 2014; Lai et al., 2014; Spencer et al., 
2017; Larrieu and Laye, 2018; Adan et al., 2019; Dinan et al., 2019). For instance, 
dietary polyphenols are a group of naturally occurring phytochemicals which are 
present in high amounts in fruits and vegetables and are characterised by the 
presence of multiple hydroxyl groups on aromatic rings (Vauzour, 2012). Several 
studies have focused on the potential of polyphenolic compounds in protecting 
cognitive function and reducing risk for developing neurodegenerative disorders 
(Spencer, 2008). In particular, some pre-clinical studies have confirmed the 
antidepressant capacity of polyphenols in different animal models (Anjaneyulu et al., 
2003; Kulkarni et al., 2008; Yi et al., 2008). Moreover, dietary polyphenols are capable 
of modulating the composition of the gut microbial community by inhibiting or 
stimulating the growth of certain bacteria (Lee et al., 2006). Hence, there is increasing 
interest in using polyphenols to target the microbiota-gut-brain axis to treat mental 
disorders (Filosa et al., 2018; Matarazzo et al., 2018). 
Polyphenolic compounds are characterised as having different functional activity 
depending on their chemical structure (Manach et al., 2004; Vauzour et al., 2010). 
For instance, phlorotannins are a type of polyphenolic tannins found in marine brown 
algae, which have been shown to possess anti-oxidant activity, as well as beneficial 
effects for different diseases such as cancer, cardiovascular problems and diabetes 
(Kim and Himaya, 2011). Other polyphenols can only be isolated from specific 
sources. Xanthohumol, for example, is described as a prenylated chalcone, a principal 
component of the female hop plant, Humulus lupulus (Stevens and Page, 2004). 
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Some health benefits associated with xanthohumol intake include anti-inflammatory 
and neuroprotective effects (Liu et al., 2015). In contrast, some members of the 
flavonoid family like quercetin are widely distributed in nature (Manach et al., 2004). 
Quercetin is one of the most studied polyphenols and has been demonstrated to 
confer protection against certain types of cancer, cardiovascular and 
neurodegenerative disorders (Boots et al., 2008). 
Recently, we showed that across a wide number of polyphenols, xanthohumol and 
quercetin were able to reverse the impact of corticosterone exposure in primary 
cortical neurons (Donoso et al., 2019). Moreover, although the antidepressant 
effects of several polyphenols have been studied in different preclinical studies (Xu 
et al., 2005; Bhutada et al., 2010; Liu et al., 2014), their therapeutic effects have not 
yet been examined in models of early life stress, nor the mechanisms underlying the 
polyphenol-mediated alleviation of mood. Therefore, the purpose of this study was 
to explore the therapeutic effects of different naturally derived polyphenols, 
including phlorotannins, xanthohumol and quercetin in the MS model in rats. In 
addition, the consequences of MS and polyphenol diet intervention on different 
aspects of the microbiota-gut-brain axis were explored.  
In this regard, we evaluated important components involved in the regulation of this 
axis, including BDNF, which is a crucial neurotrophin associated with plasticity and 
neuronal survival (Brunoni et al., 2008; Lee and Kim, 2010); the assessment of 
neurotransmitter concentrations in the brainstem, an important brain locus for 
monoaminergic transmission and which is implicated in mood disorders (Sasaki et al., 
2008), as well as highly influenced by the gut microbiota (Strandwitz, 2018); and the 
response to acute stress through the determination of plasma corticosterone, the 
main rodent stress hormone (de Kloet et al., 2005; Joels et al., 2018). Finally, we 
evaluated the consequences of MS and diet intervention with polyphenols on the gut 
microbiota abundance and through the determination of short-chain fatty acids 
(SCFAs), microbial metabolites thought to play a critical role in gut-brain 
communication (van de Wouw et al., 2018; Dalile et al., 2019). Together, findings 
from this study have the potential to provide new insights into the potential 
therapeutic effects of polyphenols and the role of the microbiota-gut-brain axis in 
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stress-related disorders, and add an important direction to future dietary advice on 





All experimental procedures involving animals were approved by the Ethics 
Committee of University College Cork. Pregnant Sprague Dawley dams weighing 250–
300 g were bred in-house in the Biological Services Unit facility, University College 
Cork. The pups were housed with their mothers in plastic cages (15 × 22 × 9 cm) in a 
temperature and humidity controlled room on a 12-h light, 12-h dark cycle (lights on 
from 7.00–19.00 h). Food and water were available ad libitum. 
2.3.3.2 Drugs 
Quercetin (Q4951) was purchased from Sigma. Xanthohumol (A-4-2014) was 
provided by Hopsteiner, GmbH (Mainburg, Germany). Phlorotannin-rich extract from 
Fucus vesiculosus (Gite et al., 2019) was obtained from National University of Ireland, 
Galway (Galway, Ireland). All diets were prepared by ssniff Spezialdiäten (Ferdinand-
Gabriel-Weg, Germany). The resulting grain based chows were isoenergetic and had 
the same proportion of macronutrients (carbohydrates, proteins and lipids). 
2.3.3.3 Maternal separation procedure 
MS was performed as previously described (O'Mahony et al., 2009; Pusceddu et al., 
2015). Briefly, pups were separated from their mother as a whole litter and placed 
into plastic cages maintained at 30 – 33 °C in a separate room to prevent 
communication through ultrasonic vocalisation (Hofer et al., 1994). Following the 3-
hour separation, pups were returned to their original home cage with their mother. 
This procedure was repeated each day (9.00am–12.00pm) from post-natal day (PND) 
2 through PND12. NS-Control rats consisted of non-handled pups, left untouched by 
the experimenter, and with their respective mothers. After postnatal day 12, pups 
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were left undisturbed except for routine cage cleaning every two days. At weaning, 
male rats were group-housed (2 – 4) in large cages. 
2.3.3.4 Treatments 
The rats were randomly assigned into five different experimental groups [1] NS-
Control diet (n = 12); [2] MS-Control diet (n = 12); [3] MS-Phlorotannins 0.03% (n = 
10); [4] MS-Xanthohumol 0.015% (n = 10); [5] MS-Quercetin 0.03% (n = 10). Dietary 
intervention of polyphenols, delivered ad libitum in food, began once the animals 
were eight weeks old and continued for eight weeks. The concentrations for the 
polyphenols tested were calculated based on doses previously reported in animal 
models and considered the average daily food intake and body weight of Sprague 
Dawley rats aged between 9 and 16 weeks (Laaksonen et al., 2013). Estimated doses 
are as follows; quercetin 20 mg/kg/day (Haleagrahara et al., 2009); xanthohumol 10 
mg/kg/day (Ceremuga et al., 2013); phlorotannins 20 mg/kg/day (Ahn et al., 2017). 
In the interest of reduction in the 3Rs a number of other interventions were also run 
contemporaneously with the control and treatment groups used here (Egerton et al. 
unpublished). 
2.3.3.5 Elevated plus maze 
The elevated plus maze (EPM) is one of the most commonly used rodent tests for 
assessing anxiety and was performed as previously described (Cryan et al., 2004; 
Pusceddu et al., 2015). Briefly, the maze consisted of two open arms (51 × 10 cm; 5 
lux) and two enclosed arms (51 × 10 × 41 cm) that all extended from a common 
central platform (10 × 10 cm). The apparatus was elevated 55 cm above the floor on 
a central pedestal. Animals were habituated to the testing room for 30 min prior 
experiment. At week 12, animals were placed in the centre of the maze facing an 
open arm to begin. Animal behaviour was recorded for 5 min. Frequency of open and 
closed arms entries were scored, as well as percentage time spent in each arm. 
2.3.3.6 Open field test 
The open field test (OFT) is commonly used as a mechanism to assess anxiolytic 
effects of compounds (Seibenhener and Wooten, 2015). Briefly, at week 13 rats were 
placed in the centre of a white open field arena (60 × 40 cm; 60 lux) and observed for 
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10 min. Animals were habituated to the test room for 30 min prior to the experiment. 
All trials were conducted between 9.00am and 1.00pm. The arena was cleaned with 
70% ethanol to avoid smell cues between each trial. At the end of each trial, animals 
were returned to their cages. Distance moved, velocity, percentage of time spent in 
inner zone, and frequency of inner zone entries were analysed and recorded using a 
tracking system (Ethovision XT 13, Noldus). 
2.3.3.7 Forced swim test 
The forced swim test (FST) is the most widely used model for predicting 
antidepressant activity in rodents, and increased immobility in this test is generally 
considered to reflect a state of behavioural despair (Porsolt et al., 1978). Briefly, at 
week 15 a modified rat FST protocol (Slattery and Cryan, 2012) was used to 
determine the antidepressant effects of polyphenols in rats. On day one, rats were 
placed individually in glass cylinders (H: 45 cm; D: 20 cm) filled with water to a depth 
of 30 cm at 24±1 °C for a 15 min pre-test period. The rats were removed from the 
water, dried and placed in their home cage. The cylinders of water were changed 
between each trial. 24 hours after the pre-test, the rats were again placed in the 
swim apparatus for 5 min and behaviours were monitored from above with a video 
camera for subsequent analysis. Behaviours rated include immobility, climbing and 
swimming (scoring of behaviours was blind to the experimental conditions). The 5-
min session was scored using a time-sampling technique, whereby the predominant 
behaviour in each 5-s period of the 300-s trial was recorded. Climbing behaviour 
consisted of upward-directed movements of the forepaws along the side of the 
cylinder. Swimming behaviour was defined as movement (usually horizontal) 
throughout the cylinder. The rat was considered to be immobile when the only 
activity observed was that which was required by the rat to keep its nose above 
water. 
2.3.3.8 Plasma corticosterone determination 
Blood sample collection was performed as previously described (Pusceddu et al., 
2015). Briefly, blood samples were collected on day one of FST via a tail-tip incision 
at five different time points: immediately before (baseline), 30 min, 60 min, 90 min 
and 120 min after the test was started. Approximately 200 µl of blood was collected 
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in a tube containing 10 µL of EDTA 0.1 M to avoid coagulation. Blood plasma was 
obtained by centrifugation at 3500 × g at 4 °C for 15 min. Corticosterone levels were 
measured using the Corticosterone EIA kit (Enzo) according to the manufacturer 
instructions, and absorbance signal was detected with a conventional plate reader 
(Synergy HT, Biotek). 
2.3.3.9 Plasma BDNF measurement 
Immediately after sacrifice, trunk blood was collected in EDTA Vacutainer tubes. 
Blood plasma was obtained by centrifugation at 3500 × g at 4 °C for 15 min. Protein 
levels of brain-derived neurotrophic factor (BDNF) were determined using an 
electrochemiluminescence multiplex system (MSD, Gaithersburg, MD, USA) 
according to the manufacturer’s protocol. BDNF levels were determined and 
analysed using the MSD QuickPlex SQ 120 Instrument. 
2.3.3.10 Brain monoamines concentration 
The monoamine neurotransmitters noradrenaline (NA), serotonin (5-HT), dopamine 
(DA) and their metabolites 5-HIAA and 3,4-dihydroxyphenylacetic acid (DOPAC) were 
determined in the brainstem using high-performance liquid chromatography (HPLC) 
with electrochemical detection as described previously (Clarke et al., 2012; Pusceddu 
et al., 2015). Briefly, samples were homogenised in mobile phase (consisting in 0.1 M 
citric acid, 0.1 M sodium dihydrogen phosphate monohydrate, 5.6 mM 1-
octanesulfonic acid, 0.01 mM EDTA, 11.1% (v/v) methanol, and 0.1 µg/mL of N-
Methyl 5-HT as internal standard and adjusted to pH 2.8). Then samples were 
centrifuged 14000 g for 15 min at 4 °C, and 20 µL of this supernatant was injected 
onto the HPLC system (consisting in a CBM-20A system controller, a EC3000 Recipe 
amperometric detector, a LC-20AD XR pump, a CTO-20A column oven at 30 ⁰C, a SIL-
20AC XR autosampler, and a Prominence DGU-20A3 degasser). A reverse-phase 
column (Kinetex 2.6u C18 100A 100 mm X 4.6 mm, Phenomenex) was employed in 
the separation using a flow rate of 0.9 mL/min. Each neurotransmitter was identified 
through their characteristic retention times and their concentration was determined 
using the ratios of peak heights of analyte versus internal standard provided by the 
LabSolutions software (Shimadzu). Results were expressed as nanograms of 
neurotransmitter per grams of fresh tissue. 
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2.3.3.11 Gut microbiota 16S rRNA sequencing 
Microbial DNA was isolated from frozen faecal samples using the QIAGEN QIAamp 
Fast DNA Stool Mini Kit (Qiagen) according to the manufacturer’s directions. DNA 
concentration and quality was determined using the NanoDrop® ND-1000 UV-Vis 
Spectrophotometer (Thermo Fisher Scientific). The V3-V4 variable region of the 16S 
rRNA gene was amplified from the DNA extracts using the Illumina 16S metagenomic 
sequencing library protocol, and PCR reactions were performed with the KAPA HiFi 
HotStart PCR Kit (KAPA Biosystems). PCR products were cleaned using AMPure XP 
magnetic bead-based purification (Beckman Coulter Life Sciences). This was followed 
by indexing PCR which attached Nextera XT barcodes and Illumina sequencing 
adapters to the 5′ overhangs and another round of AMPure XP clean-up. Finally, 
samples were sequenced on the MiSeq™ System (Illumina®), using a 2 x 250bp cycle 
kit, following standard Illumina sequencing protocols. 
 
2.3.3.12 Short chain fatty acid determination 
The SCFAs acetate, propionate, butyrate, and valerate, as well as the total branched 
chain fatty acids (BCFAs) were measured in caecal content using gas chromatography 
flame ionisation detection (GC-FID) as previously reported (van de Wouw et al., 
2018). Briefly, samples were vortexed with Milli-Q water (1:10 w/v), left to stand for 
10 min at room temperature, and then centrifuged at 14000 g for 5 min. The 
supernatant was filtered (0.2 µm) before transfer to a GC glass vial, and 2-
ethylbutyric acid (Sigma) was added as internal standard.  SCFA concentrations were 
measured using a Varian CP-3800 GC flame-ionization system, fitted with a Zebron 
ZB-FFAP column (30 m × 0.32 mm × 0.25 µm; Phenomenex) and a flame ionisation 
detector with a CP‐8400 auto‐sampler. Helium was used as the carrier gas at a flow 
rate of 1.3 ml/min. The initial oven temperature was set at 100 °C for 0.5 min, raised 
to 180 °C at 8 °C/min and held for 1 min, then increased to 200 °C at 20 °C/min, and 
finally held at 200 °C for 5 min. The temperature of the injector and the detector 
were set at 240 °C and 250 °C respectively. A standard curve made from a standard 
mix of acetic acid, propionic acid, n-butyric acid and iso-butyric acid (Sigma) at seven 
concentrations. Peaks were integrated by using the Varian Star Chromatography 
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Workstation version 6.0 software. Standards were included in each run to maintain 
calibration. 
2.3.3.13 Statistical analysis 
Statistical analysis was performed using the software SPSS 24.0, and the results were 
presented as mean ± SEM. MS-control group and NS-control group were compared 
using independent T-test to assess the MS effect. All MS groups were analysed using 
one-way analysis of variance (ANOVA) followed by Dunnett’s post hoc test. A p-value 
of 0.05 was considered statistically significant. FLASH was used to assemble paired-
end reads. Further processing of paired-end reads including quality filtering based on 
a quality score of >25 and removal of mismatched barcodes and sequences below 
length thresholds was completed using QIIME (version 1.9.0). Denoising, chimera 
detection and clustering into operational taxonomic unit (OTU) grouping were 
performed using USEARCH v7 (64-bit). OTUs were aligned using PyNAST, and 
taxonomy was assigned using BLAST against the SILVA SSURef database release 123. 
Statistical microbiome analysis was carried out in R (version 3.6.1) with Rstudio 
(version 1.2.1335). OTUs unknown on a genus level were excluded, as well as OTUs 
available in two or fewer samples. The ALDEx2 library (Fernandes et al., 2014) was 
used to compute the centred log-ratio transformed values of the remaining taxa. For 
principal component analysis, a pairwise implementation of the adonis() 
PERMANOVA function in the vegan library (Oksanen et al., 2017) followed by the 
Bonferroni-Holm correction was used to test for difference in β-diversity in terms of 
Aitchison distance. Differential abundance was assessed using a pairwise 
implementation of the aldex.test() function, followed by Benjamini-Hochberg 
correction. In these cases, a q-value < 0.1 was considered significant. α-diversity was 
computed using the iNEXT library (Hsieh et al., 2016). 
2.3.3.14 Functional prediction of Gut-Brain modules 
The Piphillin webservice (Iwai et al., 2016) was used to infer the functional 
metagenome per sample in terms of KEGG orthologues. Next, these KEGG 
orthologues were processed using the omixer library in R (Darzi et al., 2016) in order 
to calculate  abundance of gut-brain-modules (GBMs) (Valles-Colomer et al., 2019) 
and gut-metabolic modules (GMMs) in these samples. Then, the same 
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implementation from ALDEx2 was used to assess differential abundance. Scripts are 






2.3.4.1 Polyphenols reversed MS-induced depressive-like behaviours 
To investigate the therapeutic effects of the dietary interventions with polyphenols 
from MS-induced behavioural despair, animals were subjected to a battery of 
behavioural tests to examine depressive- and anxiety-like behaviours. Firstly, animals 
did not differ in terms of body weight across the different experimental groups 
throughout the duration of the treatment (Fig. 1B and C). In FST, analysis yielded a 
significant effect of MS compared to NS-control group on the time spent immobile 
(t22 = -2.349; p = .028) and swimming (t22 = 2.611; p = .016) (Fig. 2.3-2A). MS animals 
exhibited improved depressive-like behaviours with xanthohumol; moreover, 
quercetin and phlorotannins significantly decreased immobility time in the FST (F3,36 
= 4.425; p = .05 and p = .002 respectively). In addition, treatment with phlorotannins 
increased swimming time compared to the MS-control group (F3,36 = 2.984; p = .008) 
(Fig. 2.3-2A). 
 
Figure 2.3-1 Diet intervention with polyphenols did not affect body weight. (A) 
Schematic representing the experimental timeline. (B) Body weight was measured 
weekly from 6-week old until the end of the diet intervention. (C) The weight gain was 
calculated as the difference between the first body weight record (6 weeks) and the 
last measurement (15 weeks). 
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2.3.4.2 Polyphenols showed anxiolytic potential in MS animals 
MS-induced anxiety-like behaviour in the OFT by significantly reducing the time spent 
in the centre (t21 = 2.156; p = .025), as well as in the number of entries in the centre 
of the arena (t21 = 2.855; p = .009) (Fig.2.3-2D and 2.3-E). Administration of quercetin 
in MS rats resulted in a significant increase in the number of entries in the open arms 
compared to the MS-control group (F3,38 = 2.714; p = .040), which was associated with 
an anxiolytic effect (Fig. 2.3-2G). Interestingly, treatment with phlorotannins 
ameliorated MS-induced anxiogenic effects in both, time in centre (F3,37 = 2.297; p = 
.025) and in entries into the centre (F3,37 = 2.405; p = .025). However, no differences 
were found between NS-control and MS animals during the EPM (Fig. 2.3-2F and G). 
 
Figure 2.3-2 Treatment with polyphenols induced antidepressant- and anxiolytic-
like effects in MS rats. (A) MS-induced increased immobility in the FST is prevented 
through treatment with quercetin and phlorotannins, while reduced swimming time 
caused by MS is reversed only by phlorotannins treatment. (B – C) Polyphenolic diets 
nor MS produced changes in locomotor activity. (D – E) Phlorotannins treatment 
produced a significant increase in the time spent in centre and number of centre 
entries when is compared to MS-control group in the OFT. (F – G) However, MS 
animals did not show anxiety-like behaviours in the EPM. Results are expressed as the 
mean ± SEM (*p < 0.05; **p < 0.01 versus ‘vehicle’ groups; #p < 0.05; ##p < 0.01 versus 
‘CORT’ groups). 
2.3.4.3 Xanthohumol prevented the exacerbated corticosterone production in MS 
rats after acute stress 
To determine the role of the HPA axis in MS-induced depressive- and anxiety-like 
behaviours, the concentration of corticosterone in plasma was measured at different 
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time points after an acute stress (Fig. 2.3-3A). Indeed, the corticosterone production 
was close to being statistically increased in MS-control relative to the NS-control 
group as revealed by the area under the curve (AUC) of corticosterone response (t20 
= -1.949; p = .065) (Fig. 2.3-3B). Interestingly, dietary intervention with xanthohumol 
in MS animals induced a significant reduction in corticosterone AUC compared to the 
MS-control group (F3,34 = 3.827; p = .010) (Fig. 2.3-3B). In addition, all polyphenolic 
treatments induced lower baseline levels of plasma corticosterone compared to MS-
control group (F3,36 = 3.979; quercetin p = .080; xanthohumol p = .006; phlorotannins 
p = .011). 
MS-induced plasma BDNF reduction was reversed by xanthohumol treatment 
BDNF is a critical modulator of neuroplasticity and survival, abundant in the brain and 
periphery, including serum and plasma (Lee and Kim, 2010). Preclinical and clinical 
studies have demonstrated that chronic stress and depressive status reduces BDNF 
expression (Russo-Neustadt et al., 2001; Gonul et al., 2005). Indeed, MS rats showed 
lower levels of plasma BDNF compared to NS animals (t19 = 2.672; p = .015), and this 
effect was significantly prevented by xanthohumol treatment (F3,36 = 1.748; p = .047) 




Figure 2.3-3 Xanthohumol treatment prevented corticosterone elevation and BDNF 
reduction in MS rats. (A) Corticosterone levels in plasma rise after rats are exposed 
to an acute stress. (B) MS-induced increase in corticosterone release is abolished by 
treatment with xanthohumol. (C) Baseline levels of corticosterone of rats treated with 
xanthohumol and phlorotannins are significantly lower compared to MS animals. (D) 
Rats treated with xanthohumol displayed higher levels of plasma BDNF compared to 
the MS-control group. Plasma corticosterone was determined using ELISA, and BDNF 
determination was performed with MSD system. Results are expressed as the mean 
± SEM (*p < 0.05 versus ‘vehicle’ groups; #p < 0.05; ##p < 0.01 versus ‘CORT’ groups). 
2.3.4.4 MS induced decreased levels of DA and 5-HIAA in brainstem 
To further determine the effects of early life stress on neurochemistry, and its 
potential implication on the antidepressant and anxiolytic effects of polyphenols, 
monoamine neurotransmitter concentration was measured in the brainstem. MS 
produced a significant reduction of DA and 5-HIAA levels (t20 = 6.121; p = .000 and t22 
= 3.934; p = .001 respectively) (Fig. 2.3-4B and 2.3-D), reduced 5-HT turnover (t21 = 
3.519; p = .002) (Fig. 2.3-4C), and increased DA turnover (t22 = -2.153; p = .047) (Fig. 
2.3-4F). In contrast, treatment with phlorotannins increased the levels of NA and 5-




Figure 2.3-4 Polyphenols did not prevent MS-induced reductions in brainstem 
dopamine and 5-HIAA. Monoamine neurotransmitters were measured in the 
brainstem via HPLC. MS animals show depleted concentrations of dopamine and 5-
HIAA compared to NS-control rats. Phlorotannins diet intervention exerted an 
increase of noradrenaline and 5-HT MS animals, although not significant. Results are 
expressed as the mean ± SEM (*p < 0.05; **p < 0.01; ***p < 0.001 versus ‘vehicle’ 
groups; #p < 0.05 versus ‘CORT’ groups). 
2.3.4.5 MS and dietary treatments induced changes in gut bacterial diversity 
To define whether the experimental treatments also altered gut microbiota diversity 
and bacterial abundance, α- and β-diversity analyses were performed. Although no 
differences in richness were found using the Chao1 α-diversity metric (Fig. 2.3-5A), 
Shannon entropy and Simpson index both indicate that MS rats treated with 
phlorotannins showed reduced diversity within this group compared to the MS-
control experimental group (p = .072 and p < .05, respectively) (Fig. 2.3-5B and C). In 
other words, while the total estimated amount of OTUs did not differ, the microbial 
ecosystem of animals treated with phlorotannins were distributed less evenly. On 
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the other hand, principal component analysis (PCA) to measure the diversity among 
groups, indicated that MS and NS control groups were significantly different from 
each other (F4,47 = 2.012; p = .046) (Fig. 2.3-5D). In addition, treatments with 
quercetin, xanthohumol and phlorotannins also produced significant changes in β-
diversity in terms of Aitchison distance compared to MS-control group (F4,47 = 2.012; 
p = .004; p = .045; p = .046, respectively) (Fig. 2.3-5D). 
2.3.4.6 Changes in the gut microbiota composition correlated with MS status and 
polyphenolic diets 
Alteration of the gut microbiota composition has been associated with different 
mental disorders, including major depression and other stress-related psychiatric 
disorders (Cryan and Dinan, 2012). Thus, we examined the differences in the gut 
microbiota composition of maternally separated rats. Significant differences in terms 
of the relative abundance between MS-control and NS-control animals were found 
in 5 specific bacteria based on effect size (Streptococcus; Ruminococcus; 
Parabacteroides; Rothia; Christensenellaceae; q < .1) (Fig. 2.3-5E). On the other hand, 
dietary interventions with quercetin and xanthohumol in MS rats induced significant 
changes in the abundance of other bacteria genera when compared to the MS-
control group. Specifically, quercetin produced a significant increase of 
Enterorhabdus (q < .1), while xanthohumol exerted changes in the abundance of 
Asteroplasma, Lachnospiraceae, and Coprococcus (q < .1) (Fig. 2.3-5E). 
2.3.4.7 Treatment with phlorotannins and xanthohumol restore MS-induced 
changes in bacteria associated with microbiota-gut-brain pathways 
To investigate the implications of MS-induced changes in gut microbiota composition 
on metabolic pathways associated with the microbiota-gut-brain axis, we performed 
a functional prediction based in previously described GBMs (Valles-Colomer et al., 
2019). MS significantly changed the abundance of bacteria linked to 8 GBMs in terms 
of effect size, including tryptophan degradation, quinolinic acid metabolism, nitric 
oxide metabolism, and p-cresol synthesis compared to NS-control group (q < .1) (Fig. 
2.3-5F). Intriguingly, although quercetin did not alter any relevant bacteria, 
xanthohumol and phlorotannins treatment restored most of the changes produced 




Figure 2.3-5 MS and polyphenolic diets induced significant changes in gut 
microbiota composition and diversity. (A – C) Chao1, Simpson index and Shannon 
entropy were used as estimators of bacterial α-diversity. (D) Principal component 
analysis of genus level was performed to estimate the β-diversity between 
experimental groups. (E) Bacterial abundances were significantly altered in MS rats 
in terms of effect size (q < .1). In contrast, xanthohumol and quercetin changed other 
bacteria compared to MS animals. (F) Functional prediction of GBMs was utilised to 
detect potential microbiota-gut-brain pathways affected by MS or dietary 
treatments. Colours represent effect size, only microbiome features found to be 
significantly different in at least one comparison are shown (*q < .1; **q < .05; ***q 
< .01 vs MS-control group). 
 
 
2.3.4.8 Xanthohumol prevented MS-induced reduction of intestinal SCFAs 
To determine whether the observed changes in the gastrointestinal microbiota 
composition and diversity correlate with alteration in SCFA production, the levels of 
acetate, propionate, butyrate, valerate were determined in caecal content (Fig. 2.3-
6). Interestingly, maternal separation induced a significant reduction of acetate (t22 
= 2.409; p = .025), propionate (t22 = 2.988; p = .01), isobutyrate (t21 = 3.354; p = .006), 
isovalerate (t21 = 2.779; p = .016), total SCFAs (t21 = 2.228; p = .037), and total BCFAs 
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(t21 = 3.181; p = .008). In contrast, phlorotannin treatment significantly reversed the 
MS-induced propionate reduction (F3,38 = 4.646; p = .022), and exerted positive 
effects on isobutyrate, valerate and total levels of BCFAs. 
 
Figure 2.3-6 MS rats exhibited lower levels of gut microbiota-derived metabolites 
(A – H). MS induced significant reduction of gut microbiota-derived metabolites 
including acetate, propionate, isobutyrate and isovalerate, as well as decreased total 
short-chain fatty acids (SCFA) and branched-chain fatty acids (BCFA). Xanthohumol 
treatment ameliorated MS-induced propionate decrease and tends to improve 
isobutyrate and valerate levels. Fatty acid determination was performed through 
HPLC in caecal content. Results are expressed as the mean ± SEM (*p < 0.05; **p < 





There has been increasing attention given to the potential of nutritional approaches 
to ameliorate the effects of stress (Lakhan and Vieira, 2008; Marzola et al., 2013; 
Rechenberg and Humphries, 2013). In the present study, we tested different 
naturally-derived polyphenols as potential therapeutic strategies for depression and 
anxiety associated with early life trauma. Indeed, the polyphenols quercetin, 
xanthohumol and phlorotannins exert varying degrees of antidepressant- and 
anxiolytic-like responses in rats subjected to MS. Moreover, dietary interventions 
also modified gut microbial composition and diversity, suggesting that their 
therapeutic effects could be associated with the microbiota-gut-brain axis.  
The MS rat is an excellent model to study the negative effects of early life stress on 
brain function and structure, which are associated with the development of 
depression and anxiety (O'Mahony et al., 2011; Vetulani, 2013). MS in rats induce a 
robust depressive-like phenotype in adult animals, including changes in gut 
microbiota, dysregulation of the HPA axis, and an imbalance in neurotransmitter 
levels (Daniels et al., 2004; Aisa et al., 2007; O'Mahony et al., 2009; Desbonnet et al., 
2010; Liao et al., 2019). Furthermore, we demonstrated that all polyphenolic 
treatments tend to reverse these depressive-like behaviours. In particular, the 
phlorotannin-enriched diet produced a significant improvement in immobility and 
swimming behaviour in the FST compared to the MS-control group. Although the 
effect of polyphenols has been recently investigated in animal models of stress 
(Kwatra et al., 2016; Yang et al., 2017; Samad et al., 2018), to our knowledge there is 
no data on the effects of dietary intervention with polyphenols in animal models of 
early life stress per se.  
Regarding anxiety, quercetin administration exerted a significant anxiolytic effect in 
MS animals, resulting in an increase in the number of entries into the open arms of 
the EPM. Similarly, quercetin- and xanthohumol-enriched diets tend to induce 
anxiolytic effects in the OFT, while phlorotannin treatment revealed a significant 
improvement. Although the concept of a potential therapeutic effect of polyphenols 
in animal models of stress is not completely new (Anjaneyulu et al., 2003; Hurley et 
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al., 2014; Aubry et al., 2019), the neurobehavioural effects of polyphenols in a model 
of early-life stress have not to our knowledge been examined previously. 
We further investigated the role of the HPA axis in the therapeutic effects of 
polyphenol administration. Accumulated lines of evidence indicate that depressive 
or chronically stressed patients have an over activated HPA axis (Pariante and 
Lightman, 2008; Keller et al., 2017). Similarly, animals subjected to chronic stress 
possess a dysregulated HPA axis and increased baseline levels of glucocorticoids 
(O'Mahony et al., 2011; Uschold-Schmidt et al., 2012). Indeed, we demonstrated that 
the dietary intervention with xanthohumol significantly reduced the exacerbated 
production of corticosterone in MS animals. 
Next, we demonstrated that treatment with xanthohumol prevented the MS-
induced reduction in plasma BDNF. BDNF has strongly been implicated in 
antidepressant activity, and plasma BDNF has been shown to reflect aspects of that 
centrally and to be a biomarker of antidepressant effect (Sen et al., 2008; Lee and 
Kim, 2010; Woelfer et al., 2019). In addition, a positive correlation of BDNF levels 
between blood and brain has been demonstrated in rats (Karege et al., 2002; 
Sartorius et al., 2009; Harris et al., 2016), and a substantial amount of the circulating 
BDNF has been proposed to originate from the CNS itself (Dawood et al., 2007; 
Krabbe et al., 2007; Rasmussen et al., 2009). Although the possible pathways 
involved in BDNF rescue must be further investigated, it is tempting to speculate that 
the positive effects of xanthohumol on behaviour could be partly mediated by 
normalising BDNF expression. 
The relationship between stress and the gut microbiota is gaining a lot of attention 
(Foster et al., 2017; Bastiaanssen et al., 2020). Additionally, we have demonstrated 
that MS is able to induce strong changes to the gut microbiota in terms of 
composition and diversity which is in line with previous reports (O'Mahony et al., 
2009; Moussaoui et al., 2017). Although, we did not detect changes at the α-diversity 
level, analysis of β-diversity revealed that MS groups treated with polyphenols differ 
from the MS control group. We followed this up by assessing differential abundance 
of bacterial genera between the treatment groups. Notably, only xanthohumol and 
quercetin treatments produced significant changes in certain bacterial genera in MS 
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rats, suggesting that some polyphenol-enriched diets have the potential to modify 
bacterial composition in the gastrointestinal system. Several studies have 
demonstrated the capacity of polyphenolic intake to shape the gut microbiota 
(Etxeberria et al., 2013; Ozdal et al., 2016). The fact that all types of polyphenol intake 
were found to alter β-diversity compared to MS control, but only xanthohumol and 
quercetin yielded differences in the abundances of specific genera may suggest that 
polyphenols induce a general shift in the microbial composition, which may be 
indicative of a change in functionality in the microbiome. 
Therefore, we performed a functional prediction of the gut metagenome and used 
this to infer the abundance of GBMs, metabolic modules that are involved in the 
microbiota-gut-brain axis (Valles-Colomer et al., 2019). Indeed, the analysis predicted 
that MS is able to increase the abundance of GBMs associated with the modulation 
of several pathways altered in depression and other neuropsychiatric disorders, 
including metabolism of tryptophan (Curzon and Bridges, 1970; Oxenkrug, 2010), 
inositol (Coupland et al., 2005), p-cresol (Persico and Napolioni, 2013), quinolinic acid 
(Steiner et al., 2011), nitric oxide (Dhir and Kulkarni, 2011), and glutamate (Sanacora 
et al., 2012; Murrough et al., 2017). Interestingly, treatment with xanthohumol and 
phlorotannins reversed these predicted MS-induced changes, suggesting that 
restoration of these GBMs may partially explain their positive effects in behaviour. 
An important limitation due to the nature of 16S sequencing is that functional 
analysis can only be inferential. Future metabolomics-based studies should address 
this experimentally. 
In addition, our data revealed that MS rats exhibited decreased production of SCFAs 
compared with the NS-control group. We detected a significant reduction of acetate, 
propionate, isobutyrate, and isovalerate. The production of SCFAs is highly 
associated with certain bacterial populations in the gut, and there is common 
agreement surrounding the impact of SCFAs on human metabolism and health 
(Morrison and Preston, 2016). Indeed, it is widely accepted that SCFAs play a critical 
role in gut-microbiota-brain communication, and consequences for mental health 
and behaviour (Stilling et al., 2016; Dalile et al., 2019). A preclinical study showed 
that a depression-associated microbiota makeup can impact SCFA production (Kelly 
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et al., 2016), and that SCFAs can reverse the enduring effects of stress in a mouse 
model (van de Wouw et al., 2018). In our study, we demonstrated that treatment 
with xanthohumol specifically prevented the reduction of propionate in MS rats. 
Since the xanthohumol diet intervention induced acute changes in bacterial 
composition of the MS gut microbiota, we presume that the changes observed in 
propionate levels could be a product of improved microbial metabolism. 
In conclusion, our present work confirmed that the naturally derived polyphenols 
xanthohumol, quercetin and phlorotannins can alleviate depressive- and anxiety-like 
behaviours in the rat MS model. We further found that treatment with xanthohumol 
prevented exacerbated production of corticosterone after acute stress in MS 
animals, and reversed MS-induced plasma BDNF depletion. In addition, our data 
revealed that MS-induced behavioural despair correlated with significant changes in 
bacterial composition and diversity, alteration of predicted microbiota-gut-brain 
pathways, and reduced SCFA production. Although all polyphenols caused changes 
in diversity, only xanthohumol induced significant changes in several bacterial taxa 
and prevented the reduction of propionate in MS rats. Taken together, our findings 
present evidence of the therapeutic properties of polyphenols and provide a novel 
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Background: Evidence is accruing to suggest that microbiota-gut-brain signalling 
plays a regulatory role in cardiorespiratory physiology. Chronic intermittent hypoxia 
(CIH), modelling human sleep apnoea, affects gut microbiota composition and elicits 
cardiorespiratory morbidity. We investigated if treatment with prebiotic fibres, 
promoting the expansion of beneficial microbes, ameliorates cardiorespiratory 
dysfunction in CIH-exposed rats.  
Methods: Adult male rats were exposed to CIH (96 cycles/day, 6.0% O2 at nadir) for 
14 consecutive days with and without prebiotic supplementation (fructo- and 
galacto-oligosaccharides) beginning two weeks prior to gas exposures. 
Findings: CIH increased apnoea index and caused cardiac autonomic imbalance and 
hypertension. CIH exposure had modest effects on the gut microbiota, decreasing 
the relative abundance of Lactobacillus rhamnosus, but had no effect on microbial 
functional characteristics. Faecal short-chain fatty acid (SCFA) concentrations, 
plasma and brainstem pro-inflammatory cytokine concentrations and brainstem 
neurochemistry were unaffected by exposure to CIH. Prebiotic administration 
modulated gut microbiota composition and diversity, altering gut-metabolic (GMMs) 
and gut-brain (GBMs) modules and increased faecal acetic and propionic acid 
concentrations, but did not prevent adverse CIH-induced cardiorespiratory 
phenotypes. 
Interpretation: CIH-induced cardiorespiratory dysfunction is not critically dependent 
upon decreased gut SCFA concentrations. Prebiotic-related boosting of SCFAs and 
modulation of GBMs and GMMs were not sufficient to prevent CIH-induced apnoea 
and hypertension in our model. Our findings reveal that although multiple 
correlations were evident between bacterial species and blood pressure, it is 
improbable that the gut microbiota play a critical role in the development of CIH-
induced cardiorespiratory and autonomic dysfunction. Interestingly, prebiotic 
administration altered ventilatory responses to hypercapnic chemostimulation. Our 
findings are relevant to human sleep-disordered breathing and contribute to an 
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emerging interest in the potential manipulation of the gut microbiota as an 
adjunctive therapy for human cardiorespiratory disease. 
 
2.4.2 Introduction 
Obstructive sleep apnoea (OSA), the most common form of sleep-disordered 
breathing (SDB), is recognised as a major worldwide health crisis with devastating 
consequences for integrative body systems (Garvey et al., 2015). OSA is characterised 
by repetitive collapse of the pharyngeal airway during sleep, with episodic oxygen 
fluctuations culminating in recurrent exposure to chronic intermittent hypoxia (CIH). 
It is now apparent that exposure to CIH has adverse effects on the cardiorespiratory 
control network and is recognised as a major driver of OSA-related morbidities 
(Prabhakar et al., 2007; Julien et al., 2008; Edge and O'Halloran, 2015; O'Halloran, 
2016; Iturriaga et al., 2017; Laouafa et al., 2017; Elliot-Portal et al., 2018).  
 
Studies have recurrently implicated the carotid bodies, the dominant peripheral 
oxygen sensors, in the manifestation of CIH-induced cardiorespiratory dysfunction 
(Prabhakar et al., 2007; Peng et al., 2011; Iturriaga et al., 2015; Del Rio et al., 2016; 
Iturriaga et al., 2017). However, exposure to CIH elicits cardiorespiratory and 
autonomic disturbances in guinea-pigs with hypoxia-insensitive carotid bodies (Docio 
et al., 2018; Lucking et al., 2018), revealing that sites beyond the carotid bodies can 
contribute to the manifestation of CIH-induced cardiorespiratory and autonomic 
disturbances. It is known that CIH-induced plasticity also occurs at other key sites of 
the cardiorespiratory control circuit, including the nucleus tractus solitarius (NTS), 
pre-Bötzinger complex, ponto-medullary network and paraventricular nucleus of the 
hypothalamus (Veasey et al., 2004; Almado et al., 2012; Moraes et al., 2013; Garcia 
et al., 2016; Garcia et al., 2017; Li et al., 2018). More recently, studies have described 
effects of CIH on other peripheral sites including the gut microbiota (Moreno-Indias 
et al., 2015; Moreno-Indias et al., 2016; Lucking et al., 2018; AlMarabeh et al., 2019; 




The microbiota-gut-brain axis plays a critical regulatory role in physiological systems. 
Dysregulated microbiota-gut-brain axis signalling affects homeostatic neurocontrol 
networks manifesting in pathophysiological behaviours and brain functions 
(Golubeva et al., 2015; Kelly et al., 2016; Dinan and Cryan, 2017). Recent studies 
extend this concept to cardiorespiratory control (Lucking et al., 2018; O'Connor et al., 
2019). There is considerable interest in the modulatory role of the gut microbiota 
and gut microbiota metabolites, particularly short-chain fatty acids (SCFAs), in 
cardiovascular and autonomic function (Durgan et al., 2016; Ganesh et al., 2018; Kim 
et al., 2018; Meng et al., 2019). Proliferation of lactate-producing, as well as 
diminished butyrate- and acetate-producing taxa is evident in hypertensive models 
(Yang et al., 2015; Durgan et al., 2016; Adnan et al., 2017; Kim et al., 2018). 
Hypertensive donor faeces transferred to normotensive animals leads to the 
development of hypertension in recipient animals (Durgan et al., 2016; Adnan et al., 
2017; Toral et al., 2019). Moreover, in a rat model of SDB, prebiotic administration 
stimulates the expansion of beneficial commensal microbiota augmenting several 
SCFA-producing taxa, restoring caecal acetate concentrations and preventing the 
establishment of hypertension (Ganesh et al., 2018). Chronic acetate administration 
into the caecum of OSA + high-fat diet (OSA+ HFD) rats prevents the development of 
high blood pressure (Ganesh et al., 2018). Additionally, butyrate treatment in 
angiotensin-II-induced hypertensive mice as well as spontaneously hypertensive rats 
prevented the establishment of hypertension (Kim et al., 2018; Robles-Vera et al., 
2020).   
 
In rat models, disruption of the gut microbiota using antibiotic administration, faecal 
microbiota transfer or pre-natal stress results in altered ventilatory responses to 
hypoxic and hypercapnic chemostimulation (Golubeva et al., 2015; O'Connor et al., 
2019). Respiratory frequency response to hypercapnic chemostimulation correlated 
with altered bacterial genera in adult rats with antecedent pre-natal stress (Golubeva 
et al., 2015). Several genera, predominantly from the phylum Firmicutes correlated 
with brainstem neuromodulators crucial in the control of breathing (O'Connor et al., 
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2019). Exposure to CIH dysregulates cardiorespiratory control in guinea pigs resulting 
in aberrant phenotypes including altered autonomic control of heart rate, decreased 
respiratory variability and prevalence of protective sighs and brainstem 
noradrenaline concentrations, as well as disturbed gut microbiota indicating that 
aberrant gut microbiota may at least partly contribute to cardiorespiratory and 
autonomic malaise in CIH-exposed guinea pigs (Lucking et al., 2018).  
 
Collectively, these studies highlight a contributory role of perturbations to 
microbiota-gut-brain axis signalling in the manifestation of CIH-induced 
cardiorespiratory dysfunction, of relevance to OSA. There is a growing interest in 
developing strategies to manipulate the microbiota as a potential therapeutic 
intervention in the treatment of cardiorespiratory disease. Rodent and human 
studies have revealed that prebiotic administration has positive impacts on brain 
neurochemistry and functions (Savignac et al., 2013; Burokas et al., 2017; Dinan and 
Cryan, 2017; Mika et al., 2017). Moreover, prebiotic feeding prevented the 
development of hypertension in a rat model of OSA (Ganesh et al., 2018). Therefore, 
we assessed cardiorespiratory physiology and gut microbiota composition and 
diversity in adult rats following exposure to normoxia (Sham) or CIH. We 
hypothesised that there would be evidence of cardiorespiratory and autonomic 
dysfunction and altered gut microbiota in CIH-exposed rats. We examined the effects 
of prebiotic fibre supplementation to test the hypothesis that manipulation of the 
gut microbiota ameliorates or prevents the deleterious effects of exposure to CIH on 
cardiorespiratory physiology. We performed whole-genome shotgun sequencing in 
an attempt to identify microbial patterns that underscore cardiorespiratory 




2.4.3 Materials and Methods 
 
2.4.3.1 Ethical approval 
Procedures on live animals were performed in accordance with European directive 
2010/63/EU under authorisation from the Government of Ireland Department of 
Health (B100/4498) and Health Products Regulatory Authority (AE19130/P070). 
Ethical approval was obtained from University College Cork (AEEC #2013/035; 
#2017/023) and procedures were carried out in accordance with guidelines laid down 
by University College Cork’s Animal Welfare Body. 
 
2.4.3.2 Experimental animals 
Eight- to ten-week old adult male Sprague Dawley rats (n=72; purchased from Envigo, 
UK) were housed as age-matched pairs in standard rat cages. Rodents had ad libitum 
access to standard rat chow and were housed under a 12-hr light: 12-hr dark cycle. 
 
2.4.3.3 Prebiotic administration 
Eight-week old rats (n=24) were randomly allocated to receive prebiotic fibres in the 
drinking water (PREB; galactooligossaccharides and fructooligosaccharides) with ad 
libitum access for 4-weeks to promote the growth of beneficial host microbiota as 
previously described (Savignac et al., 2013; Gronier et al., 2018; Yang et al., 2018). 
After 2 weeks of PREB treatment, a subset of rats were exposed to CIH (see section 
2.4) for the final 2 weeks creating two groups: Sham+PREB (n=12) and CIH+PREB 
(n=12). 
 
2.4.3.4 Chronic intermittent hypoxia rat model 
Ten-week old rats (n=48) were randomly assigned to one of two groups, each 
receiving vehicle (VEH): Sham+VEH (n=24) and CIH+VEH (n=24). CIH exposed rats 
were placed in chambers wherein ambient oxygen concentration was tightly 
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regulated using a dynamic oxygen/nitrogen controller (Oxycycler™; Biospherix, New 
York, NY, USA). CIH exposure was comprised of 96 cycles of 90 secs of exposure to 
hypoxia (nadir, FiO2 = 0.06, balance N2) and 180 secs of exposure to normoxia (FiO2 
=0.21; balance N2), over 8 hours during the light phase for 14 consecutive days. 
Animals were studied on the day subsequent to the last day of CIH exposure. 
Concurrently, rats assigned to the Sham group were exposed to room air (normoxia) 
in the same room with similar environmental cues for the duration of the study.  
 
2.4.3.5 Assessment of respiratory flow in rats during quiet rest 
 
2.4.3.5.1 Whole-body plethysmography 
During quiet rest, whole-body plethysmography (DSI, St. Paul, Minnesota, USA) was 
used to record respiratory flow signals during quiet rest. Animals were placed into 
custom plethysmograph chambers (601-1427-001 PN, DSI) with a room air flow rate 
maintained at 3l/min. Animals were allowed to acclimate for 30-90 minutes to 
encourage habituation to the new surroundings. Paired contemporaneous 
observations were performed during light hours in Sham+VEH (n=12) versus CIH+VEH 
(n=12) and subsequently Sham+PREB (n=12) versus CIH+PREB (n=12) using a pair of 
plethysmograph chambers. 
 
2.4.3.5.2 Metabolic measurements 
O2 consumption (VO2) and CO2 production (VCO2) were measured in rodents 
throughout the experimental protocol (O2 and CO2 analyser; AD Instruments, 
Colorado Springs, CO, USA) as previously described (Haouzi et al., 2009; Bavis et al., 
2014; Lucking et al., 2018; O'Connor et al., 2019). 
2.4.3.5.3 Experimental protocol 
Once the acclimation period was complete and animals were confirmed to be at quiet 
rest, baseline parameters were recorded during a 10-15 minute steady-state 
normoxia period (FiO2 = 0.21; balance N2). This was followed by a 10 minute 
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poikilocapnic hypoxia challenge (FiO2=0.10; balance N2). Normoxia was subsequently 
restored in each chamber to re-establish stable baseline breathing. Thereafter, a 
second baseline period was recorded followed by a 10 minute hypercapnia challenge 
(FiCO2 = 0.05; balance O2). Subsequently, a third normoxic baseline period was 
recorded. Rats were then exposed to a 10 minute hypoxic hypercapnic challenge 
(FiO2 = 0.10; FiCO2 =0.05, balance N2). 
 
2.4.3.5.4 Data analysis for whole-body plethysmography 
Respiratory parameters including tidal volume (VT), respiratory frequency (fR), 
minute ventilation (VI), expiratory time (Te) and inspiratory time (Ti) were recorded 
on a breath-by-breath basis for analysis (FinePointe software Buxco Research 
Systems, Wilmington, NC, USA). Artefacts relating to animal movement and sniffing 
in respiratory flow recordings were omitted from analysis. A single baseline period 
during normoxia was determined by averaging the three baseline recording epochs 
to determine resting steady-state respiratory and metabolic parameters. Ventilatory 
and metabolic data were averaged and reported for the final 5 minutes of acute 
poikilocapnic hypoxia, hypercapnia and hypoxic hypercapnia allowing sufficient time 
for gas mixing in the custom plethysmograph chambers. Data are expressed as 
absolute change from baseline values. Respiratory flow recordings were assessed for 
the occurrence of augmented breaths (sighs) during normoxia, poikilocapnic hypoxia 
and hypercapnia, as well as the frequency of apnoea events (post-sigh and 
spontaneous apnoeas) during normoxia as previously described (Edge et al., 2012). 
The criterion for an apnoea was a pause in breathing greater than two consecutive 
missed breaths. Apnoea data are expressed as apnoea index (apnoea events per 
hour), combining post-sigh and spontaneous apnoeas. A sigh was defined as an 
augmented breath, double the amplitude of the average VT. The frequency and 
amplitude of sighs were determined. Poincaré plots expressing breath-to-breath 
(BBn) versus subsequent breath-to-breath interval (BBn+1) were extrapolated 
allowing for determination of short- (SD1) and long-term (SD2) respiratory timing 
variability during steady-state baseline breathing. VT, VI, VT/Ti, VO2 and VCO2 were 




2.4.3.6 Assessment of cardiorespiratory parameters under urethane anaesthesia 
 
2.4.3.6.1 Surgical protocol and cardiorespiratory measures 
Following whole-body plethysmography, cardiorespiratory parameters were 
assessed in Sham+VEH, CIH+VEH, Sham+PREB and CIH+PREB rats (n=11-12 per 
group) under urethane anaesthesia (1.5 g/kg i.p.; 20% w/v) following isoflurane 
induction (5% by inhalation in room air). Throughout the surgical and experimental 
protocol, the depth of anaesthesia was carefully assessed by monitoring reflex 
responses to tail/paw pinch and the corneal reflex. Supplemental doses of 
anaesthetic were given as required. Rodents were placed in a supine position on a 
homeothermic blanket system (Harvard Apparatus, Holliston, MA, USA) and a rectal 
temperature probe and heating pad used to maintain core temperature at 37 °C. A 
mid-cervical tracheotomy was performed, followed by intravenous (i.v.) cannulation 
of the right jugular vein for infusion of supplemental anaesthetic and drugs. The 
carotid (n=22)/femoral artery (n=1) was cannulated for the recording of arterial 
blood pressure and the withdrawal of blood samples for arterial blood gas, pH and 
electrolyte analysis (i-STAT; Abbott Laboratories Ltd). Using a foot clip, arterial 
oxygen saturation (SaO2; Starr Life Sciences, PA, USA) was determined and 
maintained above 95% via a bias flow of supplemental O2 passing the tracheal 
cannula sourced from a gas mixing system (GSM-3 Gas Mixer; CWE Inc.). A 
pneumotachometer (Hans Rudolf) and a CO2 analyser (microCapStar End-Tidal CO2 
analyser; CWE Inc., USA) were connected to the tracheal cannula to measure tracheal 
flow and end-tidal CO2 (ETCO2), respectively. Diaphragm electromyogram (EMG) 
activity was continuously measured using a concentric needle electrode (26G; Natus 
Manufacturing Ltd., Ireland). Signals were amplified (x5,000), filtered (band pass; 
500–5000 Hz) and integrated (50 ms time constant; Neurolog system, Digitimer Ltd., 
UK).  Data were digitised via a PowerLab-LabChart v7 (ADInstruments) data 




2.4.3.6.2 Experimental protocol 
An arterial blood sample was obtained from each animal following a 30 minute 
stabilisation period, after which, a minimum 10 minute baseline recording period was 
observed for assessment of baseline parameters (FiO2 = 0.25-0.40; balance N2). The 
rats were exposed to a poikilocapnic hypoxia challenge (FiO2 = 0.12, balance N2) for 
5 minutes, followed by a recovery period. Animals were then exposed to a 5 minute 
hypoxic hypercapnic challenge (FiO2 = 0.12, FiCO2 = 0.05, balance N2). Following a 
recovery period, sodium cyanide (NaCN; 200 μg/kg i.v.) was administered to evoke 
carotid body-dependent increases in ventilation. After an adequate recovery period 
and removal of the pneumotachometer, a second arterial blood sample was taken. 
Next, the serotonin type 3 (5-HT3) receptor agonist phenylbiguanide (PBG; 25 μg/kg 
i.v.) was administered to stimulate pulmonary vagal afferent C-fibres (Dutta and 
Deshpande, 2010; Lucking et al., 2018) eliciting the classic pulmonary chemoreflex. 
Successively, phenylephrine (50 μg/kg i.v.), sodium nitroprusside (50 μg/kg i.v.), 
atenolol (2 mg/kg i.v.), propranolol (1 mg/kg i.v.) and hexamethonium (25mg/kg i.v.) 
were administered to assess cardiovascular responses to pharmacological 
manipulation with sufficient recovery periods allowed between each 
pharmacological challenge. Animals were euthanised by urethane (i.v) overdose. One 
animal (Sham+PREB, n=1) presented with uncharacteristically poor ventilatory and 
cardiovascular responses throughout the experimental protocol; this animal was 
excluded from data analysis. In all animals, blood was collected, prepared in 3% 
Na2EDTA (disodium salt dehydrate) and centrifuged. Plasma was snap frozen in liquid 
nitrogen for subsequent analysis of corticosterone and pro-inflammatory cytokine 
concentrations. Whole brains were removed, separated into pons and medulla 
oblongata, frozen in isopentane at −80 °C and stored at −80 °C un l subsequent 
analysis by high-performance liquid chromatography. The lungs were removed and 
weighed and were allowed to air dry at 37°C for at least 48 hrs before being re-
weighed to provide an index of pulmonary oedema. The caecum was removed, 
weighed and caecal contents were removed and snap frozen in liquid nitrogen for 
whole-genome shotgun sequencing. Faeces was removed from the colon for the 
assessment of SCFA concentrations by gas chromatography. The heart was removed, 
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and the right ventricle was separated from the left ventricle + septum and each were 
weighed separately. 
 
2.4.3.6.3 Data analysis of cardiorespiratory parameters in anaesthetised rats 
 
Baseline parameters were averaged over 10 minutes of stable recording and data are 
presented as absolute values. For cardiorespiratory and EMG responses to 
poikilocapnic hypoxia and hypoxic hypercapnia the average of the last minute of 
recordings was determined and data were compared with the 1 minute pre-
challenge baseline. Data for drug challenges were averaged into 3 or 5 second bins 
and the peak cardiorespiratory responses to NaCN, PBG, phenylephrine, sodium 
nitroprusside, atenolol, propranolol and hexamethonium administration were 
determined and compared to the respective 1 minute pre-challenge baseline. 
Maximum apnoea and post-apnoea tachypnoea in response to PBG are expressed as 
the duration of the apnoea or tachypnoea period normalised in each trial to the 
average cycle duration determined during the 30 sec pre-challenge baseline period. 
All cardiorespiratory responses to chemostimulation and drug administration are 
expressed as percent change from the preceding baseline values. 
 
2.4.3.7 Brainstem monoamine concentrations 
 
2.4.3.7.1 High-performance liquid chromatography (HPLC) coupled to 
electrochemical detection for the measurement of brainstem monoamine 
concentrations 
 
Pons (n=11-12/group) and medulla oblongata (n=11-12/group) tissues were 
sonicated in 1 ml of chilled mobile phase, spiked with 2ng/20μl of a N-methyl 5-HT 
(internal standard; Bandelin Sonolus HD 2070). Brainstem monoamine, precursor 
and metabolite concentrations were measured as previously described (Lucking et 
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al., 2018; O'Connor et al., 2019). Noradrenaline (NA), dopamine (DA), serotonin (5-
HT), and monoamine metabolites and precursor, 5-hydroxyindoleacetic acid (5-
HIAA), homovanillic acid (HVA), 3,4-Dihydroxyphenylacetic acid (DOPAC) and L-3,4 
dihydroxyphenylalanine (L-DOPA) were identified by their characteristic retention 
times. This was determined by standard injections run at regular intervals during 
sample analysis. 
 
2.4.3.7.2 Data analysis 
Class-VP5 software was used to process chromatographs. Concentrations (ng/g) of 
monoamines, precursors and metabolites in each sample were determined using 
analyte:internal standard peak response ratios. 
 
2.4.3.8 Plasma and brainstem pro-inflammatory cytokine concentrations 
 
2.4.3.8.1 Brainstem tissue homogenisation and protein quantification 
 
A separate cohort of rats (Sham, n=12; CIH, n=12) were euthanised by 
pentobarbitone (i.v.) overdose and whole brains were removed. The pons and 
medulla oblongata were separated from the brain, frozen in isopentane at -80oC and 
stored at -80oC until subsequent determination of brainstem cytokine 
concentrations. Pons and medulla oblongata tissue (Sham, n=12; CIH, n=12) were 
weighed and sonicated (1 ml per 100 mg of tissue) in radioimmunoprecipitation assay 
(RIPA buffer) (10X RIPA, deionised H20, 200Mm sodium fluoride, 100Mm, 
phenylmethylsulfonylfluoride (PMSF), 1X protease inhibitor cocktail and 1X 
phosphate inhibitor cocktail). Samples were centrifuged at 10,000  g for 15 minutes 
at 4 °C, to pellet membranes and nuclei. The protein concentration of each sample 
was determined using a bicinchoninic acid (BCA) protein quantification assay 




2.4.3.8.2 Multiplex assay for measurement of plasma and brainstem pro-
inflammatory cytokines 
 
Concentrations of interleukin(IL)-1β, IL-4, IL-5, IL-10, IL-13, interferon (IFN)-γ, 
keratinocytechemoattractant/growth-related oncogene (KC/GRO) and tumor 
necrosis factor (TNF)-α were measured in plasma (all groups; n=11-12/group) as well 
as pons and medulla oblongata (Sham and CIH only; n=12 each group) supernatants 
by sandwich immunoassay methods using commercially available detection kits (V-
Plex Pro-inflammatory Panel 2 (rat) kit; Meso Scale Discovery, Gaithersburg, USA) as 
per the manufacturer’s instructions. For pons and medulla oblongata tissues, 100 μg 
of protein sample was loaded per well as previously described (Lucking et al., 2018). 
Plates were read using QuickPlex SQ 120 imager and computer (Meso Scale 
Discovery). 
 
2.4.3.9 Plasma corticosterone 
Plasma samples were thawed and concentrations of corticosterone were determined 
using commercially available enzyme-linked immunosorbent assay kit according to 
the manufacturer’s instructions (ENZO Life Sciences, UK) using a spectrophotometer 
(SpectraMax M3, Molecular devices). 
 
2.4.3.10 Microbiota composition and function  
 
2.4.3.10.1 DNA extraction from caecal material 
DNA was extracted from caecal material as previously described (Gough et al., 2018).  
 




Whole-metagenome shotgun libraries were prepared in accordance with the Nextera 
XT DNA Library Preparation Guide from Illumina with the exception that the 
tagmentation time was increased to 7 minutes. After indexing and clean-up of the 
PCR products as described in the protocol, each sample was run on an Agilent 
bioanalyser high sensitivity chip (Agilent) to determine the size range of the 
fragments obtained. The concentration of the samples was also determined at this 
point using a Qubit High Sensitivity Assay (Life-Sciences). Samples were then pooled 
equimolarly and the final concentration of the pooled library was determined by 
quantitative PCR using the Kapa Library Quantification kit for Illumina (Roche). The 
pooled library was then sequenced on the Illumina NextSeq using the 2 x150 High 
Output kit according to standard Illumina sequencing protocols. 
 
2.4.3.10.3 Metagenomic bioinformatic analysis 
Shotgun metagenomic sequence files (BCL, base calls) were converted to fastq 
format using bcl2fastq version 2.19. Forward and reverse fastq files were processed 
using KneadData version 0.7.2 from the Huttenhower bioBakery suite (McIver et al., 
2018). A reference library was created to remove host DNA in Bowtie2 version 2.3.4 
from the NCBI rat genome (Rattus norgegicus, GCF 000001895.5). Quality filtering 
was performed using the default setting (ex., phred=33) and trimming with 
Trimmomatic version 0.38-1. Resulting high quality paired-end reads for each sample 
were then concatenated in KneadData. Kraken2 version 2.0.7-beta was used for 
taxonomic classification with the standard database. Report files of taxonomic 
counts for each sample were merged into a single count file using a custom R script 
and ran in R version 3.5.2.  
 
2.4.3.10.4 Functional annotation, gut-brain module and gut-metabolic module 
analysis 
Humann2 was used to generate a table of Kyoto Encyclopedia of Genes and Genomes 
(KEGG) Orthologues. This table was aggregated into gut-brain modules (GBMs) and 
gut-metabolic modules (GMMs), pathways of functions performed by the gut 
131 
 
microbiome that have the potential to influence the host brain (Vieira-Silva et al., 
2016; Valles-Colomer et al., 2019), using the omixer-rpmR library for R (Darzi et al., 
2016). 
 
2.4.3.11 Faecal short-chain fatty acid concentrations 
 
SCFA analysis and extraction were carried out by MS-Omics (Vedbaek, Denmark) as 
follows. Faecal water was prepared by homogenising the faecal samples 
(approximately 100 mg) in ultrapure water (3µl/µg). Samples were then vortexed for 
2 minutes followed by centrifugation (5 minutes, 30000 g, 5°C). The supernatant was 
transferred to a centrifuge filter and the filtered samples were used for analysis. The 
filtrate was acidified using hydrochloride acid, and deuterium labelled internal 
standards where added. All samples were analysed in a randomized order. Analysis 
was performed using a high polarity column (Zebron™ ZB-FFAP, GC Cap. Column 30 
m x 0.25 mm x 0.25 µm) installed in a gas chromatography (GC; 7890B, Agilent) 
coupled with a quadropole detector (59977B, Agilent). The system was controlled by 
ChemStation (Agilent). Raw data was converted to netCDF format using Chemstation 
(Agilent), before the data was imported and processed in Matlab R2014b 
(Mathworks, Inc.) using the PARADISe software (Johnsen et al., 2017). Data are 
expressed as absolute concentration in mM. 
 
2.4.3.12 Statistical analysis 
Data (except microbiota data) was assessed for outliers, normal distribution and 
equality of variances using box-plots, Shapiro-Wilk test and Levene’s test, 
respectfully.  In situations of normal distribution, data were statistically compared 
using independent samples t-test and two-way ANOVA followed by Fisher’s least 
significant test for pairwise comparisons, where appropriate. In some instances, the 
assumptions of no significant outliers and homogeneity of variances were violated 
for the two-way ANOVA. When the assumption of normal distribution was violated, 
data were statistically compared using non-parametric Mann-Whitney U test and 
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non-parametric Kruskal-Wallis test followed by Mann-Whitney U test for pairwise 
comparisons, where appropriate. Statistical significance was assumed at p<0.05. 
Bonferroni correction was applied to adjust for multiple comparisons with the 
exception of microbiota data. Statistical significance for multiple comparisons was 
accepted at p<0.05 divided by the number of comparisons made.  
 
When handling compositional data such as the microbiome taxonomic data, GBM 
and GMM, the compositionally appropriate centered-log ratio (clr) transformation 
was performed using the ALDEx2 R library in preparation of statistical testing 
(Aitchison, 1982). The ALDEx2 library was also used to test for differentially abundant 
features, using a pairwise implementation of the aldex.ttest() function to compare 
multiple groups. Benjamini-Hochberg (BH) adjustment procedure was applied with 
the false discovery rate (FDR) set at 10% to correct for multiple testing in the relative 
abundance microbiota data.  The 2D principal component analysis (PCA) was 
constructed using the clr transformed values computed using the ALDEx2 (Fernandes 
et al., 2013) library in R (version 3.6.0) with Rstudio (version 1.1.453), as is 
appropriate for compositional data (Gloor et al., 2017) using recommended 
parameters and 1000 permutations. For correlation analysis between bacterial 
species and physiological parameters of interest, Hierarchical All-against-All 
association testing (HAllA) (Rahnavard et al., 2017) was used (version 0.8.7) with 
Spearman correlation as correlation metric, medoid as clustering method and q < 0.1 
as threshold for significance. Microbiota data are expressed as median (IQR). All 
other data are expressed as mean ± SD or displayed graphically as box and whisker 
plots (median, IQR and minimum to maximum values). SPSS v25 was used for all 
other statistical analysis. GraphPad Software v6 (GraphPad Software, San Diego, CA, 
USA) and R software environment were used to generate graphs. Adobe illustrator 




2.4.4.1 Body and tissue weights 
CIH exposure and prebiotic administration had a significant effect on body weight 
(Diet*CIH, F (1, 43) = 5.426, p=0.025, ƞ2=0.112, Table 1). The combination of 
CIH+PREB, decreased body weight gain compared with CIH+VEH or Sham+PREB rats; 
Sham+PREB rats were also lighter than Sham+VEH rats. CIH exposure had no effect 
on caecum weight but as expected, prebiotic supplementation increased caecum 
weight. Differences between groups in normalised cardiac ventricle weights relate to 
changes in body weight (Supplementary table 1).  
2.4.4.2 Baseline ventilation and metabolism in rats during quiet rest 
CIH exposure did not affect the majority of respiratory parameters during normoxia. 
Prebiotic fibre supplementation increased baseline VI, VT and VT/Ti in Sham+PREB and 
CIH+PREB compared with Sham+VEH and CIH+VEH rats, respectively (Table 2), but 
the differences related to body weight (Supplementary Table 1). CIH exposure had 
no effect on VCO2 production; CIH+PREB rats had significantly increased VCO2 
production compared with CIH+VEH rats, but VCO2 production in Sham+PREB rats 
was not different compared with Sham+VEH (Table 2). CIH exposure had no effect on 
VI/VCO2 (breathing as a function of metabolism), but prebiotic administration 
increased VI/VCO2, however post hoc analysis revealed no difference between groups 
(Table 2). In summary, CIH exposure and prebiotic administration had modest effects 
on ventilation and metabolism during normoxia. 
2.4.4.3 Respiratory timing variability, apnoeas and sighs during normoxia in rats 
during quiet rest 
Assessments of short-term (SD1) and long-term (SD2) respiratory timing variability 
during normoxia did not reveal differences between groups (p>0.05; Fig. 2.4-1a-f). 
Apnoea index was significantly increased by CIH exposure (X2(3) = 9.284, p=0.026, 
Fig. 2.4-1j), a consequence of alterations in spontaneous apnoea events; no 
statistically significant differences were evident in post-sigh apnoea events (Table 2). 
Post hoc analysis revealed that apnoea index was increased in CIH+PREB compared 
with Sham+PREB rats (p=0.008; Fig. 2.4-1j). The frequency of sighs was not affected 
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by CIH exposure or prebiotic administration (p>0.05; Fig. 2.4-1k). Sham+PREB had 
elevated sigh amplitude compared with Sham+VEH rats (Table 2). The major finding 
was that CIH exposure increased apnoea index during quiet breathing at rest 
(normoxia) and prebiotic administration did not prevent this aberrant phenotype.  
 
Fig 2.4-1. Poincaré plots of breath-to-breath (BBn) and subsequent breath-to-breath 
(BBn + 1) interval of expiratory duration (Te; a) and total breath duration (Ttot; b) for 
Sham+VEH, CIH+VEH, Sham+PREB and CIH+PREB. Group data for Te short-term 
variability (SD1; c) and long-term variability (SD2; d) and Ttot SD1 (e) and SD2 (f) in 
Sham+VEH, CIH+VEH, Sham+PREB and CIH+PREB rats during normoxia. 
Representative respiratory flow traces (downward deflections represent inspiration) 
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illustrating a spontaneous sigh followed by an apnoea (g), a spontaneous apnoea (h) 
and a spontaneous sigh (i). Group data of apnoea index (j) and sigh frequency (k). CIH, 
chronic intermittent hypoxia; PREB, prebiotic; VEH, vehicle. Groups (c-f, j, k) are 
expressed as box and whisker plots (median, IQR and minimum to maximum values); 
n = 11–12. Groups were statistically compared using two-way ANOVA, followed by 
Fisher's least significant difference (LSD) post hoc where appropriate, or non-
parametric Kruskal-Wallis test, followed by Mann-Whitney U test, where appropriate. 
Apnoea index was significantly affected by CIH exposure (p = 0.026; Fig. 1j). 
Assessments of respiratory timing variability and frequency of sighs were not 
different between groups (p>0.05; Fig. 1a-f, 1k). # p = 0.008, CIH+PREB versus 
Sham+PREB. 
2.4.4.4 Ventilatory and metabolic responsiveness to chemostimulation in rats 
during quiet rest 
2.4.4.4.1 Ventilatory and metabolic responsiveness to hypoxic chemostimulation 
No significant differences were evident in CIH+VEH compared with Sham+VEH rats. 
CIH+PREB rats had decreased fR, VI, VT/Ti and increased Ti and Te compared with 
Sham+PREB rats (Table 3). Ti was decreased in Sham+PREB compared with 
Sham+VEH rats (Table 3). Sigh frequency and amplitude were not different in 
CIH+VEH compared with Sham+VEH rats, but CIH+PREB rats had less frequent but 
larger sighs compared with CIH+VEH rats. Sigh frequency was reduced in CIH+PREB 
compared with Sham+PREB rats (Table 3). The major observation was that prebiotic 
administration reduced the frequency of sighs during hypoxia in CIH-exposed rats.  
2.4.4.4.2 Ventilatory and metabolic responsiveness to hypercapnic 
chemostimulation 
CIH exposure elevated sigh frequency during hypercapnia, as such CIH+VEH rats had 
increased generation of sigh compared with Sham+VEH rats. Other respiratory and 
metabolic parameters were not different in CIH+VEH compared with Sham+VEH rats 
in response to hypercapnia (Table 3). Prebiotic administration in CIH-exposed rats 
elevated VT/Ti compared with CIH+VEH rats. Interestingly, Sham+PREB rats had 
elevated ventilation (VI) and increased drive to breathe (VT/Ti) in response to 
hypercapnia compared with Sham+VEH rats, with no change in VI/VCO2 (Table 3). 
Furthermore, Sham+PREB rats had augmented sigh frequency and amplitude 
compared with Sham+VEH rats. There was no difference between CIH+PREB and 
Sham+PREB rats (Table 3). The major finding was that prebiotic fibre 
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supplementation increased sigh frequency and the ventilatory response to 
hypercapnia. 
2.4.4.4.3 Ventilatory and metabolic responsiveness to hypoxic hypercapnic 
chemostimulation 
No significant differences were evident in CIH+VEH compared with Sham+VEH rats. 
CIH+PREB rats had elevated VI compared with CIH+VEH rats. Sham+PREB rats had an 
elevated ventilatory response to hypoxic hypercapnia compared with Sham+VEH 
rats, evident by increased VI, VT and VT/TI; VI/VCO2 was not different between groups 
(Table 3). Furthermore, there was no apparent difference between Sham+PREB and 
CIH+PREB rats. The major observation was that prebiotic administration elevated the 
ventilatory response to hypoxic hypercapnia.  
2.4.4.4.4 Baseline cardiorespiratory and blood gas parameters in anaesthetised 
rats 
CIH exposure had no effect on respiration in the anaesthetised rat during baseline 
conditions (Table 4). VI and VT were increased in PREB+CIH rats compared with CIH-
exposed rats (Table 4). CIH exposure significantly increased diastolic blood pressure 
(DBP) (CIH; F (1,41) = 16.321, p<0.0005, ƞ2=0.285, Fig. 2.4-2b). As a consequence, 
mean arterial blood pressure (MAP) was elevated (CIH; F (1, 41) = 17.485, p<0.005, 
ƞ2=0.299). Post hoc analysis revealed CIH+VEH had elevated blood pressure 
compared with Sham+VEH rats (DBP, p=0.006, Fig. 2b; MAP, p=0.004, Fig. 2.4-2a). 
DBP was not restored by prebiotic administration as CIH+PREB had elevated DBP 
compared with CIH+VEH rats (p=0.007, Fig. 2.4-2b). There was no statistical 
difference evident in MAP between CIH+PREB compared with CIH+VEH (p>0.05, Fig. 
2.4-2a), and MAP was elevated in CIH+PREB compared with Sham+PREB rats 
(p=0.006; Fig. 2.4-2a). CIH exposure or prebiotic administration had no effect on 
systolic blood pressure or heart rate (p>0.05, Fig. 2.4-2c, 2.4-2d). CIH exposure had 
no effect on haematocrit and haemoglobin concentrations; Sham+PREB had reduced 





Fig. 2.4-2 Group data for MAP (a), DBP (b), SBP (C), heart rate (D), LF: HF (e) and LF 
(f) for Sham+VEH, CIH+VEH, Sham+PREB and CIH+PREB. MAP, mean arterial blood 
pressure; DBP, diastolic blood pressure; SBP, systolic blood pressure; LF, low-
frequency band; HF, high frequency band; CIH, chronic intermittent hypoxia; PREB, 
prebiotic; VEH, vehicle. Groups (a-f) are expressed as box and whisker plots (median, 
IQR and minimum to maximum values); n = 10–12 for all groups. Groups were 
statistically compared using two-way ANOVA, followed by Fisher's least significant 
difference (LSD) post hoc where appropriate, or non-parametric Kruskal-Wallis test, 
followed by Mann-Whitney U test, where appropriate. CIH significantly affected MAP, 
DBP, LF: HF and LF (p<0.005, p<0.0005, p = 0.008 and p = 0.017, respectively; Fig. 2a, 
2b, 2e, 2f). There was no change in SBP or HR (p>0.05, Fig. 2c, 2d).* p = 0.004, 
CIH+VEH versus Sham+VEH; # p<0.01, CIH+PREB versus Sham+PREB. 
 
CIH exposure increased the low-frequency band (LF) (CIH; nu, F (1, 40) = 6.170, 
p=0.017, ƞ2=0.134, Fig. 2.4-2 f; %, F (1, 40) = 6.723, p=0.013, ƞ2=0.144, Table 5) and 
decreased the high-frequency band (HF; nµ) (CIH, F (1, 40) = 1.159, p=0.014, 
ƞ2=0.142, Table 5) elevating the LF: HF ratio (CIH, F (1, 40) = 7.748, p=0.008, ƞ2=0.162, 
Fig. 2.4-2 e) during steady-state baseline recordings, indicating sympathetic 
dominance. LF:HF was increased in CIH+VEH compared with Sham+VEH rats 
(p=0.059, Fig. 2.2-4 e). There was no difference in CIH+PREB compared with CIH+VEH 
rats (p>0.05), however CIH+PREB rats had elevated LF:HF ratio compared with 
Sham+PREB rats (p=0.053, Fig. 2.4-2 e). After adjusting for multiple comparisons 
these changes were not statistically significant (Table 5). Other heart rate variability 
parameters were not different between groups (Table 5). The major finding was that 
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CIH exposure caused hypertension and cardiac autonomic imbalance, which were 
not alleviated by prebiotic supplementation.  
2.4.4.5 Cardiorespiratory responses to 5-HT3 receptor agonism evoking the 
cardiopulmonary reflex 
Stimulation of 5-HT3 receptors expressed on pulmonary vagal afferent nerve fibres, 
using PBG, evoked the integrated cardiopulmonary reflex. CIH exposure had no effect 
on hypotension, bradycardia, apnoea or post-apnoea induced tachypnoea associated 
with the pulmonary chemoreflex (Fig. 2.4-3 b-e). Prebiotic supplementation altered 
apnoea duration (Diet, F (1, 41) = 4.950, p=0.032, ƞ2=0.108, Fig. 2.4-3b), however, 
post hoc analysis revealed no differences between groups. There was no significant 
difference between groups in all other parameters (Fig. 2.4-3c-e). The major finding 
was that pulmonary chemoreflex responses to vagal afferent stimulation were 
unaffected by CIH exposure.  
 
 
Fig. 2.4-3 a) Representative traces of blood pressure, heart rate, peripheral oxygen 
saturation (SpO2) and raw and integrated diaphragm (Dia) electromyogram (EMG) 
activity during intravenous administration of the 5-HT3 agonist, phenylbiguanide (25 
μg.kg−1 i.v.). Group data for maximum apnoea duration (b) and tachypnoea (c) 
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normalised to respective baseline respiratory period in Sham+VEH, CIH+VEH, 
Sham+PREB and CIH+PREB rats. Absolute change in MAP (d) and heart rate (e) in 
response to PBG in Sham, CIH, Sham+PREB and CIH+PREB rats. MAP, mean arterial 
blood pressure; CIH, chronic intermittent hypoxia; PREB, prebiotic; VEH, vehicle. Data 
(b-e) are expressed as box and whisker plots (median, IQR and minimum to maximum 
values); n = 9–12. Groups (b-e) were statistically compared using two-way ANOVA, 
followed by Fisher's least significant difference (LSD) post hoc where appropriate, or 
non-parametric Kruskal-Wallis test, followed by Mann-Whitney U test, where 
appropriate. CIH exposure had no effect on hypotension, bradycardia, apnoea or 
post-apnoea induced tachypnoea (p>0.05; Fig. 2.4-3b-e). Prebiotic supplementation 
had a significant effect on apnoea duration (p = 0.032; Fig. 2.4-3b), with no effect on 
any of the other parameters (p<0.05; Fig. 2.4-3c-e). 
2.4.4.6 Cardiovascular responses to pharmacological blockade of sympathetic 
activity in anaesthetised rats 
The blood pressure response to β1 receptor antagonist administration (atenolol) was 
significantly increased by CIH exposure (X2(3) = 9.347, p=0.025). CIH+VEH was not 
different compared with Sham+VEH rats. There was a greater depressor response in 
CIH+PREB compared with Sham+PREB rats; the associated bradycardia was similar 
between all groups (Table 6). Intravenous infusion of the non-selective β-
adrenoceptor blocker (propranolol), and sympathetic ganglion blocker 
(hexamethonium) evoked similar bradycardia and hypotensive responses across all 
groups (Table 6).  
2.4.4.7 Pons and medulla oblongata neurochemistry 
Comparison of L-DOPA and DOPAC concentrations in the pons, as well as DOPAC/DA, 
HVA, HVA/DA, 5-HT and 5-HIAA concentrations in the medulla oblongata revealed 
group differences (p<0.05; Fig.2.4- 4a, 2.4-4c-f, 2.4-4h, 2.4-4i). However, post hoc 
analysis revealed that monoamine, monoamine metabolites and precursors were not 
different in CIH+VEH compared with Sham+VEH rats in the pons or medulla 
oblongata (Fig. 2.4-4a-j). Pontine L-DOPA (p=0.020) and medulla oblongata 5-HIAA 
(p=0.008) concentrations were significantly increased, with medulla oblongata HVA 
(p=0.041) levels decreased in CIH+PREB compared with CIH+VEH rats. CIH+PREB rats 
had increased pontine L-DOPA (p=0.038) concentrations compared with Sham+PREB 
rats. Sham+PREB rats had reduced pontine DOPAC (p=0.021) as well as medulla 
oblongata HVA (p=0.006) and HVA/DA (p=0.016) concentrations compared with 
Sham+VEH rats. Additionally, Sham+PREB rats had elevated pontine L-DOPA 
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(p=0.012) concentrations compared with Sham+VEH rats. After adjusting for multiple 
comparisons, differences in pontine L-DOPA and medulla oblongata HVA 
concentrations in Sham+PREB compared with Sham+VEH and medulla oblongata 5-
HIAA concentrations in CIH+PREB compared with Sham+PREB remained significantly 
different. In summary, prebiotic administration, but not CIH, altered brainstem 
neurochemistry.   
 
Fig. 2.4-4 Group data for l-DOPA (a), dopamine (b), DOPAC (c) DOPAC/Dopamine (d), 
homovanillic acid (e), homovanillic acid/dopamine ratio (f), noradrenaline (g), 
serotonin (h), 5-HIAA (i) and 5-HIAA/Serotonin ratio (j) in Sham+VEH, CIH+VEH, 
Sham+PREB and CIH+PREB. l-DOPA, l-3,4-dihydroxyphenylalanine; DOPAC, 3,4-
dihydroxyphenylacetic acid; 5-HIAA, 5-hydroindoleacetic acid; CIH, chronic 
intermittent hypoxia; PREB; prebiotic; VEH, vehicle. Data (a-j) are expressed as box 
and whisker plots (median, IQR and minimum to maximum values); n = 10–12. Groups 
were statistically compared using two-way ANOVA, followed by Fisher's least 
significant difference (LSD) post hoc where appropriate, or non-parametric Kruskal-
Wallis test, followed by Mann-Whitney U test, where appropriate. l-DOPA (p = 0.003; 
Fig. 2.4-4a) and DOPAC (p = 0.006; Fig. 2.4-4c) concentrations in the pontine region 
as well as DOPAC/DA (Diet*CIH, p = 0.042; Fig. 2.4-4d), HVA (p = 0.001; Fig. 2.4-4e), 
HVA/DA (p = 0.020; Fig. 2.4-4f), 5-HT (Diet, p = 0.043; Fig. 2.4-4h) and 5-HIAA (p = 
0.043; Fig. 4i) concentrations in the medulla oblongata are different. Other 
monoamine, metabolites and precursors were not statistically different between 
groups (p>0.05; Fig.2.4- 4b, 2.4-4g, 2.4-4h, 2.4-4j). ~ p = 0.008, CIH+PREB versus 
CIH+VEH; $ p = 0.006, Sham+PREB versus Sham+VEH. 
 
2.4.4.8 Plasma cytokine and corticosterone concentrations 
Pro-inflammatory cytokines, IL-4 (X2(3) = 8.042, p=0.045, Fig. 2.4-5c) and TNF-α (X2(3) 
= 10.784, p=0.013, Fig. 2.4-5h) were different between groups. Post hoc analysis 
adjusted for multiple comparisons revealed that CIH exposure had no significant 
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effect on IL-4 or TNF-α levels. However, TNF-α and IL-4 were decreased in 
Sham+PREB compared with Sham+VEH rats. All other pro-inflammatory cytokines 
and corticosterone concentrations were not different between groups (Fig. 2.4-5a-b, 
2.4-5d-g). In summary, CIH exposure had no effect on plasma cytokine or 
corticosterone concentrations. Prebiotic administration reduced TNF-α and IL-4 
concentrations compared with VEH rats.  
 
Fig. 2.4-5 Corticosterone and inflammatory mediators were equivalent between 
groups Group data for corticosterone concentration (a), IFN-γ (b), IL-4 (c), IL-6 (d), IL-
10 (e), IL-13 (f), KC/GRO (g) and TNF-α (h) in Sham+VEH, CIH+VEH, Sham+PREB and 
CIH+PREB. IFN-γ, interferon-γ; IL-4, interleukin-4; IL-6, interleukin-6; IL-10, 
interleukin-10;  IL-13, interleukin-13;   TNF-α, tumour necrosis factor-α; KC/GRO, 
keratinocyte chemoattractant/growth-related oncogene; CIH, chronic intermittent 
hypoxia; PREB; prebiotic; VEH, vehicle. Data (a-h) are expressed as box and whisker 
plots (median, IQR and minimum to maximum values); n = 11–12. Groups (a-h) were 
statistically compared using two-way ANOVA, followed by Fisher's least significant 
difference (LSD) post hoc where appropriate, or non-parametric Kruskal-Wallis test, 
followed by Mann-Whitney U test, where appropriate. Pro-inflammatory cytokines, 
IL-4 (p = 0.045; Fig. 5c) and TNF-α (p = 0.013; Fig. 5h) were affected by prebiotic 
administration. $ p = 0.003, Sham+PREB versus Sham+VEH. 
2.4.4.9 Caecal microbiota 
2.4.4.9.1 Microbiota composition and diversity 
CIH exposure had no effect on indices of alpha diversity (Fig. 2.4-6b-d). Prebiotic 
treatment significantly reduced bacteria species evenness in all statistical 
comparisons, indicated by decreases in Shannon and Simpson indices of alpha 
diversity (Fig. 2.4-6c-d). However, bacterial species richness, indicated by Chao1 
index was not affected by prebiotic administration (Fig. 2.4-6b). These findings 
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suggest proliferation of a select number of bacterial species with no overall 
difference in bacterial richness. Principal component analysis revealed that CIH 
exposure did not affect β-diversity. Prebiotic administration shifted β-diversity in 
Sham+PREB and CIH+PREB compared with Sham+VEH and CIH+VEH rats, respectively 
(Fig. 2.4-6a, p<0.001, PERMANOVA).  
 
 
Fig. 2.4-6 Prebiotic administration alters rat caecal microbiota structure Group data 
for principal coordinate analysis (a) in 2-dimensional representations, Chao1 (b), 
Shannon (c), Simpson (d) in Sham+VEH, CIH+VEH, Sham+PREB and CIH+PREB. CIH, 
chronic intermittent hypoxia; PREB; prebiotic; VEH, vehicle. Data (b-e) are expressed 
as box and whisker plots (median, IQR and minimum to maximum values); n = 11–12. 
Data (b-e) were statistically compared by non-parametric Mann-Whitney U test. P-






Whole-metagenome shotgun sequencing identified around 3200 bacteria species of 
34 phyla. BH adjustment for multiple comparisons at bacterial species level did not 
reveal statistically significant differences between CIH+VEH and Sham+VEH rats given 
the exhaustive multiple comparisons performed. However, 3 large effect sizes (~1) 
were evident between CIH+VEH and Sham+VEH rats. Pathogenic species, namely, 
Streptomyces sp. 452 and Raoultella planticola were increased and Lactobacillus 
rhamnosus (Fig. 2.4-6e), a beneficial commensal bacterial species, was decreased in 
CIH+VEH compared with Sham+VEH rats. Similarly, no statistically significant 
difference was evident between Sham+PREB and CIH+PREB rats, but large effect sizes 
(~0.8) were evident in 4 species. The pathogenic species Helicobacter bilis was 
increased whereas Candidatus Gullanella endobia, Pectobacterium wasabiae and 
Corynebacterium striatum were decreased in CIH+PREB compared with Sham+PREB 
rats (~0.8 effect size). A total of 420 bacterial species were statistically different in 
CIH+VEH rats compared with CIH+PREB rats, with 549 species different in Sham+VEH 
rats compared with Sham+PREB rats. The largest difference between these 
comparisons was due to a significant increase in the beneficial bacterial species 




Fig. 2.4-7 Lactobacilli species are decreased in CIH+VEH compared with Sham+VEH 
Group data for Lactobacillus amylovorous (a), Lactobacillus apis (b), Lactobacillus 
helveticus (c), Lactobacillus jensenii (d), Lactobacillus amyloyticus (e), Lactobacillus 
acetotolers (f), Lactobacillus johnsonii (g) and Lactobacillus kefiranofaciens (h) in 
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Sham+VEH, CIH+VEH, Sham+PREB and CIH+PREB. CIH, chronic intermittent hypoxia; 
PREB; prebiotic; VEH, vehicle. Data (a-h) are expressed as box and whisker plots 
(median, IQR and minimum to maximum values); n = 11–12. Data (b-e) were 
statistically compared by non-parametric Mann-Whitney U test. 
2.4.4.9.2 Gut-brain module and gut-metabolic module analysis 
Using GBMs and GMMs we evaluated gut microbial functions. Our novel findings 
reveal that CIH exposure did not affect GBMs and GMMs analysis of caecal 
microbiota. Prebiotic administration altered the microbial potential of 10 and 31 
GBMs and GMMs, respectively (adjusted p<0.05). Several GMMs and GBMs were 
enriched (positive effect size) and reduced (negative effect size) in prebiotic treated 
rats compared with vehicle treated rats. Interestingly, GABA degradation (p=0.9; 
effect size=0.4, CIH+VEH versus Sham+VEH; p=0.9, effect size=0.4, CIH+PREB versus 
Sham+PREB; p=0.009, effect size ~1, CIH+PREB versus CIH+VEH; p=0.001, effect size 
~1, Sham+PREB versus Sham+VEH; Fig. 2.4-7c) and butyrate synthesis I (p=0.9; effect 
size=0.4, CIH+VEH versus Sham+VEH; p=0.9, effect size=0.3, CIH+PREB versus 
Sham+PREB; p=0.2, effect size=0.6, CIH+PREB versus CIH+VEH; p=0.9, effect size=0.4, 
Sham+PREB versus Sham+VEH; Fig. 2.4-7d) abundance trended in diverging 





Fig. 2.4-8 Prebiotic administration alters GBMs and GMMs Group data for GBMs (a) 
and GMMs (b) in heatmap representation, GABA degradation (c) and Butyrate 
synthesis I (d) in Sham+VEH, CIH+VEH, Sham+PREB and CIH+PREB. CIH, chronic 
intermittent hypoxia; PREB; prebiotic; VEH, vehicle. Data (c-d) are expressed as box 
and whisker plots (median, IQR and minimum to maximum values); n = 11–12. A 
pairwise implementation of the aldex.ttest() function was used to compare multiple 
groups. CIH exposure did not alter GBMs and GMMs. Prebiotic administration 
significantly modulated many metagenomes of the GBMs and GMMs. A positive 
effect size indicates an increase in prebiotic treated rats, a negative effect size 
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indicates a decrease in prebiotic treated rats. Benjamini-Hochberg corrected q-
values,* q<0.05, ** q<0.01, *** q<0.001. GABA degradation and Butyrate synthesis I 
diverge in CIH-exposed compared with Sham rats, depending on prebiotic 
administration. ~ p<0.01, CIH+PREB versus CIH+VEH; $$$ p< 0.001, Sham+PREB 
versus Sham+VEH. 
2.4.4.10 Correlation analysis 
Using Hierarchical All-against-all correlation analysis the relative abundance of 
Francisella sp. FSC1006 strongly negatively correlated with sigh frequency during 
hypercapnia in rats that did not receive prebiotics. No other significant correlations 
were evident. A total of 269, 16 and 110 bacterial species correlated with mean, 
diastolic and systolic blood pressure, respectively, when we independently 
investigated if blood pressure parameters correlated with bacterial species 
(Supplementary tables 9-11).  
2.4.4.11 Faecal short-chain fatty acid concentrations  
PCA analysis did not identify distinct clustering of CIH+VEH compared with 
Sham+VEH rats. However, separation of vehicle from prebiotic groups was evident 
(Fig. 8a). The loading plot (Fig. 8b) demonstrates this separation is due to higher 
concentrations of acetic, propanoic and hexanoic acid in prebiotic groups. Further 
analysis revealed that prebiotic supplementation significantly influenced faecal 
acetic (X2(3) = 22.420, p<0.0005, Fig. 8c) and propanoic (X2(3) = 11.211, p=0.011, Fig. 
2.4-8d) concentrations. Prebiotic treatment significantly increased faecal acetic acid 
in all statistical comparisons (CIH+PREB versus CIH+VEH, p=0.002; Sham+PREB versus 
Sham+VEH, p=0.001; Fig. 2.4-8c), propanoic acid concentrations were increased in 
CIH+PREB compared with Sham+PREB rats (p=0.009; Fig. 2.4-8d). There was no 
significant difference in other SCFA concentrations (Fig. 2.4-8e-h). CIH exposure had 
no effect on SCFA, whereas prebiotic administration increased SCFA concentrations 




Fig. 2.4-9 Prebiotic administration increases faecal acetic and propanoic acid Score 
plot (a) from principal component analysis (PCA) model calculated on the relative 
concentrations of detected SCFA and loading plot (b) from PCA model calculated on 
the relative concentrations showing which variables are responsible for the pattern 
observed in (a). Group data for acetic acid (c), propanoic acid (d), hexanoic acid (e), 
butanoic acid (f), pentanoic acid (g) and 3-methylbutanoic acid (h) in Sham+VEH, 
CIH+VEH, Sham+PREB and CIH+PREB. CIH, chronic intermittent hypoxia; PREB; 
prebiotic; VEH, vehicle. Data (c-h) are expressed as box and whisker plots (median, 
IQR and minimum to maximum values); n = 11–12. Groups (c-h) were statistically 
compared using two-way ANOVA, followed by Fisher's least significant difference 
(LSD) post hoc where appropriate, or non-parametric Kruskal-Wallis test, followed by 
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Mann-Whitney U test, where appropriate. Acetic (p<0.0005; Fig. 2.4-8c) and 
propanoic acid (p = 0.011; Fig. 2.4-8d) were increased as a result of prebiotic 
supplementation. All other SCFAs were not different (p>0.05 Fig. 2.4-8e-h). ~ p = 




There is a growing evidence-based consensus that the gut microbiota plays a 
modulatory role in physiological homeostasis. Recent studies posit that 
cardiorespiratory morbidity is linked to aberrant microbiota-gut-brain axis signalling 
(Ganesh et al., 2018; Meng et al., 2019; O'Connor et al., 2019; Toral et al., 2019). 
Investigations in rodents reveal that exposure to CIH disturbs the gut microbiota 
(Moreno-Indias et al., 2015; Moreno-Indias et al., 2016; Lucking et al., 2018). 
Exposure to CIH elicits cardiorespiratory dysfunction (O'Halloran, 2016; Laouafa et 
al., 2017; Elliot-Portal et al., 2018; Laouafa et al., 2019), predominantly considered to 
be mediated via CIH-induced carotid body sensitisation (Prabhakar et al., 2007; 
Iturriaga et al., 2009; Iturriaga et al., 2017), but also suggested to relate to aberrant 
signalling from other sites (Docio et al., 2018; Lucking et al., 2018). When viewed 
together, these observations encourage a new line of enquiry. Dysregulated 
microbiota-gut-brain axis signalling in CIH-exposed rodent models may play a 
modulatory role in cardiorespiratory disturbances evident in animal models of SDB. 
Manipulation of the gut microbiota via antibiotic administration/faecal microbiota 
transfer perturbs the gut microbiota and alters cardiorespiratory control (O'Connor 
et al., 2019). Prebiotic administration, promoting the expansion of beneficial 
microbes, could prove effective in the prevention of CIH-induced cardiorespiratory 
dysfunctions.  
We sought to explore the interplay between cardiorespiratory physiology and the gut 
microbiota in a rat model of SDB, investigating if manipulation of the gut microbiota 
by prebiotic fibre administration could prevent or ameliorate cardiorespiratory 
dysfunctions evident in a CIH animal model. The principal novel findings of this study 
are: 1) CIH-exposed rats have reduced relative abundance of L. rhamnosus; prebiotic 
administration shifted the bacteria microbiota composition and diversity but did not 
restore L rhamnosus relative abundance; 2) CIH exposure did not alter GBMs and 
GMMs analysis of caecal metagenomes; prebiotic administration modulated 
microbial functions; 3) CIH-exposed rats developed hypertension, which prebiotics 
failed to prevent; 4) CIH exposure had no effect on faecal SCFA concentrations; acetic 
and propanoic acid are increased in prebiotic groups; 5) CIH exposure increased the 
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apnoea index during normoxia, which was unaffected by prebiotic administration; 6) 
Monoamine, monoamine precursor and metabolite concentrations were unaffected 
by exposure to CIH; prebiotic administration had modest effects on brainstem 
neurochemistry; 7) Cardiorespiratory responsiveness to vagal afferent nerve 
stimulation was unaffected by CIH exposure; prebiotic administration had modest 
effects on apnoea duration; 8) CIH did not affect ventilation or metabolism; prebiotic 
administration increased ventilatory responsiveness to hypercapnia 
Exposure to CIH elicited hypertension and a shift in autonomic balance towards 
sympathetic dominance, as evident by alterations in heart rate variability and 
spectral analysis parameters (Zoccal et al., 2007; Yamamoto et al., 2013). 
Furthermore, there was an elevated propensity for central apnoea apparent in CIH-
exposed rats, (Julien et al., 2008; Edge et al., 2012; Donovan et al., 2014; Souza et al., 
2015). There is considerable evidence supporting CIH-induced sensitisation of the 
carotid bodies, the principal peripheral oxygen sensors, with persistent elevation in 
chemo-afferent traffic to the NTS of the brainstem and resultant potentiation of 
sympathetic nervous outflow giving rise to hypertension (Fletcher et al., 1992; Kumar 
and Prabhakar, 2012; Iturriaga et al., 2015; Del Rio et al., 2016; Lucking et al., 2018). 
Carotid body ablation prevents CIH-induced hypertension and elevations in heart 
rate variability indicative of cardiac autonomic dysfunction (Iturriaga et al., 2015; Del 
Rio et al., 2016). Nevertheless, CIH-exposed guinea-pigs, with hypoxia-insensitive 
carotid bodies, have altered autonomic control of heart rate associated with 
modification in gut microbiota composition and diversity (Lucking et al., 2018). 
Moreover, exposure to severe CIH elicits sympathetic over-activity and hypertension 
in guinea-pigs in the absence of carotid body sensitisation (Docio et al., 2018), 
revealing sites beyond the carotid bodies that can contribute to the manifestation of 
CIH-induced hypertension.  
Increased apnoea index, an observation commonly observed in CIH animal models, 
is proposed to manifest due to disturbances in the respiratory control network 
(Nsegbe et al., 2004; McKay and Feldman, 2008; Ramirez, 2014; Mateika et al., 2019). 
Carotid body plasticity and altered chemoreflex responsiveness is also suggested to 
be a driver of respiratory instability and apnoea (Prabhakar et al., 2007; Marcus et 
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al., 2010; Julien et al., 2011) and may have been a driver of apnoea in our model, 
although the lack of change in basal breathing and ventilatory responses to hypoxia 
in our study suggest a central origin. Numerous studies have recently linked the 
development of aberrant cardiorespiratory phenotypes, particularly hypertension, to 
perturbed gut microbiota, aberrant function profiles of gut microbes and altered 
SCFA production (Yang et al., 2015; Adnan et al., 2017; Li et al., 2017; Santisteban et 
al., 2017; Yan et al., 2017; O'Connor et al., 2019; Toral et al., 2019).  
In our study, whole-metagenome shotgun sequencing revealed novel data showing 
that CIH+VEH hypertensive rats have modest alterations in bacterial species, 
however, gut microbial functional alterations where not different compared with 
Sham+VEH normotensive rats. The greatest bacterial species difference was in the 
relative abundance of the beneficial commensal bacterial species, L. rhamnosus, 
which was decreased in CIH+VEH compared with Sham+VEH rats. Interestingly, L. 
rhamnosus supplementation ameliorated CIH+HSD-induced hypertension in rats (Liu 
et al., 2019). Of note, the relative abundance of L. rhamnosus remained decreased in 
hypertensive CIH+PREB rats, suggesting that CIH-induced reductions in the relative 
abundance of L. rhamnosus may have contributed to the development of 
cardiovascular and autonomic dysfunction in our study, at least the development of 
hypertension. However, L. rhamnosus abundance was also reduced in Sham+PREB 
rats. If gut microbiota contribute to CIH-induced hypertension, it is more likely that a 
complex interplay of bacterial species contribute to the development of 
hypertension or the maintenance of normal blood pressure per se. In our study, a 
large number of bacterial species correlated with blood pressure parameters.   
To our knowledge there are no studies using whole-genome shotgun sequencing to 
investigate the predicted gut microbial functions in OSA/hypertensive rodent models 
or animals treated with prebiotics. This area of research is in its infancy. In humans, 
numerous modules, essential for the host, were reduced and enriched in 
hypertensive compared with normotensive patients (Li et al., 2017; Yan et al., 2017; 
Kim et al., 2018). In our study, GBMs and GMMs were not altered in Sham+VEH 
compared with CIH+VEH rats and Sham+PREB compared with CIH+PREB rats, 
revealing that the predicted microbial function is unaltered as a result of CIH 
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exposure. Prebiotics had significant effects on gut microbial functions, resulting in 
increases and decreases in multiple modules important to the host. For example, 
increases in acetate degradation and propionate synthesis in prebiotic groups as 
predicted using GBMs and GMMs, coincides with elevated acetic and propionate 
acid, respectively in prebiotic treated rats.  
Acetate-producing bacteria taxa, such as Holdemania were shown to be decreased 
in hypertensive rodents (Yang et al., 2015; Ganesh et al., 2018). Intriguingly, probiotic 
or prebiotic administration prevented the progression of hypertension in an 
OSA+HFD rat model, increasing caecal acetate and various SCFA producing bacteria 
that are diminished in the hypertensive rats (Ganesh et al., 2018). In our study, SCFA 
concentrations were unaffected by CIH exposure, yet, CIH-exposure caused 
hypertension, revealing that depletion of gut SCFAs is not obligatory for the 
development of CIH-induced hypertension. Prebiotic administration increased faecal 
acetic and propionic acid concentrations but had no beneficial effects on 
cardiovascular control; hypertension and enhanced heart rate variability were 
evident in CIH+PREB rats. In our study, elevations in SCFAs in prebiotic treated 
rodents may have had equal ‘buffering effects’ on blood pressure given that SCFAs 
act via olfactory receptor 78 (Olfr78) and G-protein-coupled receptor (Gpr41) to 
increase and decrease blood pressure, respectively having opposing effects on blood 
pressure regulation (Pluznick, 2013). This may contrast to outcomes in Ganesh et al., 
2018 wherein elevated acetate concentrations prevented the development of 
hypertension in OSA+HFD rodents, perhaps via Gpr41 receptor activation. Prebiotic 
administration did not ameliorate CIH-induced hypertension revealing that 
elevations in SCFA concentrations (or at least increases in acetic acid and propionic 
acid) or changes to microbial functional characteristics do not protect against CIH-
induced hypertension.  
We did not examine the effects of CIH exposure on intestinal function, but of interest 
CIH exposure did not increase plasma (or brainstem) pro-inflammatory cytokines in 
this study, although prebiotic administration decreased plasma TNF-α and IL-4 levels 
in Sham rats. Others have reported that CIH exposure in rodents increases plasma 
lipopolysaccharides (LPS) and elevates gut inflammation, contributing to intestinal 
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barrier dysfunction (Moreno-Indias et al., 2015; Wu et al., 2016), a phenotype also 
evident in other hypertensive models (Santisteban et al., 2017; Kim et al., 2018). 
Faecal microbiota transfer from donor normotensive to hypertensive recipient rats, 
and prebiotic and probiotic administration each independently decrease blood 
pressure, and prevent intestinal dysfunction and neuroinflammation in hypertensive 
models, including OSA animal models (Ganesh et al., 2018; Liu et al., 2019; Toral et 
al., 2019).  
Prebiotic administration increased chemoreflex control of breathing in response to 
hypercapnia and hypoxic hypercapnia. Hypercapnia is primarily sensed by central 
chemoreceptors residing in the brainstem. Increased ventilatory responsiveness to 
hypercapnia is particularly interesting given that rats exposed to pre-natal stress 
exhibit altered ventilatory responsiveness to hypoxic and hypercapnic 
chemostimulation in adulthood, which correlated with changes in the gut microbiota  
(Golubeva et al., 2015). Moreover, antibiotic administration and faecal microbiota 
transfer were shown to perturb the gut microbiota composition and blunt 
chemoreflex control of breathing (O'Connor et al., 2019). The latter observation 
combined with findings from the present study suggests that the gut microbiota may 
shape brainstem responsiveness to carbon dioxide (acidosis) with implications for a 
range of respiratory control disorders.  
We assessed monoamines and monoamine metabolites and precursors in the pons 
and medulla oblongata of the brainstem that are crucial in the neuromodulation of 
cardiorespiratory control. No significant modifications in monoamine, metabolite 
and precursor concentrations were evident in the brainstem of CIH-exposed rats. 
There was a trend for reduced dopamine turnover in the medulla oblongata of 
Sham+PREB rats, with elevated ventilatory responses to hypercapnia and hypoxic 
hypercapnia compared with Sham+VEH rats. This finding is particularly interesting 
given that antibiotic treated and faecal matter transfer rodents with perturbed gut 
microbiota each display blunted ventilatory responses to hypercapnia and exhibit 
increased brainstem dopamine turnover (O'Connor et al., 2019). Perhaps, D1 
receptor activation may underpin elevated ventilatory responses to 
chemostimulation in Sham+PREB rats (Lalley, 2004). Previous studies demonstrate 
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that prebiotic administration affected DOPAC concentrations in the brainstem and 
frontal cortex of mice (Burokas et al., 2017). Yet, prebiotic administration did not 
alter other monoamine, metabolites and precursors of the dopaminergic pathway in 
animal models (Kannampalli et al., 2014; Burokas et al., 2017). CIH+PREB rats 
revealed significantly increased 5-HIAA concentrations in the medulla oblongata 
compared with CIH+VEH rats. Noteworthy, lesions of raphé serotonergic neurons 
and transgenic rodents without 5-HT neurones display reduced respiratory 
responsiveness to hypercapnic chemostimulation (Dias et al., 2007; Hodges et al., 
2008; Li and Nattie, 2008; Hodges and Richerson, 2010). However, serotonin 
turnover was not different in CIH+PREB rats compared with CIH+VEH. It is not likely 
that serotonin mediated the elevated ventilatory drive to breathe in response to 
hypercapnia associated with prebiotic supplementation. Altered 5-HT receptor levels 
and 5-HT concentrations have been observed in the rodent pre-frontal cortex after 
prebiotic administration (Savignac et al., 2016; Burokas et al., 2017). Our data suggest 
that reduced dopamine turnover in Sham+PREB rats may be associated with 
increased ventilatory responses to hypercapnic chemostimulation.  
The afferent vagal pathway is a pivotal signalling pathway of the microbiota-gut-brain 
axis, which responds to various stimuli including cytokines, bacterial metabolites 
including SCFAs, gut hormones and neurotransmitters (Goehler et al., 2000; 
Raybould et al., 2003; Johnston and Webster, 2009; Nohr et al., 2015). Central 
integration of vagal afferent signals occurs within the NTS of the brainstem. PBG, 
which is a 5-HT3 receptor agonist, activates pulmonary vagal afferent C-fibres 
manifesting the pulmonary chemoreflex characterised by decreased blood pressure, 
bradycardia, apnoea and post apnoea-induced tachypnoea. Exposure to CIH did not 
affect the pulmonary chemoreflex but prebiotic administration increased apnoea 
duration. Post hoc analysis determined that there were no statistically significant 
differences between groups suggesting that vagal influence over these critical control 
centres was unaltered by any potential changes in microbiota-gut-brain signalling. Of 
interest, cardiorespiratory responses to PBG was also unaffected in other models of 
disrupted gut microbiota (O'Connor et al., 2019). Thus, notwithstanding alterations 
to the gut microbiota in CIH+VEH rats, as well as the notable changes in the gut 
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microbiota, SCFA concentrations, microbial functional characteristics and brainstem 
neurochemistry in prebiotic groups, no major differences in cardiorespiratory 
efferent responses to vagal afferent stimulation were observed revealing intact 
pulmonary chemoreflex circuit function in CIH-exposed and prebiotic supplemented 
animals. This does not preclude however, the possibility of altered vagal signalling 
from the gut in our models, which warrants attention in future studies.  
 
2.4.6 Conclusion 
Our novel findings add to the growing field investigating the role of the microbiota-
gut-brain axis in the control of breathing and cardiovascular function (Ganesh et al., 
2018; Liu et al., 2019; O'Connor et al., 2019). Herein we confirm that CIH exposure 
leads to the development of adverse cardiorespiratory and autonomic control, 
resulting in hypertension, cardiac autonomic imbalance and elevated propensity for 
apnoea. We revealed for the first time using whole-metagenome shotgun 
sequencing that a beneficial commensal species, L. rhamnosus, was decreased in CIH-
exposed rats, but gut microbial functional characteristics were unaltered. 
Furthermore, faecal SCFA concentrations were not altered by CIH exposure.  
Prebiotic administration did not restore L. rhamnosus relative abundance in CIH-
exposed rats and it decreased L. rhamnosus abundance in Sham+PREB rats. 
Prebiotics increased SCFAs and modulated GBMs and GMMs in CIH-exposed and 
Sham rats. Our findings suggest that microbiota-gut-brain axis signalling is unlikely to 
play a critical role in the development of the principal cardiovascular and respiratory 
maladies observed in CIH-exposed rats. These observations further support the 
pivotal role of the carotid bodies in the manifestation of CIH-induced 
cardiorespiratory malaise, which has relevance for human cardiorespiratory control 
disorders. Interestingly, ventilatory responses to hypercapnic and hypoxic 
hypercapnic chemostimulation were altered in prebiotic treated groups. Significant 
modulations to the gut microbiota may shape brainstem responsiveness to acidosis 
which has implications for homeostatic function of integrative body systems. Our 
findings extend previous knowledge of the relationship between the gut microbiota 
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and cardiorespiratory control in OSA animal models. Further studies are required to 
unravel discrepancies within the field, which will lead to a better understanding of 
the role of the microbiota-gut-brain axis in OSA animal models, and the potential use, 
where appropriate, of interventional adjunctive therapies focussed on the gut 
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Adolescence is a critical developmental period that is characterised by growth spurts 
and specific neurobiological, neuroimmune and behavioural changes. In tandem the 
gut microbiota, which is a key player in the regulation of health and disease, is shaped 
during this time period. Diet is one of the most important regulators of microbiota 
composition. Thus, we hypothesised that dietary disturbances of the microbiota 
during this critical time window may result in long-lasting changes in immunity, brain 
and behaviour. C57BL/6 male mice were exposed to either high fat diet or cafeteria 
diet, which consists of normal chow and a high caloric treat presented each day, 
during the adolescent period from postnatal (P) day 28 to P49 and were tested for 
anxiety and social-related behaviour in adulthood. Our results show long-lasting 
effects of dietary interventions during the adolescent period on microbiota 
composition and the expression of genes related to neuroinflammation or 
neurotransmission. Interestingly, changes in myelination-related gene expression in 
the prefrontal cortex following HFD exposure were also observed. However, these 
effects did not translate into overt behavioural changes in adulthood. Taken 
together, these data highlight the importance of diet-microbiota interactions during 
the adolescent period in shaping specific outputs of the microbiota-gut-brain axis in 





Adolescence, the transition period from childhood to adulthood, is a critical 
developmental period characterised by the onset of puberty, as well as specific 
neurobiological processes and behavioural changes (Larsen and Luna, 2018). As 
adolescence is the last developmental stage before adulthood, it is not surprising that 
major refinement of neuronal structure and function during the adolescent period 
are associated with the maturation of social behaviours and cognitive abilities that 
promote individuation (Burnett et al., 2011). However, the growth and specialization 
of the adolescent brain that allow for maturation and adjustments to environmental 
challenges, also creates vulnerability and can result in maladaptation of brain circuits 
(Spear, 2013). Hence, adolescence is also a high-risk period for the onset of 
psychological disorders including psychosis, substance use disorders, eating 
disorders, impulse control disorders and affective disorders (Walker, 2002). 
In recent years there is a growing appreciation that the microbiota, which describes 
the trillions of microbes including bacteria, archaea, eukarya, viruses and parasites 
living in and on their host, plays a key role in all aspects of host health including 
neurodevelopment and behaviour (Borre et al., 2014; Sampson and Mazmanian, 
2015; Gilbert et al., 2018; Cryan et al., 2019). Hence, changes in the gut microbiota 
during the adolescent period are likely to impact brain and behaviour of the 
developing individual but are not well studied (McVey Neufeld et al., 2016; Cowan et 
al., 2019). 
The microbiota during the developmental period is shaped by a variety of internal 
and external factors (Spor et al., 2011; Gilbert et al., 2018) which make the 
microbiota susceptible to external impact during development that might lead to 
maladaptation later in life. One of the most important factors that determines the 
composition of gut microbiota is diet. A corpus of studies have shown that different 
nutritional composition of the daily diet can drastically alter gut microbiota 
composition in humans and rodents (Klurfeld et al., 2018). These changes can occur 
rapidly and are transient in the adult rodents and humans. For example, consuming 
specific animal-based or plant-based diets alters the composition of the microbiota 
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composition within 24 hours and returns to baseline within 48 hours of termination 
of that specific diet (David et al., 2014; Singh et al., 2017) and microbiota composition 
of mice fed a high fat diet for 12 weeks reverts to baseline after 4 weeks (Zhang et 
al., 2012). 
Regarding the microbiota-gut-brain axis there are a number of studies that show that 
dietary interventions in adulthood or early life can affect neurobiological, 
neuroimmune and behavioural changes (Sandhu et al., 2017). For example, exposure 
to high fat diet for either 18 days or 21 weeks results in impaired spatial learning in 
the Morris water maze (Denver et al., 2018) as well as in the object location memory 
and social memory during adolescence (Khazen et al., 2019; Yaseen et al., 2019), and 
increases levels of anxiety in the light/dark exploration test (Kang et al., 2014), as well 
as depressive-like behaviour in the trail suspension- and forced swim test (Vagena et 
al., 2019). Similarly, exposure to various forms of cafeteria diet, which is a variation 
of high fat and high sugar diet results in cognitive impairment in the novel object 
recognition task and the Morris water maze (Stranahan et al., 2008; Beilharz et al., 
2014; Feijo et al., 2019) as well as alterations of anxiety-related behaviour in the 
elevated plus maze (Ferreira et al., 2018). 
However, there is a paucity of studies focusing on the enduring effects of diet-
induced changes in the adolescent microbiota-gut brain axis. We hypothesize that 
due to its relative instability, the adolescent microbiota is likely to be affected more 
drastically than the adult microbiota, which could result in long-lasting alterations in 
microbiota composition. To this end we investigate to which extent changing the diet 
from normal chow to either high fat diet (HFD) or cafeteria diet (CafD) during 
adolescence long-lastingly impacts microbiota composition and examine 
neurobiological, neuroimmune and behavioural outputs in adulthood. 
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2.5.3 Material and Methods 
 
All experiments were conducted in accordance with the European Directive 
2010/63/EEC, the requirements of the S.I No 543 of 2012 and approved by the Animal 
Experimentation Ethics Committee of University College Cork (2012 #45) and the 
Health Products Regulatory Authority (HPRA). All efforts were made to reduce the 
number of animals used and minimise animal suffering. 
 
2.5.3.1 Animals 
36 male C57BL/6JOlaHsd mice (Envigo, UK) were received at our facility at postnatal 
(P) day 21 and allowed to acclimatise for one week. Mice were marked and housed 
in groups of four in standard mouse cages. Mice were kept in ventilated rooms under 
a 12h light/dark cycle with lights on at 7.30am. Water and the diets described below 
were accessible ad libitum. The experimental timeline is depicted in figure 2.5-1. 
 
 
Figure 2.5-1: Experimental timeline. 3CSIT three-chamber social interaction task, 
EPM elevated plus maze, FC fear conditioning, NORT novel object recognition task. 
 
 
2.5.3.2 Dietary Intervention 
To impact gut microbiota during the adolescent period, three different diets were 
provided; standard diet, high fat diet (HFD) and cafeteria diet (CafD). Teklad Global 
18% Protein Rodent Diet (2018S, Envigo, UK) was purchased as standard diet. This 
diet provided 3.1 kcal/g, 18% energy as fat, 58% as carbohydrate and 24% as protein. 
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HFD (D12451, Rodent Diet with 45% kcal% fat) was ordered from Research Diets Inc., 
USA. This diet provided 4.7kcal/g, 45% energy as fat, 35 % as carbohydrate and 20% 
as protein. Both diets were accessible ad libitum. CafD consisted of a variety of high 
caloric food items (Table 1) of which one was presented in addition to normal chow 
each day. To avoid strong individual differences in food intake of these items induced 
by hierarchy (Lee et al., 2018) all food items were presented in excess. Food items 
were weighed before presentation and the remainder was weighed after 24h. The 
information provided by the manufacturer was then used to calculate the energy 
intake (kcal). On average this diet provided 4.1 kcal/g, 36% energy as fat, 50% as 
carbohydrate and 14% as protein.   
Animals were assigned to experimental groups (n=12) matching the average weight 
per cage (n=4), per treatment group (Ctrl 12 ± 1 g, 12 ±1 g HFD, 12 ± 2 g CafD). At the 
onset of adolescence (P28) (Schneider, 2013), HFD or CafD were provided ad libitum 
for treatment groups. Control animals were provided with normal chow throughout 
the experiment. On P49 treatment groups were switched back to normal chow. 
Water was accessible ad libitum throughout the experiments. Bodyweight was 
measured in regular intervals to monitor weight gain.  
 
 













4.8 20.0 96.0 69.0 331.2 5 24.0 
Craze milk chocolate 
Cereals 
Aldi Own Brand 4.4 13.0 56.6 70.0 304.5 7.4 32.2 




Table 1: List of food items presented during CafD treatment. 
 
2.5.3.3 Behavioural Testing 
Behavioural testing commenced three weeks after the end of treatment (P73). At 
least three days were allowed between tests for the animals to rest. Tests were 
performed between 9.00 am and 3.00 pm. Apart from the elevated plus maze, which 
was run under red light, all experiments were performed under dim light.  
 
Doritos tangy cheese 
flavoured corn chips 




3.0 1.1 3.3 67.1 199.3 4.5 13.4 
Asian two minutes 
noodles 








5.1 25.3 129.3 59.2 302.5 9.7 49.6 
roasted salted peanuts Tesco Own Brand 6.2 50.5 312.1 10.6 65.51 27.2 168.1 
Tapas crackers 
(leek&onion) 
Valeo foods 5.1 25.0 126.8 60.0 304.2 8.7 44.1 
Chocolate dairy milk Cadbury 5.3 30.5 161.7 56.5 299.5 7.5 39.8 
Kitkat Nestle 5.1 24.8 126.7 27.2 139.0 2.4 12.3 
Peanut butter Tesco Own Brand 6.6 57.2 377.5 9.1 60.1 24.7 163.0 
165 
 
2.5.3.4 Elevated Plus Maze 
The elevated plus maze (EPM) was used to assess anxiety-related behaviours. 
Anxiety-related behaviours have been shown to be influenced by the gut microbiota 
(Bravo et al., 2011; Savignac et al., 2014). The transfer of microbiota from an anxious 
strain to a less anxious strain for example causes increased anxiety in the recipient 
(Bercik et al., 2011). The EPM was carried out as described previously (Savignac et 
al., 2014). Mice were habituated to the testing room 60 min prior testing. The plus 
shaped maze was elevated 75 cm above the ground and consisted of two open and 
two enclosed arms (30 × 5 cm with 20 cm wall height). Mice were placed in the centre 
of the elevated plus maze facing the open arm and allowed to explore the maze for 
5 min. The experiments were conducted under red light (5 lx). In between animals 
the maze was cleaned with 70% Ethanol. Experiments were recorded using a ceiling 
camera. The amount of entries into and time mice spent in the arms, as well as the 
time spent in the centre was manually scored by a blind observer. An entry into an 
arm was scored when all four paws entered. 
 
2.5.3.5 Three-Chamber Social Interaction Task 
It has been shown that social behaviour is dependent on the gut microbiota 
(Desbonnet et al., 2014; Stilling et al., 2015) and that the presence of microbiota 
during development is essential for the development of normal social behaviour 
(Stilling et al., 2018). Therefore, we assessed social behaviour in the three-chamber 
social interaction task. The test was conducted in a grey plastic box (36 x 19 x 30 cm, 
L x W x H) with three chambers interconnected by small openings as previously 
described (Stilling et al., 2018). A thin layer of fresh bedding was covering the ground 
and light levels were set to 60lx throughout the box. The test procedure 
consisted of three 10 min exploration trials, each starting with the mouse being 
placed in the middle chamber. During the initial phase, two empty wire cages 
(10 cm bottom diameter, 13 cm H) were placed in the outer chambers of the box 
and mice were allowed to explore for 10 min. In the second phase, an age-, sex- 
and strain-matched unfamiliar mouse and an inanimate object (rubber duck) were 
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placed in either of the wire cages and the test mouse allowed to explore for another 
10 min. Following this session, mice were tested for social memory. They were placed 
back in the middle chamber and then allowed to explore a wire cage with the familiar 
mouse from the previous test session or a wire cage with an unfamiliar mouse. The 
time mice spent interacting with either of the wire cages was scored manually. 
Following, mice were moved back to their homecage.  
  
2.5.3.6 Novel Object Recognition Task 
Cognition is another parameter that has been shown to be impacted by microbiota 
composition (Davari et al., 2013; Desbonnet et al., 2015; Frohlich et al., 2016). We 
used the novel object recognition task to assess the memory in our animals.  Novel 
object recognition is a well characterised test for working memory (Antunes and 
Biala, 2012) and was carried out essentially as described previously (Desbonnet et al., 
2015). The arena was illuminated with 60lx. For this test the mice were habituated 
to a grey, plastic open field (40 cm x 30 cm x 25 cm, L x W x H) for 10 minutes. On the 
subsequent day, mice are placed in the same open field and exposed to two identical 
objects for 10 min. Following, mice were placed back in their homecage and allowed 
to rest for 1 hour. When they were placed in the open field one object had been 
replaced by a new object. Mice were again left to explore for 10min. The entire 
sessions were video-taped, and the time spent exploring either of the objects was 
scored manually by an observer blind to the experimental groups. 
2.5.3.7 Differential Fear-Conditioning Paradigm 
Hoban and colleagues had demonstrated that the gut microbiota is involved 
in amygdala dependent fear recall. Differential fear conditioning was adapted 
from Verma and colleagues (Verma et al., 2016) and run in a box 
with transparent front and metal side walls and evenly distributed metal rods 
as a floor (Med Associates, 30.5 cm × 24.1 cm × 21.0 cm). The chamber was 
illuminated with 80 lx. The box itself was enclosed by a sound-attenuating 
chamber. On day 1 of testing, mice were subjected to a differential fear-
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conditioning paradigm in which an auditory stimulus (conditioned stimulus 
(CS+), 30 s white noise, 80 dB) was paired with a mild electric foot shock 
(unconditioned stimulus (US), 0.5mA for 2s). All mice received 5 CS+ with 
random inter-stimulus interval, starting 120 s after the mouse was placed in 
the box, followed by another 120 s without presentation of CS+/US at the end 
of conditioning. On day 2, mice were placed back in the same context as the 
previous day for 12 min to assess contextual fear. Between mice the box was 
cleaned with 70% Ethanol. For fear extinction and extinction recall on the 
following days, the grid floor was covered by white Plexiglas and a black 
triangle changing the dimensions of the box. Furthermore, the box was 
cleaned with 1% acetic acid instead of ethanol. For extinction, the CS+ was 
presented 25 times (30s, inter-stimulus interval 5 s) following a 120 s 
habituation period. Mice were removed from the box 120 s after the last CS+ 
presentation. For extinction recall on day 4, mice were placed in the same 
context but only presented with 5 CS+. Freezing was assessed by automated 
tracking software (Video Freeze®, Med Associates Inc). The motion threshold 
index was set 18 and a minimum freezing duration of 30. Freezing during 
extinction was averaged into 5-trail blocks for analysis. Trial block 1 which 
consisted of the first 5 CS tones was used to depict memory retention.  
 
2.5.3.8 Sample Collection 
Mice were decapitated rapidly, and brain and gastrointestinal tract were removed. 
Randomly, 10 out of the 12 brains per group were gross dissected and the regions of 
interest snap frozen on dry ice. The other two were immersion perfused in 4% PFA 
and kept for analysis. Colon length, caecal weight and the amount of mesenteric fat 
were determined before samples were snap frozen. All samples were stored at -80 C 




2.5.3.9 Quantitative RT-qPCR 
For quantitative RT-qPCR total RNA was extracted from the amygdala and the 
prefrontal cortex. Genes that were analysed were chosen based on having been 
shown to be influenced by the gut microbiota and/or their involvement in the 
behaviours under investigation. All genes analysed are listed in table 2. Total RNA 
was extracted with the mirVana total RNA extraction kit (Ambion, United Kingdom). 
RNA was reverse transcribed using high-capacity cDNA reverse transcription kit 
(Thermo Fisher Scientific, Waltham, MA, USA) in a G-storm thermocycler (G-storm, 
Surrey, UK). Gene expression was analysed SYBR® Green real-time PCR was 
performed on the cDNA samples using SYBR green (SensiFAST™ SYBR®, BioLine) to 
evaluate gene expression levels. Gene expression levels were analysed on an AB7300 
system (Applied Biosystems, Thermo Fisher Scientific). Expression levels were 
calculated as the average of three replicates for each biological sample from all three 
groups (n=8-9 per group) relative to β-actin expression. Fold changes were calculated 
using the ΔΔCt method (van de Wouw et al., 2018). 
 
2.5.3.10 Caecal content DNA extraction 
The QIAmp Fast DNA Stool Mini Kit (Qiagen, Sussex, UK) was used for caecal DNA 
extraction. The procedure was coupled with an initial bead-beating step. Briefly, 200 
mg of each caecal sample were homogenised in 2 ml screw-cap tubes (Sarstedt, 
Wexford, Ireland) containing 0.25 g of a 1:1 mix of 0.1 mm and 1.0 mm sterile zirconia 
beads plus a single 3.5 mm diameter bead (BioSpec Products, Bartlesville, USA) with 
1 ml of Qiagen InhibitEX® buffer as previously described (van de Wouw et al., 2018). 
Subsequent extraction steps followed the manufacturer’s instructions. DNA was 
quantified using the QubitTM 3.0 Fluorometer (Bio-Sciences, Dublin, Ireland) and the 
Qubit® dsDNA HS Assay Kit (Life Technologies, Oregon, USA). Extracted DNA was 






2.5.3.11 16S rRNA Gene Sequence-based microbiota analysis 
Caecal microbiota collected at the end of the experiment (in adulthood) was used for 
16S rRNA gene sequencing. No sequencing was done right at the end of the dietary 
intervention.  Amplification and preparation for sequencing of the V3-V4 
hypervariable region of the 16S rRNA gene was done as outlined in the Illumina 16S 
Metagenomic Sequencing Library Protocol and as previously described (Boehme et 
al., 2019). Briefly, 5 ng/μl of microbial genomic DNA was run with 1 μM of each 
primer (forward primer 
(5’TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3') and 
reverse primer (5’-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACH VGG 
GTATCTAATCC-3') and 12.5 μl 2X Kapa HiFi Hotstart ReadyMix (Kapa Biosystems Ltd., 
UK) in a total volume of 25 μl. PCR was run under the following conditions: initial 
denaturation at 95 ºC x 3 min; 25 cycles of 95 ºC x 30 s, 55 ºC x 30 s, 72 ºC x 30 s; and 
72 ºC x 5 min for final extension. PCR products were purified using the Agencourt 
AMPure XP system (Beckman Coulter Genomics, Takeley, UK). Dual indices and 
Illumina sequencing adapters were attached to PCR products using the Nextera XT 
Index Kit (Illumina, San Diego, USA). 5 μl of purified DNA with 5 μl index primer 1 
(N7xx), 5 μl index primer 2 (S5xx), 25 μl 2x Kapa HiFi Hot Start Ready mix and 10 μl 
PCR grade water was amplified using the previous program with only 8 amplification 
cycles instead of 25. Thereafter, DNA was again purified using the Agencourt AMPure 
XP system. PCR products were quantified, normalized and pooled in an equimolar 
fashion using the Qubit® dsDNA HS Assay Kit (Life Technologies, Oregon, USA). 
Following, samples were run on the Agilent Bioanalyser for quality analysis and 
samples prepared for sequencing following Illumina guidelines. Samples were 
sequenced on the MiSeq sequencing platform (Clinical Microbiomics, Denmark), 
using a 2 × 300 cycle kit. 
 
2.5.3.12 Microbiota Bioinformatics  
Statistical analysis of microbiota data was performed in the R (version 3.6) software 
environment with Rstudio (verison 1.1.453). Alpha diversity was calculated using the 
iNEXT library (Hsieh et al., 2016).  Wilcoxon Rank Sum followed by Bonferroni post 
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hoc tests were used to assess difference in Alpha diversity scores. For principal 
component analysis (PCA), permutational multivariate analysis of variance 
(PERMANOVA) was used to identify relationships of significance between variables 
the adonis() function from the vegan library on Aitchison distance matrices 
calculated with the ALDEx2 library (Fernandes et al., 2013). A pairwise 
implementation of the ALDEx2 function aldex.t.test() was also used to calculate 
pairwise differential abundance. The benjamini-hochberg procedure was used to 
account for multiple comparisons, a q-value of 0.1 was deemed significant.  
 
2.5.3.13 Statistical analysis 
Data was checked for normality using D’Agostino & Pearson normality test. 
Behavioural results, physiological results and gene expression were analysed using a 
one-way ANOVA (post hoc Dunett). Kruskal-Wallis test (post hoc Dunn) was used 
when data was not distributed normally. For body weight analysis as well as the 
learning curve and cued extinction in the fear conditioning paradigm two-way 
repeated measures ANOVA was used and corrected for multiple comparison using 






2.5.4.1 Dietary intervention affects body weight 
An overall effect of dietary intervention during the adolescent period on body weight 
was observed (repeated measures ANOVA for treatment F(2, 33)=3.36 p=0.047 and 
interaction F(14,231)=2.195 p<0.001, figure 2.5-2A). Tukey post hoc analysis showed 
that mice exposed to HFD had a significant increase of body weight at the end of 
treatment at day 21 (p<0.01), when compared to controls and displayed increased 
body weight compared to CafD treated mice from day 21 to day 51 (p<0.05). No 
difference in body weight was seen between groups at the end of the experiment on 
day 64.  
 
2.5.4.2 Animals on HFD have higher energy intake during the treatment period 
 
The energy provided by the different type of diets comes from different proportions 
of macronutrients available in the diet (figure 2.5-2B). While HFD provides the largest 
% of energy as fat, CafD like control diet provided the largest % of energy as 
carbohydrates. However, unlike control diet the % energy provided as proteins was 
much lower in CafD and the % energy provided as fat was elevated. Figure 2C depicts 
the chow intake of the three groups during the course of the experiment. An overall 
effect of dietary intervention during the adolescent period on chow intake was 
observed (repeated measures ANOVA for treatment F(2, 6)=8.13 p=0.02 and 
interaction F(16, 48)=13.38 p<0.0001, figure 2.5-2C). Tukey post hoc analysis 
revealed that mice exposed to CafD had a lower chow intake during the time of 
treatment in comparison to controls. This is an expected compensation for the 
increased intake of the food items in the cafeteria diet. There also is a significant 
increase in the amount of chow in HFD animals in the second half of the treatment 
period. This results in a different daily average energy intake per cage as depicted in 




Figure 2.5-2 HFD but not CafD has enduring effects on Body weight. A Body weight 
was measured weekly during the experiment. Grey area highlights the period of 
dietary intervention. B Difference in kcal% of macronutrients depending on diet. The 
values for CafD represent the average macronutrient distribution over the entire 
treatment period. C Intake of chow and HFD during the experiment. Intake of treats 
of CafD are not included in this measure. D Average daily intake of energy per cage. 
Mean ± SEM. A, C & D n = 3, A & B Repeated Analysis of Variance (ANOVA) post hoc 
Tuckey, D Kruskal Wallis post hoc Dunn: * significant difference between CTRL and 




revealed that mice exposed to HFD show significantly increased energy intake per 
cage when compared to control mice and mice exposed to CafD (p=0.023). When 
switched back to normal chow, no significant difference in chow intake can be 




2.5.4.3 Physiological readouts were not affected by adolescent dietary 
manipulations 
Alterations in diet have been linked to changes in physiological measures of the 
gastrointestinal tract (Beraldi et al., 2015; Soares et al., 2015; Le Roy et al., 2019). 
Therefore, we measured caecum weight, colon length and the amount of visceral fat. 
No differences in either parameter were observed between mice that underwent 
dietary intervention during adolescence and control mice (caecum weight F(2, 
33)=0.677 p=0.515, colon length F(2, 33)=1.126 p=0.336, visceral fat F(2, 33)=0.623 
p=0.543, data not shown). 
2.5.4.4 Enduring effects of dietary intervention on microbiota  
To investigate the long-term effects of dietary intervention during adolescence on 
the gut microbiota, the caecal microbiota was analysed from adult mice at the end 
of the experiment. Long-lasting effects of dietary intervention on the microbiota 
composition and structure of adult mice were observed in mice exposed to either 
HFD or CafD during the adolescent period. HFD and CafD differentially affected alpha 
and beta diversity. 
Alpha diversity, which describes the diversity of species in a community, was 
measured by calculating indices for richness and evenness based on ASV (amplicon 
sequence variant) level. Richness was estimated using Chao1. Figure 2.5-3A shows 
that there are no significant differences in the number of species within a group 
between control mice and mice that were exposed to dietary intervention during 
adolescence (pairwise comparison using Wilcoxon rank sum test, p>0.05). However, 
a significant decrease in Shannon diversity was observed in HFD treated mice 
(pairwise comparison using Wilcoxon rank sum test, followed by Bonferroni post hoc 
test, p=0.011), indicating a decrease in evenness across ASVs. No difference in 
evenness was seen for CafD treated mice (p>0.05).  
On the beta diversity level, which describes the difference between communities, 
principal component analysis (PCA) identified long-lasting structural differences in 
microbiota following dietary intervention during adolescence (PERMANOVA 
followed by pairwise PERMANOVA; p<0.001 in all cases; figure 2.5-3B). Notably, the 
positive part of the second component is exclusively populated by subjects that were 
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exposed to dietary intervention (figure 2.5-3B blue area). The long-lasting effects of 
dietary intervention on the microbiota are also reflected by changes in the relative 
abundance of families (figure 2.5-3C). Members of the families Ruminococcaceae, 
Lachnospiraceae, Erysipelorichaceae, Coriobacteriaceae and Alcaligenaceae are 
changed following both dietary interventions (figure 2.5-3C). However, differences in 
the structural properties of microbial communities between HFD and CafD treated 
mice compared to controls were observed in the relative abundance at the ASV level. 
Whereas a significant change in the relative abundance of UCG-010 (q<0.05), 
NK4A214 (q<0.05), one ASV of Roseburia (q<0.05), 5 ASVs of the genus NK4Q136 (all 
q<0.05), two ASVs of Lachnoclostridium (q<0.05), Turicibacter (q<0.05), 
Gordonibacter (q<0.05), two ASVs of Enterorhabdus (q<0.05) and Parasutterella 
(q<0.05) were observed in HFD-treated mice when compared to controls. Changes 
after CafD treatment only occurred in one ASV of Roseburia (q<0.05), one ASV of 
NK4A136 (q<0.05), Turicibacter (q<0.05)and one ASV of Enterorhabdus (q<0.05) but 
showed a strong and significant increase in an ASV of UCG-002 (q<0.001). HFD and 
CafD treated mice differed significantly in the relative abundance of 
Ruminiclostridium 9 (q<0.05), Anaerotruncus (q<0.05), UCG-001 (q<0.05), one ASV of 
NK4A1136 (q<0.05) and Parasutterella (q<0.05). Overall, more genera are affected 
by HFD than CafD treatment but, genera seem to be more strongly affected by CafD 
than HFD. The ASV UCG-002 is very strongly increased in CafD treated mice. 
 
2.5.4.5 Altered Gene Expression in the Amygdala 
During recent years, many studies have demonstrated a link between the gut 
microbiota and gene expression in the amygdala (Arentsen et al., 2015; Stilling et al., 
2018). To understand to which extent short-term exposure to different diets and 
subsequent changes in the gut microbiota during the adolescent period could impact 
gene expression, we therefore focused on genes that have previously been shown to 





Figure 2.5-3 Long-lasting changes in Caecal Microbiota Composition following 
dietary intervention. A. α-diversity indices, Chao1 and Shannon Index depicting the 
richness and evenness of the sample, respectively, Mean ± SEM. B. β-diversity, PCA 
blots of all groups together, HFD and CafD in comparison and HFD and CafD 
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compared to controls. C. Heat map representing relative abundance of ASVs that 
were significantly changed between controls, HFD and CafD mice. A Wilcoxon Rank 
Sum test, post hoc Bonferroni, * p<0.05 B Permutational multivariate analysis of 
variance (PERMANOVA), followed by pairwise PERMANOVA post hoc Benjamini–
Hochberg, C Mann–Whitney U test post hoc Benjamini–Hochberg, Benjamini–
Hochberg false discovery rate (FDR) q value < 0.2. Asterisks in the heat map represent 




We analysed various genes from whole amygdala lysates. 22 genes involved in 
neuroimmunity (Carrillo-Salinas et al., 2017), neurotransmission (Bravo et al., 2011; 
Hoban et al., 2018), tight junctions (Braniste et al., 2014; van de Wouw et al., 2018) 
or short chain fatty acid signalling (Erny et al., 2015; van de Wouw et al., 2018) were 
analysed. mRNA levels in the amygdala of adult mice were drastically changed 
following dietary intervention during adolescence in all clusters of genes analysed. 
Out of the 22 genes 19 were altered by adolescent exposure to HFD and 18 in CafD 
treated mice (figure 2.5-4F). Furthermore, genes were differentially affected by HFD 
or CafD treatment (results and statistics are summarised in Table 2). Of the genes 
involved in immune response, interleukin 1b (Il1b) was only increased in HFD, 
whereas interleukin 10 (Il10) was only increased in CafD treated mice. Gene 
expression for Fc fragment of IgG receptor IIb (Fcgr2b), toll-like receptor 4 gene 
(Tlr4), complement component 3 (C3), complement C1q A chain (C1qa), interleukin 
8 receptor alpha (Cx3cr1) and Rho GTPase Rac2 (Rac2) was elevated following HFD 
and CafD treatment (figure 4A). This indicates that there are persistent changes in 
genes involved in neuroimmunity following adolescent treatment to diets. 
Genes involved in neurotransmission were also upregulated (figure 2.5-4B). The gene 
expression of genes encoding for the gamma-aminobutyric acid type A receptor 
alpha2 subunit (Gabra2), dopamine receptor D1 (Drd1), metabotropic glutamate 
receptor type 5(Grm5), corticotropin- releasing hormone receptor 1 (Crhr1,) 
neuropeptide Y (Npy) and its Y1 receptor (Npyr1) was increased in mice following 
exposure to HFD and CafD during adolescence. However, gene expression for 
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glucocorticoid receptor NR3C1 was only increased in mice exposed to HFD and no 
change in gene expression was seen for the gamma-aminobutyric acid type B 
receptor subunit 1 (Gabbr1) for either HFD or CafD treated mice. Taken together 
these results suggest a high possibility for changes in neuronal transmission in the 
amygdala. Gene expression of genes associated with short chain fatty acids, free fatty 
acid receptor 1 (Ffar1) and the solute carrier subtypes (Slc5a8 and Slc16a1) were also 
upregulated in both experimental groups (figure 2.5-4C). Gene expression for tight 
junction proteins, however, was affected differentially (figure 2.5-4D). Whereas gene 
expression for tight junction protein 1 (Tjp1) was upregulated in HFD treated mice, 
claudin 5 (Cldn5) was only upregulated in CafD treated mice. Occludin (Ocld) was 
upregulated in both experimental groups. 
2.5.4.6 Altered gene expression related to myelination in the prefrontal cortex 
The gut microbiota has been shown to be involved in the regulation of myelination 
in the prefrontal cortex which in turn influences anxiety (Gacias et al., 2016; Hoban 
et al., 2016; Lu et al., 2018). We therefore investigated whether myelination-related 
genes were affected in mice exposed to HFD or CafD during adolescence by analysing 
the gene expression levels of myelin regulatory factor (Myrf), the proteolipid protein 
1 (Plp1) and the transcription factor sox-10 (Sox10) (figure 2.5-5). One-way ANOVA 
revealed that Myrf) and Sox10 were not changed by dietary intervention (F(2, 





Figure 2.5-4 Altered Gene Expression in the Amygdala following dietary 
intervention. Gene expression related to A Neuroimmunity, B Neurotransmission, C 
Short chain fatty acids and D Tight junction proteins. E Overview of extent of changes 
in gene expression for all genes investigated. C1qa complement C1q subunit A, C3 
complement component 3, Cldn5 claudin 5, Crhr1 corticotropin-releasing hormone 
receptor 1, Cx3cr1 interleukin 8 receptor alpha, Drd1 dopamine receptor 1, Fcgr2b 
IgG receptor FcγRIlb gene, Ffar1 free fatty acid receptor 1, Gabbr1 gamma-
aminobutyric acid type B receptor subunit 1,  Gabra2 gamma-aminobutyric acid type A 
receptor alpha2 subunit, Grm5 glutamate metabotropic receptor type 5, Il1b 
interleukin 1b, Il10 interleukin 10, Npy: neuropeptide Y, Nr3c1 glucocorticoid 
receptor, Ocld occludin,  Rac2 Ras-related C3 botulinum toxin substrate 2, Slc16a1 
Solute Carrier Family 16 Member 1, Slc5a8 Solute Carrier Family 5 Member 8, Tlr4 
toll-like receptor 4, Tjp1 tight junction protein 1, Npy1r neuropeptide Y receptor Y1, 
Mean ± SEM. A-D n=8-9, A one way ANOVA post hoc Dunnett, except Tlr4 Kruskal 
Wallis post hoc Dunn, B one way ANOVA post hoc Dunnett, except Npy1r Kruskal 
Wallis post hoc Dunn, C one way ANOVA post hoc Dunnett, D one way ANOVA post 
hoc Dunnett, * p<0.5, ** p< 0.01, *** p<0.001  
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Sox1 F(2, 27)=1.857, p=0.176), whereas gene expression of Plp1 was affected (Plp1 
F(2, 27)=4.778, p=0.017). Post-hoc analysis using Dunnett’s multiple comparisons 
test revealed that Plp1 was significantly elevated following HFD exposure during 
adolescence (p=0.012). 
 
Figure 2.5-5 Changes in myelination related gene expression in the prefrontal 
cortex following HFD exposure. Genes related to myelination in the prefrontal cortex. 
PLP1 is significantly upregulated following HFD exposure during adolescence.  Myrf 
myelin regulatory factor; Plp1 proteolipid protein; Sox10 SRY-Box Transcription Factor 
10. Mean ± SEM, n=9-10, for all comparisons one-way ANOVA post hoc Dunnett, **; 
p<0.01.  
 
2.5.4.7 No enduring behavioural effects of either dietary interventions during 
adolescence 
To investigate possible long-lasting effects of dietary interventions and subsequent 
changes of microbiota composition during adolescence on behaviour, mice were run 
through a battery of tests in adulthood analysing aspects of anxiety, fear, sociability 
and memory. No differences in anxiety-related behaviour was observed in the 
elevated plus maze (figure 2.5-6A). Mice did not demonstrate differences in the % 
time spend in the open arm (F(2, 27)=0.957, p=0.397, figure 2.5-6A) or the % of 
entries made into the open arm (F(2, 27)=3.36, p=0.05, post-hoc analysis using 
Dunnett’s multiple comparison test p>0.05 for both treatments, figure 2.5-6B). 
Similarly, social behaviour as measured in the three-chamber social interaction task 
(figure 2.5-6C) was not affected by dietary interventions. Mice did not show 
alterations in the time spent with either an inanimate object or a conspecific (2-way 
180 
 
ANOVA interaction F(2, 54)=1.83 p=0.17) or when exploring a familiar versus an 
unfamiliar mouse (2-way ANOVA interaction F(2, 54)=1.774, p=0.179 and treatment 
F(2, 54)=0.854, p=0.432, data not shown). This was further supported by the lack of 
differences in the total time the mice spent exploring both the inanimate object and 
the conspecific (Kruskal-Wallis test H(2)=3.579, p=0.167, figure 2.5-6D) or the familiar 
and the unfamiliar mouse (F(2, 27)=0.097, p=0.908, data not shown).  When tested 
in the novel object recognition task dietary intervention has no effect on memory 
either (one-way ANOVA F(2, 27)=0.187, p=0.831, data not shown). Furthermore, 
dietary interventions during adolescence did not show any effects on fear 
conditioning. Mice show a normal learning curve (figure 2.5-6E). When exposed to a 
sequence of foot shocks mice showed no differences in the increase of % freezing 
over time (two-way repeated measures ANOVA F(10, 135)=1.092, p=0.373, and 
treatment F(2, 27)=1.204, p=0.316). Mice also did not show any differences in the % 
freezing when exposed to the training context (one-way ANOVA F(2, 27)=1.294, 
p=0.291 figure 2.5-6F), indicating no differences in hippocampal dependent fear 
learning. When placed in a different context and exposed to the tone, freezing 
response dropped similarly for all groups, hence, no difference was seen in cue 
extinction (two-way repeated measures ANOVA interaction F(12, 162)=0.372, 
p=0.9712 treatment F(2, 27)=0.711, p=0.5 figure 2.5-6F). Fear recall was tested 
thereafter and again dietary intervention did not have any effects on this parameter 




                         
Figure 2.5-6 No effects of dietary intervention in adolescence on behaviour in 
adulthood. Behavioural parameters from the elevated plus maze A. % time spend in 
the open arm B. % entries into the open arm. C. Time spent interacting with the mouse 
and the object in the three-chamber social interaction task D. Total time of 
exploration for both object and mouse. Data from the fear conditioning paradigm E. 
Learning curve with the first foot-shock being administered after the pre-shock phase 
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followed by 5 time bins following one foot-shock each. F. Total amount of freezing in 
contextual fear conditioning. G. Cued fear extinction H. Extinction recall. Mean ± SEM, 
A-H n=10, A & B, one-way ANOVA post hoc Dunnett, C two-way ANOVA post hoc 
Bonferroni, D Kruskal Wallis post hoc Dunn, E two-way ANOVA post hoc Bonferroni, 
F one-way ANOVA post hoc Dunnett, G two-way ANOVA post hoc Bonferroni, H one-







In this study we assessed the long-term effects of short-term exposure to unbalanced 
diets during adolescence on gut microbiota composition as well as on molecular and 
behavioural parameters in adulthood. As gut microbiota composition is strongly 
influenced by dietary composition, we hypothesised that there would be differential 
enduring effects of such adolescent exposure to unbalanced diets and subsequent 
alterations to the adolescent gut microbiota on the adult microbiota composition as 
well as gene expression in the amygdala and the prefrontal cortex and behaviour. 
Interestingly, although we demonstrated that exposure to three weeks of HFD or 
CafD during the critical adolescent period results in significantly altered microbiota 
composition and altered gene expression in adult mice these changes did not 
translate to enduring alterations in overt changes in the behaviours under 
investigation. Thus, our hypothesis was only partially confirmed. 
In these studies we show a persistent effect of diet on the microbiota which are in 
line with previous studies that have demonstrated effects of a variety of deleterious 
diets on human and rodent gut microbiota (Brown et al., 2012; David et al., 2014) 
and it is known that different dietary components differentially shape microbiota 
composition (Albenberg and Wu, 2014; Klurfeld et al., 2018). For example, exposure 
to cafeteria diet has caused alterations in the abundance of the phyla Firmicutes, 
Actinobacteria and Proteobacteria (Del Bas et al., 2018) in rats, whereas long-term 
treatment with high fat diets has altered Firmicutes, Bacteroidetes, Proteobacteria 
and Actinobacteria (Kim et al., 2012; Daniel et al., 2014; Kim et al., 2019). Obviously, 
depending on the composition of high fat and control diet (Huang et al., 2013), length 
of treatment (Kim et al., 2019) and age period (Villamil et al., 2018), changes on the 
phylum, family or genus level can differ. For example, 8 weeks treatment of C57BL/6J 
mice with high fat diet (60 kcal % fat, Research Diets) resulted in increase of 
Ruminococcaceae and Rikenellaceae (Kim et al., 2012), whereas a 12 weeks 
treatment of C57BL/6NCrl mice with high fat diet (60 kcal % fat, Ssniff GmbH) 
resulted in a decrease of Ruminococcaceae and an increase of Rikenellaceae (Daniel 
et al., 2014). However, overall Ruminococcaceae, Rikenellaceae and Lachnospiraceae 
seem to be the families that are commonly affected by diet with high fat content 
184 
 
(Kim et al., 2012; Daniel et al., 2014; Lecomte et al., 2015; Reichelt et al., 2018). This 
is supported by a recent meta-analysis study of the effects of high fat diet on the 
microbiota in mice stating that Ruminococcaceae and Lachnospiraceae are highly 
enriched following high fat diet treatment (Bisanz et al., 2019). Such changes in 
microbiota composition agree with those observed in the current study with changes 
in the phyla Firmicutes and Actinobacteria following CafD exposure and altered 
abundances of Firmicutes, Proteobacteria but also Actinobacteria in adulthood 
observed following HFD treatment during adolescence. Furthermore, we observe 
changes in Ruminococcaceae and Lachnospiraceae in HFD treated mice and changes 
in Lachnospiraceae in CafD treated mice.  
The different effects of HFD and CafD on phylum, family and genus level observed in 
this study are most likely induced by differences in diet composition and 
consumption. Mice exposed to HFD consumed more fat and less carbohydrates than 
control mice, whereas mice on CafD consumed more fat and a similar level of 
carbohydrates but consumed far less proteins than the control animals. 
Furthermore, it is worth noting that as fat in the CafD was provided by a variety of 
different food items in addition to the normal chow, lipids and fatty acids provided 
by this diet differed in source, type and quantity from the fat provided by HFD. 
Thereby, the dietary composition and the consumption are likely to have 
differentially impacted microbiota composition.  
 
The effects of dietary intervention seen on genus level, in comparison to what is 
observed in the literature might be not only due to differences in dietary composition 
but also the difference in treatment time. It is worth noting that in most common 
dietary intervention studies mice are exposed to the diet for long periods without 
interruption and are usually still receiving the diet at the termination of the 
experiment lab (Boitard et al., 2014; Boitard et al., 2015; Labouesse et al., 2017; 
Hassan et al., 2018; Reichelt et al., 2018), whereas mice in our study only had the diet 
during a critical developmental time period - adolescence. The fact that the effects 
of these diets on the microbiota and brain can still be observed even after 47 days of 
normal chow exposure, could be explained by the developmental instability of the 
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gut microbiota during adolescence. Microbiota composition in adulthood is 
considered rather stable, however, it only acquires its stability by slowly being 
shaped by internal and external factors during the developmental period (Walsh et 
al., 2014). Therefore, changes to the microbiota composition during the adolescent 
period are likely to have a far bigger and longer-lasting impact than when exposed to 
the same external factor in adulthood (Borre et al., 2014). Hence, our data suggests, 
that the impact of dietary intervention on the gut microbiota during adolescence is 
long-lasting, and that microbiota composition does not recover fully after exposure 
to either HFD or CafD. However, the data available on the regeneration of the gut 
microbiota following exposure to unbalanced diet in adulthood is inconsistent. 
Whereas exposure to four weeks of 60% high fat diet results in an altered microbiota 
composition even after 21 weeks of normal chow (Thaiss et al., 2016) switching back 
to normal chow after a 8 week exposure to 60% high fat diet was sufficient to 
normalise changes observed in gut microbiota composition (Safari et al., 2019). 
Overall, these data strongly suggest that gut microbiota composition was changed 
during the adolescent period and did not recover fully from this exposure until the 
end of the experiment. However, further studies are therefore needed to investigate 
whether indeed the same treatment in adulthood would result in changes in gut 
microbiota composition after switching to normal chow.  
Diet induced changes in gut microbiota have been linked to alterations in 
immune response (Zinocker and Lindseth, 2018), neurotransmission (Hassan 
et al., 2018), and alterations of the microbiota by other factors has been 
implicated in myelination (Gacias et al., 2016; Hoban et al., 2016). As we were 
interested in the effect of changes in the microbiota during the adolescent 
period, we focused on gene expression analysis in the amygdala and the 
prefrontal cortex, as it has been shown previously that gene expression in these 
areas is strongly affected by microbiota during development (Stilling et al., 
2015; Hoban et al., 2016). Here we show that dietary intervention during the 
adolescent period leads to permanent changes in gene expression of genes 
involved in neurotransmission, short chain fatty acid transport and signalling 
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or blood brain barrier integrity in the amygdala, as well as genes involved in 
myelination (Plp1) in the prefrontal cortex in HFD treated mice. 
The microbiota, not only during the developmental period but also thereafter 
plays an important role in the induction and training of the host immune 
system and the symbiotic relationship with the microbiota is essential for 
proper immune system functioning (Belkaid and Hand, 2014). Changes in 
microbiota composition induced by dietary intervention therefore are likely to 
impact the immune system. Furthermore, excessive consumption of diets rich 
in fat results in increased secretion of pro-inflammatory cytokines (Thaler et 
al., 2012) and disruption of blood-brain-barrier integrity (Kanoski et al., 2010; 
Guillemot-Legris and Muccioli, 2017; Reichelt et al., 2018). Gene expression for 
the pro-inflammatory cytokines Il1b was upregulated in mice exposed to HFD 
and the anti-inflammatory cytokine Il10 was upregulated in CafD treated mice, 
indicating that there is a possibility for differential immune response activation 
in adulthood following dietary intervention during adolescence. Other genes 
involved in immune response, however, were elevated in both dietary 
intervention groups. These include genes involved in microglial-mediated 
phagocytosis and synaptic remodelling as well as components of the innate 
immune systems (Fcgr2b, Rac2, C3, C1qa, Cx3cr1, Tlr4), indicating that overall 
immune system activity is elevated resulting in neuroinflammation. Increased 
levels of neuroinflammation would suggest a decrease in blood-brain-barrier 
integrity, which plays an important role in regulating the brain’s response to 
inflammation (Zlokovic, 2008). We find elevated levels of expression of genes 
involved in blood-brain barrier integrity which are differentially affected by 
dietary intervention. CafD seems to be affecting blood barrier-related genes 
more drastically than HFD as gene expression of claudin 5, which is thought to 
be the dominant tight junction protein, is significantly increased in CafD but 
not in HFD treated mice. HFD treatment on the other hand increased gene 
expression of tight junction protein ZO-1 and occludin, which could still 
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translate into changes of blood-barrier permeability as it was shown that these 
proteins play a much bigger role in blood-brain-barrier integrity than 
previously assumed (Berndt et al., 2019). Interestingly, blood-brain-barrier 
integrity is decreased in germ-free mice and rescued upon colonisation of 
germ-free mice, indicating that an increase of blood-brain-barrier integrity is 
possible following changes in gut microbiota composition (Braniste et al., 
2014).  
The gut microbiota produces short-chain-fatty acids by fermentation of 
indigestible polysaccharides. These have been implicated in gastrointestinal 
homeostasis, immune regulation, host metabolism but also in brain and 
behaviour (van de Wouw et al., 2018; Li et al., 2019; Vagena et al., 2019). Dietary 
intervention has been shown to affect short-chain-fatty acid metabolism 
(Maciejewska et al., 2018), which in turn can affect brain homeostasis and 
behaviour (van de Wouw et al., 2018; Vagena et al., 2019). Here we observe 
changes in the expression of Ffar1 and Slc5a8 and Slc16a1 indicating that 
transportation and signalling of short-chain fatty acids following dietary 
intervention in adolescence have changed. Furthermore, classical and 
peptidergic neurotransmission is likely to be affected by dietary intervention 
during the adolescence period, as gene expression is changed for the genes 
encoding the GABA receptor a2 (Gabar2), the metabotropic glutamate 
receptor (Grm5), dopamine receptor 1, corticotropin-releasing factor receptor 1 
(Crhr1), neuropeptide Y receptor 1 (Y1) and its ligand neuropeptide Y (Npy). 
Although, gamma-aminobutyric acid receptor 1b is not affected be either of the 
treatments and expression of the glucocorticoid receptor Nr3c1 was only 
affected by HFD treatment, we can say that overall neurotransmission is 
changed by dietary intervention during adolescence. This is in line with results 
published in literature which has shown that changes in the microbiota results 
in altered neurotransmission. For example, the administration of a single 
bacterium, Lactobacillus rhamnosus, results in altered gene expression of 
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Gabra2 in the amygdala (Bravo et al., 2011) and is known to be changed 
drastically in the amygdala of germ free mice (Hoban et al., 2018). Overall, it 
can be concluded that the gene expression profile of the amygdala is 
drastically and long-lastingly changed following dietary intervention in 
adolescence.  
In contrast to the amygdala which matures much faster, the prefrontal cortex 
still develops during adolescence. As it was shown previously that the 
microbiota affects myelination in the prefrontal cortex (Gacias et al., 2016; 
Hoban et al., 2016), we also analysed whether dietary intervention could alter 
gene expression of myelination-related genes. Indeed, HFD induced increased 
expression of Plp1, which could result in abnormal myelination in the 
prefrontal cortex (Karim et al., 2007) and therefore affect emotional learning. 
However, as myelination-related genes were only marginally changed by the 
dietary intervention and subsequent changes in gut microbiota composition 
we speculate that gene expression in the prefrontal cortex is not as drastically 
changed as in the amygdala.  Although this data points towards a role of the 
gut microbiota in the regulation of gene expression in the amygdala and the 
prefrontal cortex, we cannot fully exclude the influence of the diet on its own 
on these parameters. Further studies will be needed to fully disentangle the 
role of the gut microbiota on long-lasting changes of gene expression during 
the adolescent period. 
However, even though dietary intervention had long-lasting effects on the 
microbiota composition and gene expression, no long-lasting effects on 
physiological readouts or behaviour were observed. Different reasons might 
explain the lack of these effects. First, we cannot rule out that the lack of 
translatability of changes in the microbiota composition and gene expression to 
behavioural readouts are due to the selection of the test battery we used. We have 
focused on amygdala dependent tests, which have been shown to be affected by 
changes or the lack of microbiota (Cowan et al., 2018; Hoban et al., 2018; Stilling et 
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al., 2018). However, dietary intervention or the gut microbiota of high fat diet fed 
mice are often linked to changes in depressive-like and exploratory behaviour, as well 
as cognitive abilities (Bruce-Keller et al., 2015; Almeida-Suhett et al., 2017), which 
were not specifically tested in depth in this study. Furthermore, studies have shown, 
that behavioural effects at least in part can be reversed when switching back to 
normal chow following a high fat diet intervention (Sobesky et al., 2014; Boitard et 
al., 2016; Carlin et al., 2016) and 21 days is a relatively short time of diet exposure 
and brain changes in the adolescent brain can continue through to P60, which could 
account for the lack of behavioural differences in adulthood.  
Overall, this study highlights the importance of the microbiota during the 
developmental period in shaping its host microbiota and brain. The results presented 
here support the need for further studies investigating the effect of dietary 
intervention during the adolescent period and their long-term effects on the 
microbiota, gut, immunity, brain and behaviour. Given that a dietary pattern high in 
fat and sucrose is associated with increased risk of mental health problems in 
adolescents (Oddy et al., 2018) it is important to determine to which degree the 
changes persists and to which extent they can be opposed by dietary intervention to 
prevent vulnerable phenotypes for mental health disorders. Furthermore, as it is 
difficult to fully disentangle the effects of the dietary intervention itself from the 
effects of altered gut microbiota composition during the adolescent period, it will be 
useful for future studies to study these effects utilising different factors to alter the 
microbiota such as antibiotics. Moreover, future studies should also investigate the 
underlying mechanisms underpinning such changes with a focus on differentiating 
between immune, humoral and neuronal communication routes (Cryan et al., 2019). 
Given that the vagus nerve is so important in such communication (Fulling et al., 
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3.1.1 Introductory paragraph 
The gut microbiota is increasingly recognized as an important regulator of host 
immunity and brain health. The aging process yields dramatic alterations in the 
microbiota, which is linked to poorer health and frailty in elderly populations. 
However, there is limited evidence for a mechanistic role of the gut microbiota in 
brain health and neuroimmunity during aging processes. Therefore, we conducted 
fecal microbiota transplantation (FMT) from either young (3-4 months) or old (19-20 
months) donor mice into aged recipient mice (19-20 months). Transplant of a 
microbiota from young donors reversed aging-associated differences in peripheral 
and brain immunity, as well as the hippocampal metabolome of aging recipient mice. 
Finally, the young donor-derived microbiota attenuated selective age-associated 
impairments in cognitive and social behavior when transplanted into an aged host. 
Our results reveal that the microbiome may be a suitable therapeutic target to 
promote healthy aging.   
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3.1.2 Main Body  
Aging triggers metabolic and immune alterations that lead to perturbation of brain 
function and behavior, including impairments in hippocampal-associated cognitive 
functioning and social behavior (Matt and Johnson, 2016; Bettio et al., 2017; Boehme 
et al., 2019; Boyer et al., 2019). Notably, the gut microbiota, encompassing the  
population of trillions of micro-organisms, undergoes a parallel community shift, 
which has been correlated to changes in host frailty and cognition (Claesson et al., 
2012; Jackson et al., 2016; Jeffery et al., 2016; Cryan et al., 2019; Ghosh et al., 2020).  
 
Animal models have shown specific roles for the microbiota in shaping hallmarks of 
aging in the gut (Stebegg et al., 2019; Donaldson et al., 2020). Moreover, the 
consequences of an elderly-associated microbiota on a young host showing 
alterations in host immunity, neurogenesis, and cognition (Fransen et al., 2017; 
Kundu et al., 2019; D’Amato et al., 2020; Li et al., 2020). Interestingly, transferring 
microbiota from young fish (African turquoise killifish) into middle-aged fish 
improves lifespan and motor behavior (Smith et al., 2017). However, it is completely 
unknown if microbiota from young donors can restore aging-associated impairments 
in mammals.  
 
To determine if fecal microbiota transplantation (FMT) from young mice can 
ameliorate aging-induced neurocognitive and immune impairments, we collected 
fecal microbiota from naïve young mice (3-4 months) and transplanted this into aged 
mice (Aged yFMT, 19-20 months). A separate group of aged mice received fecal 
microbiota from naïve old mice to control for handling during FMT administration 
(Aged oFMT, 19-20 months). To allow aging-associated comparisons, naïve young 
mice received the same yFMT mixture (Young yFMT). We found aging-associated 
differences in microbiota (Fig. 3.1-1, Supplementary Table 1, 2), immunity (Fig. 3.1-
2, Extended Data Fig. 2, 3), hippocampal neurogenesis (Extended Data Fig. 2), 
hippocampal metabolomics (Fig. 3.1-3, Supplementary Table 3), and behavior (Fig. 
3.1-4, Extended Data Fig. 5) – some, but not all, of which were attenuated by 
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microbiota transplantation from a young mouse into an aged host. Our research 
offers the intriguing possibility that a microbiota from a young individual may have 
beneficial effects when given to an aged host. 
 
3.1.2.1 Age-associated Changes in the Gut Microbiota are Shifted Following FMT 
To investigate the impact of aging on fecal microbiota, we analyzed baseline fecal 
microbiomes of young and aged mice using 16S rRNA amplicon sequencing. We 
reassessed composition and diversity after 4 weeks of FMT to examine engraftment 
and colonization dynamics of the FMT (Fig. 3.1-1a).  Pre-FMT, we found clear 
differences between young and aged mice in beta-diversity. However, following FMT, 
differences in beta-diversity were no longer significant (Fig. 3.1-1b). No temporal or 
intergroup alpha-diversity changes were significant using Simpson or Shannon 
indices. The fact that only richness, measured by Chao1, dropped significantly 
following FMT in all groups (Fig. 3.1-1c), indicates that evenness was retained among 
the reduced number of taxa post-FMT. Twenty genera were significantly changed 
following FMT (Fig. 3.1-1d). Some of these temporal differences appeared congruent 
between aged mice regardless of treatment, indicating potential age-dependent 
responses regardless of the content of the FMT. On the other hand, certain genera, 
including Enterococcus, were altered in aged mice, but transitioned towards young 




Fig. 3.1-1 – FMT Alters the Microbiota on a Taxonomic and Functional Level (a) 
Overview of the experimental design and the study timeline. Vertical bars represent 
one week. Behaviors conducted include Y-Maze, Novel Object Recognition Test (NOR), 
Elevated Plus Maze (EPM), Intestinal Motility (IM), Three-Chamber Social Interaction 
Test (SIT), Morris Water Maze (MWM), Observation Battery (OB), and, in Study 2, the 
Novelty-Induced Hypophagia Test (NIH). BrdU indicates intraperitoneal injection of 
bromodeoxyuridine. (b) Principal Component Analysis showing the effects of FMT on 
the fecal microbiome in young and aged mice in terms of beta-diversity as measured 
196 
 
in Aitchison distance. Arrows indicate the trajectory per group following its respective 
treatment. Ellipses show the 95% confidence intervals per group. WD*: p < 0.001. (c) 
Violin plots displaying the effects of FMT on young and aged mice in terms of alpha-
diversity. Black horizontal lines in violin plots depict the medians. The Chao1 index 
showed a decrease after FMT; two-way ANOVA: (F(1,144)= 50.1 p<0.001). 
***p<0.001. No effects were found in the Shannon or Simpson index. (d) Heatmap 
showing genera differentially altered by FMT. Color depicts effect size, with blue 
(negative) indicating higher abundances pre-treatment and red (positive) indicating 
higher abundances post-treatment. *q < 0.1, **q < 0.01, ***q < 0001. Comprehensive 
statistical results can be found in Supplementary Table 1. (e) Violin plots showing 
Enterococcus abundance is restored to young levels in old mice after yFMT but not 
after oFMT. Black horizontal lines in violin plots depict the medians. Y-axis shows CLR-
transformed abundance. Dashed horizontal red line depicts a threshold for estimated 
abundance of 0 (Mann-Whitney U test: p<0.001, q<0.001, e=1.48). (f) Heatmap 
showing gut-brain modules (GBMs) differentially altered by FMT. Color depicts effect 
size, with blue (negative) indicating higher abundances pre-treatment and red 
(positive) indicating higher abundances post-treatment. *q< 0.1, **q<0.01, 
***q<0.001. Comprehensive statistical results can be found in Supplementary Table 2. 
(g) Violin plots showing the differences in Aitchison distance traveled per microbiome 
after treatment. Black horizontal lines in violin plots depict the medians. Aged oFMT 
group changed more than Young yFMT (F(72)=3.82 p=0.026). Tukey’s HSD: Young 
yFMT vs Aged oFMT: p=0.03. Young yFMT vs Aged yFMT: p=0.88. Aged yFMT vs Aged 
oFMT: p=0.082. *p<0.05, & p<0.1.  
 
Functionally, we found significant changes in nine gut-brain modules (GBMs)(Valles-
Colomer et al., 2019) following FMT (Fig. 3.1-1f). Interestingly, propionate synthesis 
III and acetate degradation were reduced in Aged yFMT, but not in Aged oFMT mice, 
suggesting differences in the metabolism of short-chain fatty acids (SCFA), which are 
involved in gut-brain communication  and aging(Unger et al., 2016; Dalile et al., 
2019). We found that Aged oFMT microbiota composition had changed significantly 
more than Young yFMT in terms of Aitchison distance post FMT, while no significant 
change was observed between Aged yFMT and Young yFMT (Fig. 3.1-1g).  
 
3.1.2.2 yFMT Modulates Age-Associated Mesenteric Lymph Node and 
Hippocampal Immune Changes 
The gut microbiota is a key regulator of host immunity especially in aging (Fransen et 
al., 2017; Thevaranjan et al., 2017). Moreover, the immune system influences 
hippocampal-associated cognitive and social behavior (Filiano et al., 2016; Mohle et 
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al., 2016; Cruz-Pereira et al., 2020). Thus, the immune system may be an important 
link between alterations in the gut microbiota and potential effects on the brain in 
aging.  
 
To determine if aging-invoked immune alterations can be ameliorated by FMT from 
a young donor, we characterized innate and adaptive immunity in the mesenteric 
lymph nodes (MLNs) and circulation. Aging triggered a substantial increase in early 
activated CD8+ T-Cells in MLNs, which was reversed by yFMT (Fig. 3.1-2a). In contrast, 
memory CD8+ T-cells (CD44hi) were unaffected (Extended Data Fig. 3a), perhaps due 
to the low turnover rate of memory CD8+ T-cells (Baliu-Pique et al., 2018). 
Furthermore, CD103+ dendritic cells, which are tightly linked to CD8+ T-cell activation 
(Joffre et al., 2012) and sensitive to changes in the microbiome (Tan et al., 2016), 
were reduced in Aged yFMT mice compared to Aged oFMT mice (Fig. 3.1-2a). yFMT 
into aged mice decreased the proportion of F4/80+ macrophages in MLNs and 
rescued the decrease of the activation marker CD11b on Ly6Chi monocytes (Fig. 2a). 
Despite strong effects of aging on innate and adaptive immunity in the circulation 
(Extended Data Fig. 3c, d), yFMT only trended towards decreasing the aging-
associated rise of marker CD11b on Ly6G+ neutrophils (Fig. 3.1-2b) (Uhl et al., 2016) 
while rescuing the aging-associated rise in peripheral IL-10 (Fig. 3.1-2b). However, 
yFMT did not reverse aging-associated reductions in IFNγ and IL-5, which are both 
predominantly produced by T-cell populations, implying a stage of 
immunosenescence (Fig. 3.1-2b). This indicates that yFMT into an aged host may 
selectively modulate peripheral immunity. The mesenteric lymph node immune 
profile was particularly sensitive to FMT-induced changes in the aged host. 
 
Given the relationship between the gut microbiota, neuroinflammatory processes, 
and brain plasticity (Erny et al., 2015; Mohle et al., 2016; Thion et al., 2018; van de 
Wouw et al., 2019), we characterized microglia, the brain’s resident macrophages, in 
the hippocampus, a brain region critical for cognition. Microglia are essential for 
regulating cellular aspects of cognition, supporting neuroplasticity (Rogers et al., 
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2011; Elmore et al., 2018), and responding to various signals, including cytokines. 
Higher populations of activated microglia, distinguished by enlarged somas, are 
prominent in neurodegenerative conditions (Tay et al., 2017; Hickman et al., 2018). 
Aged oFMT mice showed substantial enlargement in microglia cell soma size, which 
was further pronounced when microglia somas were classified as ‘large’ or ‘small’ 
(Fig. 3.1-2c) (Kozareva et al., 2019). This phenotype was reversed by yFMT (Fig 3.1-
2c). However, we did not observe changes in microglia complexity, or maximum or 
average branch length (Extended Data Fig. 2c).  
 
Fig. 3.1-2 - FMT from Young to Aged Mice Modulate Peripheral Immunity and 
Hippocampal Neuroimmunity (a) Immune profile in mesenteric lymph nodes (MLN) 
was assessed by Flow Cytometry at the end of the study. Differences were detected 
in both early activated CD8+ T-cells (CD69+) (F(2,44)=9.418, p<0.001) and CD103+ 
dendritic cells (DC) (H(3)=7.836, p=0.02) in MLNs. Interestingly, yFMT into aged mice 
reversed (p=0.022) the age-associated increase (p<0.001) in early activated CD8+ T-
cells, while Aged yFMT showed reduced levels of CD103+ DCs compared to Aged oFMT 
(p=0.023). (b) Immune profile in circulation was assessed before mice were assessed 
for behavior. Distinct marker expression change, assessed by median fluorescence 
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intensity (MFI), for the activation marker CD11b on Ly6G+ neutrophils (F(2,46)=12.53, 
p<0.001), were found with an increased expression in Aged oFMT (CD11b: p<0.001) 
which tended to be rescued in Aged yFMT (CD11b: p=0.0645). Cytokine levels were 
assessed in the circulation. Notably, both IFNγ and IL-5 decreased in both age groups 
(F(2,42)=9.331, p<0.001, and (F(2,39)=8.758, p<0.001) respectively) while an age-
associated increase in IL-10 in Aged oFMT  F(2,42)=4.357, p<0.001, post-hoc: p=0.03) 
was found which was counteracted in Aged yFMT (p=0.033). Interestingly, Aged yFMT 
exhibited decreased IL-6 compared to Young yFMT (F(2,42)=3.768, p=0.031, post-hoc: 
p=0.027). (c) Hippocampal neuroimmunity was assessed by examining microglia 
soma area (F(2, 13)=8.418. p=0.005). There was a significant increase in microglia 
soma size in Aged oFMT mice compared to Young yFMT mice (p=0.005), which was 
reversed in Aged yFMT mice compared to Aged oFMT (p=0.042). When microglia 
were further classified as having a ‘large’ or ‘small’ soma (F(2, 13)=6.328, p=0.012), 
Aged oFMT mice had significantly more microglia classified as ‘large’ compared to 
Young yFMT (p=0.022) and Aged yFMT (p=0.264). Mean ± SEM. n = 12-21, *p<0.05, 
**p<0.01, ***p<0.001 & p<0.1.  
 
In addition to supporting brain immunity, microglia regulate hippocampal 
neurogenesis (Gemma et al., 2010; Sierra et al., 2010), a key activity in some learning 
and memory processes(Sahay et al., 2011; Anacker and Hen, 2017), which is hindered 
in aging (Klempin and Kempermann, 2007). Intestinal microbiota can alter 
hippocampal neurogenesis, potentially contributing to age-associated disruptions in 
neurocognition (Ogbonnaya et al., 2015; Kundu et al., 2019). Using another cohort of 
animals (Fig. 3.1-1a) we confirmed a decrease in the number of surviving newly-born 
hippocampal neurons in aged mice (Extended Data Fig. 2a). But this was not 
prevented with yFMT.  
 
3.1.2.3 The Aged Hippocampal Metabolome is Sensitive to the Rejuvenating Effects 
of yFMT 
Given the aging-associated changes in the brain and the influence of gut microbiota 
on hippocampal function (Mohle et al., 2016), we examined whether FMT from 
young to aged mice shaped the hippocampal metabolome.  
 
Aging induced significant differences in hippocampal metabolites, with aged and 
young mice clustering separately (Fig. 3.1-3a, 3.1-3c). Notably, 35 metabolites altered 
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in aging were restored towards pre-aged levels by yFMT (Fig. 3.1-3b, 3.1-3d and 
Supplementary Table S3), resulting in Aged yFMT mouse hippocampal metabolomes 
clustering between aged and young individuals (Fig. 3.1-3c). Notably, GABA and N-
glycolylneuraminate were among those restored by yFMT. These metabolites play 
critical roles in cognition and brain plasticity (Wang, 2012; Fritschy and Panzanelli, 
2014). In line with previous research (Hunsberger et al., 2020), arginine increased 
with aging, and is linked to the nitric oxide pathway and neurodegeneration (Wu and 
Morris, 1998; Malinski, 2007); its reversal by yFMT into aged mice proposes possible 
neuroprotective effects of yFMT on the aged brain. Functionally, these restored 
metabolites are enriched in six metabolic pathways (Fig. 3.1-3e), predominantly 
related to amino acid metabolism, which is critical for healthy cognition (Canfield and 
Bradshaw, 2019), and aminoacyl tRNA biosynthesis, which is crucial for proper 




Fig. 3.1-3 - FMT from Young to Aged Mice Shapes the Hippocampal Metabolome 
Volcano plots depicting the effect of aging (a) and the difference between oFMT and 
yFMT (b) in the hippocampal metabolome. Metabolites on the 5% extremes of effect 
sizes of differential abundance are labelled. Horizontal dashed lines represent p=0.05. 
Comparisons with p>0.05 or q>0.2 are depicted as smaller and more transparent. 
Comprehensive statistical results including the full legend for the abbreviations can 
be found in Supplementary Table 2. (c) Principal Component Analysis showing the 
effects of FMT on the hippocampal metabolome in young and aged mice in terms of 
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Aitchison distance. Ellipses show the 95% confidence intervals per group. 
PERMANOVA: p<0.001. (d) Violin plots representing the 35 metabolites that were 
significantly altered by aging and restored towards young levels after yFMT. Black 
horizontal lines in violin plots depict the medians. Y-axis shows CLR-transformed 
metabolite concentrations. Q-values can be seen in the bottom-right corners of every 
figure. Significance symbols represent Mann-Whitney U-test post-hoc tests: *p<0.05, 
**p<0.01, ***p<0.001, # p<0.1. Comprehensive statistical results can be found in 
Supplementary Table 2. (e) Scatterplot showing the results of the MetaboAnalyst 
Pathway analysis. Labeled, dark-blue points depict the pathways that withstood FDR 
at a 0.1 threshold.  
3.1.2.4 yFMT Counteracts Hippocampal-Dependent Cognitive and Social 
Behavioral Changes in Aging.  
Alterations in the gut microbiome have been widely linked to changes in behavior, 
including hippocampal-dependent cognition (Cryan et al., 2019), which declines 
during the aging process (Smith et al., 2000; Scheff et al., 2006; Koh et al., 2014). 
Thus, we examined if yFMT rescued aging-induced, hippocampus-associated 
behavioral abnormalities in aged mice in a series of cognitive tasks. Consistent with 
the extant literature, aging was associated with an increase in the latency to enter 
the target quadrant in the Morris Water Maze probe trial. However, this was 
attenuated in aged mice that received FMT from a young donor (Fig. 3.1-4c), 
indicating that yFMT may improve aging-associated impairments in long-term spatial 
memory. Notably, there were no differences in locomotor activity between groups 
(Fig 3.1-4e).  
 
We also assessed short-term working memory and short-term recognition memory 
using the Y-Maze and Novel Object Recognition (NOR) tests. While there were no 
significant aging-induced impairments in either spontaneous alternation behavior in 
the Y-Maze or the novel object recognition index (Fig. 3.1-4a, b), Aged oFMT mice 
tended to interact less with objects in the NOR test (Fig. 3.1-4b). Furthermore, in the 
Three-Chamber Social Interaction Test, Aged oFMT mice spent significantly less time 
interacting with a social partner than their Young yFMT counterparts (Fig. 3.1-4d). 
Both aging-associated deficits in environmental interaction were rescued by FMT 
from young donors (Fig. 3.1-4b, d).  Overall, these data suggest that yFMT can rescue 




Fig. 3.1-4 - FMT from Young to Aged Mice Influence Behavior (a) Short-term memory 
assessed by spontaneous alternation behavior (Y-maze). No significant differences 
were observed between groups. (b) Short-term memory and exploration in the Novel 
Object Recognition (NOR) test. While long-term memory in the NOR was not 
significantly different across groups, there were significant differences in exploration 
of the objects (F(2,44)=3.388, p=0.028), with aged mice receiving yFMT (Aged yFMT) 
showing an increased exploration activity compared to Aged oFMT (p=0.043). (c) 
Learning and memory in Morris Water Maze: Latency-to-find platform over five 
training days summarized as area under-the-curve (AUC) displays the learning 
efficacy to find the platform. Interestingly, neither age nor FMT did affect learning 
efficacy. Subsequently, we assessed long-term memory in the probe trial 24 h after 
the last training day by measuring the latency to find the target quadrant. The 
treatment significantly altered the time to reach the target quadrant (F(2,47)=3.357, 
p=0.043) with Aged oFMT (p=0.041) needed a longer time to allocate the target 
quadrant which was not seen in aged mice which received yFMT. d) Social behavior 
and memory: Treatment affected social behavior with respect to the time the test 
mouse interacted with a con-specific mouse (over an object) in the second phase of 
the 3-chamber social interaction test (F(2,49)=4.168, p=0.021) while interaction with 
a novel mouse (over the now familiar mouse) in the third phase of the 3-Chamber 
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Social Interaction Test remained unaffected by the treatment. Post-hoc analysis 
indicated decreased interaction with a con-specific mouse in Aged oFMT compared 
to Young yFMT (p=0.022) which trended to be rescued by yFMT into aged mice 
(p=0.077). (e) Locomotion: Locomotion was unaltered by age (Aged oFMT) or FMT 
from young to aged mice (Aged yFMT). (f) Observation Battery: Bar plots show 
observation battery score prior to FMT compared to end of study. Both aged groups 
showed a decreased score prior to FMT compared to Young yFMT (H(3)=13.33, 
p=0.001; post-hoc: Aged oFMT p=0.001, and Aged yFMT p=0.038, respectively). In 
contrast, Aged yFMT did not more show a significant difference (p=0.46) at the end 
of the study while Aged oFMT retained a decreased score compared to Young yFMT 
(H(3)=6.146, p=0.046; post-hoc: p=0.04). Mean ± SEM. n = 14-21, *p<0.05, **p<0.01, 
& p<0.1.  
 
3.1.3 Conclusion 
Here, we demonstrate, for what is to our knowledge the first time, that transplanting 
microbiota from healthy, young male mice into aged male mice can significantly 
attenuate aging-associated deficits in cognitive behavior. Upon investigating 
potential mechanisms for how the intestinal microbiota may orchestrate these 
improvements, we found specific aspects of peripheral immunity and 
neuroimmunity were restored following yFMT into aged male mice. Moreover, we 
uncovered amelioratory effects of yFMT on the aging hippocampal metabolome, 
which coincided with the improvements in behavior. While specific aging-associated 
deficits in behavior, immunity, or neurogenesis were not restored by yFMT, this 
research provides fundamental evidence that the gut microbiota should be 
considered as a therapeutic target for treating aspects of aging-associated decline in 
hippocampus-related function. 
 
3.1.4 Methods  
3.1.4.1 Animals 
Male young adult C57BL/6 mice (n=25; Envigo, Cambridgeshire, UK; 10-12 weeks) 
and aged C57BL/6mice (n=50; Charles River, UK, 19-20 months) were used in this 
study. All experiments were performed in accordance with European guidelines 
following approval by University College Cork Animal Ethics Experimentation 
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Committee (AE19130/P052). Animals were habituated to the animal facility for at 
least four weeks before experiments started and were kept under a 12-hour 
light/dark cycle, with a temperature of 21 ± 1 °C and humidity of 55 ± 10%. Food and 
water were given ad libitum.  
 
3.1.4.2 Fecal collection and fecal microbiota transplant (FMT) 
For all fecal material collection, mice were placed in an empty plastic cage, free of 
bedding and sterilized with 70% ethanol, until defecation. For future microbiome 
analysis, fecal pellets were immediately collected and snap-frozen on dry ice, then 
stored at -80 °C until sequencing.  
 
To collect material for FMT, a separate cohort of naive young adult C57BL/6 mice (n 
= 40, Envigo, Cambridgeshire; 12-15 weeks at collection, group-housed), and the 
same aged mice defined above, supplemented with additional naive old mice to 
ensure enough collection volume (n = 83, 18.8-20 months at collection, group-
housed), were used, prior to the start of the experimental timeline. Fecal pellets were 
collected fresh and immediately transferred to an anaerobic hood, where they were 
pooled per group to ensure enough volume. Fecal material was homogenized in 
reduced sterile phosphate buffered saline (PBS) with 20% glycerol (w/v), and filtered 
through a 70 µm strainer to remove large particles before being aliquoted and frozen 
at -80 °C. To ensure enough volume of FMT material without risking potential cross 
contamination, collection was spaced out over six to nine collection days per group, 
one group at a time. Prior to FMT, equal aliquots from every collection day were 
pooled together to consistently generate enough volume. 
Fecal microbiota transplantation (FMT) was performed by oral gavage bi-weekly (100 
µl of 100 mg/ml homogenized fecal slurry). Briefly, mice were gently scruffed, and 
the fecal slurry was administered through an oral gavage needle (23G). FMT occurred 
once per day for the first three days to encourage microbiota engraftment, then 




3.1.4.3 Study design and experimental timeline 
Aged mice were randomly delegated into one of two groups, balanced by weight: 
aged mice receiving FMT from young donor mice (Aged yFMT), and to control for 
handling, aged mice receiving FMT from old donor mice (Aged oFMT). Young mice 
were given FMT from young mice (Young yFMT) to allow for inter-age comparisons. 
To ensure appropriate engraftment of microbiota, and to allow for potential 
microbiota-driven neurocognitive and behavioral effects, mice were orally gavaged 
with FMT once per day for the first three days, then twice weekly thenceforth in line 
with previous research (Bruce-Keller et al., 2015). 
 
Baseline fecal samples were collected prior to the start of the study and after four 
weeks of FMT inoculation to assess the effects of FMT on recipient fecal microbiota 
prior to the start of the behavioral battery. Following four weeks of FMT, blood was 
collected, and flow cytometry was run to assess markers of mesenteric and 
peripheral immunity accompanied with cytokines measurements (see flow 
cytometry methodology under 3.6, and cytokine assessment under 3.10). Mice then 
underwent a series of behavioral tests designed to assess a variety of locomotor, 
social, cognitive and anxiety-like parameters, including the following: Y-Maze,  Novel 
Object Recognition, Elevated Plus Maze, 3-Chamber Social Interaction Test 
(Sociability and Social Memory), and the Morris Water Maze. Finally, mice were 
euthanized via decapitation, and blood and tissues immediately harvested for further 
analysis. See experimental timeline Fig. 1a. 
 
Aged and young mice were monitored throughout the study through a dedicated 
observation battery which compromises different aspects of health including general 
appearance, physical characteristics and sensorimotor reflexes(Roux et al., 2005; 




An additional study was performed following a similar design as above to allow for 
visualization and further investigation potential mechanisms of action, including 
microglia and adult hippocampal neurogenesis. Herein, mice were treated once per 
day with 150 mg/kg Bromodeoxyuridine (BrdU; Sigma-Aldrich, cat. no. 59-14-3) 
diluted to 20 mg/ml in sterile saline via intraperitoneal injection during the first three 
FMT inoculation days to label proliferating cells. Following four weeks of FMT 
inoculation, the Novelty-Induced Hypophagia Test was performed. Finally, mice were 
anesthetized with 90 mg/kg pentobarbital and tissue fixed via transcardial perfusion 
with chilled sterile saline for two minutes, followed by eight minutes of 4% 
paraformaldehyde (PFA). Brains were harvested and transferred into 4% PFA 
overnight, then transferred to 15% sucrose overnight, and finally 30% sucrose for 24 
hours before being snap-frozen in isopentane and stored at -80 °C. 
 
3.1.4.4 DNA extraction for 16S rRNA amplicon microbiota analysis 
DNA was extracted using the QiaAMP Power Fecal Pro kit (Qiagen) according to the 
manufacturer’s instructions. DNA concentration was normalized and 16S rRNA 
amplicon libraries were prepared using primers to amplify the V3-V4 region of the 
bacterial 16S rRNA gene, with Illumina adapters incorporated as described in the 
Illumina 16S rRNA Metagenomic Library Preparation guide, with the exception that 
30 amplification cycles were used. Following index PCR and purification, the products 
were quantified using the Qubit high sensitivity DNA kit (Life Technologies) and 
pooled equimolarly. The pooled libraries were assessed using an Agilent high 
sensitivity DNA kit and examined by quantitative PCR (qPCR) using the Kapa 
Quantification kit for Illumina (Kapa Biosystems, USA) according to the 
manufacturer’s guidelines. Libraries were then diluted and denatured following 
Illumina guidelines and sequenced (2 × 300 bp) on the Illumina MiSeq platform. 
 
3.1.4.5 16S Microbiota analysis and bioinformatics 
Paired-end reads were pre-filtered based on a quality score threshold of >28 and 
trimmed, filtered for quality and chimaeras using the DADA2 library in R (version 
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3.6.3)(Callahan et al., 2016). QC was done using the fastqc program in Ubuntu 18.04. 
Samples with fewer than 10,000 reads after filtering were discarded. Taxonomy was 
assigned with DADA2 against the SILVA SSURef database release v138(Quast et al., 
2013). Parameters as recommended in the DADA2 manual were adhered to unless 
mentioned otherwise. Amplicon Sequence Variants (ASVs) were aggregated at genus 
level. Those that were unknown on the genus level were not considered in 
downstream analysis, as were genera that were only detected as non-zero in 10% or 
fewer of total samples. After filtering, 86 different genera were left in total over all 
microbiome samples. 
 
Microbiota bioinformatics were done in R (version 3.6.3) with the Rstudio GUI 
(version 1.2.5033). Principal component analysis was performed on center log-ratio 
transformed (clr) values using the ALDEx2 library(Fernandes et al., 2014). The 
number of permutations was always set to 1000. The iNEXT library was used to 
calculate alpha diversity using the Chao1, Shannon and Simpson indices. Beta-
diversity was assessed in terms of Aitchison distance and visualized via principle 
component analysis(Hsieh et al., 2016). Wd*(Hamidi et al., 2019) followed by a 
pairwise post-hoc and Bonferroni was used to find structural differences between 
treatments on a compositional level. The degree of change per mouse through time 
was calculated in terms of Aitchison distance, using one-way ANOVA followed by 
Tukey’s test. Degree of change in the microbiome after treatment, or volatility, was 
calculated as Aitchison distance. The Piphillin web server was used to infer the 
functional metagenome in terms of KEGG-orthologues(Iwai et al., 2016). Using these 
KEGG-orthologues, Gut-Brain Modules and Gut-Metabolic Modules were calculated 
using the omixerRpm R library(Valles-Colomer et al., 2019). Differential abundance 
of microbial genera as well as functional modules was calculated using the Wilcoxon 
signed-rank test implementation in the ALDEx2 library. To correct for multiple testing 
(FDR) in tests involving microbiota features, the internal ALDEx2 implementation of 
the Benjamini-Hochberg (BH) post-hoc procedure was performed with a q-value of 
0.1 as a cut-off. All custom R scripts are available online at 
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https://github.com/thomazbastiaanssen/Tjazi (Bastiaanssen, 2018). Microbiota 
figures were generated using ggplot2.  
 
3.1.4.6 Flow cytometry 
To assess immunity following four weeks of intervention with FMT, before mice were 
subjected to behavioral assessments, blood sample preparation was done as 
previously described with minor modifications(van de Wouw et al., 2020). Briefly, 
blood was collected by tail tipping using Eppendorf tubes containing 2.5 µL 3% EDTA 
solution to prevent blood clotting. Blood was resuspended in each 10 mL home-made 
red blood cell lysis buffer (15.5 mM NH4Cl, 1.2 mM NaHCO3, 0.01 mM tetrasodium 
EDTA diluted in deionized water) for three min. Blood samples were subsequently 
centrifuged (1500×g, 5 min), plasma taken for cytokine analysis using the 
Proinflammatory Panel 1 (mouse) V-PLEX Kit (Meso Scale Discovery, Maryland, USA) 
(see 3.10 for full details of methodology), and cells resuspended in PBS containing 
1:1000 FVS780 (PE-Cy7) (BD Biosciences, cat. no.  565388) and incubated for 15 min 
at RT to distinguish live from dead cells. Subsequently, samples were centrifuged 
(1500×g, 5 min) and each aliquot (two per sample) resuspended in 50 µl BV staining 
buffer (BD Biosciences, cat. no. 563794). All subsequent procedures were conducted 
on ice / at 4°C. For the staining procedure, 5 μl of FcR blocking reagent (Miltenyi, cat. 
no. 130-092-575) was added to each sample. Samples were subsequently incubated 
with a mix of antibodies for extracellular staining to investigate (a) innate immune 
system properties focused on monocytes / neutrophils, and (b) adaptive immune 
system properties focused on T-cells (see Table 1) and incubated for 30 min on ice. 
Samples for panel a (monocytes / neutrophils populations) were subsequently 
washed in staining buffer and fixed in 4% PFA for 30 min on ice, whilst samples for 
panel b (T-cells populations) underwent intracellular staining using the eBioscience™ 
Foxp3/Transcription Factor Staining Buffer Set (Thermo Fisher Scientific, cat. no. 00-
5523-00), according to the manufacturer's' instructions, together with FoxP3-APC 
(Thermo Fisher Scientific, cat. no. 17-5773-82). Fixed samples were subsequently 
resuspended in the staining buffer and analyzed the subsequent day using the BD 
FACSCelesta. Data was analyzed using FlowJo (version 10). Target populations were 
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normalized to the number of live cells or the respective parent population. Gating 
strategy is depicted in Extended Data Fig. 4.  
 
To assess gut-associated immunity at the end of the study, mesenteric lymph nodes 
(MLNs) were carefully dissected and processed for Flow Cytometry as previously 
described(van de Wouw et al., 2020). Briefly, MLNs were transferred onto a 70 μm 
strainer and disassembled using the plunger of a 1-mL syringe. The strainer was 
subsequently washed with 10 mL media (RPMI-1640 medium with L-glutamine and 
sodium bicarbonate, supplemented with 10% FBS (Sigma, cat. no. F7524l) and 1% 
Pen/strep (Sigma, cat. no. P4333), centrifuged and 3×106 cells were resuspended in 
90 μl staining buffer and split into three aliquots for the staining procedure. Samples 
were always kept on ice. For the staining procedure, 5 μl of FcR blocking reagent 
(Miltenyi, cat. no. 130-092-575) was added to each sample. Samples were 
subsequently incubated with a mix of antibodies (see Table 2) for 30 min on ice 
followed by a washing step and final fixation using 4% PFA for 30 min on ice. Samples 
were analyzed the subsequent day using the BD FACSCalibur. Data was analyzed 
using FlowJo (version 10). The investigated cell populations were normalized to the 
number of obtained peripheral blood mononuclear cells (PBMCs). 
 
Table 1  
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3.1.4.7 Hippocampal Metabolomics  
Mice were decapitated at the end of the study, the hippocampus carefully dissected, 
immediately snap frozen in liquid nitrogen and stored at -80 °C until use. For 
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metabolomics, the left hemisphere of the hippocampus was used. Hippocampal 
metabolomics were conducted at Metabolon using UHPLC/MS/MS.  
 
Samples were prepared using the automated MicroLab STAR® system from Hamilton 
Company. Several recovery standards were added prior to the first step in the 
extraction process for QC purposes. To remove protein, dissociate small molecules 
bound to protein or trapped in the precipitated protein matrix, and to recover 
chemically diverse metabolites, proteins were precipitated with methanol under 
vigorous shaking for 2 min (Glen Mills GenoGrinder 2000) followed by centrifugation. 
The resulting extract was divided into five fractions: two for analysis by two separate 
reverse phase (RP)/UPLC-MS/MS methods with positive ion mode electrospray 
ionization (ESI), one for analysis by RP/UPLC-MS/MS with negative ion mode ESI, one 
for analysis by HILIC/UPLC-MS/MS with negative ion mode ESI, and one sample was 
reserved for backup. Samples were placed briefly on a TurboVap® (Zymark) to 
remove the organic solvent. The sample extracts were stored overnight under 
nitrogen before preparation for analysis.   
 
Several controls were analyzed in concert with the experimental samples: a pooled 
matrix sample generated by taking a small volume of each experimental sample (or 
alternatively, use of a pool of well-characterized human plasma) served as a technical 
replicate throughout the data set; extracted water samples served as process blanks; 
and a cocktail of QC standards that were carefully chosen not to interfere with the 
measurement of endogenous compounds were spiked into every analyzed sample, 
allowed instrument performance monitoring and aided chromatographic 
alignment.  Instrument variability was determined by calculating the median relative 
standard deviation (RSD) for the standards that were added to each sample prior to 
injection into the mass spectrometers. Overall process variability was determined by 
calculating the median RSD for all endogenous metabolites (i.e., non-instrument 
standards) present in 100% of the pooled matrix samples. Experimental samples 
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were randomized across the platform run with QC samples spaced evenly among the 
injections. 
 
For analysis, a Waters ACQUITY ultra-performance liquid chromatography (UPLC) and 
a Thermo Scientific Q-Exactive high resolution/accurate mass spectrometer 
interfaced with a heated electrospray ionization (HESI-II) source and Orbitrap mass 
analyzer operated at 35,000 mass resolution was utilized.  The sample extract was 
dried then reconstituted in solvents compatible to each of the four methods. Each 
reconstitution solvent contained a series of standards at fixed concentrations to 
ensure injection and chromatographic consistency. One aliquot was analyzed using 
acidic positive ion conditions, chromatographically optimized for more hydrophilic 
compounds. In this method, the extract was gradient eluted from a C18 column 
(Waters UPLC BEH C18-2.1x100 mm, 1.7 µm) using water and methanol, containing 
0.05% perfluoropentanoic acid (PFPA) and 0.1% formic acid (FA). Another aliquot was 
also analyzed using acidic positive ion conditions; however, it was 
chromatographically optimized for more hydrophobic compounds.  In this method, 
the extract was gradient eluted from the same C18 column using methanol, 
acetonitrile, water, 0.05% PFPA and 0.01% FA and was operated at an overall higher 
organic content.  Another aliquot was analyzed using basic negative ion optimized 
conditions using a separate dedicated C18 column. The basic extracts were gradient 
eluted from the column using methanol and water, however with 6.5mM Ammonium 
Bicarbonate at pH 8. The fourth aliquot was analyzed via negative ionization 
following elution from a HILIC column (Waters UPLC BEH Amide 2.1x150 mm, 1.7 µm) 
using a gradient consisting of water and acetonitrile with 10mM Ammonium 
Formate, pH 10.8. The MS analysis alternated between MS and data-dependent MSn 
scans using dynamic exclusion.  The scan range varied slighted between methods but 




Raw data was extracted, peak-identified and QC processed using Metabolon’s hard- 
and software. Compounds were identified by comparison to library entries of purified 
standards or recurrent unknown entities.   
 
Peaks were quantified using area-under-the-curve. Biostatistics were done in R 
(version 3.6.3) with the Rstudio GUI (version 1.2.5033). Missing values were imputed 
by taking 95% of the minimum observed abundance per metabolite. Metabolites that 
were detected in less than 10% of samples were dropped from analysis. Principal 
component analysis was performed on centered log-ratio transformed (clr) values 
using the ALDEx2 library(Fernandes et al., 2014). Number of permutations was 
always set to 1000. PERMANOVA followed by a pairwise PERMANOVA was used to 
find structural differences between treatments on a compositional level. In order to 
find metabolites that were altered by aging and restored by yFMT, we first did a 
Mann-Whitney U-test between all yFMT samples and the Aged oFMT group, 
identifying metabolites where the Aged oFMT group was different from the two 
yFMT groups. Then we did pairwise Mann-Whitney U-tests in between both 
individual yFMT groups and the Aged oFMT group, to verify that both yFMT groups 
were indeed different from the Aged oFMT group levels individually. To correct for 
multiple testing in tests involving metabolomics features, Storey’s q-value post-hoc 
procedure was performed with a q-value of 0.2 as a cut-off. Metabolites that were 
found to be altered in aging and restored by yFMT were mapped to their 
corresponding Human Metabolome Database (HMDB) identifier and subjected to 
pathway analysis using the MetaboAnalyst online pipeline, choosing the murine 
KEGG library as a reference. Custom R scripts are available online at 
https://github.com/thomazbastiaanssen/Tjazi. Metabolomics figures were 
generated using ggplot2.  
3.1.4.8 Behavior 





3.1.4.8.1 Spontaneous alternation in the Y-Maze 
To access short-term working memory, spontaneous alternation behavior in the Y-
maze tests hippocampal-dependent spatial memory and exploration and was carried 
out and analyzed as previously described(Scott et al., 2017). Briefly, mice were 
habituated to the room 30 min prior to testing, and behavior recorded for five 
minutes using a ceiling-mounted camera.  
3.1.4.8.2 Novel Object Recognition 
To assess short-term recognition memory, mice were subjected to the Novel Object 
Recognition (NOR) task as previously described with some modifications(Golubeva 
et al., 2017). Animals were habituated to the room 60 min before the test. On the 
pre-trial day, mice were habituated to the empty, open arena (40×45×45 cm, L×W×H) 
in two habituation phases (10 min each, with 3h time in between). One the following 
day, test mouse was exposed for 10 min to two identical objects placed in the corners 
of the arena (acquisition phase). 3 h later, one of the familiar objects was substituted 
with a novel object, and the animal could explore the objects for 10 min (retention 
phase). The test was conducted under dimmed lighting (15 lux). Animal behavior was 
video recorded; time spent in exploration of the objects was blindly scored in 
Ethovision version 15 (Noldus). Exploration behavior was defined as orienting the 
nose towards the object at a distance < 2 cm, or direct contact with the object. 
Discrimination index was calculated according to the formula: (t [novel] − t [familiar]) 
/ (t [novel] + t [familiar]). Mice who interacted in sum less than 12 seconds with either 
the novel or the familiar object, were excluded from the analysis.  
 
3.1.4.8.3 Open Field 
The Open Field is a widely used assay to assess approach avoidance behavior, 
locomotor activity and the behavioral response to a novel context and was 
conducted as previously described with some modifications(van de Wouw et al., 
2020). Briefly, mice were placed in an open arena (40×45×45 cm, L×W×H) and could 
explore the arena for 10 min, which represented the first habituation phase for the 
NOR testing. Animals were habituated to the room 60 min prior to the test. Testing 
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was performed under dim light (15 lux). The open field test box was cleaned with 
70% ethanol in-between animals. Experiments were videotaped using a ceiling-
mounted camera and were analyzed for time spent in the virtual center zone (33% 
of the total area) and total distance travelled using Ethovision 15. 
 
 
3.1.4.8.4 Elevated Plus Maze 
The Elevated Plus Maze test was used to assess anxiety-like behavior and was 
conducted as previously described(van de Wouw et al., 2020). Briefly, mice were 
allowed to explore the maze, which was elevated 1 m above the ground and 
consisted of a grey cross-shaped maze with two open arms and two closed arms (50 
× 5 cm with 15 cm walls in the closed arms and 1 cm walls in the open arms) for five 
minutes. Mice were habituated to the room 30 min prior to the test. Experiments 
were conducted in red light (5 lux). The Elevated Plus Maze apparatus was cleaned 
with 70% ethanol in-between animals. Experiments were videotaped using a ceiling-
mounted camera and time spent as well as the number of entries in the open arms, 
which was defined as all paws in the open arm, measured. 
 
3.1.4.8.5 3-Chamber Social Interaction Test 
Sociability and social novelty were assessed in a three-chamber apparatus as 
previously described(van de Wouw et al., 2020). The test consists of three sequential 
ten minutes’ trials: (1) habituation; (2) sociability (analysis of time animals spent in 
the chamber with the conspecific mouse or with the object). (3) social novelty 
preference (analysis of time animals spent in the chamber with the novel mouse or 
in the chamber with the familiar mouse).   
 
3.1.4.8.6 Morris Water Maze 
The Morris Water Maze represents a test for spatial learning(Vorhees and Williams, 
2006) and was conducted as previously described(Cryan et al., 2019). Briefly, mice 
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were trained over five days, with four trials per day each lasting two minutes to 
spatially allocate the submerged platform. On day six, the platform was removed and 
a probe trial lasting 30s conducted.  
 
3.1.4.9 Plasma collection and corticosterone assay 
Using Lithium-Heparin-coated capillaries, trunk blood was collected at the terminal 
time point of the study. Blood was centrifuged at 3500g at 4°C temperature for 15 
min. Plasma was aspirated and stored at −80°C. Plasma CORT was measured as 
previously described(Scott et al., 2017) by ELISA, following vendor instructions (ENZO 
Corticosterone ELISA, cat. no. ADI-900-097). Concentration is expressed in ng/ml.  
  
3.1.4.10 Cytokine assay 
Cytokine secretion was assessed using the Proinflammatory Panel 1 (mouse) V-PLEX 
Kit (Meso Scale Discovery, cat. no. K15048D-1). Samples were run in duplicates. 
Reading and analyses were performed using the MESO QuickPlex SQ 120, SECTOR 
Imager 2400. Values under the fit curve range and detection range were excluded. 
Concentration is expressed in pg/ml. 
 
3.1.4.11 Microglia analysis 
For morphological characterization of microglia an Iba1 staining was performed with 
modifications as previously described(Boehme et al., 2014). Brains were sliced at -
20°C in 30μm sections into antifreeze solution. Iba1 (ionized calcium-binding adapter 
molecule 1) is a Ca-dependent cytosolic protein that is expressed in the brain in 
microglia(Ito et al., 1998). 
 
Iba1 staining was carried out using the 3,3'-Diaminobenzidine (DAB) method as 
described previously(Boehme et al., 2014). Briefly, slices (free-floating) were washed 
six times for 5 min in PBS, before sections were incubated for 30 min in 0.24% H2O2 
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(in PBS) and then washed four times for 5 min each in PBS-T (PBS with 0.2% Triton). 
After blocking in PBS-T serum (0.2% Triton, 3% NDS) for 1 hour, incubation was 
carried out overnight at 4°C with the primary antibody (rabbit anti-Iba1, 1:2000 in 
PBS-T, #019-19741; Wako Pure Chemical Industries, Osaka, Japan). On day two, slices 
were washed four times for 5 minutes in PBS-T and blocked with 3% PBS-T serum for 
15 minutes, followed by a two-hour incubation with the biotin-conjugated secondary 
antibody (Biotin-Sp conjugated donkey anti-rabbit IgG, 1: 500 in PBS-T; Jackson 
ImmunoResearch, cat. no.  711-065-152). After washing four times for 5 min in PBS-
T, sections were transferred to Vectastain ABC peroxidase kit (Vector Laboratories, 
cat. no. PK-6100) for 1 h. Following a four-fold five-minute wash with PBS-T, the DAB 
reaction was started. Using the SIGMAFAST™ DAB Tablets (Sigma, cat. no. D4293), 
slices were put in DAB and the reaction started by adding 1:1 H2O2 urea, slices were 
subsequently incubated for ten minutes. After four times wash with PBS for five 
minutes, sections were mounted using DPX (Sigma, cat. no. 06522) as a mounting 
media and stored for analysis at room temperature. 
 
The morphological complexity of microglia was assessed using the ImageJ-based 
"Sholl Analysis Tool"(Ferreira et al., 2014) and conducted following previously 
described guidelines(Gonzalez Ibanez et al., 2019). The focus was on the cornu 
Ammonis CA1 region of the hippocampus as it has been widely related to spatial 
memory(Tsien et al., 1996). The analysis was performed blinded. Altered morphology 
of the microglia, e.g. as a result of a lipopolysaccharide application, can be used to 
characterize whether the microglial cells are in the ramified or in the activated state. 
As a result of activation, microglial cells retract their processes into the cell body, 
thereby increasing its size(Kettenmann et al., 2011). 
 
The Sholl analysis(Sholl, 1953) is a common technique used to evaluate and describe 
branching of cells, and is frequently used to analyze microglia morphology. The 
algorithm places concentric rings from a previously defined point and with a defined 
span and radius over the corresponding cell and counts the intersections of the 
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structures with these rings to automatically detect the number of branches. The 
"Advanced Sholl Analysis Tool" version 3.6.12 (https://imagej.net/Sholl) was used. 
Images were taken on the Olympus BX53 Upright Microscope with a 40x objective in 
Tagged Image File Format (.tif), to prevent losing any image information. The 
resolution was 2880x1800 pixels. The pictures were converted to 8-bit. Twelve cells 
per hemisphere per animal were evaluated. Cells were selected according to the 
following criteria: the entire cell had to be in focus, the cell had to be as clear as 
possible from its surrounding neighboring cells separable (i.e., the extensions should 
be as clearly as possible in the case of overlap), the cell was allowed on average not 
oblique be cut and it had to be always a single cell - duplications or superimpositions 
of several microglial cells in the area of Somas and/or the extensions were excluded. 
Care was taken that the analyzed cell within the frame was cropped according to the 
extent of branches that were clearly connected to the cell body of interest and fully 
separable from crossing branches of other cells. The evaluation of specifically 
selected microglial cells was performed as follows: First, the soma of the 
corresponding cell was marked using the ImageJ Polygon Selection tool. Thus, the 
parameters important for the further course could be grasped: the center of gravity 
of the cell (as starting point for the Sholl analysis), the area of the cell and the pixel 
coordinates, in order to cut out the soma from the later obtained skeleton. The cell 
with the highlighted soma was subsequently cut out of the corresponding image 
using the Freehand Selection tool. Then a binary image was created. This binary 
image was skeletonized in the next step. Subsequently, the soma was cut out. The 
focus point of the analyzed soma was marked and the Sholl analysis performed. The 
chosen radius was 2 to 60 μm to detect the complete cell. The distance of the 
concentric rings placed over each cell was 1 μm. On average, the first intersection 
was registered at 4 μm. Finally, the number of intersections per radius, the average 
maximum length of the projections and the soma size were evaluated per microglia.  
 
3.1.4.12 Analysis of neurogenesis (BrdU+/NeuN+ staining, immunohistochemistry) 
The same brains used in microglia analysis were used to assess the survival of newly 
born hippocampal neurons. Washing steps involve washing tissue in PBS on a gentle 
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plate mixer three times for 5 min each unless otherwise indicated. Free-floating 
sections were washed then incubated in 2N HCl at 37°C for 15 min. Sections were 
then rinsed twice in a sodium tetraborate buffer for 5 min, then washed in PBS. 
Blocking solution (10% normal donkey serum (NDS), 0.3% PBS-T) was added and 
sections set onto a gentle shaking plate for 1hr at RT. Sections were incubated in 
Anti-Rat BrdU (Abcam, cat. no.  AB6326) in 1% NDS, 0.1% PBS-T, 1:100 dilution at 4°C 
overnight. Following BrdU antibody retrieval, sections were washed. All subsequent 
steps were carried out in darkness. Sections were incubated sections in secondary 
antibody (Donkey Anti-rat 594, 1:200; Thermo Fisher Scientific, cat. no. A-21209) for 
90mins at RT in 1% NDS, 0.1% PBS-T in PBS, then washed. For NeuN staining, samples 
were blocked again for 30 min in the previously described blocking solution, then 
incubated in mouse anti-NeuN (Merck, cat. no. MAB377) in 1% normal goat serum 
(NGS; Abcam, cat. no. ab7481), 0.1% Triton-X 100, in PBS, 1:100 dilution at 4°C 
overnight. Sections were washed and placed in the second secondary antibody 
(Donkey Anti-mouse 488, 1:200; Thermo Fisher Scientific, cat. no. A-21202) for 
90mins at RT in 1% NDS, 0.1% PBS-T. Finally, sections were washed, mounted onto 
slides and cover-slipped using PVB DABCO, and stored at 4°C until imaging. Stained 
slices were imaged under dim light at room temperature using an Olympus BX53 
Upright Research Microscope. Hippocampal BrdU+/NeuN+ cells were quantified as 
cells that were distinguishably co-stained for both BrdU and NeuN fluorescent 
markers. 
 
3.1.4.13 Intestinal motility assay 
Gastrointestinal motility was assessed as previously described(Golubeva et al., 2017). 
Briefly, mice were single-housed at 8.00 a.m. with ad libitum access to food and 
drinking water. Three hours later, 0.2 ml of non-absorbable 6% carmine red in 0.5% 
methylcellulose dissolved in sterile PBS was administered by oral gavage, after which 
drinking water was removed. The latency for the excretion of the first red-colored 




3.1.4.14 Assessment of fecal water content and weight 
Mice were singly housed for 1 h during which fecal pellets were collected (five per 
animal). Pellets were subsequently weighed, dried at 50 °C for 24 h and weighed 
again. The average weight per pellet and percentage of fecal water content was 
calculated. 
 
3.1.4.15 Telomere detection 
Telomere attrition is a hallmark of aging(Lopez-Otin et al., 2013). To measure 
telomere length DNA was extracted from whole blood samples, which were collected 
at the end of the study, using the High Pure PCR Template Preparation Kit (Roche, 
cat. no. 11796828001) according to the manufacturer's instructions. Subsequently, 
the average telomere length was determined and calculated using the Absolute 
Mouse Telomere Length Quantification qPCR Assay Kit (ScienCell, cat. no. M8918) 
following the manufacturer's instructions. 
 
3.1.4.16 Statistical analysis 
Statistical analyses were conducted using SPSS 25 (IBM Corp., Armonk, NY, USA) and 
Graphpad Prism 8.3.0 (GraphPad Software, Inc., La Jolla, CA, USA). Prior to statistical 
analysis, data were analyzed for normality using the Shapiro-Wilk test and for 
equality of variances using the Levene's test. Non-parametric data were analyzed by 
Kruskal-Wallis post-hoc Dunn‘s. Parametric data were analyzed using one-way 
analysis of variance (ANOVA) post-hoc Holm-Sidak, and is shown as Mean ± SEM. All 
tests were two-sided where applicable. Outliers were excluded using the ROUT 
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The gut microbiota is an essential regulator of many aspects of host physiology. 
Disruption of gut microbial communities affects gut-brain communication which 
ultimately can manifest as changes in brain function and behaviour. Transient 
changes in gut microbial composition can be induced by various intrinsic and extrinsic 
factors, however, it is possible that enduring shifts in the microbiota composition can 
be achieved by perturbation at a timepoint when the gut microbiota has not fully 
matured or is generally unstable, such as during early life or ageing. In this study we 
investigated the effects of 3-week microbiota depletion with antibiotic treatment 
during the adolescent period and in adulthood. Following a washout period to 
restore the gut microbiota, behavioural and molecular hallmarks of gut-brain 
communication were investigated. Our data revealed that transient microbiota 
depletion had long-lasting effects on microbiota composition and increased anxiety-
like behaviour in mice exposed to antibiotic treatment during adolescence but not in 
adulthood. Similarly, gene expression in the amygdala was more severely affected in 
mice treated during adolescence. Taken together these data highlight the 
vulnerability of the gut microbiota during the critical adolescent period and the long-
lasting impact manipulations of the microbiota can have on gene expression and 





The adolescent period is a key developmental period which marks the transition from 
childhood to adulthood (Paus et al., 2008). It is during this last developmental stage 
before adulthood that the brain is highly responsive to certain environmental cues 
that will shape neuronal architecture and promote maturation of social behaviours, 
emotional and cognitive capabilities and is hence a vulnerable period for the onset 
of psychiatric diseases (Borre et al., 2014). The gut microbiota composition of an 
adolescent is usually simpler and more unstable when compared with an adult, which is 
highly diverse and stable (Fouhy et al., 2012; Borre et al., 2014). These differences are 
probably due to relative immaturity of the gut microbiota during the adolescence, which 
make it more vulnerable to environmental stressors such as infection, use of antibiotic 
and poor diet. In addition to this, gonadal hormones are peaking during the puberty and 
it has been shown to have a long-term on the microbiota diversity (Paus et al., 2008; 
Yurkovetskiy et al., 2013). Overt changes in the gut microbiota composition might 
therefore contribute to the onset of such disease and could be targeted by the use 
of biotherapeutics, antibiotics or different types of diet to intervene (Borre et al., 
2014; McVey Neufeld et al., 2016). Nonetheless, the consequences of gut microbiota 
manipulation during adolescence are yet to be fully understood. 
The gastrointestinal tract is colonised by trillions of bacteria that are tightly 
associated with host physiology. When the equilibrium of the microbial milieu in the 
gut is shifted it can have long lasting effects on whole-body health including the brain 
and behaviour (Diaz Heijtz et al., 2011; Codagnone et al., 2018; Cryan et al., 2019). In 
mammals, the initial microbiota is obtained during the birthing process and develops 
alongside its host from a rather instable to a highly stable and diverse community in 
adulthood (Borre et al., 2014; Walsh et al., 2014). Microbiota composition during the 
developmental period is shaped by a combination of genetic and environmental 
factors to be highly adapted to the host and the host’s environment (Walsh et al., 
2014). However, maladaptation of the gut microbiota could affect innate and 
adaptative immunological players within the intestine and at site anatomically 
remote such as the brain and alter the host response to infection and vaccination as 
well as increase the susceptibility to brain disorders (Borre et al., 2014; Cowan et al., 
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2019). For example, altered gut microbiota composition can immediately affect brain 
function by impacting the turnover and release of neurotransmitters, hormones as 
well as growth factors and consequently affect behavioural parameters and thereby 
increase the susceptibility to develop neuropsychiatric disorders (Verdu et al., 2006; 
Cryan and Dinan, 2012; Buffington et al., 2016; Leclercq et al., 2017).  
One way to study the perturbation of the gut microbiota during critical periods is by 
using antibiotic-induced depletion. Antibiotics are one of the most important factors 
influencing the gut microbiota composition and structure (Hoban et al., 2016). 
Studies in both female and male mice (Cox et al., 2014; Hoban et al., 2016; Leclercq 
et al., 2017; Ruiz et al., 2017) and children (Ferrer et al., 2017; Korpela et al., 2018) 
have shown that antibiotic administration can induce changes in physiology, brain 
and behaviour. Antibiotic depletion of the microbiota for a defined time period 
represents an advantage in comparison to classic approach such as germ-free (GF) 
animals as the effects of microbiota depletion during the developmental period can 
be avoided (Luczynski et al., 2016; Lundberg et al., 2016). It has been shown, that the 
use of antibiotics to chronically deplete the gut microbiota during adulthood has 
been associated with hormonal changes and alterations in gene expression, 
decreased adult hippocampal neurogenesis, and changes anxiety-related responses, 
exploratory behaviour, and cognitive abilities (Desbonnet et al., 2015; Frohlich et al., 
2016; Hoban et al., 2016). Moreover, early life exposure to antibiotics induces long-
lasting increases in visceral pain responses (O’mahony et al., 2014) as well as altered 
metabolic programming (Cox et al., 2014). We have previously shown that microbiota 
depletion with antibiotics commencing in adolescence all the way through adulthood 
resulted in deficits in anxiety and cognitive behaviour (Desbonnet et al., 2015). It is 
not clear whether such changes are a result of microbiota changes specifically in 
adolescence, in adulthood or a combination.  
Thus, in these experiments we investigated the consequences of gut microbiota 
depletion specifically during adolescence or adulthood and their associated long-




3.2.3 Experimental Procedures 
3.2.3.1 Animals and experimental design 
Adolescent and adult male C57Bl/6OlaHsd mice (Envigo, UK) were housed 4 per cage 
in standard cages. All mice were housed in our animal facility and maintained under 
a 12-h light/dark cycle. All experiments were conducted in accordance with the 
European Directive 86/609/EEC. Approval by the Animal Experimentation Ethics 
Committee of University College Cork and Health Products Regulatory Authority 
were obtained before commencement of all experiments. To comply with 3Rs 
(reduction, refinement and replacement) and animal welfare, the adolescent aspect 
of the experiment was run simultaneously with another experiment investigating the 
gut microbiota (Fülling et al., 2020). The same control group was used in this study. 
In order to sufficiently deplete the gut microbiota, a wide-spectrum antibiotic 
cocktail (ABX) consisting of ampicillin (1 g/L, CAS no. 69-52-3), vancomycin (0.5 g/L, 
CAS no. 1404-93-9), ciprofloxacin HCL (0.2 g/L, CAS no. 93107-08-5), imipenem (0.25 
g/L, CAS no. 74431-23-5) and metronidazole (1 g/L, CAS no. 443-48-1) was prepared 
(Fig. 1B) (Hoban et al., 2016; Fülling et al., 2020). All substances were purchased from 
Discovery Fine Chemicals, UK. This antibiotic cocktail has little to no oral 
bioavailability and was prepared freshly with autoclaved water every second day for 
three weeks (Frohlich et al., 2016). Control mice received autoclaved water (CTRL). 
Mice were treated during adolescence (P28-P49) or adulthood (P76-97) and will be 
referred to as ABXadolescence and ABXadulthood, respectively (see 3.2-Fig. 1A). Behavioural 
tests commenced 24 days after the final antibiotic exposure. Mice were equally 
assigned to experimental groups based on bodyweight to ensure equally distribution 
among the groups. Behavioural tests investigating aspects of anxiety, cognition, 
social behaviour and fear conditioning were chosen as these behaviours have been 
shown to be affected by alterations in gut microbiota composition and structure [14, 
41–44]. Tissue samples were collected 24 h after the last behavioural test. Body 
weight was monitored throughout the experiment. The investigators who were 
involved in sample processing and data analysis were blinded to the groups. All 
behaviours were assessed by two independent scorers blind to the groups. See 
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supplemental methods for detailed information of all procedures and analysis run in 
this study. 
 
Fig. 3.1-1: Experimental design and body weight performance during the 
experiment. A Schematic representation of the experimental timeline. Numbers 
represent the age of the mice at that specific timepoint. B List of drugs used for the 
antibiotic cocktail. C, D Changes in body weight during adolescence (C) and adulthood 
(D) over the time course of the experiment. ABX-treated mice show a significant body 
weight loss on PND10 which is restored afterwards. Mean ± SEM. *p < 0.05. Sample 
size for adolescence: CTRL n = 12 and ABX n = 10, adults: CTRL and ABX n = 11. Two-
way repeated measures ANOVA followed by Sidak’s post hoc test. PND: postnatal 
day, CTRL: control, ABX: antibiotic, 3CSIT: three-chambered social interaction test, 
NORT: novel object recognition task, EPM: elevated plus maze, FC: fear conditioning, 
Beh: behavioural test. 
 
 
3.2.3.2 Elevated Plus Maze 
The elevated plus maze (EPM) was used to investigate anxiety-like behaviours 
(Fülling et al., 2020). Mice were allowed to explore the maze for 5 min; the time spent 





3.2.3.3 Novel Object Recognition Task 
Novel object recognition task (NORT) is a test for working memory (Desbonnet et al., 
2015). Mice were exposed to two identical objects which they could explore for 10 
min. One hour later they were exposed to a familiar and a new object. The time they 
spent exploring the new object was taken as indication of their memory function. 
 
3.2.3.4 Three-chamber social approach test  
Sociability and social novelty were investigated using the three-chamber social 
interaction test (3CSIT) (Fülling et al., 2020). The test consisted of three sequential 
10-min trials: (1) habituation, (2) sociability, measured as the time the mouse spent 
in proximity to a conspecific or an object and (3) social novelty preference as 
measured by the time the mouse spent with an unfamiliar conspecific or a familiar 
one.  
 
3.2.3.5 Differential fear-conditioning paradigm.  
Fear conditioning (FC) is based on pairing an initially neutral and non-aversive 
stimulus, an auditory cue or context (conditioned stimulus, CS), with an aversive 
stimulus, such as a foot shock (unconditioned stimulus, US), which will result in a fear 
response in the presence of the CS (Verma et al., 2015). The paradigm was run over 
four consecutive days: day 1 (context A): conditioning, day 2 (context A): contextual 
extinction, day 3 (context B): conditioned extinction in a novel context, day 4 (context 
B): context recall.  
 
3.2.3.6 RNA extractions, reverse transcription and quantitative RT-PCR 
Whole amygdala and prefrontal cortex were rapidly gross-dissected on an ice-cooled 
Petri dish following coordinates described in the “The Mouse Brain in Stereotaxic 
Coordinates” (Paxinos and Franklin, 2012) and snap-frozen on dry-ice. These brain 
regions were chosen as they are major contributor to anxiety and fear learning 
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(amygdala) and proper neuronal communication during development (prefrontal 
cortex) (Bravo et al., 2011; Stilling et al., 2015; Hoban et al., 2016; Cowan et al., 2018; 
Stilling et al., 2018). The list of genes was elaborated together with the experimental 
design to assess major components modulated by the gut microbiota, such as 
immune and microglia-related markers, tight junction proteins and myelin- and 
stress-related genes (Stilling et al., 2015; Hoban et al., 2016; Stilling et al., 2018; Cryan 
et al., 2019; Fülling et al., 2020). Additionally, based on the behavioural phenotype, 
we included genes associated with anxiety-like behaviour such as the genes involved 
in the GABAergic and glutamatergic system, NPY system and genes related with 
neuroplasticity (Bravo et al., 2011; Frohlich et al., 2016; Lach et al., 2018; Cryan et al., 
2019; Fülling et al., 2020). Total RNA was extracted with the mirVana total RNA 
extraction kit (Ambion, UK) and RNA was reverse transcribed using a high-capacity 
cDNA reverse transcription kit (Thermo Fisher Scientific, Waltham, USA) in a G-storm 
thermocycler (G-storm, Surrey, UK). Real-time PCR was performed on the cDNA 
samples using SYBR green (SensiFAST™ SYBR®, BioLine, UK) and gene expression 
levels were analysed on an AB7300 system (Applied Biosystems, Thermo Fisher 
Scientific, USA). Expression levels were calculated as the average of three replicates 
for each biological sample from all three groups relative to the endogenous control. 
Fold changes were calculated using the ΔΔCt method (Fülling et al., 2020). The 
expression of the housekeeper ACTB was not affected by ABX treatment or age.  
 
3.2.3.7 Caecal microbiota composition (16S rRNA gene sequecing)  
The QIAmp Fast DNA Stool Mini Kit (Qiagen, Sussex, UK) was used for caecal DNA 
extraction. The procedure was coupled with an initial bead-beating step. 
Amplification and preparation for sequencing of the V3-V4 hypervariable region of 
the 16S rRNA gene was done as outlined in the Illumina 16S Metagenomic 
Sequencing Library Protocol and as previously described (Fülling et al., 2020). Briefly, 






PCR products were purified using the Agencourt AMPure XP system (Beckman 
Coulter Genomics, UK). Dual indices and Illumina sequencing adapters were attached 
to PCR products using the Nextera XT Index Kit (Illumina, USA). PCR products were 
quantified, normalized and pooled in an equimolar fashion using the Qubit® dsDNA 
HS Assay Kit (Life Technologies, USA). Following, samples were run on the Agilent 
Bioanalyser for quality analysis and samples prepared for sequencing following 
Illumina guidelines. Samples were sequenced on the MiSeq sequencing platform 
(Clinical Microbiomics, Denmark).  
3.2.3.8 Microbiome bioinformatics processing 
Three hundred base pair paired-end reads were prefiltered based on a quality score 
threshold of >28 and trimmed, filtered for quality and chimaeras using the DADA2 
library in R (Callahan et al., 2016). Samples with fewer than 10.000 reads after 
trimming and filtering were dropped. Taxonomy was assigned with DADA2 against 
the SILVA SSURef database release v132. Parameters as recommended in the DADA2 
manual were adhered to unless mentioned otherwise. ASVs that were only detected 
as non-zero in 2 or fewer of total samples were excluded. 
 
3.2.3.9 Statistics 
Power analysis was performed beforehand using the Software G*Power 3.1 to 
ensure adequate sample size number to detect changes in behaviour and gene 
expression. Statistical analysis and plotting were conducted using Prism 7 (GraphPad, 
USA). Data were checked for normality using D’Agostino & Pearson normality test 
and the ROUT method was used to check for outliers. Two-tailed Welch’s t-test was 
used for comparison between ABX treated mice and their respective controls for the 
EPM, NORT as well as context and extinction recall in FC. Two-way analysis of 
variance (ANOVA) was used for 3CSIT and two-way repeated measures ANOVA was 
used to analyse data for body weight as well as acquisition and cued extinction in FC. 
Sidak's multiple comparisons post hoc test was used where applicable. Statistical 
significance was set at p<0.05.  
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Statistical analysis of microbiota data was performed using the R software (version 
3.6) environment with Rstudio (version 1.1.453). Alpha diversity was calculated using 
the iNEXT library (Hsieh et al., 2016).  Wilcoxon Rank Sum followed by Bonferroni 
post hoc tests were used to assess differences in Alpha diversity scores. For principal 
component analysis (PCA), permutational multivariate analysis of variance 
(PERMANOVA) was used to identify relationships of significance between variables 
using the adonis() function from the vegan library on Aitchison distance matrices 
calculated with the ALDEx2 library (Fernandes et al., 2014). A pairwise 
implementation of the ALDEx2 function aldex.t.test() was also used to calculate 
pairwise differential abundance, using the Bonferroni procedure as a post-hoc. In the 
case of microbiome analysis, the benjamini-hochberg procedure was used to account 




3.2.4.1 Antibiotic treatment in adolescence affects body weight 
Two-way repeated measures ANOVA showed an overall effect of ABX treatment 
during adolescence on body weight (interaction F(3,48)=3.84, p=0.015, treatment 
F(1,16)=7.18, p=0.017), whereas such an effect was not seen following treatment 
with ABXadulthood (interaction F(3,60)=12.56, p<0.001, treatment F(1,20)=0.11, 
p=0.75; Fig. 3.2-1C, D). Sidak’s multiple comparison, however, revealed that body 
weight was significantly lower in the ABX treatment in both ABXadolescence and 
ABXadulthood mice on day 10 of the treatment (p=0.003 and p=0.05, respectively). 
 
3.2.4.2 Microbial diversity was only affected by ABX treatment during adolescence 
To investigate possible long-lasting effects of ABX treatment during adolescence and 
adulthood on the gut microbiota, microbiota was sequenced from caecal contents 
49 days after termination of the treatment. Overall, sequencing demonstrated that 
microbial diversity and structure was shifted only in ABXadolescence mice (Fig. 3.2-2A-
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C). With regards to beta-diversity PERMANOVA identified significant differences 
between ABXadolescence mice when compared to their controls (p<0.001, R2=0.193, 
padj=0.004; Fig. 3.2-2A), but no such change was observed in ABXadulthood (p=0.029, 




Fig. 3.2-2: Long-lasting changes in caecal microbiota composition following ABX 
intervention during adolescence. A PCA blots depicting differences in beta-diversity 
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between mice treated with ABX and their respective controls. While beta-diversity 
was affected by ABXadolescence treatment no such effects were seen following 
ABXadulthood treatment. B alpha-diversity indices: Chao1, Shannon and Simpson. 
Changes in the Chao1 and Simpson indices are observed following treatment with 
ABX during adolescence but not after treatment in adulthood. C Heat map 
representing relative abundance of ASVs. Significant differences were observed 
between control mice and ABX-treated mice during adolescence but not when treated 
during adulthood. Some differences in ASVs were observed when comparing both ABX 
treatments and controls with one another. The latter does not explain the effect on 
relative abundance of ABX treatment during adolescence. Mean ± SEM. *p < 0.05. 
Sample size for adolescence: CTRL n = 12 and ABX n = 10; for adults: CTRL and ABX 
n = 11. A Permutational multivariate analysis of variance (PERMANOVA), followed by 
pairwise PERMANOVA post hoc Benjamini–Hochberg, B Wilcoxon rank-sum test, post 
hoc Bonferroni, *p < 0.05, C Mann–Whitney U test post hoc Benjamini–Hochberg, 
Benjamini–Hochberg false discovery rate (FDR) q < 0.2. Asterisks in the heat map 
represent the following q values: *p < 0.1, **p < 0.01, ***p < 0.001. 
 
Alpha diversity, which describes the diversity of species within a community, was 
measured by calculating indices for richness and evenness based on amplicon 
sequence variants (ASV) level. Figure 3.2-2B shows reduced numbers of bacterial 
species between ABXadolescence and their controls (Chao1 Index; pairwise comparison 
using Wilcoxon rank sum test, p<0.001) while no changes were observed in 
ABXadulthood mice. Moreover, a significant decrease in evenness across ASVs was 
observed in ABXadolescence mice (Shannon Index; pairwise comparison using Wilcoxon 
rank sum test, p<0.001), indicating that treatment with ABX during adolescence 
disrupted the uniformity of the population size of each of the species present. No 
effects of treatment during adolescence or adulthood were observed for the 
Simpson’s index. 
ABX treatment only resulted in significant changes in relative abundance comparing 
ABX treated mice with controls when mice were exposed to ABX during the 
adolescent period. In comparison to control mice, ABXadolescence mice showed reduced 
relative abundance of most of the strains affected. At the phylum level, Firmicutes 
and Bacteriodetes were most affected by the ABXadolescence intervention (Fig. 3.2-2C). 
Changes in the phylum Actinobacteria were restricted to the family 
Coriaobacteriaceae, with increased numbers in the genus UCG002 while the genus 
Enterorhabdus was differentially affected depending on the ASVs. Relative 
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abundance of all the affected genera in the phylum Bacteriodetes was decreased, 
with the strongest reduction in the genera Bacteroides. Firmicutes was the phylum 
most affected by ABXadolescence treatment. Genera in this phylum were differentially 
affected by ABXadolescence treatment. In the family Lachnospiraceae relative 
abundance of all affected ASV of the genera Rosburia, UCG-001, UCG-004, UCG-010, 
FCS020 group and Pseudobutyrivibrio was decreased, whereas at least one ASV form 
the genera UCG-006, NK4A136 group, Lachnoclostridium and Blautia showed 
increased relative abundance following ABXadolescence treatment. Of the affected ASVs 
of the family Ruminococcaceae relative abundance of all the ASVs in the genera UCG-
003, UCG-009, UCG-010 and UCG-013 was decreased while one ASV each of the 
genera Ruminiclostridium 5, Ruminiclostridium 9 and Anaerotruncus was significantly 
increased. Similarly, one ASV of the genus Lactobacillus of the family Lactobacillaceae 
was strongly decreased, whereas another ASV of this genus was strongly increased 
following ABXadolescence treatment. The relative abundance of all affected ASVs of the 
family Family XIII and Eryspelotrihaceae was decreased. The only affected ASV of the 
phylum Proteobacteria was also decreased. No significant effects of ABXadulthood on 
relative abundance were observed. However, differences in relative abundance were 
observed when comparing ABX treated groups or control groups with one another. 
When comparing ABX treated groups, relative abundance of most of the ASVs is 
increased in ABXadulthood mice in comparison to ABXadolescence treated mice and vice 
versa (e.g. ASVs of the genera Parabacteroides and Odoribacter). This is in line with 
the decrease observed in the comparison of relative abundance of ABXadolescence mice 
and their controls. Similarly, the differences seen between the controls of either 
treatment is not in contradiction with the differences observed in relative abundance 
of ABXadolescence mice in comparison to their controls. The differences in relative 
abundance between controls mostly occurred in ASVs that are not affected in the 
ABXadolescence, 14 out of the 25 ASVs that were different between the controls where 





3.2.4.3 Treatment with antibiotics strongly affected anxiety-like behaviour, with a 
more pronounced effect in mice treated during adolescence  
To test effects of ABX treatment on anxiety-like behaviour, mice were tested in the 
EPM. Mice that underwent antibiotic treatment showed increased anxiety-like 
behaviour. Unpaired t-test with Welch’s correction showed that the percentage of 
time into the open arms as well as the number of head dips (t=2.846, p=0.01 and 
t=2.909, p=0.01, respectively; Fig. 3.2-3A, B) were affected significantly in 
ABXadolescence mice. Student t-test showed that the percentage of entries into the open 
arms also was affected significantly in ABXadolescence mice (t=2.529, p=0.02; Fig. 3.2-
3C). Welch’s t-test revealed no statistical significance in the percentage of entries 
into the open arm in ABXadulthood mice (t=1.946, p=0.06; Fig. 3.2-3K). Mann-Whitney 
non-parametric test found that the percentage of time into the open arms as well as 
head dips were no difference in ABXadulthood compared to the controls (U=38, p=0.148 
and U=38, p=0.145, respectively; Fig. 3.2-3I, J). Entries into the closed arm did not 
differ between treatment groups (adolescence: t=0.419, p=0.68; adulthood: t=0.449, 





Fig. 3.2-3: ABX treatment during adolescence affects anxiety-like behaviour and the 
fear response during fear acquisition. A–D Mice treated with ABX during adolescence 
showed increased anxiety-like behaviour as they showed decreased % time in and % 
entries into the open arm as well as decreased number of head dips. I–L No significant 
decrease in anxiety-like behaviour was seen in mice treated with ABX during 
adulthood. E–H An effect of treatment was seen for the acquisition of fear 
conditioning in mice treated with ABX during adolescence, but no other parameter 
was affected. M–P Treatment with ABX during adulthood had no effect on any 
parameter measured in the fear-conditioning paradigm. Mean ± SEM. A–D, F, H, I–L 
Welsh’s t-test comparison between CTRL and ABX. E, G, M, O two-way repeated 
measures ANOVA, followed by Sidak’s post hoc test when applicable *p < 0.05 and 
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**p < 0.01. Sample size for adolescence (CTRL: n = 9; ABX: n = 10) and adulthood 
(CTRL: n = 11; ABX: n = 11). 
3.2.4.4 Sociability and memory processes were not affected by antibiotic 
treatment in adolescence or adulthood 
As social behaviour and cognition have been shown to be impacted by alterations in 
gut microbiota composition, we investigated the effects of ABX treatment on 
measures in 3-CSIT and NORT. ABX treatment during adolescence or adulthood had 
no effects on sociability or social novelty. Control and ABX treated mice both 
preferred a stranger mouse (S1) over an innate object (O) (two-way repeated 
measures ANOVA, interaction: S1 x O: F(1,17)=52.92, p<0.001, treatment: 
F(1,17)=1.76, p=0.20 for adolescence; interaction: S1 x O: F(1,20)=0.59, p=0.44, 
treatment: F(1,20)=0.013, p=0.90 for adulthood, supplementary Fig. 1B, E, 
respectively). Similarly, no effect of ABX treatment was seen on social novelty, as no 
differences were observed between ABX treated mice and their respective controls 
(two-way repeated measures ANOVA, interaction: S1 x S2: F(1,17)=13.96, p<0.01, 
treatment: F(1,17)=3.03, p=0.09 for adolescence; interaction: S1 x S2: F(1,20)=2.74, 
p=0.11, treatment: F(1,20)=0.61, p=0.44 for adulthood, supplementary Fig. 1C, F, 
respectively)  
In the NORT, neither ABXadolescence or ABXadulthood exhibited differences in the ability to 
recognize a distinct object one hour after the training session, expressed by the time 
exploring the novel object (adolescence: t=1.233 df=16.47, p=0.23; adulthood: 
t=0.5288 df=16.77, p=0.60, supplementary figure 2A, D).  
 
3.2.4.5 Fear learning is only affected in animals treated with antibiotics during 
adolescence  
Fear conditioning aimed to investigate different fear responses, such as fear learning, 
contextual fear, and cued extinction (Fig. 3.2-3E-H, M-P). All experimental groups 
learned the task as indicated by increasing freezing behaviour during acquisition 
(two-way repeated measures ANOVA; CS presentation, adolescence: F(4,68)=38.11, 
p<0.001; adulthood: F(4,80)=27.36, p<0.001; Fig. 3.2-3E, M). Only ABXadolescence mice 
significantly increased freezing behaviour compared to the control group during fear 
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acquisition, while in adults, ABX did not affect fear acquisition (two-way repeated 
measures ANOVA; treatment, adolescence: F(1,17)=4.48, p=0.04; adulthood: 
F(1,20)=0.17, p=0.67). Sidak’s multiple comparison post hoc test did not find a 
significance between CTRL and ABX in any timepoint in both adolescence and adults 
mice. On day 2, contextual fear was assessed. Unpaired t-test with Welch’s correction 
revealed that the treatment did not affect freezing behaviour in adolescent mice 
(t=1.70, p=0.10; Fig. 3.2-3F). Student t-test revealed the same in adult mice (t=0.73, 
p=0.47; Fig. .2-3N). In the cued extinction session (day 3), the response to the CS 
(paired sound) was analysed. All experimental groups reduced their freezing 
response over the course of CS presentation (CS presentation, two-way repeated 
measures ANOVA adolescence: F(4,68)=18.03, p<0.001, adulthood: F(4,80)=15.15, 
p<0.001; Fig. 3.2-3G, O), suggesting that all experimental groups were able to 
extinguish cued fear. Fear extinction was not affected by treatment (two-way 
repeated measures ANOVA; adolescence: F(1,17)=0.095, p=0.76, adulthood: 
F(1,20)=0.11, p=0.74). Pre and post CS freezing were similar in ABX treated mice 
compared to their controls (Welch’s t-test; adolescence; pre: t=0.36, P=0.72; post: 
t=0.61, p=0.54; adulthood; pre: t=0.22, p=0.82; post: t=0.15, p=0.88), indicating the 
absence of generalized fear. Fear recall was tested on day four and no difference was 
observed (Welch’s t-test; adolescence: t=0.86, p=0.39, adulthood t=0.93, p=0.36; Fig. 
3.2-3H, P). Taken together, this data show that transient depletion of the gut 
microbiota has little potential to long-lasting affect fear response.  
 
3.2.4.6 Amygdala gene expression is more strongly affected by treatment during 
adolescence than adulthood 
Many studies have demonstrated a link between the gut microbiota and gene 
expression in the amygdala [52, 58]. In amygdala homogenates, mRNA levels 
revealed a stronger effect of ABXadolescence than ABXadulthood treatment (Fig. 3.2-4 and 
Table 1). The immune response was heavily affected by ABX treatment during 
adolescence and adulthood (Fig. 3.2-4A, E). For instance, elevated levels of Fcgr2b 
(Fc Fragment of IgG Receptor IIb) gene were observed in both ABXadolescence and 
ABXadulthood mice. The toll-like receptor 4 gene (Tlr4) was oppositely affected by ABX 
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treatment with elevated gene expression following ABXadolescence treatment and 
reduced expression after ABXadulthood treatment. In contrast, interleukin 1b (Il1b) was 
elevated following ABXadulthood treatment but not following ABXadolescence treatment, 
while the microglia-related gene C1qa (encodes the A-chain polypeptide of serum 
complement subcomponent C1q) and Cx3cr1 (interleukin 8 receptor, alpha) were 
only upregulated in ABXadolescence mice. Rac2 (Rho GTPase Rac2), which regulates 
phagocytosis was upregulated in both experimental groups. The complement 
component 3 (C3) which is also involved in the regulation of phagocytosis, was only 
upregulated in ABXadulthood mice. Classical and peptidergic neurotransmission was 
strongly affected by ABXadolescence treatment but remained mostly unaltered in 
ABXadulthood mice (Fig. 3.2-4B, F). The levels of gamma-aminobutyric acid receptor 
subunit alpha-2a (Gabra2) and beta-1b (Gabrb1), the metabotropic glutamate 
receptor subunit 5 (Grm5), neuropeptide Y (NPY) and its Y1 receptor (Npy1r) and the 
glucocorticoid receptor (Nr3c1) were only increased in ABXadolescence mice. The 
corticotropin-releasing hormone receptor subunit 1 (Crh1r) was the only gene 
affected in ABXadulthood mice, that was not altered by ABXadolescence treatment. 
Neuroplasticity genes were differently affected by ABXadolescence and ABXadulthood (Fig. 
3.2-4C, G). While the levels of postsynaptic density protein 95 (Psd95) and 
synaptophysin (Syp) were increased in ABXadolescence mice, these genes were 
downregulated following ABXadulthood treatment. Interestingly, genes associated with 
short chain fatty acids (SCFAs), the solute carrier subtypes (Slc5a8 and Slc16a1) were 
only elevated in ABXadolescence mice. Similarly, the gene expression of tight junction 
genes, such as occludin (Ocln) and tight-junction protein 1 (Tjp1) were only increased 
in ABXadolescence mice. Taken together, although more genes are affected in 





Fig. 3.2-4: Amygdalar gene expression is more drastically changed following ABX 
treatment during adolescence. A, B While genes related to neuroimmunity and 
microglia are similarly affected in ABXadolescence and ABXadulthood mice, gene 
expression genes involved in C, D neurotransmission, E, F neuroplasticity, short-chain 
fatty acids and tight-junction proteins are more drastically affected in 
ABXadolescence mice. Mean ± SEM. Unpaired t-test with Welch’s correction 
comparing vehicle and antibiotic treatment for each gene. *p < 0.05, **p < 0.01 and 
***p < 0.001. Sample size for adolescence: CTRL and ABX n = 8 (Il10, Il1b, Gabra2, 
Gabbr1, Npy1r, Psd95 and Tjp1), CTRL n = 8 and ABX n = 9 (Fcgr2b, Cx3cr1, Rac2, C3, 
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C1qa, Grm5, Chr1r, Npy, Syp, Ffar1, Slc5a8, Slc16a1, Ocln), CTRL n = 9 and ABX n = 8 
(Tlr4), CTRL and ABX n = 9 (Nr3c1). Sample size for adults: CTRL and ABX n = 9 (Fcgr2b, 
Il1b, Cx3cr1, Rac2, C3, Gabra2, Gabbr1, Grm5, Crh1r, Npy1r, Psd95, Syp, Ffar1, Slc5a8, 
Ocln, Tjp1), CTRL n = 10 and ABX n = 9 (Il10, Tlr4, Nr3c1, Slc16a1), CRTL n = 9 and ABX 
n = 8 (C1qa, Npy). SCFA: short-chain fatty acid, C1qa: complement C1q subunit A, C3: 
complement component 3, Crh1r: corticotropin-releasing hormone receptor 1, 
Cx3cr1: chemokine receptor 1, Fcgr2b: Fc fragment of IgG receptor IIb, Ffar1: free 
fatty acid receptor 1, Gabrb1: gamma-aminobutyric acid type B receptor subunit 1, 
Gabra2: gamma-aminobutyric acid type A receptor alpha2 subunit, Grm5: glutamate 
metabotropic receptor 5, Il1b: interleukin 1b, Il10: interleukin 10, Npy: neuropeptide 
Y, Npy1r: neuropeptide Y receptor Y1, Nr3c1: glucocorticoid receptor, Ocln: occludin, 
PSD95: postsynaptic density protein 95, Rac2: Ras-related C3 botulinum toxin 
substrate 2, Slc5a8: solute carrier family 5 member 8, Slc16a1: solute carrier family 




Finally, we analysed myelination-related genes in the prefrontal cortex, which have 
been suggested to be modulated by the gut microbiota [38, 59]. Therefore, we 
analysed gene expression of myelin regulatory factor (Myrf), proteolipid protein 1 
(Plp1) and the transcription factor SOX-10 (Sox10). ABXadulthood treatment resulted in 
increased gene expression of Myrf and Sox10 while ABXadolescence showed no effects 




Adolescence is a particularly vulnerable time for the onset of psychopathology. 
Understanding what factors mediate such susceptibility is an important area in 
biological psychiatry research. In the present studies we assessed the long-term 
effects of transient gut microbiota depletion using an ABX cocktail in mice during 
adolescence or adulthood. ABXadolescence had long-lasting effects on composition and 
structure of the gut microbiota and anxiety-like behaviour, whereas ABXadulthood had 
no effects. This long-lasting shift in the gut microbiota when depleted during 
adolescence highlights the vulnerability of the gut microbiota during development 
and may be responsible for the anxiety-like phenotype and pronounced changes in 
gene expression within the amygdala observed in ABXadolescence mice. To our 
knowledge, this is the first study demonstrating that the long-lasting effects on gut 
microbiota only occur when treated during a critical developmental period.  
In mammals, the initial microbiota is acquired during the birthing progress and is 
shaped during the developmental period by genetics and environmental factors until 
early adulthood (Borre et al., 2014; Ruiz et al., 2017; Korpela et al., 2018). During this 
developmental process, the gut microbiota adapts to its host’s needs and becomes 
increasingly stable and resistant to challenges such as ABX treatment or transient 
changes in diet. Here, we observed long-lasting changes in alpha- and beta-diversity 
as well as relative abundance of the gut microbiota following exposure to 
ABXadolescence treatment only. ABX intervention during early development is 
characterized by long-lasting shifts in gut microbiota composition (Borre et al., 2014; 
Cowan et al., 2019) and exposure to ABX during adulthood drastically shifts gut 
microbiota composition and structure (Cox et al., 2014; Hoban et al., 2016; Leclercq 
et al., 2017; Ruiz et al., 2017). It is not surprise that the rearrangement of the 
microbiota composition is age dependent (Boehme et al., 2019). Increased stability 
and maturity of the gut microbiota in adulthood is likely to have prevented long-
lasting effects of ABXadulthood treatment and buffers some effects of ABX treatment, 
which could explain why behavioural and gene expression changes were only 
observed in ABXadolescence mice. 
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Many studies have described the interaction between gut microbiota depletion 
either by ABX treatment or in GF mice and alterations in behaviour (Desbonnet et al., 
2015; Frohlich et al., 2016; Hoban et al., 2016; Cryan et al., 2019). Here, we observed 
a statistically significant increase in anxiety-like behaviour in the EPM in ABXadolescence 
mice but not in ABXadulthood mice, reproducing the pattern that was observed for 
changes in microbiota composition and structure. The role of gut microbiota 
depletion in anxiety, however, is controversial with studies describing a reduction of 
anxiety-like behaviours (Bercik et al., 2011; Desbonnet et al., 2015), no effect 
(Frohlich et al., 2016; Hoban et al., 2016) or an anxiolytic effect following microbiota 
depletion (Leclercq et al., 2017). Firmicutes, Actinobacteria and Bacteroides are 
known to affect anxiety levels, with lower abundance being associated with elevated 
anxiety-like behaviour in rodents and humans (Bercik et al., 2011; Bravo et al., 2011), 
which is in line with the changes in gut microbiota composition observed in 
ABXadolescence mice. In particular, we found Lacotbacillus acteroides and 
Lachnospiraceae NKA136 reduced in ABXadolescence mice.  
 
 
 Indeed, the stronger effect observed in adolescent mice over adults may have been 
influenced by sex hormones peaking during adolescence. Preclinical studies in males 
suggest that testosterone yields protective benefits against anxiety [79] while 
decreased levels of testosterone is associated with significantly higher prevalence of 
anxiety disorders in men, compared to those with normal levels [80–82]. Moreover, 
high levels of testosterone during the adolescence is known to influence the 
commensal bacteria Firmicutes/Bacteroides ratio [8, 67, 68]. Therefore, the 
depletion of the gut microbiota during a critical developmental window itself has 
impaired the natural interaction between the testosterone and commensal bacteria 
that, together with the enduring shift in microbiota composition and structure are 




In addition, it has previously been found that administration of probiotics containing 
Lactobacillus (Firmicutes) correlates with the expression of Gabrb1 within the 
amygdala, an effect that has been shown to be influenced by vagal communication 
[49, 83]. Given that Gabrb1 is strongly reduced in mice treated with ABX during 
adolescence but not during adulthood this data suggest that alterations in gut 
microbiota composition induced by ABX treatment plays a role in GABA receptor 
expression in the amygdala which translates in behavioural alterations.  
Interestingly, despite the body of literature showing that the gut microbiota is 
implicated in social behaviour or cognitive abilities [28, 36–38, 60, 64, 84–88], we did 
not observe any overt effect of ABX treatment in the three chamber task nor the 
novel object recognition task suggesting that with the parameters we used these 
phenotypes are not responsive to long-lasting effects of gut microbiota depletion. 
Moreover, it has been shown that deficient synaptic pruning, which is associated with 
weak synaptic transmission and decreased functional brain connectivity is correlated 
with deficits in social interaction and other neuropsychiatric disorders [89]. These 
failure in the synaptic connectivity is due to lack of activity of the Cx3cr1 gene [89, 
90]. Since Cx3cr1 here was found upregulated, this is probably play locally role on 
brain inflammatory response which is not directly associated with sociability.  In 
addition, fear conditioning which has previously been shown to be modulated by 
microbiome manipulations [42, 49, 91] was only marginally affected by gut 
microbiota depletion as only ABXadolecence mice showed increased freezing behaviour 
during fear acquisition, indicating that learning and memory indeed is not overtly 
influenced by ABX treatment. 
Changes in gut microbiota composition and structure have been linked to changes in 
gene expression in the brain [92]. Here we focused on the amygdala to understand 
to which extent changes in gene expression could underly the differences observed 
in the anxiety-like behaviour. Gene expression in the amygdala was more drastically 
affected in ABXadolescence mice, with twice as many genes of those tested affected 
compared to ABXadulthood mice. Despite the highest prevalence of overall gene 
expression changes in ABXadolescence, the administration of ABX induced similar 
disturbance for genes involved in neuroimmunity reponse in ABXadolescence and 
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ABXadulthood mice. Gene expression of various genes related to microglial-mediated 
phagocytosis and components of the innate immune system were strongly affected. 
Given the importance of microglia in the normal brain function, it is not surprising 
that these genes have been associated with the ABX treatment. The microglia-related 
genes Fcgr2b and Rac2 were upregulated in both groups, while Cx3cr1 and C1qa were 
elevated only in ABXadolescence mice, confirming a role for microbiota recolonization 
observed in ABXadulthood (but not in ABXadolescence) with restored microglia features 
[90]. It has been suggested that elevated levels of the Cx3cr1 ligand CX3CL1 is 
associated with pro-neurogenic response by altering the environment in which new 
cells are born [93], suggesting that together with C1qa, Cx3cr1 are playing a role in 
the prevention of chronic inflammation induced by the gut microbiota depletion. In 
fact, microglia seems to keep engulfing apoptotic debris even after antibiotic 
treatment [94], which together with elevated Tlr4 expression followed by 
ABXadolescence treatment could indicate certain level of neuroinflammation has been 
occurring without the participation of the cytokines. In addition, it is well known that 
SCFAs directly affect immune response with the intention to maintain homeostasis 
by finetuning microglial function and production of inflammatory cytokines, further 
suggesting that the overexpression of the SCFAs transporters Slc5a8 and Slc16a1 in 
the amygdala of ABXadolescence mice could be related with the microbiome-derived 
factors that are involved in modulate adaptive immune responses in  the brain.  
C3 is a downstream member of the component cascade with an extremely versatile 
role that it is not restricted to immune responses but also in tissue regeneration and 
synapse pruning [95]. Interestingly, C3 and Il1β were elevated only in ABXadulthood. This 
could suggest that neuronal loss and consequently cognitive deficits associated with 
long-term depression caused by C3 could have been counteracted by production of 
Il1β, a cytokine with a neuromodulatory role on neurogenesis [96].  
Tight junction proteins at the blood-brain barrier are known to be regulated by the 
gut microbiota, where the decreased expression of these proteins are associated 
with an increase in blood-brain barrier [97–99]. Although gut depletion is necessary 
to promote tight junction protein changes in the brain, the direction of these changes 
is dependent of the brain region and protein tested. Herein, we observed an 
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upregulation of amygdalar Tjp1 and Ocln only in ABXadolescence mice, confirming the 
role of depleted gut microbiota on brain permeability [37, 99]. Moreover, this study 
also showed that natural recolonization of the gut microbiota is enough to normalize 
the functionality of the information transfer between the gut and brain. Taken 
together, our findings show that the immunological markers changed in ABXadolescence 
and ABXadulthood mice are not a result of a brain leakage through the blood-brain 
barrier but probably due to local synthesis or volume diffusion into the brain at the 
circumventricular organs that lack a blood-brain barrier [100, 101]. 
When examining the pattern of expression of genes involved in neurotransmission it 
was clear that they were more strongly affected in ABXadolescence than ABXadulthood 
mice. Gabra2, Gabrb1, Grm5, Npy, Npy1r and Nr3c1 were upregulated in the 
amygdala of ABXadolescence mice, while Crh1r was the only gene affected in ABXadulthood 
mice. Elevated levels of Crh1r in brain regions like the hypothalamus and the 
hippocampus are usually found immediately after ABX treatment or in GF mice [12, 
38] while downregulation of the transcription levels of Crh1r has been found after 
biotherapeutics or SCFA treatment in stressed animals [102, 103] and could explain 
why we see altered Crh1r expression in ABXadulthood mice. In addition, NPY and 
activation of NPY1R are known to promote stress resilience and have anxiogenic 
effects [104–109]. NPY locally influences GABAergic activity through NPY1R, and both 
were found to be upregulated in chronic stress events [108, 109], in line with the 
results observed in ABXadolescence mice. In fact, evidence suggest that the gut 
microbiota may contribute to resilience after repeated stress [110–113]. For 
instance, it has been shown that chronic stress significantly improve the gut 
microbiota diversity in antibiotic-treated mice and neutralize not only stress-inducing 
anhedonia phenotype as well blood levels of inflammatory markers, suggesting that 
the development of susceptibility to stress in mice is subjected to the gut microbiome 
composition [110, 113].  
Interestingly, genes related with neuroplasticity, postsynaptic density protein 95 
(Psd95) and synaptophysin (Syp) were oppositely affected by ABXadolescence and 
ABXadulthood, suggesting a direct role of the gut microbiota composition on the 
expression of these genes. A recent study has shown that depletion of the gut 
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microbiota drastically elevated the levels of such genes in the brain [113], whereas 
restoration of the gut microbiota normalizes the levels of Syp and Psd95 [15]. 
Therefore, the upregulated expression of these genes in ABXadolescence mice could be 
due to the long-lasting shift in microbiota composition and structure, whereas the 
decrease observed in ABXadulthood mice might come from an exaggerated 
downregulation of these genes due to a possibly overexpression during the gut 
microbiota depletion period. 
Unexpectedly, ABXadulthood treatment seems also to play a role in myelin-related gene. 
Recent studies have shown upregulation of myelination-related genes in the PFC of 
animals with disrupted gut microbiota, suggesting a role for the gut microbiota in the 
formation of myelin [50, 114]. Our study indicates that depletion of the gut 
microbiota does not exclusively affect myelination during critical developmental 
periods but can also influence myelination-related gene expression in adulthood. 
Whether these changes in gene expression translates to altered myelination, 
however, still needs to be investigated. 
Overall, this study highlights vulnerability of the gut microbiota during the adolescent 
period and the importance of the microbiota during the developmental period in 
shaping its host’s microbiota, brain and behaviour. Adolescence is a time where the 
body and brain are in dramatic shift, facing a handful of stressful experiences such as 
unstable hormones and changes in functional connectivity in the brain. Taking into 
account the role of the gut microbiota in the brain and sexual hormones, adolescence 
is a sensitive period where minimal interventions have a huge impact that may be 
carried to life. Future studies are needed to determine if the behavioural effects are 
driven by the discrete genes in gene expression in the amygdala. Further, 
understanding what pathways of communication between the gut and the brain are 
responsible for such changes at this time period are also required (eg. vagus nerve) 
[115, 116]. Moreover, whether the effects seen can be reversed, ameliorated or even 
worsened by specific dietary interventions would be of further interest to investigate 
[40, 117]. Finally, as adolescence is a time for antibiotic usage clinically [118] and its 
use is epidemiologically relevant to the risk of several psychiatric conditions [119], 
the results presented here support the need for further studies investigating their 
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impact and their long-term effects on the microbiota and associated risks to the brain 
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There is considerable interest in the contribution of microbiota-gut-brain signalling 
in integrative physiological systems, which has recently extended to 
cardiorespiratory control. Chronic antibiotic strategies to reduce the microbiota are 
commonly employed. However, the optimal approach to normalise the gut 
microbiota, and interactions that occur during efforts to recolonise the gut 
microbiota after significant microbial perturbations, are currently unknown.  
 
In adult male rats, we sought to characterise the effects of prebiotics, faecal 
microbiota transfer and natural recolonisation on the gut microbiota after 4-week 
administration of a cocktail of antibiotics or vehicle. 16S sequencing of the caecal 
contents was performed for microbiota analysis. Furthermore, high-performance 
liquid chromatography and whole-body plethysmography was used to assess 
brainstem neurochemistry and respiratory control, respectively. 
  
Using a compositionally appropriate approach, an interaction was found between 
antibiotics and prebiotics for the colonisation rate of Blautia, as well as five functional 
modules in the microbiota. Blautia was found to be responsible for a large partition 
of these modules. Modulation of the gut microbiota caused significant disruptions to 
brainstem monoamine neurochemistry, but had no major effect on respiration 
during room air breathing or in response to hypoxic or hypercapnic 
chemostimulation.   
 
Natural recolonisation appears the optimal approach to restore the gut microbiota 
following antibiotic administration in rodents.  Blautia was shown to only colonise 
the caecum following antibiotic administration, in the subsequent presence of 
prebiotics. We posit that these findings have significant implications for studies 







The gut microbiota defines an extensive community of numerous commensal, 
pathogenic and symbiotic microbes that reside within the gastrointestinal tract. This 
ecosystem includes bacteria, archaea, viruses and fungi. It is estimated that the 
gastrointestinal bacterial population establishes a ratio of host:bacterial cells 1:1 
(Sender et al., 2016). The gut microbiota is influenced throughout life by various 
factors including life-style, hormones, ageing, stress, health status, environment, 
medication, amongst others (Woodmansey, 2007; O'Mahony et al., 2011; Albenberg 
and Wu, 2014; Panda et al., 2014; Golubeva et al., 2015; Kelly et al., 2015; Foster et 
al., 2017; Boehme et al., 2019). Extensive evidence suggests that the gut microbiota 
plays a fundamental role in whole-body health and disease (Cryan and O'Mahony, 
2011; Grenham et al., 2011; Kelly et al., 2016; Sarkar et al., 2016; Kelly et al., 2017). 
Studies in rodents display that aberrant gut microbiota is associated with numerous 
maladies, including anxiety, depression and cardiorespiratory pathologies (Kelly et 
al., 2015; Burokas et al., 2017; Ganesh et al., 2018; O'Connor et al., 2020). Similarly, 
disrupted gut microbiota is increasingly associated with a broad range of human 
diseases such as cardiovascular disease, obesity and inflammatory bowel 
disease/syndrome (Benjamin et al., 2012; Burke et al., 2017; Yan et al., 2017). It is 
widely accepted that antibiotic administration, in rodents and humans, damages the 
natural gut microbiota composition and diversity (Blaser, 2016; Gasparrini et al., 
2016; Haak et al., 2019; O'Connor et al., 2019). Despite this, best practice for 
remediation of the antibiotic-depleted gut microbiota in rodent models and in 
standard clinical practice is unknown (Gagliardi et al., 2018; O'Connor et al., 2019; 
Wilson et al., 2019).  
 
In rodents, broad spectrum antibiotics are routinely used to investigate the role of a 
depleted gut microbiota on integrative body systems (Hoban et al., 2016; Galla et al., 
2018; O'Connor et al., 2019). Normalisation or beneficial expansion of the gut 
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microbiota following antibiotic administration would benefit investigations aiming to 
tease out associations between the gut microbiota and brain/physiological functions. 
Furthermore, mounting evidence suggesting a casual role of aberrant gut microbiota 
in disease has led to the necessity to develop targeted therapeutic approaches to 
restore or beneficially promote the microbial composition. Among these, faecal 
microbiota transfer (FMT) has demonstrated a profound capability to shift the gut 
microbiota in rodents and in patients (Mullish et al., 2015; Suez et al., 2018; Wilson 
et al., 2019). FMT studies in rodents, using a variety of transplantation methods, aim 
to assess if ‘restoration’ of the gut microbiota reverses abnormal brain behaviours, 
such as depression, anxiety and cardiorespiratory impairments (Kelly et al., 2015; 
Burokas et al., 2017; O'Connor et al., 2019). In recent years, FMT has been widely 
used as a treatment for recurrent Clostridium difficile infections in patients, and 
advances have been made in other chronic diseases (Wilson et al., 2019). Prebiotics 
are another method of microbiota modulation. Prebiotic fibres are fermented in the 
gut and produce specific changes in bacterial composition, promoting the growth of 
beneficial gut microbes (Gibson et al., 2010).  Prebiotics have recently been included 
in the definition of ‘psychobiotics’ and have effects on emotional, central and 
systemic functions in rodents and in clinical populations (Sarkar et al., 2016).  We 
explored whether the gut microbiota, depleted as a result of broad spectrum 
antibiotics, could be restored or beneficially expanded through the use of 
intervention strategies known to modulate the gut microbiota and/or by natural 
recolonisation. Furthermore, we examined the effects of altered gut microbiota on 
the control of breathing, given that we previously reported that disruption to the gut 
microbiota was associated with respiratory dysfunction, which was related to 




3.3.3 Materials and Methods  
3.3.3.1 Ethical approval  
Procedures on live animals were conducted under licence from the Government of 
Ireland Department of Health (B100/4498) in accordance with National and 
European directive 2010/63/EU. Ethical approval was obtained from University 
College Cork (AEEC #2013/035) and procedures were carried out in accordance with 
guidelines laid down by University College Cork’s Animal Welfare Body. 
Fig. 3.3-1 Experimental setup. Schematic representation of the experimental design 
utilised in this study. 
 
3.3.3.2 Experiment animals 
Ten-week old adult male Sprague Dawley rats (n=60; purchased from Envigo, UK) 
were housed as age-matched pairs in standard rat cages under a 12-hour light: 12-




3.3.3.3 Antibiotic administration 
Rats were randomly allocated to receive autoclaved deionised water (vehicle, VEH; 
n=30) or a cocktail of antibiotics (ABX; n=30) for 4-weeks. In an effort to deplete the 
microbiota, broad–spectrum antibiotics including ciprofloxacin (20 mg/l), imipenem 
(250 mg/l), ampicillin (1 g/l), vancomycin (500 mg/l) and metronidazole (1g/l) in 
autoclaved deionised water were utilised. Water bottles were replenished every 
second day. Rat body weights, water consumption and food intake were recorded 
every other day. Fresh bedding was transferred to ABX rats every second day.  
 
3.3.3.4 Collection and processing of microbiota for faecal microbiota 
transplantation 
Faecal microbiota was obtained from the pooled faeces of 3 VEH rats. Faeces was 
collected and processed as previously described (O'Connor et al., 2019). 
 
3.3.3.5 Prebiotic and FMT administration  
Rats consuming broad spectrum antibiotics for 4-weeks remained on antibiotics for 
an additional 31 days (ABX-ABX; n=10) or received a washout period of autoclaved 
deionised water for 3 days. Following the washout period, rats remained on 
autoclaved deionised water (ABX-NAT; n=10) or were transferred to prebiotics (PREB; 
7.5 g/L of galactooligossacharides and fructooligosaccharides) in autoclaved 
deionised water for 4-weeks, with or without FMT administration (ABX-PREB-FMT, 
n=10; ABX-PREB, n=10, respectively), as previously described (O'Connor et al., 2019; 
O'Connor KM, 2020). After 31 days, rats assigned to vehicle administration continued 
to receive water (VEH-VEH; n=10) or were transferred to prebiotics (VEH-PREB; n=10) 
for 4-weeks. Rat body weights, water consumption and food intake were recorded 
every other day. Fresh bedding was transferred to ABX-ABX cages every second day.  
Bedding was changed for all other cages weekly; VEH-VEH, VEH-PREB and ABX-NAT 
cages were transferred to fresh bedding. In order to promote host microbiota 
establishment, ABX-PREB and ABX-PREB-FMT cages received bedding from VEH-




3.3.3.6 Assessment of respiratory flow and metabolism in the unrestrained rat 
during quiet rest 
3.3.3.6.1 Whole-body plethysmography  
In unrestrained rats during quiet rest, whole-body plethysmography (DSI, St. Paul, 
Minnesota, USA) was used to record respiratory flow recordings. Rats were 
introduced into custom plethysmograph chambers (601-1427-001 PN, DSI). Room air 
moved through the chambers (3l/min) ensuring adequate oxygen (O2) and carbon 
dioxide (CO2) environmental conditions. Rats were allowed to settle for 30-90 min to 
encourage habituation to the surroundings.  
 
3.3.3.6.2 Metabolic measurements 
CO2 production (VCO2) and O2 consumption (VO2) were measured in rats throughout 
the protocol (O2 and CO2 analyser; AD Instruments, Colorado Springs, CO, USA) as 
previously described (Haouzi et al., 2009; Bavis et al., 2014; Lucking et al., 2018). 
3.3.3.6.3 Experimental protocol 
Following the acclimation period, baseline parameters were assessed during a 10-15-
min steady-state normoxia period (FiO2 = 0.21; balance N2). This was followed by a 
10-min poikilocapnic hypoxia challenge (FiO2=0.10; balance N2). Each rat was re-
exposed to normoxia to re-establish stable basal breathing. Subsequently, animals 
were exposed to a 10-min hypercapnia challenge (FiCO2 = 0.05; balance O2) followed 
by a recovery period.  
 
3.3.3.6.4 Data analysis for whole-body plethysmography 
Respiratory variables including respiratory frequency (fR), minute ventilation (VI), 
tidal volume (VT), expiratory time (Te) and inspiratory time (Ti) were recorded on a 
breath-by-breath basis for analysis (FinePointe software Buxco Research Systems, 
Wilmington, NC, USA). Artefacts in respiratory flow signals relating to animal 
movement and sniffing were omitted from analysis. A steady-state normoxia period 
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was averaged to assess baseline respiratory and metabolic parameters. Ventilatory 
and metabolic data were reported for the final 5-mins of the acute poikilocapnic 
hypoxic and hypercapnic challenges allowing for adequate gas mixing in the 
plethysmograph chambers ensuring steady-state assessment of respiratory and 
metabolic parameters. Data are expressed as a change in absolute from baseline 
values. Respiratory flow signals were examined for the occurrence of augmented 
breaths (sighs) during normoxia, hypoxia and hypercapnia as well as for apnoea 
events (spontaneous and post-sigh apnoeas) during normoxia as previously 
described (Edge et al., 2012). The criterion for apnoea was a pause in breathing for a 
duration greater than two consecutive missed breaths. Apnoea data are expressed 
as apnoea index (apnoea events per hour). A sigh was defined as an augmented 
breath twice the amplitude of the average VT. Poincaré plots expressing breath-to-
breath (BBn) versus subsequent breath-to-breath interval (BBn+1) were constructed 
allowing for determination of respiratory timing variability during steady-state 
baseline bouts and hypoxic and hypercapnic challenges. VT, Vi, VT/Ti, VO2 and VCO2 
were normalised per 100g body mass. 
 
3.3.3.7 Tissue collection  
Animals were euthanised by decapitation under isoflurane anaesthesia (5% by 
inhalation in room air). Blood was collected immediately, prepared in 3% Na2EDTA 
(disodium salt dehydrate) and centrifuged (14,000g for 20 min at 4 °C) for 
subsequent analysis. Plasma was snap frozen in liquid nitrogen. Whole brains were 
harvested and frozen at -80°C isopentane for subsequent high-performance liquid 
chromatography analysis. The lungs were removed and weighed and were allowed 
to air dry at 37°C for at least 48 h and re-weighed. The faeces from the colon as well 
as the caecum were harvested. The caecum was weighed and caecal contents were 
quickly removed and snap frozen in liquid nitrogen. The heart was removed and the 




3.3.3.8 Brainstem monoamine concentrations 
3.3.3.8.1 High-performance liquid chromatography (HPLC) coupled to 
electrochemical detection for measurement of pons and medulla oblongata 
monoamine concentrations 
The brainstem was dissected from the brain and separated into two distinct regions, 
pons and medulla oblongata at -20˚C. The pons and medulla oblongata were 
sonicated (Bandelin Sonolus HD 2070) in 1 ml of chilled mobile phase, spiked with 
2ng/20μl of a N-methyl 5-HT (internal standard). High-performance liquid 
chromatography coupled to electrochemical detection was performed as previously 
described (Lucking et al., 2018; O'Connor et al., 2019). Noradrenaline (NA), dopamine 
(DA), serotonin (5-HT), monoamine precursor L-3,4 dihydroxyphenylalanine (L-DOPA) 
and metabolites 5-hydroxyindoleacetic acid (5-HIAA) and homovanillic acid (HVA) 
were quantified. Each monoamine, precursor and metabolite was identified by its 
characteristic retention times. Standard injections were run at intervals during 
sample analysis. 
 
3.3.3.8.2 Data analysis 
Chromographs were processed using Class-VP5 software. Concentrations of 
monoamines, precursors and metabolites were determined using analyte:internal 
standard peak response ratios. Data are expressed as nanograms of 
neurotransmitter per gram of tissue weight (ng/g). 
 
3.3.3.9 Plasma corticosterone concentrations 
Plasma samples were thawed and concentrations of corticosterone were determined 
using commercially available enzyme-linked immunosorbent assay kit (ENZO Life 
Sciences, UK) according to the manufacturer’s instructions. A spectrophotometer 




3.3.3.10 16S rRNA sequence-based microbiota composition and diversity analysis 
in caecal content  
3.3.3.10.1 DNA extraction from caecal matter 
DNA was extracted from caecal matter as previously described (Gough et al., 2018).  
 
3.3.3.10.2 16S rRNA Gene Sequence-based microbiota analysis. 
Primers were used to prepare the 16S metagenomic libraries by amplifying the V3-
V4 region of the 16S gene, with Illumina adaptors incorporated as described in the 
Illumina 16S Metagenomic Library preparation guide with the following exceptions: 
the first PCR reaction was performed in a total volume of 50μl instead of 25μl and 
the number of cycles used in the first PCR was increased from 25 cycles to 30. The 
volume of AMPure XP beads (NEB) used in the initial clean-up was scaled up 
accordingly. Following index PCR and purification, Qubit high sensitivity DNA kit (Life 
technologies) was used to quantify the products. The PCR products were pooled 
equimolarly. The pooled libraries were assessed by Agilent high sensitivity DNA kit 
and quantified by qPCR using the Kapa Quantification kit for Illumina (Kapa 
Biosystems) according to the manufacturer’s guidelines. Libraries were diluted and 
denatured following Illumina guidelines and sequenced on the Illumina MiSeq using 
the V3 600 cycle kit according to Illumina sequencing protocols at the Teagasc 
sequencing facility, Teagasc Food Research Centre, Fermoy, County Cork, Ireland. 
 
3.3.3.10.3 Bioinformatic sequence analysis 
The resulting amplicons after sequencing with the MiSeq Illumina platform (2x300pb 
paired-end reads) were pre-filtered based on a quality score threshold of >28 and 
trimmed, filtered for quality and chimaeras using the DADA2 (Callahan et al., 2016) 
library in R (v3.6.3). Taxonomy was assigned with DADA2 against the SILVA SSURef 
database release v132. Parameters recommended in the DADA2 manual were 
adhered to. Amplicon Sequence Variants (ASVs) were aggregated at genus level, 
those that were unknown on the genus level were not considered in downstream 
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analysis, as were genera that were only detected as non-zero in five per cent or fewer 
of total samples.  
 
3.3.3.10.4 Data analysis 
Microbiome based data analysis was performed in R (v3.6.3) in the Rstudio 
environment (v1.2.5033). The ALDEx2 (Fernandes et al., 2014) library in R was used 
to perform a center log-ratio (clr) transformation in order to account for the 
compositional nature of microbiome data sets. Alpha diversities were calculated 
using the iNEXT (Hsieh et al., 2016) library. Beta diversity was calculated as Aitchison 
distance and differences were assessed by PERMANOVA followed by a pairwise 
implementation of PERMANOVA as a post-hoc. Functional inference was performed 
by use of the online Piphillin service (Iwai et al., 2016). The resulting count table of 
Kegg orthologues was piped into the omixerRpm R library in order to detect gut-brain 
modules (GBMs) and gut-metabolic modules (GMMs)(Valles-Colomer et al., 2019). 
Custom R scripts and functions are publically available online (Bastiaanssen, 2018). 
In all cases, FDR was controlled by Benjamini Hochberg, with a threshold of 20%.  
 
3.3.3.11 Universal 16S bacterial PCR in faecal matter 
DNA was extractad from faecal material of ABX-ABX and VEH-VEH rats using QIAamp 
Fast DNA Stool mini kit (Qiagen), following the manufacturer’s protocol. An 
additional bead-beating step was added to increase DNA yield. Qubit dsDNA broad 
range kit was used to quantify dsDNA.  The final 16S PCR reaction mix (0.2µl F: 5’-
CGGCAACGAGCGCAACCC-3’ (1114) (10 mM work solution), 0.2µL R: 5’-
CCATTGTAGCACGTGTGTAGCC-3’ (1275) (10 mM work solution), 5µl KAPA SYBR® 
FAST qPCR Kit Master Mix (2x) Universal and DNA 10ng/well diluted in PCR H20) was 
10µl/well. RT-PCR was carried out using a LightCycler 96 (Roche Diagnostics Ltd.) on 
a 96-well plate. All reactions were performed in triplicate. Relative number of copies 





3.3.3.12 Statistical analysis 
Data were assessed for outliers, normal distribution and equality of variances using 
box-plots, Shapiro-Wilk test and Levene’s test, respectively.  For data sets with 
confirmed normal distribution, a one-way ANOVA with Dunnett’s test was used to 
test for statistically significant between group differences. When data were normally 
distributed, but the assumption of homogeneity of variances was violated, a Welch 
ANOVA with Games-Howell test was used. For data sets where normal distribution 
was violated, non-parametric Mann-Whitney U test or Kruskal-Wallis test with Mann-
Whitney U test for pairwise comparisons was used to test for statistical significance. 
Statistical significance was assumed at p<0.05. Bonferroni correction was applied to 
adjust for multiple comparisons, with the exception of microbiota data. The ALDEx2 
R library was used for the generalised linear model (GLM) and differential abundance 
testing for microbiome features. Benjamini-Hochberg (BH) adjustment procedure 
was applied with the false discovery rate (FDR) set at 20% to correct for multiple 
testing in the clr-transformed microbiota data. Microbiota data are expressed as 
median (IQR). All other data are expressed as mean ± SD or displayed graphically as 
box and whisker plots (median, IQR and minimum to maximum values). SPSS v25 was 
used for all other statistical analysis. GraphPad Software v6 (GraphPad Software, San 
Diego, CA, USA) and R software environment were used to generate graphs. Adobe 






3.3.4.1 Body and tissue weight 
Microbiota modulation had significant effects on body weight, right and left ventricle 
weights, and caecum and dry lung weights (Table 1). ABX-ABX and ABX-PREB rats had 
reduced body weight. Furthermore, heart weight was decreased in ABX-ABX rats. As 
expected, ABX-ABX had significantly heavier caecum, which was similar to previous 
studies (Hoban et al., 2016; O'Connor et al., 2019). Similarly, prebiotic administration 
significantly increased caecum weights in all groups due to heightened fibre intake. 
Natural recolonisation normalised caecum weight of rats previously treated with 
ABX.  
3.3.4.2 Caecal microbiota composition and diversity  
ABX-ABX rats had significantly depleted 16s bacterial DNA compared with VEH-VEH 
rats (data not shown) and perturbed gut microbiota (Supplementary excel). In terms 
of alpha diversity, beta diversity (Fig. 3.3-2a-b) and differentially abundant genera 
(Supplementary Fig. 1a, Fig 2c), naturally recolonised rodents (ABX-NAT) showed no 
differences compared to VEH (Fig 3.3-2a-c, Suppl Fig. 1a). Both ABX-PREB and VEH-
PREB showed a similar change in terms of beta diversity (Fig. 3.3-2b). The ABX-PREB-
FMT group showed the largest differences compared to VEH in alpha diversity, beta 
diversity and differential abundance (Fig. 3.3-2a-c and Supplementary Fig. 1a). After 
Bonferroni correction, ABX-PREB-FMT was lower than VEH in the Chao1 (Fig. 3.3-2a; 
W = 7, p = 0.0049) and Shannon (Fig. 3.3-2a; W = 11, p = 0.021) metrics. In terms of 
beta-diversity, all groups were different from VEH in a pairwise PERMANOVA (Fig. 
3.3-2b; all p < 0.001, vs VEH-PREB F = 3.35, R2 = 0.157; vs ABX-PREB F = 4.15, R2 = 
0.19; vs ABX-PREB-FMT F = 12.11, R2 = 0.40 ) except for VEH vs ABX-NAT (p > 0.05; F 
= 0.95; R2 = 0.05). In order to leverage the partial two-factor design of the study, we 
applied the ALDEx2 GLM implementation with the intent to test for interactions 
between ABX and PREB on a genus level. After the Benjamini-Hochberg procedure, 
only Blautia was found to have a significant interaction (Fig. 3.3-3a; q = 0.072, t = -
4.33). Administration of PREB substantially increased the abundance of Blautia in the 




Fig. 3.3-2. Natural recolonisation normalised gut microbiota diversity. Group data 
for alpha diversity (a), principal component analysis (PCA; b) in 2-dimensional 
representation and stacked barplots showing taxa present at at least 0.1% at least 
once (c) for VEH-VEH, VEH-PREB, ABX-NAT, ABX-PREB and ABX-PREB-FMT. VEH, 
autoclaved deionised water; PREB, Prebiotic treated; ABX, antibiotic-treated; NAT, 
Natural recolonisation; FMT, faecal microbiota transfer.  Data (a) are expressed as 
266 
 
box and whisker plots (median, IQR and minimum to maximum values). Data (a) were 
statistically compared by non-parametric Mann-Whitney U test. 
3.3.4.3 Gut-brain modules and gut-metabolic modules  
Pursuing the functional consequences of the difference in Blautia, we proceeded to 
detect affected gut-brain modules (GBMs) and gut metabolic modules (GMMs) with 
a similar pipeline to previous studies (Supplementary Fig. 1b, c) (Butler et al., 2020; 
Donoso et al., 2020). Using the same statistical procedure on the floored count 
tables, a significant interaction between PREB and ABX administration was found for 
two GBMs and three GMMs after post-hoc correction. Specifically, Inositol 
degradation; q = 0.0747; t = -4.07 and Glutamate degradation II; q = 0.0288; t = -4.58, 
for the GBMs (Fig. 3.3-3b, c) along with Glutamate degradation III; q = 0.0468; t = -
4.52, Aspartate degradation II; q = 0.1249; t = -3.47 and Pyruvate:formate lyase; q = 
0.1031; t = -3.55, for GMMs (Fig. 3.3-3b-f). These functional modules were increased 
by PREB, but the effect was substantially stronger following microbiota depletion by 
ABX. By tracing back the genomes in the KEGG database that contributed to these 
functions and aggregating these genomes on a genus level, we found that Blautia 
genomes contribute a substantial proportion of the detected 16S sequences that 





Fig. 3.3-3. Antibiotics and prebiotics interaction increases Blautia relative 
abundance and alters predicted function. Group data for Blautia relative abundance 
(a), inositol degradation abundance (b), glutamate degradation II abundance (c), 
glutamate degradation III abundance (d), aspartate degradation II abundance (e) and 
pyruvate:formate lyase abundance (f) in VEH-VEH, VEH-PREB, ABX-NAT, ABX-PREB 
and ABX-PREB-FMT. VEH, autoclaved deionised water; PREB, Prebiotic treated; ABX, 
antibiotic-treated; NAT, Natural recolonisation; FMT, faecal microbiota transfer. 
 
3.3.4.4 Inflammatory markers and corticosterone 
No statistically significant differences were evident in pro/anti-inflammatory 





Fig. 3.3-4. Blautia relative abundance represents degradation and lyase of 
predicted functional characteristics in antibiotic-treated rats administered 
prebiotics. Bar columns for relative abundance of bacterial genera related to inositol 
degradation abundance (a), Glutamate degradation II abundance (b), Glutamate 
degradation III abundance (c), Aspartate degradation II abundance (d) and 
Pyruvate:formate lyase abundance (e) in VEH-VEH, VEH-PREB, ABX-NAT, ABX-PREB 
and ABX-PREB-FMT. VEH, autoclaved deionised water; PREB, Prebiotic treated; ABX, 
antibiotic-treated; NAT, Natural recolonisation; FMT, faecal microbiota transfer. 
 
3.3.4.5 Monoamine concentrations in the pons and medulla oblongata  
Comparisons of L-DOPA, HVA, HVA/DA, 5-HT, 5-HIAA and 5-HIAA/5-HT in the pons 
and medulla oblongata revealed significant differences between groups (Fig. 3.3-5a, 
c, d, f-h). Additionally, DA and NA were altered in the pons and medulla oblongata, 
respectively (Fig. 3.3-5b, e).  Post hoc analyses revealed significant differences 
compared with VEH-VEH rats. Medulla oblongata NA concentrations were decreased 
in VEH-PREB rats (p=0.004). HVA concentrations in the pons (p=0.002) and medulla 
oblongata (p<0.0001) of VEH-PREB rats was significantly reduced, which resulted in 
blunted dopamine turnover (HVA/DA) in the pons (p<0.0005). ABX-ABX rats had 
diminished HVA (p=0.004) and HVA/DA (p=0.002) concentrations in pons and 
medulla oblongata regions. Elevated serotonin turnover (5-HIAA/5-HT) was evident 
in the medulla oblongata of ABX-ABX rats (p=0.006). Pontine HVA (p=0.002) and 
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medulla oblongata 5-HIAA (p=0.001) concentrations were decreased and increased, 
respectively in ABX-Nat rats. Pontine L-DOPA (p=0.008), HVA (p=0.01) and HVA/DA 
(p=0.006) concentrations were reduced in ABX-PREB; pontine DA (p=0.001) and 
medulla oblongata 5-HIAA/5-HT (p=0.002) concentrations were increased. ABX-
PREB-FMT had elevated DA (p=0.007) and 5-HIAA (p=0.007) concentrations in the 
pons and medulla oblongata, respectively.  Decreased dopamine turnover (p=0.001) 
and NA concentrations (p=0.008) were evident in the pons and medulla oblongata, 




Fig. 3.3-5. Microbiota modulation alters pontine and medulla oblongata 
neurochemistry. Group data for L-3,4-dihydroxyphenylalanine (a), dopamine 
(b), homovanillic acid (c), homovanillic acid/dopamine ratio 
(d), noradrenaline (e), serotonin (f), 5-hydroxyindole acetic acid (g) and 5-
hydroxyindole acetic acid/serotonin ratio (h) for pons and medulla in VEH-VEH, VEH-
PREB, ABX-ABX, ABX-NAT, ABX-PREB and ABX-PREB-FMT rats. VEH, 
autoclaved deionised water; PREB, Prebiotic treated; ABX, antibiotic-treated; NAT, 
Natural recolonisation; FMT, faecal microbiota transfer. Groups (a-h) are expressed 
as box and whisker plots (median, IQR and minimum to maximum values). n=7-10. 
Groups were statistically compared using one-way ANOVA, Welch’s ANOVA or non-
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parametric Kruskal-Wallis test. Dunnetts test, Games-Howell and Mann-Whitney U 
test, were used appropriate for post hoc analysis.  * p<0.05 divided by the number of 
comparisons made.  
 
3.3.4.6 Baseline, hypoxic and hypercapnic ventilation 
During room air and hypoxic breathing, long-term breathing instability (SD2) was 
altered by microbiota manipulation (Supplementary Table 1). Drive to breathe (VT/Ti) 
and inspiratory time (Ti) in response to hypercapnic chemostimulation were affected 
by microbiota manipulation; sigh amplitude during hypercapnia was also different 
between groups (Supplementary Table 1). Other respiratory parameters assessed 
during room air and in response to hypoxic and hypercapnic chemostimulation were 







A collective body of consensus-based evidence emphasises the regulatory role of the 
gut microbiota on whole-body function in health and disease states (Cryan and 
O'Mahony, 2011; Grenham et al., 2011; Kelly et al., 2016; Sarkar et al., 2016; Kelly et 
al., 2017). In rodent microbiota intervention studies (i.e. antibiotic administration 
and FMT), aberrant gut microbiota is a potent contributor to numerous maladies 
including depression, anxiety and cardiovascular pathologies (Kelly et al., 2015; 
Burokas et al., 2017; Ganesh et al., 2018) . More recently, we have extended this line 
of enquiry by linking disturbed gut microbiota to altered control of breathing (Lucking 
et al., 2018; O'Connor et al., 2019). In humans, disrupted gut microbiota composition 
and diversity has been associated with multiple illnesses such as cardiovascular 
disease as well as neurodegenerative, neurodevelopmental, metabolic and 
biopsychosocial disorders (Benjamin et al., 2012; Burke et al., 2017; Yan et al., 2017). 
Given the rapid advancements in research regarding the potential of the gut 
microbiota to shape physiological and brain function there is increased necessity for 
the development of targeted approaches to restore or beneficially promote the gut 
microbiota. 
 
We sought to explore whether disruption of the gut microbiota composition and 
diversity as a result of broad spectrum antibiotic cocktail administration could be 
normalised or beneficially expanded through natural recolonisation and/or the use 
of interventions known to alter the gut microbiota.  Furthermore, we expand on 
present knowledge investigating the influence of the gut microbiota on the 
respiratory control system. The principal findings of this study are: 1) Following 
antibiotic administration, natural recolonisation led to a similar gut microbiota 
composition, diversity and predicted microbial function to that of vehicle treated 
animals; 2) Prebiotic administration modulated composition and function of the gut 
microbiota; 3) Prebiotic administration significantly expanded Blautia relative 
abundance in animals pre-treated with antibiotics; Blautia relative abundance was 
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associated with predicted gut microbiota functions that were altered in ABX-PREB 
and ABX-PREB-FMT rats; 4) FMT shifted the gut microbiota composition, diversity 
and predicted function in the presence of prebiotics in rats previously treated with 
antibiotics; 5) Manipulation of the microbiota had minimal effects on breathing, 
metabolism and ventilatory responsiveness to chemostimulation. 
 
It is well-established that antibiotic administration in rodents and humans perturbs 
gut microbiota structure and diversity (Hoban et al., 2016; Suez et al., 2018; O'Connor 
et al., 2019). In our study, 8 weeks of antibiotics almost completely depleted 16S 
bacterial DNA (data not presented). After 4 weeks of antibiotic administration, a 
variety of approaches were used in our study in an effort to recolonise the gut 
microbiota. These included natural recolonisation, and prebiotic administration with 
and without FMT. We found that natural recolonisation appears the optimal 
approach compared with other invention strategies (i.e. prebiotic administration 
with and without FMT) to normalise the gut microbiota configuration of antibiotic-
treated rats; animals treated with antibiotics followed by natural recolonisation 
(ABX-NAT) had similar composition, diversity and function to that of vehicle 
treatment rats (VEH-VEH). Other investigators have reported similar findings when 
the gut microbiota is assessed before antibiotic treatment and after natural 
recolonisation. For example, in mice, 4 weeks of spontaneous recovery (natural 
recolonisation) following antibiotic administration partially restored baseline 
bacterial richness and load (Suez et al., 2018). In humans, 4 weeks after completion 
of ciprofloxacin administration, which has milder effects on the gut microbiota 
compared with the cocktail of antibiotics used in this current study, the composition 
of the microbiota closely resembled its state prior to antibiotic treatment (Dethlefsen 
et al., 2008). Furthermore, within 60 days of stopping an antibiotic treatment in 
humans there was 89% gut microbiota similarity to that of pre-treatment (De La 
Cochetiere et al., 2005). Noteworthy, in our study we did not assess the gut 




Our group along with others have previously reported that prebiotic administration 
alters the gut microbiota composition and modulated metagenomic functions 
(Gibson et al., 2004; Boehme et al., 2019; O'Connor KM, 2020). Similarly, in the 
current study, we showed that prebiotic administration in vehicle treated rats 
significantly altered microbiota composition and modulated predicted function of 
the gut microbiota, although differences between GBMs and GMMs were not 
statistically significant. Probiotics have widely been used for prevention of 
antibiotics-associated gut microbiota disturbances and related adverse effects, 
although certain discrepancies are evident in terms of beneficial effects (Kechagia et 
al., 2013; Suez et al., 2018; Forssten et al., 2020). Although, prebiotics are also shown 
to have positive effects on gut microbiota composition, few studies have investigated 
these effects following antibiotic administration (Johnson et al., 2015; Burokas et al., 
2017). We revealed that prebiotics alter gut microbiota composition and diversity in 
specific patterns depending on previous vehicle or antibiotic administration, with an 
interaction evident between ABX and prebiotics in both taxonomy and functionality. 
Specifically, antibiotic treated animals that received prebiotic administration 
thereafter (ABX-PREB and ABX-PREB-FMT rats) had increased Blautia relative 
abundance; the efficiency with which Blautia was able to colonise the murine gut was 
dependent on prior perturbation by antibiotics. This finding was accompanied by 
inferred functional changes in a similar direction, increasing the likelihood that these 
alterations have noticeable impact. Similarly, others have described that in humans, 
antibiotics and dietary fibres interact in their effect on metabolic function and gut 
microbiota composition, stating that in some cases, prebiotics restored microbiota 
growth and metabolic function diminished by antibiotic administration and in other 
cases antibiotics treatment negated the effects of the dietary fibres (Johnson et al., 
2015). Interestingly, in a human study, inulin prebiotic administration resulted in 
elevated Blautia taxonomy frequency in individuals that had received gentamin 
antibiotic administration (Johnson et al., 2015). Our findings suggest that microbial 
colonisation is dependent on at least two different factors. First, as antibiotic 
perturbation was necessary for efficient colonisation by Blautia, the stability of the 
existing microbiome seems to be an important factor. Second, as the administration 
of prebiotics, GOS and FOS, were required for colonisation, the metabolic 
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environment of the microbiome seems to be of equal importance. Thus, it may well 
be that the availability of the exogenous microbe in the environment is required, 
however given our experimental design we did not investigate this hypothesis. 
Notably, as ABX-PREB and ABX-PREB-FMT cages received bedding from VEH-PREB 
and VEH cages, respectively this may have enhanced availability of Blautia in the 
environment (Johnson et al., 2015).   
 
Studies have described that within 8 days of FMT in mice, alpha diversity was 
indistinguishable to the control group and after 28 days, composition was similar 
(Manichanh et al., 2010; O'Connor et al., 2019). Furthermore, autologous FMT in 
humans resulted in a microbiota structure similar to that of the pre-antibiotic state 
as early as 1 day post autologous FMT (Suez et al., 2018). On the other hand, our 
group and others have previously shown that FMT can disturb the gut configuration 
and a unique bacterial composition and diversity develops (Halkjaer et al., 2018; 
O'Connor et al., 2019). In the current study, we explored a combination of FMT and 
prebiotics to examine the effects of two well-known microbiota intervention 
strategies on the gut microbiota structure. Others have previously reported that FMT 
combined with dietary fibres showed increased short- and long-term clinical efficacy 
in patients with slow transit constipation (Ge et al., 2016; Zhang et al., 2018). Novel 
findings in the current study revealed that ABX-PREB-FMT rats had increased gut 
microbiota diversity, altered composition and predicted functionality compared with 
vehicle treated rats. 
 
Noteworthy, ABX-PREB rats displayed a watery faecal content for 6-7 days after 
completing antibiotics and commencing prebiotic supplementation, whereas the 
ABX-PREB-FMT rats had diarrhoea-like faecal matter for 3-4 days. It is likely that 
prebiotic administration following antibiotic administration resulted in watery faecal 
content, due to the fact that there was little bacterial abundance after ABX 
administration, as evident by 16S bacterial DNA, to feed on dietary fibres. The influx 
of bacteria due to the FMT in ABX-PREB-FMT rats likely improved the diarrhoea-like 
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symptoms.  Indeed, multiple bacteria taxa administrated to the host using FMT may 
have thrived in the environment induced by prebiotic administration, which might 
contribute to important functionality in ABX-PREB-FMT rats i.e. some functional 
changes may be deemed beneficial such as elevations in butyrate, propionate and 
acetate synthesis (Roberfroid et al., 2010; Ganesh et al., 2018).  On the contrary, FMT 
influx might result in colonisation of some pathogens that otherwise would not have 
been able to expand in the population. Considering the significant differences in 
composition, diversity and function in the ABX-PREB-FMT group, our study supports 
the suggestion that for successful FMT administration, pre-screening of faeces to 
prevent induction of pathogenic microbiota is likely required (Papanicolas et al., 
2020; Stallmach et al., 2020). Notably, the FMTs were not autologous, but rather 
pooled from control animals. It is possible unpooled or autologous FMT would result 
in a different outcome in terms of recolonisation. More research is needed in this 
regard.  
 
3.3.6 Summary and conclusion 
Natural recolonisation is the most effective method to normalise the gut microbiota 
composition, diversity and predicted microbial function following antibiotic 
administration, which may have relevance in rodent studies assessing the role of the 
gut microbiota in microbiota-gut-brain axis signalling and in clinical settings, where 
normalisation or restoration of the gut microbiota structure is deemed a successful 
end-point of a therapeutic strategy. Furthermore, considering that expansion of 
Blautia is evident as a result of an antibiotic/prebiotic interaction, depending on the 
specific goal of a microbial intervention strategy, destabilisation of the gut 
microbiota might be warranted in order to ensure optimal engraftment of target 
microbes (Ji et al., 2017). Although parameters for engraftment and colonisation of 
gut microbiota are still unclear, we present evidence supporting the idea that 
stability of the gut microbiota may play a fundamental role in the engraftment of 
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3.4.1 Summary  
Birth by Caesarean (C)-section impacts early gut microbiota colonization and is 
associated with an increased risk of developing immune & metabolic disorders. 
Moreover, alterations of the microbiome have been shown to affect 
neurodevelopmental trajectories. However, the long-term effects of C-section on 
neurobehavioural processes remain unknown. Here, we demonstrated that birth by 
C-section results in marked but transient changes in microbiome composition in the 
mouse, and in particular the abundance of Bifidobacterium spp. was depleted in early 
life. Mice born by C-section had enduring social, cognitive and anxiety behavioural 
deficits in early-life and adulthood. Interestingly, we found that these specific 
behavioural alterations induced by the mode of birth were also partially corrected by 
co-housing with vaginally born mice. Finally, we show that supplementation from 
birth with a Bifidobacterium breve strain, or with a dietary prebiotic mixture that 
stimulates the growth of bifidobacteria, reverses selective behavioural alterations in 
C-section mice. Taken together, our data link the gut microbiota to behavioural 
alterations in C-section born mice and suggest the possibility of developing 
adjunctive microbiota-targeted therapies which may help to avert long-term 
negative consequences on behaviour associated with C-section birth mode.  
 
3.4.2 Introduction 
The gut microbiota -the collection of bacteria, archaea and eukarya residing in the 
gastrointestinal tract- has co-evolved with their hosts over thousands of years 
resulting in an intricate mutual relationship wielding significantly benefit to host 
health (Kundu et al., 2017). Interactions between the gut microbiota and the host 
involve signalling via chemical neurotransmitters and metabolites, neuronal 
pathways, and the immune system (Cryan et al., 2019). There is growing appreciation 
that microbiota, especially in early-life, influences the development and function of 
multiple hosts physiological systems, including the central nervous system (Sampson 
et al., 2016; Codagnone et al., 2019). Thus, it has been posited to be a key pillar in 
understanding the developmental origins of mental health and disease (Dinan and 
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Cryan, 2017; Codagnone et al., 2019). Preclinical studies using mice born and raised 
without exposure to microorganisms, germ-free mice, have highlighted the long-
lasting effects of the disruption of the normal acquisition and maturation of the gut 
microbiota on cognition (Gareau et al., 2011), social behaviour (Desbonnet et al., 
2014), and brain development (Heijtz et al., 2011). However, germ-free animals are 
specialized model systems and it is unclear if more medically relevant alterations in 
microbiome composition in early life can have enduring psychological and 
neurobehavioral effects.  
In mammals, the composition of the gut microbiota starts to develop mainly upon 
birth and continues to mature and change throughout life, influenced by several 
factors including breast-feeding patterns (Pannaraj et al., 2017), diet (Zmora et al., 
2019) antibiotic exposure (Becattini et al., 2016), and birth mode (Dominguez-Bello 
et al., 2010). In humans, birth by Caesarean (C)-section results in a different pattern 
of microbiota colonization and it is associated with increased likelihood of developing 
immune and metabolic disorders in childhood (Horta et al., 2013; Martinez et al., 
2017; Wampach et al., 2018; Shao et al., 2019). Moreover, babies born by C-section 
exhibit lower relative abundance of maternally transmitted commensal bacteria and 
higher relative abundance of opportunistic microorganisms that are commonly found 
in the hospital environment (Shao et al., 2019). Despite this, the number of infants 
delivered by C-section worldwide has rapidly increased over recent years, and in 
many jurisdictions far exceeds the World Health Organization guidelines of between 
10-15% (Dominguez-Bello et al., 2016). Until recently, there has been limited 
epidemiological data examining behavioural and psychiatric outcomes in individuals 
born by C-section. Associations have been made with autism, psychosis, depression, 
attention deficit disorder and school performance (Curran et al., 2015; O'Neill et al., 
2016; Curran et al., 2017; Yang et al., 2019), though some of these associations fail 
to stand up when familial confounding is considered (Curran et al., 2015; O'Neill et 
al., 2016). Although the importance of maternal vaginal microbiome transmission for 
programming of the offspring brain has been recently demonstrated (Jasarevic et al., 
2018), C-section-induced changes in the microbiome have been largely neglected in 
the context of brain health.  
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Within the gut microbiota bifidobacteria are among the earliest and most abundant 
bacterial colonizers of the gut and are essential for appropriate immune, metabolic 
and gastrointestinal development in infancy (Arboleya et al., 2016; Vatanen et al., 
2018). The establishment of Bifidobacterium spp. seeding in the neonatal gut is 
largely influenced by vertical transmission from mother-to-infant during vaginal 
delivery (Hill et al., 2017; Wang et al., 2020). Birth by C-section circumvents early 
bifidobacterial colonization and, compared to vaginally born babies, C-section babies 
have decreased Bifidobacterium spp. relative abundance in their gut microbiota 
(Dominguez-Bello et al., 2010; Dominguez-Bello et al., 2016; Korpela et al., 2018; 
Shao et al., 2019). Although this difference tends to normalize somewhere between 
6 months and 4 years (Dominguez-Bello et al., 2016; Fouhy et al., 2019), it may lead 
to maladaptive programming of brain and behaviour. Intervention strategies that 
promote a healthy balance of the gut microbiota in babies born by C-section have 
included the use of prebiotics and probiotics to promote growth of Bifidobacterium 
spp. and other beneficial bacteria (Moya-Perez et al., 2017).  
 
Given the importance that initial colonization of the gut microbiota has on brain 
development we used a mouse model to assess the long-term consequences of birth 
by C-section on neurobehavioural outcomes and the potential role of gut microbiota-
based interventions in remediating such effects. To interrogate these interactions, 
we used three different approaches. First, we compared the gut microbiota 
composition and neurobehavior of pups delivered by C-section and given to foster 
dams (C-section, CS) with pups delivered spontaneously and nursed by their own 
mothers (Vaginally born, VB) or by a fostered dam (Cross-fostered, CF) (Figure 3.4-
1A). To prove the importance of the microbiome in mediating such effect we 
transfered microbiota from VB to CS born mice at weaning through co-housing. Co-
housing may be the simplest and most convenient technique for microbial transfer 
as it offers opportunities of microbiota mixing between co-housed partners due to 
the coprophagic nature of mice (Robertson et al., 2019). Finally, we treated pups from 
birth with a Bifidobacterium breve strain, or with a dietary prebiotic mixture, which 
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stimulates the growth of bifidobacteria, to investigate if it could avert the long-term 
negative consequences on behaviour associated with delivery C-section. 
 
3.4.3 Results  
 
3.4.3.1 Gut microbiota alterations induced by C-section mode of birth across 
lifespan  
 
To address our hypothesis that birth by C-section can affect the programming of the 
microbiota-gut-brain-behaviour axis, we used 16S rRNA gene sequencing to profile 
the gut microbiota composition in CS, VB and CF offspring in early-life (postnatal day 
(P) 9), pre-weaning adolescence (P21) and adulthood (week (wk) 20).  
Regardless of the delivery mode, the composition of the gut microbiota was the most 
diverse, with regard to alpha diversity, and exhibited the highest inter-animal 
variability in early-life (P9), with the overall dominance of the Lactobacillus genus 
from the Firmicutes phylum (Table S1 and Figure S1A). Principal component (PCA) 
and canonical correspondence (CCA) analyses showed that the structure of the 
intestinal microbial community was significantly altered in both CS and CF offspring 
across the lifespan (Figure 3.4-1B-D and see also Table S1). Indeed, CS clustered 
separately from the VB and CF groups at P9, and the separation persisted throughout 
adolescence and adulthood (Table S1). From weaning onwards, the microbiota 
successfully re-shaped towards an approximately equal dominance of Bacteroidetes 
and Firmicutes phyla (see also Table S1 and Table S2 and Table S 3), which is typical 
for the adult murine microbiota (Donaldson et al., 2015). 
Analysis of individual bacterial taxa abundance at the phylum, family and genus levels 
revealed that, albeit both the CS model of delivery and the CF procedure itself had a 
long-lasting impact on the gut microbiota in the affected offspring, the profile of 
observed changes was unique for each intervention. The latter can be illustrated by 
the CCA plots, with CS and CF groups diverging from the VB mice (Figure 3.4-1B-D). 
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For instance, at P9, CF offspring displayed a dramatic increase in the relative 
abundance of Gammaproteobacteria species, while CS offspring was characterized 
by an increase in the proportion of a few Bacteroidetes genera (Odoribacter, 
Parabacteroides) and a marked reduction in the Lactobacillus bacteria (see also Table 
S1). Similarly, at P21 and wk20, various genera from the Actinobacteria and 
Tenericutes phyla, as well as Rikenellaceae, Lachnospiraceae and Ruminococcaceae 
families of the Firmicutes phylum, were differentially affected by CS and CF (see also 
Table S1). Differences in the composition of the microbiota among treatment groups 
were associated with alterations in the short chain fatty acid (SCFA) profile, whereby 
caecal levels of acetate were different among groups in adolescence, but post-hoc 
testing did not yield significant results. Butyrate levels were higher in adulthood in 




Figure 3.4-1. Mode of Delivery Affects Microbial Beta-Diversity throughout the 
Lifespan (A) CS animal model and experimental design. (B–D) Principal component 
analysis (PCA) and canonical correspondence analysis (CCA) showed that beta-
diversity of intestinal (cecal) microbial community was significantly altered in the CS 
offspring in early-life (P9), adolescence (P21), and adulthood (week 20). CS did not 
impact alpha-diversity indices (Chao1, Simpson, and Shannon) at any time point. 
Alpha-diversity indices are presented as median and interquartile range with whiskers 
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representing minimum and maximum values. The x and y axes explain the variability 
between samples. (B) Early life (P9; VB n = 9, 4 litters; CF n = 22, 4 litters; CS n = 7, 4 
litters). (C) Adolescence (P21; VB n = 10, 4 litters; CF n = 7, 4 litters; CS n = 8, 4 litters), 
#p < 0.05 CS versus CF. (D) Adulthood (VB n = 14, 4 litters; CF n = 12, 4 litters; CS n = 
12, 4 litters). 
CF, cross-fostering; CS, C-section; VB, vaginal birth. Statistical details: Among-group 
differences in alpha-diversity indices were analyzed with Mann-Whitney U test. 
Benjamini-Hochberg adjustment with Q = 0.2 was used to correct p values for 
multiple testing. PCA plots at the operational taxonomic unit (OTU) level were 
constructed using Aitchison distance calculated in the ALDEx2 library; PCA was done 
using the prcomp() function. CCA plots at the OTU level were generated with the 
vegan library; ellipses represent 95% confidence interval calculated by the ggplot2 
library. The vegan implementation of PERMANOVA followed by PERMANOVA as a 
post hoc was used to test for differences at a beta-diversity level; Data S1; Figure S1. 
See also Data S3 and S4 and Table S1. 
 
3.4.3.2 C-section delivery leads to neurobehavioural changes in early life  
We then compared the consequences of mode of delivery on offspring behaviour in 
early-life, particularly focusing on social behaviour, cognitive, and anxiety-like 
aspects of a behavioural phenotype (Figure 3.4-2A). Quantification of ultrasonic 
vocalization (USV) is widely used to measure early communicative behaviour and 
aversive affective reactions to stress separation (Jung et al., 2018). Here we found 
that, in early life (P9), CS offspring exhibited a higher number of USV calls when 
isolated from their littermates and mother than CF or VB animals (Figure 3.4-2B). It 
has been previously demonstrated that by P10 pups are normally able to respond to 
relevant social stimuli and to efficiently discriminate their mother’s nest when 
physically separated (Macri et al., 2010). Unlike VB or CF animals, CS pups had less 
preference for the maternal versus neutral bedding (Figure 3.4-2C-D), thus 
expressing early social recognition and maternal attachment deficits. Together these 
results suggest that birth by C-section is interfering with early-life communication, 





Figure 3.4-2. CS Delivery Mode Leads to Neurobehavioral Changes in Early Life (A) 
Experimental timeline. (B) CS-born offspring exhibited communication deficits and 
anxiety-like behavior at P9 as measured by increased number of USV calls. ∗∗∗p < 
0.0001 CS versus VB; ###p < 0.0001 CS versus CF. (C and D) CS-born mice exhibited 
deficits in maternal attachment behavior at P10. (C) CS-born offspring failed to exhibit 
preference for their home/maternal bedding, ∗∗∗p < 0.0001 CS versus VB; ###p < 
0.0001 CS versus CF. (D) CS-born offspring displayed increased preference for a 
neutral bedding; ∗∗∗p < 0.0001 CS versus VB; ###p < 0.0001 CS versus CF. All data are 
presented as median and interquartile range with whiskers representing minimum 
and maximum values. VB n = 24, 4 litters; CF n = 12, 4 litters; CS n = 24, 4 litters. USV, 
ultrasonic vocalization. Statistical details: (B) number of calls (x2 = 33.303; p < 0.001); 
(C) time spent on the home/maternal bedding (x2 = 26.106; p < 0.0001); and (D) time 
spent on a neutral bedding (x2 = 20.577; p < 0.0001). (B–D) Among-group differences 
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were analyzed with Kruskal-Wallis test, followed by Mann-Whitney U test. See also 
Data S3 and S4. 
 
3.4.3.3 Enduring neurobehavioural effects induced by C-section  
Alterations in sociability are a common feature among a variety of neuropsychiatric 
conditions, and microbiota-deficient mice develop social deficits (Desbonnet et al., 
2014). Here we investigated whether mice born by C-section exhibit deficits in social 
behaviour in adulthood. Although CS mice displayed normal sociability in the three-
chamber test (i.e preference for mouse over object) (Figure 3.4-3A), a specific deficit 
in social novelty recognition (i.e preference for novel over familiar social partner) was 
revealed in CS mice compared with VB and CF offspring (Figure 3.4-3B). Interestingly, 
during the subsequent intervention studies where we probed adult CS mice against 
non-social cognitive cues in the novel object recognition test, the CS mice failed to 
discriminate between a novel and a familiar object in active investigation time (the 
effect was not significant in investigation index, see also Figure S2).  
The hippocampus is an important brain area for learning and memory as well as for 
the regulation of the stress response (Levone et al., 2015). Accumulating data also 
show that it represents a key node in the microbiome-gut-brain axis, with alterations 
in the gut microbiome being associated with changes in hippocampal gene 
expression, neurogenesis, and neurotransmission (Clarke et al., 2013; Ogbonnaya et 
al., 2015; Burokas et al., 2017; Chen et al., 2017). In addition, the hippocampus is 
required for proper social recognition (Raam et al., 2017) and social memory 
formation (Phillips et al., 2019). Thus, it was important to investigate whether the 
hippocampus transcriptome was sensitive to C-section induced changes in the gut 
microbiota. In agreement with the behavioural data, the transcriptome analysis of 
the hippocampal brain region in adult mice revealed substantial transcriptional 
differences in the CS offspring (Figure 3.4-4A-B). CS mice clustered separately from 
either VB or CF counterparts, while no differences between CF and VB groups were 
observed. Interestingly, of the 38 genes up-regulated in CS mice, nine belonged to 
extracellular matrix-associated group (Col8a1, Col8a2, Col4a3, Ctsc, Frdc9, Itih5, etc).  
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In addition to alterations in social novelty recognition in adulthood, CS mice exhibited 
exaggerated anxiety-like behaviour as observed by increased number of buried 
marbles in the marble burying test (Figure 3.4-3C), reduced number of entries into 
the open arms in the EPM test (Figure 3.4-3D-E), and reduced locomotion and time 
spent in the central zone of the OF test (Figure 3.4-3F-G). Most of the CS-associated 
effects on anxiety remained significant after adjustment for the litter effect (see also 
Table S3), but failed to be robustly evident in subsequent cohorts (see also Figure 
S3). This suggests a subtle nature of the pro-anxious behavioural phenotype in the 
CS offspring, and/or the importance of postnatal environment for the development 
of these outcomes. In contrast, CS-induced deficits in social novelty recognition not 
only withstood the adjustment for the litter effect (see also Table S3), but were 
consistently observed across all experimental cohorts (Figure 3.4-5C and Figure 3.4-
6H), thus indicating the robustness of the observed effects. Controlling for the early 
environment exposure was an important goal of the initial experiments and that is 
why for this first set of experiments we included all three groups (CS, CF and VB), that 
would give us a fully balanced stratified experimental design. Although the CF 
procedure itself resulted in a unique effect on the gut microbiota (Figure 3.4-1 B-D), 
these changes did not manifest in many behavioural alterations throughout (Figure 
3.4-2 and Figure 3.4-3). For statistical, logistical and ethical reasons (in order to meet 
3R requirements and minimize animal usage), we chose to only have VB group as 




Figure 3.4-3. Enduring Neurobehavioral Effects Induced by CS (A and B) CS 
delivery mode had an impact on social behavior in adulthood (three-chamber test). 
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(A) CS did not impair sociability. ∗∗∗p < 0.001 mouse versus object for the interaction 
time data. (B) CS-born mice had deficits in social novelty recognition. ∗∗∗p < 0.001 
novel versus familiar mouse for the interaction time data. ∗∗∗p < 0.001 CS versus VB 
and ###p < 0.001 CS versus CF for the interaction index data. (C–G) In adulthood, 
mice delivered by CS displayed enhanced anxiety-like behavior across various tests. 
(C) Increased number of buried marbles in the CS group. ∗∗∗p < 0.001 CS versus VB 
and ###p < 0.001 CS versus CF. (D) Decreased number of entrances into the open 
arms in the CS group. ∗p < 0.05 CS versus VB and #p < 0.05 CS versus CF. (E) 
Number of entrances in the closed arms were unchanged. (F) Reduced time spent in 
the center zone of an aversive open-field arena in the CS group ∗p < 0.05 CS versus 
VB; #p < 0.05 CS versus CF. VB n = 15, 4 litters; CF n = 13, 4 litters; CS n = 12, 4 
litters. (G) Reduced total distance traveled in the aversive open field in the CS 
group. ∗∗p < 0.05 CS versus VB. Data are presented as mean + standard error of the 
mean (SEM). (A–E and G) VB n = 15, 4 litters; CF n = 14, 4 litters; CS n = 12, 4 
litters. Statistical details: (A) interaction time: VB t (14) = 6.341, p < 0.0001; CF t 
(13) = 9.776, p < 0.0001; CS t (11) = 9.811, p < 0.0001, paired Student’s t test. 
Interaction index: F (2,38) = 1.555; p = 0.224; one-way ANOVA followed by Tukey 
post hoc tests. (B) Interaction time: VB t (14) = 7.8; p < 0.001: CF t (13) = 5.1; p < 
0.0002: CS t (11) = −0.167; p = 0.8707; paired Student’s t test. Interaction index: F 
(2,38) = 14.73; p < 0.0001; one-way ANOVA followed by Tukey post hoc tests. (C) 
Marbles: F (2,38) = 14.73; p < 0.0001. (D) Entrances to open arms: F (2,38) = 4.74; 
p = 0.015. (E) Entrances to closed arms: F (2,38) = 0.614; p = 0.4047. (F) Time in 
the center zone: F (2,37) = 1.077; p = 0.0076. (G) Distance: F (2,38) = 5.22; p = 
0.01. (C–G) One-way ANOVA, followed by Tukey post hoc tests. See also Data 








Figure 3.4-4. CS Mode of Birth Induces Enduring Changes in the 
Hippocampal Transcriptome Heatmap showing differentially expressed 
genes in the adult hippocampus of CS versus VB offspring (A) and CS versus CF 
offspring (B). Differential gene expression was determined using the DESeq2 R-
package (v1.6.2) with default parameters on pairwise comparisons of all possible 
group combinations. An adjusted p ≤ 0.1 (Benjamini-Hochberg method) was 
considered statistically significant. Red color indicates increased expression, and blue 
color indicates decreased expression levels of the affected genes. VB n = 5, 4 litters; 
CF n = 5, 4 litters; CS n = 6, 4 litters. See also Data S3 and S4. 
 
3.4.3.4 Microbiota transfer by co-housing reverses specific neurobehavioural 
changes induced by C-section  
To investigate a potential causal role for the gut microbiota in mediating the 
observed behavioural changes, we examined whether transferring microbiota from 
VB to CS born mice at weaning could prevent C-section-mediated behavioural 
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deficits. We exploited the coprophagic nature of mice and performed faecal transfer 
by co-housing one CS mouse with three VB mice in adolescence (based on the 
strategy utilized by Buffington and colleagues, (Buffington et al., 2016)). Littermates 
originating from multiple litters were randomly assigned to the different housing 
systems to minimize the litter effect. Behaviour was assessed in adulthood (Figure 
3.4-5A). Although CS mice displayed normal sociability in the three-chamber test (i.e 
mouse vs object) (Figure 3.4-5B), co-housing CS with VB mice selectively reversed C-
section-induced cognitive deficits, restoring social novelty recognition (Figure 3.4-
5C). Despite not affecting the marble-burying or EPM readouts (see also Figure S5B-
C), co-housing had anxiolytic effects in CS mice, increasing the time spent in the 
central zone of the OF (see also Figure S5D). 
Next, we investigated the gut microbiota composition in VB, CS and CS co-housed 
offspring at week 4, i.e one week following the commencement of the co-housing 
regimen). Co-housing did not affect alpha-diversity indices (see also Figure S4A, 
Table S4). Moreover, the PCA analysis did not show significant differences in the 
microbial communities structure across groups (Figure 3.4-4D), though all three 
groups clustered separately on the CCA plot (Figure S4B, p<0.05, PERMANOVA, Table 
S4, beta diversity analysis). When we looked at the individual bacterial taxa that 
showed the strongest response to mode of delivery or co-housing regimen, we 
observed that co-housing reversed C-section-associated reduction in the 
Bacteroidetes genus (Figure 3.4-5E). Furthermore, co-housing had a unique effect on 
the relative abundance of Blautia and Rikenella bacteria, while not affecting 
Bacteroidales S24-7 group and Anaeroplasma species in CS mice (Figure 3.4-5E). 
These data support the concept of plasticity within the microbiome-gut-brain axis 
and show that the enduring effects of C-section can be at least partially restored via 




Figure 3.4-5. Microbiota Transfer by Co-housing Partially Restores CS 
Behavioral Phenotype (A) Experimental timeline of the co-housing study.(B) Co-
housing did not affect sociability; ∗∗∗p < 0.001 for mouse versus object for the 
interaction time data. VB n = 11, 9 litters; CS n = 12, 6 litters; VB-CH, n = 11, 9 
litters; and CS-CH, n = 12, 7 litters. (C) Co-housing reversed social novelty 
recognition deficits in CS-born mice; **p < 0.01 and ***p < 0.001 for novel versus 
familiar mouse for the interaction time data. *p < 0.05 CS versus VB and #p < 0.05 
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CS versus CS-CH for the interaction index data. Social novelty: VB n = 10, 9 litters; 
CS n = 10, 6 litters; VB-CH, n = 10, 9 litters; and CS-CH, n = 11, 7 litters. (D) PCA 
did not show significant differences in the beta diversity among all groups in the 
intestinal (fecal) microbiome community (see also Data S2). The x and y axes explain 
the variability between samples. (E) Co-housing restored CS-associated reduction in 
the Bacteroidetes genus. Relative abundance of the bacterial taxa (clr) with the 
strongest response to mode of delivery and/or housing regimen. Data are presented 
as mean + SEM on (B) and (C) and as median and interquartile range with whiskers 
representing minimum and maximum values (E). (D and E) VB n = 9, 9 litters; CS n = 
8, 6 litters; and CS-CH, n = 11, 7 litters. CS-CH, CS co-housed. Statistical details: 
(B) interaction time: VB t (10) = 8.863, p = 0.001; VB co-housed t (10) = 11.94, p = 
0.0001; CS t (11) = 4.920, p = 0.0005; CS co-housed t (11) = 8.835, p < 0.0001, 
paired Student’s t test. Interaction index: group effect F(1,42) = 0.146, p = 0.705; 
mode of delivery effect F(1, 42) = 0.557, p = 0.646; group × mode of delivery effect 
F(1,42) = 0.692, p = 0.410, two-way ANOVA followed by Tukey post hoc. (C) 
Interaction time: VB t (9) = 4.566, p = 0.001; VB co-housed t (8) = 2.902, p = 0.0198; 
CS t (9) = 0.7423, p = 0.7873; CS co-housed t (10) = 4133, p = 0.002, paired 
Student’s t test. Interaction index: group effect F(1,37) = 6.49, p = 0.0151; mode of 
delivery effect F(1,37) = 5.565, p = 0.0237; group × mode of delivery effect F(1,37) = 
3.203, p = 0.0817, two-way ANOVA, followed by Tukey post hoc. (D) Beta-diversity, 
PCA plots, pairwise PERMANOVA, p < 0.001, Data S2 and Figures S2–S4. See 
also Data S3 and S4 and Table S2. 
 
 
3.4.3.5 Bifidobacterium spp. contribute to C-section-induced neurobehavioural 
changes 
Since 16S rRNA gene sequencing provides a general overview of microbial 
community structure, we next employed a quantitative reverse transcription 
polymerase chain reaction (RT-qPCR) approach to look at the absolute abundance of 
specific bacterial taxa. We focused on the Bifidobacterium genus, since mode of 
delivery was shown to be an important factor in shaping bifidobacteria colonization 
in infants (Penders et al., 2006; Dominguez-Bello et al., 2010; Fouhy et al., 2019). We 
quantified Bifidobacterium species in the faeces of VB and CS mice at weaning (wk 
3), adolescence (wk 4) and in adulthood (wk 7). Herein, we demonstrate a transient 
significant decrease in Bifidobacterium spp. abundance in CS offspring at weaning 
(wk 3), which was no longer observable one week or four weeks later (Figure 3.4-6A). 
Given the fact that bifidobacteria are among the earliest bacterial colonizers of the 
neonatal gut and are essential for appropriate immune, metabolic and 
gastrointestinal development in infancy, disturbances in their appropriate 
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establishment at the beginning of life could have long-term neurobehavioural 
effects. To this end, we used two different methods of dietary intervention to 
augment Bifidobacterium levels in our mouse model (Figure 3.4-6B). We 
supplemented CS-nursing dams through their diet with either human commensal 
Bifidobacterium breve M16-V (B. breve) or a prebiotic mixture of short-chain galacto-
oligosaccharides and long-chain fructo-oligossaccharides (scGOS/lcFOS) in a 9:1 
ratio, known to promote Bifidobacterium growth (Kosuwon et al., 2018). At wk 3, CS 
pups were weaned onto the corresponding maternal diet. Both scGOS/lcFOS and B. 
breve supplementation successfully restored early-life deficit in the Bifidobacterium 
spp. abundance associated with CS (Figure 3.4-6C). Notably, even as early as at P9, 
treatment with the prebiotic mixture prevented communication deficits by reducing 
the number of USV calls emitted by the CS pups when they were isolated from their 
nest (Figure 3.4-6D). Moreover, at P10, both interventions successfully restored 
neonatal recognition abilities and maternal attachment deficits in the CS pups (Figure 
3.4-6E-F). As in Figure 3.4-3, social and non-social recognition, as well as anxiety-like 
behaviour were assessed in adulthood (Figure 3.4-6G-H, see also Figure S3). In 
adulthood, CS-induced social recognition impairment persisted in mice treated with 
B. breve, while treatment with scGOS/lcFOS completely reversed this deficit (Figure 
3.4-6H). Moreover, scGOS/lcFOS treatment restored novel object recognition deficits 
(see also Figure S4C-D) in the CS group, with all positive cognitive effects remaining 




Figure 3.4-6. Targeting Bifidobacterium Genus from Birth Restores Behavioral 
Deficits in CS Mice (A) Transient significant decrease in Bifidobacterium spp. 
abundance (log10 cell/g feces) was seen in the CS offspring at weaning (week 3). 
Week 3 VB n = 24, 9 litters; CS n = 19, 6 litters; week 4 VB n = 9, 9 litters; CS n = 11, 6 
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litters; and week 7 VB n = 7, 4 litters; CS n = 6, 7 litters. ∗p < 0.05 CS versus VB. (B) B. 
breve and scGOS/lcFOS administration and experimental timeline. (C) Treatment with 
scGOS/lcFOS and B. breve restored early-life deficit in the Bifidobacterium spp. 
abundance (log10 cell/g feces) associated with CS. ∗∗p < 0.01 CS versus VB; ###p < 
0.001 CS versus CS+B. breve and CS versus CS+prebiotic. VB n = 5, 4 litters; CS n = 7, 3 
litters; CS+B. breve, n = 13, 3 litters; and CS+prebiotic, n = 11, 3 litters. (D) Prebiotic 
mixture attenuated communication deficits in CS-born mice at P9; B. breve 
supplementation had no effect on early-life communication and anxiety. ∗p < 0.05 CS 
versus VB; #p < 0.05 CS versus CS+prebiotic. VB n = 14, 4 litters; CS n = 9, 3 litters; 
CS+B. breve, n = 10, 3 litters; and CS+prebiotic, n = 6, 3 litters. (E and F) scGOS/lcFOS 
and B. breve treatments restored maternal attachment deficits in the CS pups at P10. 
VB n = 16, 4 litters; CS n = 15, 3 litters; CS+B. breve, n = 14, 3 litters; and CS+prebiotic, 
n = 8, 3 litters. (E) Time spent on the maternal bedding. ∗∗∗p < 0.001 CS versus VB; #p 
< 0.05 CS versus CS+B. breve; ###p < 0.05 CS versus CS+prebiotic. (F) Time spent on 
the neutral bedding ∗∗∗p < 0.001 CS versus VB; #p < 0.05 CS versus CS+B. breve; ###p 
< 0.05 CS versus CS+prebiotic. (A–F) Data are presented as median and interquartile 
range with whiskers representing minimum and maximum values. (G) Treatment with 
prebiotic did not affect sociability. ∗∗∗p < 0.001 for mouse versus object for the 
interaction time data. VB n = 11, 4 litters; CS n = 8, 3 litters; CS+B. breve, n = 8, 3 
litters; and CS+prebiotic, n = 8, 3 litters. (H) Treatment with prebiotic reversed social 
novelty recognition deficits in CS-born mice. B. breve supplementation had no effect 
on social novelty recognition. ∗p < 0.05 and ∗∗p < 0.01 for novel versus familiar mouse 
for the interaction time data. ∗∗p < 0.01 CS versus VB and p < 0.05 CS versus 
CS+prebiotic for the interaction index data. VB n = 11, 4 litters; CS n = 8, 3 litters; CS+B. 
breve, n = 6, 3 litters; and CS+prebiotic, n = 8, 3 litters. (G and H) Treatment with 
prebiotic did not affect sociability but reversed social novelty recognition deficits in 
CS-born mice. B. breve supplementation had no effect on social novelty recognition. 
∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.001 for mouse versus object and novel versus 
familiar mouse for the interaction time data. ∗∗p < 0.01 CS versus VB and p < 0.05 CS 
versus CS+prebiotic for the interaction index data. Data are presented as mean + SEM. 
Statistical details: (A) week 3, U = 129.00, p = 0.015; week 4, U = 56.5, p = 0.161; and 
week 7, U = 18.00, p = 0.070, Mann-Whitney U test. (C) Bifidobacterium spp. 
abundance: CS versus VB, x2 = 0.000, p = 0.004, Mann-Whitney U test; CS versus 
CS+treatment, x2 = 20.472, p < 0.0001, Kruskal-Wallis test followed by multiple 
comparisons. (D) Number of calls: CS versus VB, U = 27.500, p = 0.025, Mann-Whitney 
U test; CS versus CS+treatment; x2 = 6.203, p = 0.045, Kruskal-Wallis test followed by 
multiple comparisons. (E) Time spent on the home/maternal bedding; CS versus VB, 
x2 = 35.000, p = 0.001, Mann-Whitney U test; CS versus CS+treatment, x2 = 10.484, p 
= 0.005, Kruskal-Wallis test followed by multiple comparisons. (F) Time spent on the 
neutral bedding: CS versus VB, x2 = 35.000, p = 0.001, Mann-Whitney U test; CS versus 
CS+treatment; x2 = 10.484, p = 0.005, Kruskal-Wallis test followed by multiple 
comparisons test. (G) Sociability. Interaction time: VB t (10) = 6.150, p = 0.0001; CS t 
(7) = 6.813, p = 0.001; CS+B. breve t (7) = −2.236, p = 0.060; CS+prebio c t (7) = 4.662, 
p = 0.0023, paired Student’s t test. Interaction index: CS versus VB t (17) = 0.349, p = 
0.731, unpaired Student’s t test; CS versus CS+treatment groups F (2,21) = 0.1374, p 
= 0.8724, one-way ANOVA followed by Tukey post hoc tests. (H) Social novelty 
recognition. Interaction time: VB t (10) = 2.974, p = 0.014; CS t (7) = 0.1795, p = 0.8626; 
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CS+B. breve t (5) = 1.588, p = 0.1232, CS+prebiotic t (7) = 3.776, p = 0.0069, paired 
Student’s t test. Interaction index: CS versus VB, t (17) = 3.053, p = 0.007, unpaired 
Student’s t test; CS versus CS+treatment groups, F (2,21) = 4.379, p = 0.027, one-way 






Thousands of years of interkingdom symbiosis between gut microorganisms and 
their animal hosts have influenced the hosts physiological systems development, 
including the central nervous system (Sherwin et al., 2019). Birth is one of the key 
factors shaping the gut microbiota structure in mammals and maternal transmission 
of the gut microbiota has likely contributed to the establishment of this evolutionary 
symbiotic relationship in many different species (Funkhouser and Bordenstein, 
2013). In humans, mode of delivery at birth is one of the key factors regulating early-
life gut microbiota composition of mammals (Penders et al., 2006; Martinez et al., 
2017). Here, we establish a mouse model of C-section mode of delivery which 
recapitulates structural changes in the intestinal microbial community in early life 
that endured through adolescence. Previous human studies have demonstrated that 
C-section significantly reduces Bifidobacterium spp. Abundance in the infant 
intestine, with the observed deficit normalising later in life (Dominguez-Bello et al., 
2010; Fouhy et al., 2019). In agreement, our model shows a significant and transient 
depletion of Bifidobacterium spp. in the CS offspring in early life. Altered microbiome 
composition at critical stages of early life, during which rapid development and 
maturation of central nervous system occur, has been implicated in a variety of 
behavioural alterations in animals (O'Mahony et al., 2017) and humans (Christian et 
al., 2015; Carlson et al., 2018; Cowan et al., 2020). However, until recently there has 
been limited epidemiological data examining behavioural and psychiatric outcomes 
in individuals born by C-section, and scarce data that exists from animal models was 
inconclusive (Vaillancourt and Boksa, 1998; El-Khodor and Boksa, 2002; Castillo-Ruiz 
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et al., 2018; Swift-Gallant et al., 2018; Chiesa et al., 2019; Yang et al., 2019). Here we 
demonstrate that structural alterations in the intestinal microbial community 
induced by C-section are associated with robust and persistent behavioural changes 
in the affected offspring. CS mice display social communication and maternal 
attachment deficits in early-life, and specific impairment of social novelty recognition 
in adulthood. CS-induced deficits in recognition also extend to discrimination of non-
social cognitive cues. 
 
In order to establish if disturbances in the appropriate colonization of bifidobacteria 
at the beginning of life is implicated in the observed behavioural deficits, we used 
two alternative approaches to counteract the reduction in Bifidobacterium spp. 
abundance induced by C-section (dietary supplementation of either B. breve strain 
or a prebiotic mixture of scGOS/lcFOS). Treatment with both strategies successfully 
reversed social and non-social recognition deficits in the CS offspring. Thus, we 
provide here a causal link between deficits in early life bifidobacteria colonization of 
the gut and the behavioural phenotype associated with C-section. Strikingly, in a 
recent human study, maternal supplementation with a B.breve strain completely 
reversed the impact of birth by C-section and antibiotic treatment on the microbiota 
composition in infants (Chua et al., 2017).  
  
In the co-housing experiment, we demonstrated that non-specific faecal microbiota 
transfer from the VB to the CS offspring at weaning was similarly effective in 
reversing C-section-induced behavioural deficits, and was associated with partial 
restoration of gut microbiota composition in the CS offspring. This further supports 
the implication of gut bacteria in mediating specific behavioural changes associated 
with C-section. Here we showed that co-housing had a unique effect on the relative 
abundance of Blautia and Rikenella bacteria, while not affecting Bacteroidales S24-7 
group and Anaeroplasma species in CS mice. Thus, the exact bacteria involved in 
restoring behavioural effects are unclear and remain to be explored in future 
intervention studies (Sbahi and Di Palma, 2016). It should be acknowledged that 
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transmission of the microbiota via coprophagy may have limited efficacy on 
microbiota standardisation as it select for bacteria that are more tolerant of certain 
environments and able to conquer resident microbiota response to colonization in 
the recipient mouse (Robertson et al., 2019). Further, co-housing mice that express 
different behaviours may have an effect itself. Thus, the effects of co-housing with 
CS with VB may not be entirely to faecal microbiome transfer. 
 
A growing body of work implicates the gut microbiota in social behaviour and 
cognitive performance, and alterations of microbiota have been recently associated 
with neurodevelopmental disorders (Hsiao et al., 2013; Desbonnet et al., 2014; 
Buffington et al., 2016). The precise mechanism by which C-section affects the 
developing brain and behaviour remains to be determined. However, pathways of 
communication that may be involved include alterations in vagus nerve signalling, 
immune system response, metabolite production including bile acids, tryptophan 
metabolism, enteroendocrine signalling, and changes in blood-brain and 
gastrointestinal barrier permeabilities (Cryan et al., 2019). Future studies should 
integrate behavioural outcomes with more functional analysis of the gut microbiota 
including metabolomic and metagenomic profiling which will allow for a more 
mechanistic view of microbiota gut-brain axis alterations in C-section. We observed 
differential expression of genes belonging to the extracellular matrix-associated 
group in the hippocampus of the CS offspring. Changes to this gene cluster have been 
associated with formation of memory (Tsien, 2013), cognitive flexibility (Happel et 
al., 2014), synaptic plasticity, and autistic-like behaviours in animal models (Jung et 
al., 2018). In line with our behavioural findings, C-section has been previously 
suggested to alter the dopaminergic system (Vaillancourt and Boksa, 1998; El-Khodor 
and Boksa, 2002), to increase neuronal cell death in the mouse brain and specifically 
affect vasopressin neurons in the hypothalamus (Swift-Gallant et al., 2018), the latter 
being important for social behaviour and recognition. The role of microbiota in the 
remodelling of these pathways has yet to be elucidated. As previously demonstrated 
in the extreme situation in germ-free mice, our results reinforce the importance of 
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gut microbiota composition in early life on normal host neurobehavioural 
development.  
 
3.4.5 Conclusion  
Together our findings raise significant concerns regarding the overuse of elective C-
section deliveries in modern medicine because of likely consequential changes in the 
microbiome and neurobehavioural effects. However, it is worth noting that along 
with the microbiota, C-section can affect other physiological changes, such as stress 
and immune priming during the birthing process, all of which may also contribute to 
the phenotype (Lagercrantz and Slotkin, 1986). It is clear that certain keystone 
species (including Bifidobacterium spp.) are vitally important during critical windows 
of development; they contribute to essential immune priming and represent a viable 
target for dietary intervention in mothers and infants. Restoration of bifidobacteria 
imbalance in C-section delivered infants represents a challenge that can be 
addressed in many ways. Recently, partial restoration of the gut microbiota of infants 
born by C-section was demonstrated via vaginal microbial transfer (Dominguez-Bello 
et al., 2016). Vaginal seeding, performed by swabbing babies with vaginal fluid over 
their entire bodies, successfully colonized the newborn gut with maternal vaginal 
microbes for up to 30 days (Dominguez-Bello et al., 2016). It should be noted though, 
in cases of C-section, vaginal seeding is currently considered unsafe due to the 
potential transfer of pathogenic bacteria to the newborn infant (2017; Haahr et al., 
2018). Dietary intervention may represent a more acceptable approach, both 
interventions (dietary supplementation of either B. breve strain or a prebiotic 
mixture of scGOS/lcFOS) did not interfere with the further colonization of native 
bifidobacteria and represent a safer alternative to vaginal seeding (Moya-Perez et al., 
2017). 
 
Our study is not without limitations; we use only male mice to allow us to compare 
our findings with previously published data from both our group and others on the 
role of the microbiome in behaviour and neurodevelopment (Jaggar et al., 2019). 
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Future studies should focus on interrogating the impact of C-section-induced 
microbiota changes on behaviour in female mice (Lagercrantz and Slotkin, 1986). 
Moreover, these studies now call for the investigation of the long-term impact of C-
section on brain and behaviour in other mouse strains and other species including 
humans. Finally, since C-section deliveries when medically indicated, are unavoidable 
lifesaving interventions; our data point to the possibility of developing adjunctive 
microbiota-targeted therapies (Dominguez-Bello et al., 2016; Moya-Perez et al., 
2017) in this vulnerable population. Such interventions may help to avert any long-
term negative consequences for microbiota-gut-brain axis and behaviour. 
 
 
3.4.6 STAR Methods 
3.4.6.1 Animals 
The experiments were performed in male NIH Swiss mice of different ages. Maternal 
care was a key consideration in our choice of strain, and the NIH Swiss outbred 
female mice are attentive mothers with a lower pup retrieval latency compared to 
B6 and 129Sv mice(Champagne et al., 2007). 8-week-old female and male breeders 
were obtained from Harlan laboratories, Oxford, UK. Breeding began after 1-2 weeks 
of acclimatization to the animal holding room. The animals were kept under a strict 
12:12-h dark-light cycle, controlled temperature and humidity (20±1 oC, 55.5%), with 
food and water given ad libitum unless specified. Male offspring were weaned on 
P21 and group-housed with 3-4 mice per cage. Experimental groups consisted of 
offspring from 3-10 litters (litter numbers for each experiment are specified in the 
figure legends). 10-week old Swiss mice, purchased from Harlan laboratories, UK, 
were used as conspecifics in the three-chamber sociability test. All procedures used 
in the present study were conducted in accordance with the Directive 2010/63/EU 
for the protection of animals used for scientific purposes and were approved by the 




3.4.6.2 C-section surgery 
Mice were time-mated, and the presence of a vaginal plug was marked as gestational 
day 0.5 (G0.5). Males were removed from the cage, and pregnant females were not 
disturbed unless for cage cleaning. At full term (G19.5) female mice were euthanized 
by cervical dislocation. To reduce bacterial contamination of the abdominal cavity, 
the abdominal skin was prepped by application of 70 % ethanol. The abdomen was 
incised, the uterus was removed and placed on sterile gauze. After this step, an 
incision was made in the uterus. To prevent hypothermia of the foetuses in the 
uterus, a heating pad was placed underneath to provide thermal support. The pups 
were then removed by gentle pressure with a sterile swab, and the umbilical cord 
was cut. Sterile cotton swabs were used to tear the amniotic membrane and massage 
each pup until spontaneous breathing was noted. The pups were given to a foster 
dam that gave birth on the same day. The pups were dried by smearing them with 
the bedding material from the cage of foster dam (CS). In addition, pregnant females 
were allowed to deliver spontaneously, and these litters were used as full-term 
vaginal delivery controls (VB). To control for the effects of fostering, a cross-fostered 
vaginally born group was included in the experimental design (CF, see next section) 
(Figure 1A).  
 
3.4.6.3 Cross-fostering 
Cross-fostering was performed on litters born within 12 h of each other. On the day 
of the birth, the litters were removed and put with their foster mothers. The pups 
were nursed by their respective foster mothers until weaning. Given that CF and VB 
animals showed a very similar behavioural phenotype across the lifespan, we focused 
on the VB control group for later experiments to meet the 3R requirements and 
minimise animal usage.  
 
3.4.6.4 16S rRNA gene sequence-based microbiota analysis 
Total DNA extraction from caecal and faecal matter was performed using the QIAmp 
Fast DNA Stool Mini Kit (Qiagen, Manchester, UK) coupled with an initial bead-
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beating step. Extracted DNA was kept frozen at -20ºC until further analysis. The V3-
V4 hypervariable region of the 16S rRNA gene was amplified and prepared for 
sequencing as outlined in the Illumina 16S Metagenomic Sequencing Library Protocol 
http://www.illumina.com/content/dam/illuminasupport/documents/documentatio
n/chemistry_documentation/16s/16s-metagenomic-library-prep-guide-15044223-




Each 25 μL PCR reaction contained 5 ng/μL microbial genomic DNA, 1 μM of each 
primer and 12.5 μL 2X Kapa HiFi Hotstart ReadyMix (Kapa Biosystems Ltd, Sigma, 
Dublin, Ireland.). The PCR conditions were as follows: initial denaturation at 95 ºC for 
3 min; 25 cycles of 95 ºC for 30 s, 55 ºC for 30 s, 72 ºC for 30 s; and 72 ºC for 5 min 
for final extension. PCR products were purified with Agencourt AMPure XP system 
(Beckman Coulter Genomics, Indianapolis, IN, USA). In the next step, dual indices and 
Illumina sequencing adapters were attached to PCR products using the Nextera XT 
Index Kit (Illumina, San Diego, USA). Each 50 μL PCR reaction contained 5 μL purified 
DNA, 5 μL index primer 1 (N7xx), 5 μL index primer 2 (S5xx), 25 μL 2x Kapa HiFi Hot 
Start Ready mix and 10 μL PCR grade water. PCR amplification was completed using 
the previous program but with only 8 amplification cycles. Following this, a second 
clean-up step with the Agencourt AMPure XP system was done. PCR products were 
quantified, normalized and pooled in an equimolar fashion using the Qubit® dsDNA 
HS Assay Kit (Life Technologies, Dublin, Ireland). 2 × 300 (bp) paired-end sequencing 
was performed on the Illumina MiSeq platform, using standard Illumina sequencing 
protocols. 
 
3.4.6.5 Microbiota bioinformatic sequence analysis 
Paired-end sequences were assembled using FLASH (min overlap of 30 bp and min 
length of 460 bp) and analyzed using QIIME v1.8.0. Sequences were quality-checked 
and clustered into OTUs using USEARCH (v7.0-64bit). Taxonomic ranks were assigned 
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with a BLAST search against the SILVA SSU database v123. Alpha diversity indices 
were generated in QIIME. 
 
3.4.6.6 Microbiota statistical analysis 
Statistical analysis was done in SPSS (IBM, SPSS Statistics 24) and R software 
environment. The OTUs detected only in ≤ two animals in each group were excluded 
from the analysis, as were the OTUs that did not give any BLAST hits or were 
unidentified or unknown on the genus level. Relative abundance of bacterial taxa on 
the phylum, family and genus level was expressed as % of identified sequences. 
Among-group differences in alpha-diversity indices and in the relative abundance of 
bacterial taxa were analysed with independent Mann-Whitney U test. p value < 0.05 
was deemed significant; Benjamini-Hochberg (BH) adjustment with Q=0.2 was used 
to correct p values for multiple testing. p values are presented in Tables S1 and S4. 
For beta diversity, the Aitchison distance was calculated using the ALDEx2 library in 
R to account for zeroes. Recommended settings were used, with 1000 permutations 
per sample. Variance-based Principal Component Analysis was done using the 
prcomp() function in R (version 3.5.1) using Rstudio (version 1.1.456). The 
vegan implementation of PERMANOVA followed by PERMANOVA as a post-hoc was 
used to test for differences on a beta-diversity level. Canonical correspondence 
analysis was performed using the vegan package in R (version 3.5). CCA plots on the 
OTU level were generated with the vegan library, ellipses represent 95% confidence 
interval visualised and calculated by the ggplot2 library (ter Braak, 1986). In order to 
investigate the impact of co-housing on the microbiome in CS mice, a linear model 
was constructed based on the effect sizes for all identified bacteria in these groups 
in base R. Bacteria with the highest Cook's distance from the model were selected 
for further analysis. Samples samples with <40000 reads were excluded from the 




3.4.6.7 Behavioural testing 
The short and long-term effects of C-section on behaviour were evaluated in male 
offspring in early-life (P9/P10) and in adulthood (weeks 8-16). Mice were habituated 
to the behavioural room for 30 minutes prior to each test. The experimental 
procedures are described below; the experimental timelines are illustrated in Figure 
2A, Figure 5A and Figure 6B. The order of behavioural tests and between-test 
recovery intervals were chosen to minimize the potential confounding carryover 
effects from the previous behavioural test. Behavioural tests were analysed by three 
independent experimenters blinded to experimental groups. All tests were 
performed during the lights on phase and between the hours of 9am and 2pm. 
 
3.4.6.7.1 Isolation-induced ultrasonic vocalizations test 
Isolation-induced ultrasonic vocalizations (USV) are produced by mouse pups during 
the first two weeks of life when separated from their mother and littermates 
(Winslow et al., 2000). USV was performed as described by Robertson et 
al.(Robertson et al., 2017). Pups were isolated and placed into a clean plastic 
container enclosed in a sound-attenuating chamber. Emission of USV calls were 
monitored by an ultrasound sensitive microphone – a bat detector (US Mini-2 bat 
detector, Summit, Birmingham, USA) tuned in the range of 60-80 kHz – suspended 
above the isolated pup for 3 min. The number of calls was recorded. 
 
3.4.6.7.2 Maternal attachment test (homing test) 
Maternal attachment test evaluates the ability of pups to differentiate their mother’s 
and littermates’ nest (Macri et al., 2010). Maternal attachment was evaluated 
accordingly to Morais et al. (Morais et al., 2018). At P10, the floor of a clean mouse 
cage was subdivided into three areas by wire-mesh dividers. One area was uniformly 
covered with home cage bedding, thus containing familiar odour stimuli. The 
opposite area was covered with bedding from the cage of another litter (born at 
approximately the same time). The middle section was covered with clean bedding 
material. Pups were placed individually in the middle section for 1 min; the dividers 
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were then removed, and the pups were allowed to freely explore the arena for 2 min. 
Total time spent in each area was recorded. 
 
3.4.6.7.3 Three-chamber test  
Sociability and social novelty recognition were evaluated as previously described by 
Desbonnet et al. (Desbonnet et al., 2014). Animals were placed in a rectangular 
apparatus divided into three chambers (left and right, and a smaller center chamber) 
with transparent partitions; small circular openings allowed easy access to all 
compartments. The test was composed of three sequential 10 min trials: (1) 
habituation (the test animal was allowed to explore three empty chambers); (2) 
sociability (an unfamiliar con-specific animal was placed in an inner mesh wire cage 
in either left or right chamber, the alternative chamber had an empty inner cage); (3) 
social novelty recognition (a novel con-specific animal was placed into the previously 
empty inner cage). All animals were age- and sex-matched; each chamber was 
cleaned and lined with fresh bedding between trials. For each of the three stages, 
behaviours were recorded by a video camera mounted above the apparatus; time 
spent in active exploration of inner cages (t) was measured and sociability index was 
calculated by using the formula (t novel mouse- t familiar mouse)/ (t novel mouse+ t 
familiar mouse). 
 
3.4.6.7.4 Marble burying test 
Marble burying test was used to measure anxiety-like behaviour, indicating higher 
levels of anxiety at higher number of marbles buried as described by Burokas et al. 
(Burokas et al., 2017). Clean cages were filled with a 4-cm layer of chipped wood 
bedding. Twenty glass marbles (15 mm diameter) were gently laid on top of the 
bedding, equidistant from each other in a 4×5 matrix arrangement. Each mouse was 
placed in the cage and allowed to explore it for 30 min. The number of buried marbles 




3.4.6.7.5 Aversive open-field (OF) test 
The aversive open-field (OF) test is used to assess the locomotor activity and the 
response to a novel stressful environment. Light was set at 1000 lux. A test mouse 
was placed in the center of an aversive open-field arena (Perspex box with white 
base: 30 x 30 x 20 cm) and was allowed to explore the arena for 10 min. The distance 
moved and time in zone were recorded using Ethovision videotracking system 
(Noldus Information Technology, Nottingham, UK). Using this technology, a center 
zone was demarcated as (20 x 15 cm, L x W). The time spent in each zone and the 
frequency of entries into each zone were also measured. The box was cleaned with 
10% ethanol and allowed to dry between animals. 
 
3.4.6.7.6 Novel object recognition test 
Novel object recognition test was performed as Burokas et al. (Burokas et al., 2017). 
On day one, a test mouse was habituated to a square open-field box (Perspex sides 
and base: 34.5cm x 42.7 cm for mice) for 10 min in a dimly lit room (60 lux). On day 
two, two identical objects were positioned in adjacent corners of the arena 
approximately 5 cm from the walls, and the test mouse was placed in the arena for a 
10 min exploration period. Following a 24 h inter-trial interval, one familiar object 
was replaced with a novel object, and the test mouse was introduced for a 10 min 
exploration period. Object exploration was defined as when the animal’s nose comes 
within a 2 cm distance to the object. In-between trials, objects and testing arena were 
cleaned with 10% ethanol. Novel object recognition index was calculated by using 
the formula (t novel object- t familiar object)/ (t novel object+ t familiar object). 
 
3.4.6.8 Statistical analysis for animal behavioural data 
Statistical analysis was done in SPSS (IBM, SPSS Statistics 24) and R software 
environment (version 3.5.1). The normality of data distribution was checked with 
Shapiro-Wilk test, and the homogeneity of variances across groups was compared 
using Levene’s test. For parametric data, two-tailed un-paired Student’s T-test, two-
tailed paired Student’s T-test, one-way ANOVA followed by Tukey post-hoc tests or 
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two-way ANOVA with Tukey post-hoc tests were used to compare means between 
groups where appropriate. Extreme outliers were excluded when values exceeded 2 
x Standard Deviation from the mean.  Technical outliers were excluded when animals 
were unable to perform the test. All parametric data were expressed as mean ± 
S.E.M. For nonparametric data, a Kruskal-Wallis test and Mann-Whitney U test were 
used to compare differences across groups. Non-parametric data were expressed as 
median and interquartile range. p value < 0.05 was deemed significant; F and p values 
are presented in the figure legends or Supplemental tables. Mixed-effects regression 
model was used to re-analyse adult behavioural data using litter or cage as a fixed 
effect in order to examine the covariance structure that is inherent in the 
experimental design using R (version 3.4.1). p value < 0.05 was deemed significant; F 
and p values are presented in the Table S3. 
 
 
3.4.6.9 Co-housing procedure 
At three weeks of age, male offspring born by VB or CS were weaned, and mice were 
split across three different housing conditions: 1) VB group, where each cage 
consisted of three to four VB mice housed together (from 9 litters); 2) CS group, 
where each cage consisted of four CS mice housed together (from 6 different litters); 
3) co-housing groups, where in each cage one CS born mouse was housed together 
with three VB mice (CS co-housed, from 7 litters and VB co-housed, from 10 litters). 
For this experiment, mice from different litters were randomly distributed across 
different cages and housing regimens. The co-housing system was adopted from 
Buffington et al. (2016) (Buffington et al., 2016). In the VB co-housed group, one 
animal per cage was randomly selected to pass through behavioural tests. 
 
3.4.6.10 Quantitative determination of Bifidobacterium breve in faecal pellets 
Absolute quantification of Bifidobacterium breve species was determined by 
quantitative PCR using genus-specific primers Bifidobacterium spp. F (5’-
CTCCTGGAAACGGGTGG-3’) and R (5’-GGTGTTCTTCCCGATATCTACA-3’),(Matsuki et 
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al., 2002). Standard curves were created using bacterial DNA extracted from a pure 
culture of Bifidobacterium longum NCBIM8809 as previously reported (Arboleya et 
al., 2012) . 
 
3.4.6.11 Probiotic and prebiotic administration 
CS offspring were exposed to either probiotic Bifidobacterium breve M16V (B. breve), 
a commercially available probiotic and supplied by Danone Nutricia Research 
(Utrecht, The Netherlands) or a prebiotic mixture of short-chain galacto-
oligosaccharides (scGOS) and long-chain fructo-oligossaccharides (lcFOS)  (ssniff 
Spezialdiäten GmbH, D-59494 Soest, Germany) starting from birth and throughout 
the experiment (Table S5). B. breve was given in drinking water at a concentration of 
109 c.f.u./mL (freeze-dried bacterial stocks were re-suspended in MediDrop clear H2O 
(75-02-1001), and drinking bottles were changed daily in the evening). Prebiotic 
mixture was given in the custom-made AIN93G rodent diet in a 9 (scGOS): 1 (lcFOS) 
ratio at the final concentration of 1%. Both interventions were given to the nursing 
dams starting from birth and throughout the lactation period till weaning. Male 
offspring were weaned on P21 onto the corresponding treatment. Control VB dams 
and offspring were given MediDrop clear H2O as drinking water and AIN93G diet ad 
libitum. 
 
3.4.6.12 Hippocampal RNA sequencing  
Ventral hippocampus was dissected from adult VB, CF and CS mice (Figure 2A) using 
micro punch technique. Briefly, whole brains were snap-frozen on dry ice and stored 
at −80°C un l ready for use. Using a mouse brain slicer , 1-mm thick sections were 
obtained from the entire brain, and micro punches of ventral hippocampal tissue 
were taken using a mouse brain atlas reference (Paxinos and Franklin, 2012). Total 
RNA was isolated from the ventral hippocampus using the mirVana™ miRNA Isolation 
Kit as per manufacturer’s instructions (Thermo Fisher Scientific, Dublin, Ireland). RNA 
concentration was quantified using the ND-1000 spectrophotometer (NanoDrop®). 
RNA from hippocampal micro-punches from each group VB (N=5), CF (N=5) and CS 
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(N=6) were subsequently sequenced. Library preparation and sequencing, as well as 
Fastq-file generation was done by Beckman Coulter Genomics service (Danvers, MA, 
USA). Paired-end reads of 2×100 bp were produced on an Illumina HiSeq2500 
sequencer. 
 
3.4.6.13 Bioinformatic analysis pipeline 
Fastq-format reads were quality filtered and trimmed using Trimmomatic (v0.32) 
with the following non-default parameters: AVGQUAL: 20; SLIDINGWINDOW: 4:20; 
LEADING: 10; TRAILING: 10; MINLEN: 60. Alignment to the mouse reference genome 
(GRCm38.p3) was achieved using the STAR aligner (v2.4.0f1) with default options and 
an index compiled with gene models retrieved from the Ensembl database (release 
78). These gene models were also used for read counting for each gene using HTSeq-
Count (v0.6.0) with the following non-default parameters: -s: no; -r: pos; -q –f bam –
m intersection-nonempty. Differential gene expression was determined using the 
DESeq2 R-package (v1.6.2) with default parameters on pairwise comparisons of all 
possible group combinations. An adjusted p-value ≤ 0.1 (Benjamini-Hochberg 
method) was considered significantly differentially regulated. Raw and processed 
original data will be deposited in NCBI's Gene Expression Omnibus and made 
accessible through a unique GEO accession number upon publication. 
 
3.4.6.14 Short chain fatty acid analysis  
Caecal content (30-40mg) from adolescent and adult mice was vortex-mixed with 
1ml Milli-Q water and incubated at room temperature for 10 min and subsequently 
centrifuged at 10,000g for 5mins to pellet bacteria and other solids. The supernatant 
was filtered, transferred to a clear gas chromatography (GC) vial and 2-ethylbutyric 
acid (Sigma-Aldrich, Ireland) was added as an internal standard. Standard solutions 
of 10.0 m mol/L, 8.0m mol/L, 6.0m mol/L, 4.0m mol/L, 1.0m mol/L and 0.5m mol/L 
of acetic acid, propionic acid, isobutyric acid and butyric acid (Sigma-Aldrich), 
respectively were used for calibration. The concentrations of SCFA were measured 
using a Varian 3800 GC-flame-ionization system fitted with a ZB-FFAP column (30 m 
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X 0.32 mm X 0.25 µm; Phenomenex, Macclesfield, Cheshire, UK). Initial oven 
temperature was set at 100ºC for 30 secs and raised to 180ºC at 8ºC per min and 
subsequently held for 1 min, then increased to 200ºC at 20ºC per min and finally held 
at 200ºC for 5 min. Helium was used as the carrier gas at a flow rate of 1.3ml/min. 
The temperature of injector and the detector were set at 240ºC and 250ºC 
respectively. A standard curve was constructed with different concentrations of a 
standard mix containing acetic acid, propionic acid, isobutyric acid and N-butyric acid 
(Sigma-Aldrich). Peaks were integrated using the Varian Star Chromatography 
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Obsessive-compulsive disorder (OCD) is a psychiatric illness that significantly impacts 
affected patients, while available treatments yield suboptimal therapeutic response.  
Recently, the role of the gut-brain axis (GBA) in psychiatric illness has emerged as a 
potential target for therapeutic intervention.  However, studies concerning the role 
of the GBA in OCD are limited.  To investigate whether a naturally occurring 
obsessive-compulsive-like phenotype in a rodent model, i.e. large nest-building in 
deer mice, is associated with perturbations in the gut microbiome, we investigated 
and characterized the gut microbiota in specific pathogen free bred and housed large 
(LNB) and normal (NNB) nest building deer mice of both sexes (n = 11 per group, 
including 3 males and 8 females).  Following baseline characterisation of nest building 
behaviour, a single faecal sample was collected from each animal and the gut 
microbiota analysed.  Our results reveal the overall microbial composition of LNB 
animals to be distinctly different compared to controls (PERMANOVA p < 0.05).  
While no genera were found to be significantly altered after correcting for multiple 
comparisons, the normal phenotype showed a higher loading of Prevotella and 
Anaeroplasma, while the OC-phenotype demonstrated a higher loading of 
Desulfovermiculus, Aestuariispira, Peptococcus and Holdemanella (cut-off threshold 
for loading at 0.2 in either the first or second component of the PCA).  These findings 
not only provide proof-of-concept for continued investigation of the GBA in OCD, but 
also highlight a potential underlying etiological association between alterations in the 




Obsessive compulsive disorder (OCD) is a multidimensional psychiatric disorder that 
is characterised by intrusive and persistent thoughts or ideas, i.e. obsessions and/or 
ritualistic behaviours (compulsions) that are often expressed in an attempt to 
mitigate the level of distress caused by the obsessive thoughts (Apa, 2013; 
Abramowitz and Jacoby, 2015; Wu and Lewin, 2017).  The condition is phenotypically 
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heterogeneous and symptoms usually cluster along the basis of specific themes, e.g. 
fears of contamination and cleaning rituals, fears of harm and checking compulsions, 
a need for symmetry and just-right feelings associated with ordering compulsions, as 
well as covert inappropriate thoughts relating to, among others sexual misconduct, 
religion, and violence (Williams et al., 2013; Abramovitch and Cooperman, 2015). 
Chronic high-dose selective serotonin reuptake inhibitors (SSRIs) are currently 
recommended as first line pharmacotherapy for OCD (Albert et al., 2018), while 
increasing the dose of the SSRI used or SSRI-antipsychotic augmentation strategies 
are clinically employed in the treatment of SSRI-refractory OCD (Dold et al., 2015).  
Nevertheless, a significant number of patients respond poorly to these options and 
other available pharmacotherapeutic interventions (Albert et al., 2018).  Therefore, 
a better understanding of the etiology and pathophysiological processes underlying 
OCD is needed to develop more effective treatment options. 
During the past decade, the gut-brain axis (GBA) and its involvement in psychiatric 
disease has gained significant interest (Mayer et al., 2014; Dinan and Cryan, 2017; 
Bastiaanssen et al., 2018).  Communication between the gut and the brain takes place 
on a number of functional levels, including neural, neuroendocrine and 
immunological signalling (Foster and Neufeld, 2013; Cussotto et al., 2018).  Indeed, 
the gut microbiota is regarded as one of the major immunomodulatory influences in 
the human body (Zhao and Elson, 2018).  While the exact etiological associations 
between psychiatric illness and the gut microbiota are still not fully understood, 
altered immune responses may be instrumental in the pathogenesis of brain 
disorders, including OCD (da Rocha et al., 2008; Turna et al., 2016).  In light of this, 
several investigations into microbiota manipulation in animal models of psychiatric 
illness have been conducted, including models of depression (Kelly et al., 2016), 
anxiety (Crumeyrolle-Arias et al., 2014), and OCD (Kantak et al., 2014).  However, the 
exact translational value of these findings remains to be established (Kelly et al., 
2016). 
Regarded collectively, natural compulsive-like behavioural phenotypes expressed by 
deer mice (Peromyscus maniculatus bairdii), i.e. large nest building (LNB) and high 
stereotypy, provide a well-validated naturalistic pre-clinical framework in which to 
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study the etiopathology of OCD (Scheepers et al., 2018).  Approximately 30% of 
laboratory housed deer mice of both sexes express LNB (Wolmarans et al., 2016).  
LNB manifests by the age of 8 weeks and is persistent and repetitive over the course 
of several trials.  From a teleonomic perspective (Thornhill, 1996), LNB can be 
regarded as a maladaptation in a specific component of the normal behavioural 
repertoire of deer mice.  Indeed, considering that mice build nests for the purposes 
of safety and protection, temperature regulation and to provide adequate nurseries 
for offspring (Jirkof, 2014), excessively large nests expressed in the laboratory serve 
no unique purpose.  From an evolutionary perspective, nesting size and quality play 
a major role in mate choice and reproductive success in some species, e.g. birds 
(Holveck and Riebel, 2009), fish (Jamieson, 1995), and frogs (Felton et al., 2006).  
However, this is not true for mice, which generally exercise mate choice by random 
or on the basis of amongst others, dominance, probability of genetic success, overall 
health, or patterns of ultrasonic vocalization (for a detailed review, see Latham and 
Mason (2004)).  That both male and female deer mice engage in LNB, also excludes 
the likelihood of sex-related differences in nesting phenotype.  Therefore, it is likely 
that excessive nest-building is expressed at the cost of other functions for which 
effort, time and energy is required, and may thus be regarded as a naturalistic 
maladaptation (Crespi, 2000). 
We have previously shown that LNB is responsive to chronic high-dose (50 
mg/kg/day) oral treatment with the SSRI, escitalopram (Wolmarans et al., 2016).  This 
is in line with the therapeutic, albeit varying, effect of SSRI intervention observed in 
the majority of patients with OCD (Fineberg et al., 2006).  Moreover, normal nest 
building (NNB) and LNB can be separated based on the underlying involvement of 
serotonin in its expression, as NNB remains wholly unaltered following such 
intervention, with nests neither decreasing or increasing in size (Wolmarans et al., 
2016).  Such difference in treatment response also imply that it is not the behavioural 
act of nesting per se, but rather the aberrant cognitive processes that underlie such 
behaviour, that are modified by serotonergic intervention. 
Considering the literature reviewed here and the fact that LNB spontaneously 
manifest in a sub-population of deer mice only, the present work aimed to 
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investigate whether an association between such behaviour and natural 
modifications in the gut microbiota may exist.  In fact, bearing in mind that theories 
pertaining to the involvement of the gut-brain axis in psychiatric illness point to 
developmental relationships (Borre et al., 2014), the study of parallel, but equally 
intrinsic and non-induced changes in both behaviour and the gut microbiome may 
provide valuable insight into our understanding of neurodevelopmental psychiatric 
conditions. 
4.1.3 Materials and Methods 
4.1.3.1 Animals 
Deer mice of both sexes were obtained from the deer mouse colony of the North-
West University (NWU), Potchefstroom, South Africa (ethical approval number: 
NWU-00284-17-S5; AnimCare Research Ethics Committee, National Health Research 
Ethics Committees Registration Number: AREC-130913-015).  The original breeding 
pairs were established using animals obtained from the Peromyscus Genetic Stock 
Centre at the University of South Carolina, USA.  Since only 30% of deer mice express 
LNB behaviour (Wolmarans et al., 2016), 40 deer mice (age 12 weeks) were screened 
to identify 11 (3 male and 8 female) deer mice of each nesting cohort, i.e. NNB and 
LNB.  In line with the minimum recommendations set by the ARRIVE-guidelines 
(Kilkenny et al., 2010), and considering an extensive review of recent literature (Cani 
et al., 2008; Chang et al., 2015; Desbonnet et al., 2015; Luczynski et al., 2016; 
Sampson et al., 2016), group sizes of 3 – 8 animals are deemed sufficiently powerful 
in pre-clinical microbiome investigations.   
Animals were bred according to a standard out-bred protocol (Bateson, 1983) and 
housed and maintained in the specific-pathogen-free (SPF) area of the Vivarium at 
the North-West University, Potchefstroom, South Africa.  The initial breeding pairs—
used to breed the 40 mice screened in this investigation—were randomly allocated 
without prior knowledge of their nest building profiles.  After weaning, offspring 
were housed in same-sex groups (4 – 6 animals per cage) in individually ventilated 
cages [(35cm (l) x 20cm (w) x 13cm (h); Techniplast® S.P.A., Varese, Italy], until one 
week prior to the onset of the first nest building analysis.  From this point onwards, 
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each animal was allocated to its own cage, while all experimental analyses were 
conducted in these same cages throughout the investigation.  Animals were kept on 
a 12-hour light/dark cycle (06h00/18h00), at a temperature of 22 ± 1°C and relative 
humidity of 55 ± 5%.  Food and water were provided ad lib.  All mice received food 
from the same batch of pelleted rodent chow throughout the study.  Cages were 
cleaned and new bedding material, consistently taken from the same batch of ground 
corncob, added once a week on the same day. 
4.1.3.2 Nest building analysis 
Nest building behaviour was quantified as described previously (Wolmarans et al., 
2016).  In short, nesting behaviour was assessed in each animal for 7 consecutive 24-
hour periods.  An excess of pre-weighed, sterile, hospital-grade, non-scented cotton 
wool was introduced in the roof of each home cage every day between 15h00 and 
16h00.  As mice generally build their nests just before dawn (Jirkof, 2014), the 
remaining cotton wool was only removed and weighed between 13h00 and 14h00 
on the following day.  Each day, built nests were removed, discarded and additional 
pre-weighed cotton wool supplied.  Animals did not have access to any other form of 
nesting material, and food and water were supplied as normal.  Daily nesting scores 
were expressed in grams of cotton wool used with a cumulative nesting score, 
describing nesting size and not quality per se, determined after one week 
(Wolmarans et al., 2016).  As nest building is a natural behaviour expressed by all 
rodents (Smithers, 1983), only animals that consistently built large nests over the 
course of 7 days were included in the LNB cohort.  This was determined by plotting 
the total nesting scores against the coefficients of variance with respect to daily 
nesting behaviour, where LNB was defined as nesting behaviour that clustered 
within, or as near to, the upper quarter of the nesting score distribution, while 
demonstrating the lowest degree of variance (Figure 4.1-1).  Likewise, NNB animals 
were identified as those individuals that built the smallest nests consistently over the 
course of 7 days—for a full review of this methodology, please refer to Wolmarans 
et al. (2016).  A clear separation of the LNB and NNB cohorts (Figure 4.1-2i – 2iv) is 
important in order to directly relate the compulsive-like phenotype to perturbations 
in the gut microbiota.  As such, a group of mice that not only built smaller nests than 
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the LNB group, but also did so with the lowest possible degree of variability (Figure 
4.1-1), were set as control.  That said, while not a single animal refrained from 
engaging in nesting behaviour (Figure 4.1-1), NNB animals expressed nest building 
behaviour in a more adaptable manner (as indicated by the higher degree of 
between-day variance compared to LNB animals; Figure 4.1-1).  These characteristics 
in nesting phenotype point to a clear separation between the two cohorts, as LNB 
animals not only express the highest nesting scores but do so without significant 
between-day variation.  In other words, the motivational drive to engage in LNB is 
not only observed during a few nights of the 7-day assessment period, but across 
most of the trials (Figure 4.1-1), pointing to a OCD-like phenotype akin to behavioural 
inflexibility (Gillan et al., 2011). 
 
Fig. 4.1-1 Plot of the average total nesting scores (g) generated by each animal over 
the course of 7 days and the coefficients of variance with respect to the between‐day 
nesting scores. Horizontal dotted lines intersecting the y‐axis indicate the 25th and 
75th percentiles of with respect to the total nesting scores generated. The vertical 
dotted line intersecting the x‐axis indicates the 25th percentile with respect to the 
coefficients of variance. Blue circle: animals identified as LNB; Green oval: animals 





Fig. 4.1-2 Photographs of typical nests built by NNB (i, ii) and LNB (iii, iv) animals, 
respectively. 
4.1.3.3 DNA analyses 
4.1.3.3.1 Sample collection and DNA extraction 
Fresh faecal samples were collected during the first hour of the dark (wake) cycle 
with a sterilized tweezer, transferred to 1.5ml Eppendorf® Safe-Lock tubes and 
immediately flash frozen in liquid nitrogen (Hong et al., 2010).  Samples were kept 
frozen at -80°C until the extraction of DNA.  The QIAamp® PowerFecal® DNA kit 
(QIAGEN, Valencia, CA, USA) was used to extract the microbial DNA from faecal 
samples (0.25g/sample).  DNA extraction was performed as per the manufacturer’s 
instructions to ensure maximal cell lysis of bacterial cell wall components.  The 
Thermo-Scientific® NanoDrop One Microvolume UV-Vis Spectrophotometer was 
used to assess the quality and quantity of the extracted microbial DNA. 
4.1.3.3.2 DNA sequencing 
Paired-end sequencing of the V3 to V4 hypervariable regions of the 16S rRNA was 
performed by Macrogen® Inc. (South-Korea) using the FWD 5’-
CCTACGGGNGGCWGCAG-3’ and REV 5’-GACTACHVGGGTATCTAATCC-3’ primer pair 
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on a MiSeq (Illumina) platform.  The V3 to V4 hypervariable region was used as high 
inter-taxon variability of these regions can be used to distinguish between closely 
related bacteria.  Library preparation was performed as per the 16S Metagenomic 
Sequencing Library, Preparation Part #15044223, Rev. B protocol, except when using 
the Hercules II Fusion DNA Polymerase (Agilent, Santa Clara, USA), the Nextera Index 
Kit V2 (Illumina, San Diego, USA) and the V3-V4 primers.  Indexed adapter-ligated 
fragments were pooled and then gel purified and PCR amplified. 
4.1.3.3.3 Statistical analysis 
First, quality control of raw fastq sequencing files was performed using fastqc and 
multiqc programs respectively (Ewels et al., 2016).  Second, a Divisive Amplicon 
Denoising Algorithm (DADA) 2 (version 1.8) (Callahan et al., 2016) in R studio (R 
version 3.4.3; R-studio version 1.1.456) (Gandrud, 2016) was used for the 
construction of an amplicon sequence variant (ASV) table (Callahan et al., 2016).  The 
DADA 2 workflow consisted of the following steps: inspecting the read quality 
profiles, filtering and trimming low-quality reads, identifying error rates, 
dereplication (eliminating redundant comparisons), sample inference, merging 
paired reads, constructing an amplicon sequence variant (ASV) table, removing 
chimera’s and assigning taxonomy.  Taxonomy was assigned using the Ribosomal 
Database Project (RDP) as a reference database (Cole et al., 2005).  The vegan 
package in R was used to evaluate β-diversities.  For PCA, Aitchison distance was 
calculated using the ALDEx2 library (Fernandes et al., 2014; Gloor et al., 2017).  The 
Shannon, Simpson, Chao1, Observed and Fisher diversity indices were used to 
evaluate α-diversity.  Filtering was performed to only include taxa that were 
observed more than once in at least 15% of the animals.  Centred log-ratio 
transformed (clr) relative abundance for each ASV was also determined using 
ALDEx2.  To test for statistically significant differences in the relative abundance of 
ASVs between the gut microbial composition of NNB and LNB animals, we used 
permutational multivariate analysis of variance (PERMANOVA; vegan package).  The 
Mann-Whitney U test was used to compare alpha diversity metrics, a p-value of < 




Fig. 4.1-3 Principal Component Analysis with biplot of the faecal microbiota of LNB 
and NNB deer mice. Aitchison's distance was used as the beta‐diversity metric. 
Individual genera that were found to have a loading of at least 20% in either PC1 or 
PC2 have been depicted as arrows, with their length and orientation representing 
their respective loading. 
4.1.4 Results 
To test for differences between the gut microbial composition of NNB and LNB 
animals (3 male and 8 female animals per group, respectively), a total of 22 faecal 
samples were analysed, each from the same time point in the sleep cycle.  All samples 
passed quality control (QC) with a minimum read count threshold of 10 000 and 
median read depth of 34 686 reads per sample.  From this, 86 genera were detected. 
The Mann-Whitney U test revealed no differences in α-diversity between NNB and 
LNB animals, as measured by Chao 1, Shannon, Simpson, Observed and Fisher 
distance matrices, respectively.  However, β- diversity using Aitchison distance at the 
genus level, revealed a clear clustering of NNB and LNB cohorts (Figure 4.1-3).  PC1 
and PC2 accounted for 13.77% and 10.91% of the variance observed respectively, 
and PERMANOVA revealed this distinction to be statistically significant (p < 0.05).  In 
this regard, two clusters, having a 20% loading in either PC1 or PC2 (Camacho et al., 
2010) were observed that associated with the control (driven by the prevalence of 
Prevotella and Anaeroplasma), and the OC-phenotype (driven by the prevalence of 




The major findings of the present work are that 1) there is a significant difference in 
the overall gut microbiota composition of NNB and LNB animals, and 2) such 
difference is driven in NNB and LNB animals by the prevalence of Prevotella / 
Anaeroplasma, and Desulfovermiculus / Aestuariispira / Peptococcus / Holdemanella, 
respectively. 
The neurobiological and pathophysiological processes underlying OCD are not yet 
fully elucidated, with current treatment options also yielding suboptimal results 
(Atmaca, 2016).  During the past decade, our understanding of the GBA has expanded 
significantly (Sherwin et al., 2018), having been shown to play a role in the 
pathophysiology of a number of psychiatric illnesses, including anxiety and 
depression (Foster and Neufeld, 2013).  In terms of OCD, very little research has been 
conducted to elucidate if and how the gut microbiota may be associated with the 
condition (Kantak et al., 2014; Turna et al., 2016).  Further, although some clinical 
results have been reported that may be indicative of the potential therapeutic value 
of microbiotic modification in the treatment of central nervous system disorders 
(Messaoudi et al., 2011), it remains difficult to translate these findings to clinical 
studies (Kelly et al., 2016). 
In this investigation we interrogated possible associations between a naturally 
developing compulsive-like phenotype, i.e. LNB in the deer mouse (Wolmarans et al., 
2016), and alterations in the gut microbiota.  Our finding that the community 
composition of the gut microbiota in LNB animals is significantly different from that 
in the NNB cohort is noteworthy.  Taking into account that LNB transpires naturally 
over the course of development and given that animals included in this investigation 
have been randomly selected without litter bias and housed individually, the 
differences observed in microbial composition parallel the differences observed in 
behavioural expression; this association is therefore likely naturalistic.  Our finding 
that a clustering of Prevotella and Anaeroplasma was driving the compositional 
ordination in NNB compared to LNB animals, is noteworthy.  Interestingly, while the 
human gut microbiota demonstrates significant biogeographical stratification 
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(Donaldson et al., 2016), most organisms cluster within the phyla Firmicutes and 
Bacteroidetes, which includes the genus Prevotella, and (Albenberg and Wu, 2014; 
Marchesi et al., 2016).  Further, both Prevotella (Shenker et al., 1991) and 
Anaeroplasma (Beller et al., 2019) have been associated with significant anti-
inflammatory properties, while children diagnosed with autism, a condition also 
characterized by persistent behavioural phenotypes, have been shown to present 
with lower gut Prevotella abundance (Kang et al., 2013). 
In terms of the gut microbiota composition of LNB animals, members of the phylum 
Proteobacteria, of which Aestuariispira is an example, have been proposed as 
microbial signatures of among others, inflammatory conditions (Rizzatti et al., 2017).  
Further, hydrogen sulphide releasing bacteria, of which Desulfovermiculus 
(Loubinoux et al., 2002), and Peptococcus (Bourgault and Rosenblatt, 1979; Van 
Eldere et al., 1988) are examples, have been associated with gut mucosal injury and 
inflammatory pathology (Loubinoux et al., 2002).  Interestingly, Peptococcus, has also 
been implicated in other models of adult neurodevelopmental aberrancies following 
exposure to prenatal stress (Golubeva et al., 2015).  Therefore, considering that LNB 
develops spontaneously over time, and that this phenotype is associated with a lower 
loading of Prevotella and Anaeroplasma, it is possible that the composition of the 
microbiota in LNB animals reported here, can exert a gut-to-brain neuroimmune-
associated etiological influence on the expression of compulsive-like nest building in 
the deer mouse (Heijtz et al., 2011; Furtado and Katzman, 2015; Turna et al., 2016).  
This possibility should be elaborated in future investigation. 
4.1.6 Conclusion 
The data presented here indicates for the first time in a pre-clinical model that 
naturally developing OC-like behaviour is associated with inherent differences in the 
gut microbial composition, compared to that in normal controls.  Future 
investigations into a possible causal role of the gut microbiota in the etiology of 
compulsive phenotypes are warranted.  Specifically, the relationship between 
obsessive-compulsive behaviour, stress, and immune alterations on the one hand, 
and adaptations in the microbiota of normal and compulsive-like animals on the 
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other, needs further elucidation.  Further, using gnotobiotic mice and other means 
of microbiota modification, e.g. antibiotic treatment, it would be of value to 
characterize the behavioural response in LNB deer mice under circumstances of 
microbiota alterations.  Such studies will potentially contribute to a better 
understanding of the neurobiology underlying OCD and may ultimately lead to the 
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The microbiome-gut-brain-axis is a complex phenomenon spanning several dynamic 
systems in the body which can be parsed at a molecular, cellular, physiological and 
ecological level. A growing body of evidence indicates that this axis is particularly 
sensitive to the effects of stress and that it may be relevant to stress resilience and 
susceptibility. Although stress-induced changes in the composition of the 
microbiome have been reported, the degree of compositional change over time, 
which we define as volatility, has not been the subject of in-depth scrutiny. Using a 
chronic psychosocial stress paradigm in male mice, we report that the volatility of 
the microbiome significantly correlated with several readouts of the stress response, 
including behaviour and corticosterone response. We then validated these findings 
in a second independent group of stressed mice. Additionally, we assessed the 
relationship between volatility and stress parameters in a cohort of health volunteers 
who were undergoing academic exams and report similar observations. Finally, we 
found inter-species similarities in the microbiome stress response on a functional 
level. Our research highlights the effects of stress on the dynamic microbiome and 
underscores the informative value of volatility as a parameter that should be 
considered in all future analyses of the microbiome.   
5.1.2 Introduction 
The mammalian gut plays host to approximately 1 trillion microbial organisms 
collectively known as the gut microbiome (Sommer and Bäckhed, 2013). The 
microbiome is highly sensitive and reactive to the effects of stress to the extent that 
it is now accepted that the stress response is not solely the domain of brain function, 
but rather that it results from a synergy of mechanisms that constitute the gut-brain 
axis (Dinan and Cryan, 2012; Foster et al., 2017; Bastiaanssen et al., 2018; Cryan et 
al., 2019; Bastiaanssen et al., 2020; Cruz-Pereira et al., 2020). In particular, studies in 
rodents have correlatively linked alterations in microbiota composition to the effects 
of stress on behaviour (Bharwani et al., 2016; Bharwani et al., 2017; Burokas et al., 
2017; Marin et al., 2017; Szyszkowicz et al., 2017; Xu et al., 2020) and the 
central/peripheral inflammatory milieu (Bailey et al., 2011; Bharwani et al., 2016; 
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Bharwani et al., 2017; Burokas et al., 2017; Szyszkowicz et al., 2017). Going further, 
manipulation and perturbation of the microbiome have been shown to alter the 
reaction to stress, further solidifying the regulatory role of the microbiome in the 
stress response (Jašarević et al., 2017; Langgartner et al., 2018; Pearson-Leary et al., 
2019; Provensi et al., 2019; Stothart et al., 2019; Donoso et al., 2020; Kuti et al., 2020; 
Morais et al., 2020; Wang et al., 2020). Moreover, in humans there have been a 
number of studies confirming a relationship between stress and microbiome 
composition across the lifespan (Messaoudi et al., 2011; Zijlmans et al., 2015; Allen 
et al., 2016; Hemmings et al., 2017; Papalini et al., 2019).    
 
These observations notwithstanding, a common feature of the above cited studies is 
the fact that they are a ‘snapshot-in-time’ analyses of samples and therefore do not 
consider the compositional and temporal instability of the microbiome (Caporaso et 
al., 2011; Claesson et al., 2011). Temporal variance as a feature of the microbiome 
has been discussed before. Initially, the volatile nature of the microbiome was 
pointed out (Weinstock, 2011) and relatively soon thereafter, the term volatility was 
used to refer to the degree of change between timepoints (Goodrich et al., 2014).  In 
the context of stress, recent studies have shown differential effects on microbiota 
beta-diversity dependent on when the samples were taken – shortly after 
commencement of social stress or towards the end of the protocol (Gautam et al., 
2018), though the degree of change was not pursued, nor linked to the severity of 
the stress response. Recently, in a large human cohort, patients with Inflammatory 
Bowel Disease (IBD), a condition that is associated with an increased level of stress, 
were shown to have a more volatile microbiome than healthy volunteers (Clooney et 
al., 2020; Ryan et al., 2020). While these studies provide some evidence that volatility 
maybe related to stress, the impact of stress on microbial volatility measures remain 
unknown. Furthermore, deciphering what makes a microbial community volatile can 
provide new insights into its role in mediating the effects of stress. To further 
investigate volatility in relation to stress, we exposed mice to chronic psychosocial 
stress and assessed volatility. Based on the findings of this discovery cohort, we then 
set out to validate our findings in an independent cohort of a different strain of mice 
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under the same experimental conditions.  Finally, we also took advantage of an 
ongoing study involving healthy volunteers undergoing academic examination stress 
and sought to examine whether the interaction between volatility and stress 




5.1.3 Materials & Methods 
5.1.3.1 Animals 
For this study we used two cohorts of adult male mice. The first cohort will be 
referred to as the Discovery cohort and consisted of (B6;129-Gt(ROSA)26Sortm1(CAG-
cas9,-EGFP)Fezh/J; https://www.jax.org/strain/024857). The second cohort will be 
referred to as the Validation cohort and consisted of adult male C57BL/6 (Envigo, 
UK). There were no differences in terms of experimental treatment and handling 
between the two cohorts. There were three weeks between the arrival of the animals 
and the start of singly housing. Approximately one week before commencement of 
social defeat sessions, all mice were singly housed and weighed daily over the course 
of the experimental protocol (Figure 5.1-1). For the chronic social defeat stress 
procedure, non-experimental singly housed adult male CD1 were used as aggressors 
(Envigo, UK). Mice were kept under a 12 hr light/dark cycle (ON 7:30AM, OFF 7:30PM) 
in a temperature/humidity controlled environment (21°C, 55.5%) with food and 
water ad libitum. The main behavioural and physiological responses to chronic stress 
of the Discovery cohort have been initially reported elsewhere (Gururajan et al., 




Figure 5.1-1: Mouse experimental timeline. Mice were singly housed for 1 week prior 
to the first stool and plasma collection on Day 0. From Day 1 to 10, mice were 
randomly assigned to either the control condition (not shown) or chronic social defeat 
stress. On Day 11, plasma and faecal boli samples were again collected and social 
behaviour was assessed. The following day, all mice were culled. Trunk blood was 




5.1.3.2 Chronic social defeat stress 
Mice were randomly assigned to either the social defeat stress or control groups. 
Defeat sessions were performed as previously described (Gururajan et al., 2019). 
Control mice remained in their home-cages over the course of the stress protocol but 
were handled to an equal extent as the stressed mice in the process of measuring 
daily body weight and collecting tail-blood samples. Across the duration of the defeat 
protocol, to prevent contamination during defeat procedures, the experimenter 
removed any traces of faecal boli produced by the aggressor or the stressed mice. 
Based on the findings in the first cohort of mice, we repeated the experiment in a 
larger cohort. We refer to these cohorts as the Discovery cohort and the Validation 
cohort, respectively. Further details can be found in Supplementary Methods. 
 
5.1.3.3 Social interaction test 
The social interaction testing of mice was used to assess avoidance of the CD1 
aggressors the day after the last defeat session and was carried out as previously 
described (Gururajan et al., 2019). Social interaction (SIT) ratios were generated 
based on social investigation time in an arbitrarily defined interaction zone. Further 
details can be found in Supplementary Methods. 
 
5.1.3.4 Plasma sampling for corticosterone 
Collection and analysis of plasma samples for corticosterone was carried out as 
previously described (van de Wouw et al., 2018; Gururajan et al., 2019). Briefly, tail 
bleeds were carried out within 1 hour of the lights turning off (1930-2030). Whole 
blood was collected in sterile eppendorfs. Whole blood was centrifuged (3500g, 10 
minutes, 4 degrees C) and plasma was collected. Plasma samples were analyzed in 
duplicate using the Enzo® Corticosterone ELISA kit plate (ADI-900-097, Enzo, Exeter, 
United Kingdom) according to the manufacturer’s instructions. ELISA plates were 
read using a Multiskan® microplate photometer (Thermofisher Scientific®, Waltham, 
MA, USA) at 405 nm. See Supplementary Methods for further detail. 
331 
 
5.1.3.5 Human Study 
Briefly, healthy volunteer study participants were recruited via advertisement and 
direct contact to the student population of University College Cork (UCC). A total of 
84 volunteers responded to advertisement and direct contact; 54 were pre-screened 
by telephone call (64%); 36 were invited to a screening visit (43%); and thirty were 
enrolled in the study and randomised to treatment (36%). Inclusion criteria: 
participant must be able give written informed consent; be between 18 and 30 years 
of age; be male; be in generally good health as determined by the investigator. Prior 
to testing days, participants were asked to refrain from strenuous exercise and 
alcohol 24 hours before the session, and from caffeine three hours prior to the 
session. At the screening visit, two weeks before baseline measurement, study 
participants were asked about their demographics, general medical history, 
medication record, and other metadata. Furthermore, the participants were 
screened using the MINI International Psychiatric Interview (to exclude subjects with 
a significant DSM-V psychiatric diagnosis). Participants attended for study visits 
during 2 semesters in UCC – both 8 weeks prior to an exam period and during an 
exam period.  The exam visit took place during the participant’s exams, but not on 
the day of an exam. The measures taken during the visit included Cohen’s Perceived 
Stress Scale (PSS). Faecal samples from the morning of the visit were collected into 
plastic containers containing an Anaerogen sachet. Participants were instructed to 
keep the sample in a cool place until delivery at the study visit. Salivary Cortisol 
Awakening Response was assessed using the Cortisol ELISA kit plate ADI-900-071, 
Enzo, Exeter, United Kingdom) according to the manufacturer’s instructions. ELISA 
plates were read using a Multiskan® microplate photometer (Thermofisher 
Scientific®, Waltham, MA, USA) at 405 nm. 
 
5.1.3.6 16S rRNA Gene Sequencing 
DNA was extracted from faecal samples and prepared for sequencing using an 
Illumina 16S Metagenomic Sequencing Library Protocol. See supplementary methods 




5.1.3.7 Bioinformatics analysis 
Three hundred base pair paired-end reads were pre-filtered based on a quality score 
threshold of >28 and trimmed, filtered for quality and chimaeras using the DADA2 
library in R (version 3.6.3). Only samples with >10.000 reads after QC were used in 
analysis. Taxonomy was assigned with DADA2 against the SILVA SSURef database 
release v138. Parameters as recommended in the DADA2 manual were adhered to 
unless mentioned otherwise. ASVs were aggregated at genus level; those that were 
unknown on the genus level were not considered in downstream analysis, as were 
genera that were only detected as non-zero in 10% or few of total samples.  
 
5.1.3.8 Statistical analysis  
Further data-handling was done in R (version 3.6.3) with the Rstudio GUI (version 
1.1.453). Custom R scripts are available at at 
https://github.com/thomazbastiaanssen/Tjazi (Bastiaanssen, 2018). Stacked 
barplots were generated by normalizing counts to 1, generation proportions. Genera 
that were never detected at a 1% relative abundance or higher were aggregated and 
defined as Rare taxa for the purposes of the stacked barplots. Principal component 
analysis was performed on centred-log ratio transformed (clr) values using the 
ALDEx2 library (Fernandes et al., 2014). Number of permutations was always set to 
1000. Volatility was measured as distance between before and after the experiment 
or treatment and was calculated as the Aitchison distance between the two 
timepoints. Unlike other distance metrics such as Bray-Curtis and Jensen-Shannon 
divergence, the Aitchison distance takes into account the compositional nature of 
microbiome datasets (Aitchison et al., 2000).  Piphillin  was used for functional 
inference from 16S rRNA gene seqeunce of mouse stool samples in the form of KEGG 
orthologues (Iwai et al., 2016). Gut-Brain Modules (GBMs) and Gut-Metabolic 
Modules (GMMs) were calculated using the R version of the Gomixer tool (Valles-
Colomer et al., 2019). Differential abundance of both microbes and functional 
modules were calculated using implementations of the ALDEx2 library. As part of 
testing for  correlations between volatility and metadata, skadi, an implementation 
of jackknifing and Grubb’s test, was used to assess reliability of the data and detect 
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outliers (R scripts avaliable). Correlation was assessed using Spearmans’s rank 
correlation coefficient in the case of low N or heteroskedacity. In all other cases the 
Pearson correlation coefficient was used. Normality was assessed using the Shapiro-
Wilk test. For normally distributed data, between-group differences were analysed 
using ANOVA or unpaired two-tailed t-test and Tukey’s test for post-hoc analysis. For 
datasets in which the condition of normality was violated the non-parametric 
Kruskal-Wallis test was used and post-hoc analysis was done using the Wilcoxon test. 
A p-value of <0.05 was deemed significant in all cases. To correct for multiple testing 
in tests involving microbiota or Functional Modules, the Benjamini-Hochberg (BH) 
post-hoc was performed with a q-value of 0.1 as a cut-off. 
5.1.4 Results 
5.1.4.1 The gut microbiome is differentially volatile in response to chronic social 
defeat stress. 
To quantify volatility, which we define as the degree of compositional change of the 
microbial ecosystem over time, we calculated the intra-subject Aitchison distance 
between the genus-level count tables from the same subject taken before and after 
the experiment using the clr-transformation (Figure 5.1-2C). Stressed mice showed a 
trend toward a significantly higher degree of volatility when compared to controls in 
the Discovery cohort (Figure 5.1-2D). In the validation cohort, we again found a 
higher degree of volatility in stressed animals compared to controls, this time 






Figure 5.1-2: Microbial volatility is influenced by stress. (A) Stacked barplot showing 
the proportion of genera based on 16S sequences detected per sample in the 
Validation cohort and the (B) Discovery cohort. Volatility was defined as the Aitchison 
distance travelled over the 10-day experiment. (C) PCA showing the microbiome 
compositions of animals before and after the 10-day period. Lines link the same 
animal over time, showing the trajectory and distance travelled in time. (D) Aitchison 
distance travelled is shown on the y-axis; Mann-Whitney p=0.093. (E) The PCA of the 
validation cohort and (F) corresponding elevated volatility in stressed mice.; Mann-
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Whitney p=5.06x10-5. Discovery cohort: Control N = 9; Stress: N = 13, validation 
Control cohort: N = 10; Stress: N = 28.  
 
 
Figure 5.1-3: Volatility correlates with biological measures associated with stress. 
(A) Inverse volcano plot showing correlations between volatility and all other 
experimental parameters. Y and x-axis represent p-value on a log10 scale and 
spearman’s rho, respectively. Red dashed line depicts p = 0.05. (B-F) Show individual 
correlations between all experimental values (y-axis) and volatility (x-axis). 
Measurements were assessed for reliability using Grubbs’ test for outliers and jack-
knifing. Controls and outliers were left out for correlations (opaque circles). Lines 
represent the fitted regression line, with a full line indicating a significant correlation, 
while a dotted line indicates no significance. Spearman: (B); p = 0.016, rho = -0.676 
(C); p = 0.154, rho = 0.441 (D); p = 0.001, rho = 0.832 (E); p = 0.019, rho = 0.709 (F);  p 





5.1.4.2 Volatility of the gut microbiome is correlated with aspects of the stress 
response. 
Pursuing the elevated volatility in stressed animals compared to controls, we found 
a significant correlation between social avoidance behaviour and volatility. This 
finding was again replicated in the validation cohort (Figure 5.1-4).   
 
Figure 5.1-4: Microbial volatility is negatively correlated with Social Interaction 
Ratio after Social Defeat Stress. The x-axis shows volatility as defined by Aitchison 
distance moved over 10 days, while the y-axis shows the Social Interaction Ratio as 
defined by the ratio of time spent in proximity to an unfamiliar CD-1 mouse and time 
spent in the same area without the second mouse present. Red points show stressed 
mice, while blue points show controls. Lines represent the fitted regression line, with 
a full line indicating a significant correlation, while a dotted line indicates no 
significance. Spearman: In the Discovery cohort (Left); p = 0.017, rho = -0.68. In the 
Validation cohort (Right); p = 0.045, rho = -0.41. Discovery cohort: N = 8; stress: N = 




5.1.4.3 Volatility is correlated with absolute change in measures of alpha-diversity 
 
As alpha-diversity and beta-diversity are related metrics, we asked whether changes 
in beta-diversity, volatility, would be related to changes in alpha diversity. We 
computed alpha diversity based on the first three hill-numbers; Chao1, Simpson and 
Shannon and found correlations between these metrics and volatility in both cohorts 
in the stressed mice, but never in controls (Figure 5.1-5).  
 
Figure 5.1-5: Microbial volatility is positively correlated with absolute changes in 
Alpha Diversity indices after Social Defeat Stress. The x-axis shows volatility as 
defined by Aitchison distance moved over 10 days, while the y-axis shows the absolute 
difference in Chao1 (A,D), Simpson Index (B,E) and Shannon Index (C,F) on a genus 
level. A-C relates to the discovery cohort, whereas D-F corresponds to the Validation 
cohort. Red points show stressed mice, while blue points show controls. Lines 
represent the fitted regression line, with a full line indicating a significant correlation, 
a dashed line showing a trend (0.05< p <0.1) while a dotted line indicates no 
significance. Spearman: (A); p = 0.004, rho = 0.739 (B); p = 0.014, rho = 0.687 (C); p = 
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0.10, rho = 0.495 (D); p = 0.024, rho = 0.43 (E);  p = 0.003, rho = 0.55 (F); p = 0.002, 
rho = 0.55. Discovery cohort: Control N = 9; Stress: N = 13, validation Control cohort: 
N = 10; Stress: N = 28.   
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5.1.4.4 Perceived Stress in Humans 
To investigate whether the relation between volatility and stress was observed in 
humans, we tested for correlation between volatility and stress as measured by the 
Perceived Stress Scale (PSS) in a cohort of students undergoing academic exams. We 
found a significant correlation between volatility and PSS during stress, but not under 




Figure 5.1-6: Microbial volatility is correlated with Perceived Stress during 
academic exam stress. (A) Stacked barplot showing the proportion of genera based 
on 16S sequences detected per sample. (B) The x-axis shows volatility as defined by 
Aitchison distance while the y-axis shows the Perceived Stress Scale Score during 
academic exam stress. Line represents the fitted regression line indicating a 
significant correlation. N = 16, Spearman: p = 0.028, rho = 0.55. 
 
Additionally, we set out to compare the relationship between blood cortisol and 
corticosterone and volatility in our human and mouse cohorts, respectively. In 
humans, we found a correlation between the cortisol awakening response (AUC) and 
volatility. Analogously, we found a significant positive correlation between evening 
corticosterone levels in the discovery mouse cohort as well as a trend in the same 
direction in the validation mouse cohort (Figure 5.1-7). 
 
Figure 5.1-7: Microbial volatility is positively correlated with Cortisol and 
Corticosterone after chronic stress in humans and mice, respectively. The x-axis 
shows volatility as defined by Aitchison distance while the y-axis shows the evening 
corticosterone levels in the two left-most figures and the Cortisol Awakening 
Response in the rightmost figure. Line represents the fitted regression line, with a full 
line indicating a significant correlation and a dashed line indicating a statistical trend. 
Pearson: Discovery: p = 0.0293, rho = 0.537; Validation: p = 0.063, rho = 0.327; 
Human: p = 0.024, rho = 0.517. Discovery cohort: Control: N = 8; Stress: N = 13, 





5.1.4.5 Comparing Microbiome response to stress across cohorts 
 
Finally, we set out to investigate whether other types of changes could be replicated 
between cohorts. We assessed differential abundance on the genus level in both 
discovery and validation cohorts as well as differential abundance on the level of Gut-
Brain Modules (GBMs) and Gut-Metabolic Modules (GMMs). These modules 
represent functional pathways curated from literature that have been reported to 
take place in the microbiome and are involved in either gut-brain communication or 
in microbiome metabolism, respectively (Valles-Colomer et al., 2019). In order to 
compare the responses between the two cohorts, the effect sizes representing the 
change per microbiome feature were extracted and those modules that were present 
in both cohorts were tested for correlation. In the theoretical case of perfect 
agreement between cohorts, the rho for the correlation of the effect sizes would be 
1. We found no correlation on the genus level in all animals, but in the stressed 
animals we found a strong positive correlation in the effect sizes on both the GBM 
and GMM level (Figure 5.1-8). The same procedure was then carried out comparing 
the functional changes in the mouse cohorts to those in the human cohort. The 
mouse cohorts were aggregated in order to promote interpretability (Figure 5.1-9). 
We observed significant correlations between the responses to chronic stress for 
both GBM and GMM across human and mouse host species. In particular, in terms 
of effect sizes, GABA synthesis and Isovaleric acid synthesis seemed to increase the 
most in both host species in terms of GBMs, while Mucin degradation increased the 




Figure 5.1-8: Microbiome responds to stress similarly on a functional level but not 
on a taxonomical level. The x-axis shows the effect size per feature of the Discovery 
cohort, while the y-axis shows the effect size fer feature of the Validation cohort. 
Every dot is one microbial feature. The top (blue; A-C) row shows the comparisons 
from the Controls, while the bottom (red; D-F) shows the comparisons for the Stressed 
animals. Lines represent the fitted regression line, with a full line indicating a 
significant correlation, a dashed line showing a trend (0.05< p <0.1) while a dotted 
line indicates no significance. Pearson: (A); p = 0.657 rho = 0.052 (B); p = 0.844, rho = 
0.04 (C); p = 0.051, rho = 0.243  (D); p = 0.674, rho = 0.04 (E);  p = 0.0004, rho = 0.625 




Figure 6.1-9: Microbiome responds to stress similarly on a functional level across 
mice and humans. The x-axis shows the effect size per feature of the Mouse cohort, 
while the y-axis shows the effect size fer feature of the Human cohort. The left (A) 
figure shows Gut-Metabolic modules while the right (B) figure shows Gut-Metabolic 
Modules. Every dot is one microbial feature. Labels show the module names that had 
an absolute effect size higher than 0.2 in both mice and humans. Lines represent the 
fitted regression line, with a full line indicating a significant correlation. Pearson: (A); 






Microbiome volatility is a relatively underutilized concept in microbiome ecology. 
With regard to stress it has not been really explored previously. One exception is in 
the context of irritable bowel syndrome (IBS) (Halfvarson et al., 2017), a condition 
which has been linked to physical and psychosocial stress exposure (Mayer et al., 
2001) or Inflammatory Bowel Disease (IBD), which has also been linked to stress and 
anxiety (Mawdsley and Rampton, 2005), both of which found display more volatility 
(though it was not referred to as such) in patients compared with healthy controls 
(Clooney et al., 2020; Ryan et al., 2020). In this study, we further investigated the 
concept of volatility and, for what is to our knowledge the first time, report its 
potential influence on stress-related central and peripheral phenotypes. 
 
We firstly showed that mice which had higher values in biological measures 
commonly associated with stress, such as changes in corticosterone levels also 
showed an increased volatility. Secondly, we observed a significant negative 
correlation between volatility and social behaviour. Notably, this correlation was 
found in both the discovery and validation cohorts. The implication is that severity of 
the stressor is related to degree of volatility, indicating volatility is related to stress 
susceptibility and resilience. Clearly, some stressed animals showed a higher degree 
of volatility than others. There are two possible explanations for this observation. 
The first is that volatility is determined by the microbiome, which would imply that a 
more volatile microbiome is a marker of stress susceptibility. Conversely, a more 
stable microbiome would then be a marker of stress resilience. Second, an elevated 
volatility after stress could be the result of a more severe stressor.  While 
inconclusive, we initially sought to identify features in the baseline microbiome that 
could explain the degree of volatility after stress (data not shown), however, such 
differences in baseline did not hold up in the validation cohort or in the human study. 
Here, we were unable to find predictor features in the baseline microbiome that 
were generalizable over all three cohorts. In future studies, the volatility at baseline 
as opposed to single point measures in the current study could be measured to 
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address this question. Specifically, one may hypothesize that hosts with the most 
volatile microbiomes during neutral conditions could be the most susceptible to 
stress and that low volatility is a predictor of stress resilience.  Additionally, future 
studies are needed to examine the correlation between volatility and other 
phenotypes of relevance following chronic stress. 
 
The findings of this study have potential translational implications in understanding 
volatility in the context of human health. Indeed, the fact that we observed a 
correlation between self-reported stress during academic exams and volatility 
strengthens the notion that volatility is closely associated to stress and stress 
resilience. For example, one could consider volatility in the context of microbial-
based interventions to treat stress-induced psychopathologies, formulations 
designed to stabilise the microbiome could be administered over a period of time to 
improve response. Alternatively, given that psychotropics are themselves known to 
influence the microbiome (Cussotto et al., 2019), we speculate that pre-treatment 
with psychobiotics which introduce specific keystone species into the microbiome, 
may make it more receptive to the therapeutic effects of antidepressants or 
anxiolytics. This latter approach could be relevant especially for patients who are 
resistant to treatment using conventional approaches. This also opens the door to 
keystone species, species that when absent will destabilize the gut ecosystem, in 
psychobiotic formulations. On its own, it is unclear what the impact a more volatile 
microbiome could be on host health, if any. One could hypothesise that volatility 
destabilizes the microbiome resulting in an increased susceptibility for bacterial taxa 
to colonize. We did not find evidence of this, but this might be due to the sanitary 
housing conditions of the animals and that mice are coprophagic. Indeed, fecal 
microbiota transplantation, representing a high-alpha-diversity pool, has been 
shown to expedite colonization rate over natural recovery (Suez et al., 2018). More 




We also found consistent changes across cohorts and even between mice and 
humans in the microbiome after chronic stress. We did not, however, find such 
agreement at a taxonomic level. This is likely due to the differences in baseline 
microbiome between the two cohorts and the humans. Indeed, in humans, it is well-
known that interpersonal variability is much lower on the functional level than on 
the taxonomical level (Human Microbiome Project Consortium, 2012; Mehta et al., 
2018). From our findings we extrapolate that in the context of stress, while the 
taxonomical changes of the microbiome seem to be cohort-dependent and 
ultimately baseline microbiome dependent, there is a strong agreement in how the 
functional microbiome changes after a stressor. A stress response in the microbiome 
that seems invariant of the baseline condition could indicate some sort of adaptive 
stress response, either on the level of the microbiome or on the host level. Per 
definition, the GMMs and especially the GBMs have functional implications for host 
health. In a recent study, GBMs were shown to be influenced by diet (Valles-Colomer 
et al., 2019; Butler et al., 2020). Together with the finding that stress influences these 
modules in a specific manner, this opens up the door for psychobiotics that 
specifically aim to control the levels of specific modules that are known to be altered 
by stress. Notably, GABA synthesis was altered in both our human and mouse 
cohorts. The GABAergic system has been previously shown to be modulated by the 
microbiome in the context of the stress response (Bravo et al., 2011) and GABA-
modulating bacteria have been implicated in stress-related disorders such as 
depression in humans  (Strandwitz et al., 2019). This alteration should be pursued in 
future research. 
 
To conclude, we propose that an analysis of volatility should be considered in all 
future longitudinal microbiome research projects. Given the novelty of this concept, 
we make some basic recommendations as to how examine this variable. The 
approach to calculating volatility presented here relies on Aitchison distance. This 
metric was selected because it was specifically designed to deal with compositional 
data, such as the microbiome (Aitchison et al., 2000; Gloor et al., 2017). While other 
algorithms for beta-diversity do exist, Aitchison distance has the added benefit of 
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satisfying the criteria for being a Euclidean distance, making comparisons between 
two distances within the same analysis possible. Other popular metrics like Bray-
Curtis do not have this property, but rather give relative distance on a scale from zero 
to one, making them less suitable for the purpose of assessing volatility. We 
speculate that further convergence of high-dimensional mathematics, microbiology 
and genetics will lead to newer algorithms which prove to be more useful and easier 
to use. Lastly, in this study, volatility was calculated by assessing the distance 
‘travelled’ between two points over time. Future studies should consider collecting 
samples over multiple time points (e.g. during stress exposure) to produce higher-
dimensional geometric shapes in microbiome-space which could lead to more 
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6.1.1 Abstract  
6.1.1.1 Rationale:  
The impact of the microbiota on the gut-brain-axis is increasingly appreciated. A 
growing body of literature demonstrates that use of dietary fibre and prebiotics can 
manipulate the microbiota and affect host health. However, the influence on 
cognition and acute stress response is less well understood.  
6.1.1.2 Objectives:  
The objective of this study was to investigate the efficacy of a dietary fibre, 
polydextrose (PDX), in improving cognitive performance and acute stress responses 
through manipulation of the gut microbiota in a healthy population.  
6.1.1.3 Methods:  
In this double-blind, randomised, placebo-controlled, cross-over design study, 18 
healthy female participants received 12.5g Litesse®Ultra (>90% PDX polymer ) or 
maltodextrin for four-weeks. Cognitive performance, mood, acute stress responses, 
microbiota composition, and inflammatory markers were assessed pre- and post-
intervention.  
6.1.1.4 Results:  
PDX improved cognitive flexibility as evidenced by the decrease in the number of 
errors made in the Intra-Extra Dimensional Set Shift (IED) task. A better performance 
in sustained attention was observed through higher number of correct responses and 
rejections in the Rapid Visual Information Processing (RVP) task. Although there was 
no change in microbial diversity, abundance of Ruminiclostridium 5 significantly 
increased after PDX supplementation compared to placebo. PDX supplementation 
attenuated the increase of adhesion receptor CD62L on classical monocytes 
observed in the placebo group. 
6.1.1.5 Conclusions: 
Supplementation with the PDX resulted in a modest improvement in cognitive 
performance and inflammatory profile. The results indicate that PDX could benefit 





There is a growing realisation that the symbiotic relationship between microbes and 
their host can significantly impact on health. The gut microbiota is vital for normal 
physiological functioning, aiding in the digestion and utilization of nutrients, 
development of the immune system, and general host metabolism (Jandhyala et al., 
2015). Many diseases (e.g., inflammatory bowel disease (Sheehan et al., 2015), 
obesity (Martinez et al., 2017) or autism spectrum disorder (Strati et al., 2017; 
Berding and Donovan, 2018)) have now been associated with an altered gut microbial 
profile, often manifested by a decreased abundance of beneficial or increased 
abundance of pathogenic bacteria, or a reduced microbial diversity. Besides the 
potential involvement in psychological disease processes, an ever-increasing number 
of studies have shown that stress, anxiety, memory, cognition and 
neuroinflammation may be effected by the composition of the gut microbiota (Rea 
et al., 2016; Allen et al., 2017; Sarkar et al., 2018; Smith and Wissel, 2019). Therefore, 
modulation of the gut microbiota is emerging as an exciting potential strategy to 
support mental health and cognitive function (Dinan et al., 2019; Long-Smith et al., 
2020). In this context, the term psychobiotic was coined to describe any exogenous 
influence (i.e., probiotics, prebiotics, dietary fibre) whose positive effect on mental 
health is bacterially mediated (Dinan et al., 2013; Sarkar et al., 2016).  
The use of dietary fibre, which includes most prebiotics, has been an exciting 
opportunity to support the growth of beneficial host microbiota (Gibson et al., 1995; 
Bindels et al., 2015; Holscher, 2017). Indeed, some prebiotics fibres such as inulin, 
fructooligosaccharides (FOS), galactooligosaccharides (GOS), and polydextrose 
(PDX), which are resistant to digestion and absorption in the intestinal tract, have 
been shown to beneficially alter the microbiota composition and promote the 
growth of beneficial bacteria such as Bifidobacterium (Roytio and Ouwehand, 2014; 
Holscher, 2017). Systemically, improvements in metabolic outcomes and increased 
satiety (Hull et al., 2012) in an obese population after supplementation with PDX in 
combination with probiotic strains were described (Hibberd et al., 2019). While pre-
clinical studies have shown potential benefits for prebiotic fibres in brain health 
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(Savignac et al., 2013; Tarr et al., 2015; Burokas et al., 2017; Boehme et al., 2019), 
there are limited studies published on the effects on brain and cognitive function in 
humans. A small-scale study in healthy individuals has demonstrated that 
intervention with B-GOS resulted in an improved stress response as well as emotional 
information processing (Schmidt et al., 2015). Improvements in memory tasks and 
subjective improvements in mood were observed in a study with healthy individuals 
receiving a prebiotic of oligofructose-enriched inulin (Smith et al., 2015), while a B-
GOS formulation significantly improved anxiety levels in patients with irritable bowel 
syndrome (Silk et al., 2009). However, the impact of PDX on stress responses and 
cognitive performance has not been investigated. Therefore, in this study, we 
examined the potential of PDX (Litesse®Ultra, Danisco USA Inc., Terre Haute, IN, USA) 
to modulate the microbiota composition,  mood, cognition and acute stress 
responsivity. We hypothesized that PDX supplementation would increase the 
abundance of beneficial bacteria, positively modulate cognitive performance and 
decrease physiological and psychological response to stress.  
 
6.1.2 Methods 
This research study was conducted in accordance to the Good Clinical Practice 
guidelines and the Declaration of Helsinki. The protocol was approved by the Clinical 
Research Ethics Committee of the Cork Teaching Hospitals (Protocol Number 
APC076). Informed consent was obtained from all participants prior to enrolment 
into the study.  
 
6.1.2.1 Participants and Study Design  
This study was designed as double-blind, randomised, placebo-controlled, using a 
repeated measure cross-over design study. Due to the higher prevalence of stress-
related conditions such as depression in females, female participants between the 
ages of 18 and 40 were recruited in the Cork area and completed the study between 
March 2018 and December 2018. Eligible participants were randomised to take 12.5g 
of Litesse®Ultra (>90%PDX polymer, Danisco USA Inc., Terre Haute, IN, USA) or 
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placebo (maltodextrin; matched for taste, colour, odour) for 4 weeks, followed by a 
4-week washout period and a 4-week period of PDX or placebo (Figure 6.1-1a). The 
same dose of 12.5g per day of Litesse®Ultra was selected for this study as it closely 
resembles the efficacious doses used in previous studies for metabolic health 
(Stenman et al., 2016; Ibarra et al., 2017). Participants were instructed to consume 
one sachet of blinded study product every morning mixed in a hot drink. Reminders 
to consume the study product were sent to participant 3 times weekly. Additionally, 
participants were instructed to refrain from introducing other probiotic or nutrition 
supplements during the course of the intervention and keep dietary intake and 




Fig. 6.1-1 Study visit diagram illustrates study procedures over the 12-week study 
period (a). Intervention periods were separated by a 4-week washout period. 
Biological samples (stool, saliva, blood), cognitive performance (CANTAB), and acute 
stressor (SECPT) were collected and assessed pre- and post-intervention periods. 
Participants were block randomized (block of 4) with an allocation ratio to 
group/treatment of 1:1 of PDX:placebo to account for balanced group allocation. In 
intervention period 1, group A received PDX and group B received placebo. In 
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intervention period 2, group A received placebo and group B received PDX. b 
CONSORT diagram shows subject enrolment and allocation to treatment groups. 
 
Participants were excluded from the study if they had any significant acute or chronic 
illness, were taking medication, were peri-menopausal, menopausal or post-
menopausal, were pregnant, or lactating, were not fluent in the English language, 
were colour blind, had dyslexia or dyscalculia, were vegan, a habitual daily smoker or 
had taken any pro-, pre- or antibiotic 4-weeks prior to enrolment in the study.  
At the initial screening visit, participants were screened for any psychiatric disorder 
using the MINI International Neuropsychiatric Interview (MINI) and demographic 
data were collected. Additionally, a battery of self-reported questionnaires to obtain 
a baseline psychological profile were completed (for description of test see 
Supplementary Methods). Participants also completed the National Adult Reading 
Test (NART, (Nelson and Willison, 1991) as a brief measure of verbal IQ. Cognitive 
assessment and the acute stressor procedure as well as collection of biological 
samples and questionnaire data (as described below) were completed at visits 2, 3, 
4 and 5. All study visits were performed in the HRB Clinical Research Facility at 
University College Cork.  
Participants, study facilitators, nurses and research analysts were kept blinded until 
all data analysis was completed. The block randomisation (block of 4) of treatment 
schedules was carried out by DuPont. To balance group assignment, an allocation 
ratio to group/treatment of 1:1 PDX:placebo was used. Remaining study product was 
collected from participants to check for compliance following visit 3 and 5. 
 
6.1.2.2 Neuropsychological assessment  
The Cambridge Neuropsychological Test Automated Battery (CANTAB) was used to 
assess cognitive performance (https://www.cambridgecognition.com/cantab/). The 
test battery was presented on a touch screen monitor. A researcher provided verbal 
instructions from a standardized script as well as specific verbal prompts or 
encouragement when needed. To avoid effects of fatigue for tests completed later 
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in the session, the tests were presented in different orders for different participants, 
using a Latin square design. The whole battery lasted approximately 40 minutes and 
included the Motor Screening Test (MOT), Rapid Visual Information Processing (RVP), 
Paired Associates Learning (PAL), Spatial Span (SS), the Intra-Extra Dimensional Set 
Shift (IED) and the Emotion Recognition Task (ERT). A detailed description of each 
task can be found in the Supplementary Methods.  
 
6.1.2.3 Faecal Sample Collection and 16S rRNA sequencing 
Freshly voided faecal samples were collected from study participants into plastic 
containers containing an Anaerogen sachet (Oxoid AGS Anaerogen Compact, Fischer 
Scientific, Dublin), and kept cool in a refrigerator until delivery to the laboratory. The 
sample was aliquoted and stored at -80° for later analysis. Participants were 
instructed to collect the faecal sample as close to the study visit as possible. The 
range of times between sample produced by the participant and freezing in the 
laboratory varied between 4 to 6 hours. The samples were stored in the participant’s 
fridge until transport to the study site using a cool pack. Upon arrival at the study site 
the sample was placed in the fridge until collected by the researcher processing the 
sample.  
 
6.1.2.4 DNA Extraction:  
DNA was extracted from 250mg faecal samples using a previously described modified 
protocol, which combined the repeat bead beating method with the QIAmp Fast DNA 
Stool Mini Kit (Qiagen, Germany) (Yu and Morrison, 2004; Fouhy et al., 2015). DNA 
was quantified using the QubitTM 3.0 Fluorometer (Bio-Sciences Dublin, Ireland or 
Life Technologies or Thermo Fisher Scientific) and the Qubit® dsDNA HS Assay Kit 
(Bio-Sciences Dublin, Ireland or Life Technologies or Thermo Fisher Scientific), along 
with being run on a 1.5% agarose gel to check the DNA quality. Extracted DNA was 




6.1.2.5 16S rRNA Microbiome Sequencing 
The V3-V4 hypervariable region of the 16S rRNA gene was amplified from the DNA 
extracts and prepared for sequencing using the Illumina 16S Metagenomic 
Sequencing Library Protocol (Amplicon et al., 2013). A detailed description of the 16S 
rRNA sequencing protocol can be found in the Supplementary Methods.  
 
6.1.2.6 Blood Inflammatory Profile  
Whole blood was collected into 4 mL lithium-heparin containing tubes (Greiner Bio-
One, 454029). Plasma samples were collected into 3 mL K3EDTA tubes (Cruinn 
Diagnostics Limited, Dublin). Blood samples to analyse the impact of the acute 
stressor on inflammatory markers were taken immediately upon completion of the 
stressor (described below). Plasma samples were centrifuged at 1500g for 10 
minutes. The supernatant was aliquoted and stored at -80°C for later analysis.  
 
6.1.2.7 Whole blood stimulation 
Whole blood was diluted 1:10 with Dulbecco’s Modified Eagle’s Medium/Nutrient 
Mixture F-12 Ham (Sigma Aldrich) supplemented with 10% foetal calf serum and 5% 
penicillin streptomycin. Of the diluted mixture, 500µL was aliquoted to a 24-well 
plate. Each well was stimulated with 5 µL of the stimulant (TLR4 agonist - E. coli K12 
LPS and TLR5 agonist – S. typhimurium Flagellin, Invivogen, Toulouse, France). The 
blood was harvested after 24 hours of incubation at 37°C and stored at -80°C for later 
analysis.  
 
6.1.2.8 Cytokine quantification 
Cytokine levels from plasma samples and stimulated blood samples were quantified 
using the V-PLEX Proinflammatory Panel 1 (human) Kit (MSD, K15049D). Cytokine 
quantification was done according to the manufacturer's guidelines with one 





6.1.2.9 Flow cytometry 
Mononuclear cells were isolated using Ficoll® Paque Plus (Sigma-Aldrich, GE17-1440-
02) from whole blood. Cells were counted and 2*106 cells were used for flow 
cytometric staining. Samples were first treated with BD Horizon™ Fixable Viability 
Stain 780 (BD Biosciences, 565388), after which cells were incubated with FcR 
blocking reagent (Miltenyi Biotec, 130-059-901) and a mix of extracellular antibodies 
(Supplemental Table 1) in Brilliant Stain Buffer (BD Biosciences, 563794). Cells were 
finally fixed with 4% paraformaldehyde. Samples were analysed the following day 
using a BD FACSCelesta (BD Biosciences). Data were analysed using FlowJo (version 
10) for the gating strategy of classical monocytes (Supplemental Figure 2). Briefly, 
cells were first selected based on FSC/SSC, after which doublets were excluded. Live 
cells (FVS780-) were selected, after which SSChigh cells (granulocytes) and DUMP- cells 
(CD3+ T cells, CD19+ B cells, and CD56+ NK cells) were excluded. Classical monocytes 
(CD14+, CD16-) were subsequently selected based on CD14 and CD16 receptor 
expression. Cell numbers were normalized to total live single-cell numbers. Receptor 
expression was assessed using median fluorescent intensity (MFI). Details on the flow 
cytometry method can be found in the Supplementary Methods. 
 
6.1.2.10 Acute Stress Response 
The socially evaluated cold pressor test (SECPT) (Schwabe et al., 2008) combining a 
psychological with a physiological stressor was utilized to elicit an acute stress 
response as previously described (Allen et al., 2016). Galvanic skin response was 
measured during the stress using the NeXus 4 Software (Biotrace, Mind Media, 
Netherlands). A total of eight saliva samples were taken during the stressor, with the 




6.1.2.11 Cortisol Awakening Response  
Morning saliva samples were collected using the salivette system (Sarstedt, 
Germany). Participants were instructed to collect the saliva samples in the morning 
of the day of their study visit. A total of four samples was collected, with the first one 
collected upon wakening, the second one 30 minutes later, and the third and fourth 
one in 15 minutes increments. Participants were instructed to not brush their teeth 
until after all saliva samples were collected, to not eat or drink anything prior to the 
first sample, and to avoid eating and drinking 15 minutes prior to the remaining 
samples. Saliva samples were centrifuged at 1500g for 5 minutes, aliquoted and 
stored at -80°C for later analysis.  
 
6.1.2.12 Cortisol analysis 
Salivary cortisol (CAR and SECPT saliva) was analysed in duplicates using the ENZO 
Life Sciences enzyme-linked immunosorbent assay (ELISA) kits (Exeter, UK) per 
manufacturer’s instructions. The lower limit of detection was 0.156 nmol/L. Inter- 
and intra-assay coefficients of variability were 13.4% and 10.5%.  
 
6.1.2.13 Self-report questionnaires during study visits  
Participants completed self-reported paper-based questionnaires to assess 
perceived stress (Cohen’s Perceived Stress Scale (PSS) (Cohen et al., 1983)), 
depression and anxiety levels (Beck’s Depression Inventory II (BDI-II) (Beck et al., 
1996)), Hospital Anxiety and Depression Scale (HADS-A and HADS-D) (Bjelland et al., 
2002)) and psychopathological symptoms (Symptom Checklist-90-R (SCL-90-R) 
(Derogatis and Unger, 2010)). Dietary intake was quantified using a food frequency 
questionnaire (FFQ, (Harrington et al., 2011)). Gastrointestinal (GI) tolerability was 
assessed using a GI symptom visual analogue scale (VAS). Changes in stool type were 




6.1.2.14 Statistical Analysis 
All data were analysed using SPSS 25 (IBM, Armonk, NY, USA). All data analysis was 
performed using the intention-to-treat analysis, and the last observation carried 
forward approach was employed for missing data. Standardized z-scores (using a cut 
off value of ±3.29) and box plots were used to identify outliers.  
Data were examined for normality using the Shapiro-Wilk statistic and log 
transformed, if necessary. Differences between outcome measures between pre-and 
post-intervention were analysed using within-subject repeated measured analysis of 
variance (ANOVA) and post-hoc paired samples t-test. Where parametric 
assumptions were violated and data transformation did not achieve normal 
distribution, the Friedman and paired sample Wilcoxon signed-rank tests were 
applied. Areas under the curve for cortisol measurements were calculated with 
respect to ground (AUCg) (Pruessner, Kirschbaum, Meinlschmid, & Hellhammer, 
2003). Flow cytometry data were assessed using the paired-sample Wilcoxon signed-
rank test or t-test (differences between pre- and post-stress) or Mann-Whitney U test 
(differences between the two treatment groups). Categorical data (i.e., Bristol stool 
chart) were analysed using the Chi-squared test. Correlation between microbial 
abundance and other outcome measures were performed using spearman rank 
correlation. P<0.05 was considered significant and p<0.1 was considered a trend. 
Data is expressed as mean ± SEM. 
 
6.1.2.15 Bioinformatics analysis: 
Three hundred base pair paired-end reads were prefiltered based on a quality score 
threshold of > 28 and trimmed, filtered for quality and chimeras using the DADA2 
library in R (version 3.6.1) (Callahan et al., 2016). Samples with a quality score < 28 
and/or <10000reads were discarded, resulting in a range of reads for the kept 
samples was 10696 – 143246. Taxonomy was assigned with DADA2 against the SILVA 
SSURef database release v132. Unless mentioned otherwise, recommended 
parameters according to the DADA2 manual were adhered to. A total of 1353 
amplicon sequence variants (ASVs) were identified. ASVs were summarized on a 
genus level, with ASVs that were unknown on the genus level not being considered 
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in downstream analysis, as were genera that were only detected as non-zero in 5% 
or fewer of total samples. 
Microbiome data-handling was done in R with the Rstudio GUI (version 1.2.1555). 
Principal component analysis (PCA) was performed on centre-log ratio transformed 
(clr) values using the ALDEx2 library (Fernandes et al., 2013). Number of 
permutations was always set to 1000. Differential abundance of microbes between 
groups was assessed using the ALDEx2 library. As part of testing for correlations 
between microbial abundance and metadata, skadi, an implementation of 
jackknifing and Grubb’s test, was used to assess the reliability of the data and detect 
outliers (R scripts avaliable online, https://github.com/thomazbastiaanssen/Tjazi 
(DOI: https://doi.org/10.5281/zenodo.1480804). Correlation was assessed using 
Spearman’s rank correlation coefficient. For datasets in which the condition of 
normality was violated the non-parametric Kruskal-Wallis test was used and post-hoc 
analysis was done using the Wilcoxon test. A p-value of < 0.05 was deemed significant 
in all cases. To correct for multiple testing, the Q-value post-hoc procedure was 





A total of 18 healthy female participants completed the study. The CONSORT diagram 
is shown in Figure 6.1-1 b. Baseline demographics can be found in Table 1. 
Participants were of good health, had a normal BMI (mean: 23.7) and baseline 
psychological profile and were free of gastrointestinal symptoms or disorders.  
 
6.1.3.1 Neurocognitive performance 
In the CANTAB battery, an improvement in IED (cognitive flexibility) and RVP 
(sustained attention) after PDX supplementation was observed. 
In the IED task, there was a significant interaction effect between time (pre- vs. post-
intervention) and product (PDX vs. placebo) for completed stage errors (F(1,16) = 5.8, 
p=0.03) and completed total trials F(1,15) = 9.6, p=0.007) (Figure 6.1-2 a,b). Post-hoc 
analysis revealed that compared with the placebo phase, participants made less 
errors on the stages successfully completed (completed stage errors, t(1,17) = -3.9, 
p=0.001; 95% CI[-2.65, -0.79]) and successfully completed the stages using a lower 
number of trials (completed stage trials, t(1,17) = -4.9, p<0.001; 95%CI [-3.66, -4.95]) 
after the PDX phase. 
Similarly, improvements in the number of correct responses, total correct rejections 
and failure to respond in the RVP task after PDX supplementation were recorded 
(Figure 6.1-2 c-e). The number of correct responses (probability of hit (t(1,17) = -3.5, 
p=0.003); 95%CI [-0.18, -0.044]) and total correct rejections (t(1,17) = -3.9, p= 0.001; 
95%CI [-10.98,-3.24]) increased after the PDX but not placebo condition. There was 
also a decrease in failure to respond (total misses (t(1,17) = 3.4, p=0.003; 95%CI [1.17, 
4.83]) after PDX supplementation. However, neither of these outcome measures 




Fig. 6.1-2 PDX supplementation improved neurocognitive performance in the IED and 
RVP task of the CANTAB battery. After PDX supplementation, in the IED task, 
participants made less errors on stages successfully completed (a) and had a lower 
number of trials completed on all attempted stages (b). In the RVP task, PDX increased 
the number of correct responses (c), and total correct rejections (d) and lowered the 
number of misses (e). Individual dots represent a participant; data shown as mean ± 
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SEM; data was analysed by repeated measures ANOVA; *p < 0.05; **p < 0.01; ***p 
< 0.001; IED, intra extra dimensional set shift; RVP, rapid visual information 
processing 
6.1.3.2 Microbiota composition  
All DNA quantity was above 8.3 ng/ul which is the recommended threshold to pool 
the DNA to for sequencing. Single bright bands of the expected fragment size were 
seen for all the samples on the agarose gel. 
A boxplot of the relative abundance of microbiota composition at the genus level 
pre- and post- placebo and PDX intervention is shown in Figure 6.1-3 a. A total of 168 
genera were identified through 16S rRNA sequencing in this cohort. Undirected 
pairwise analysis (Wilcoxon rank sum test with storey’s q-value post-hoc correction) 
revealed significant changes in only one ASV after PDX intervention. A significant 
increase to the genus Ruminoclostridium 5 (q=0.002; effect size: 1.48) only after PDX, 
but not placebo supplementation, was observed (Figure 6.1-3 b).  
Microbial α-diversity within each participant quantified before and after each 
treatment course did not differ between treatments (Chao 1, p=0.85; Simpson, 
p=1.0; Shannon, p=1.0; data not shown). Likewise, no statistically significant 




Fig. 6.1-3 Abundance of Ruminiclostridium 5 increased after PDX supplementation. 
Representative graphs for changes in microbiota composition pre- and post-placebo 
and PDX supplementation. a Stacked bar plots showing abundance of microbes at 
genus level for each participants pre (left) and post (right) treatment arm. Each pair 
of bars represents one individual. b A significant increase in Ruminiclostridium 5 after 
PDX but not placebo supplementation was observed. Data was analysed by Kruskal-
Wallis and paired-sample Wilcoxon signed-rank tests; **q < 0.01; data in (b) is 
expressed as median (horizontal line), interquartile range (box), and range (whiskers) 
 
6.1.3.3 Inflammatory profile 
Flow cytometric analysis revealed that acute stress did not influence circulating 
classical monocyte (CD14+, CD16-) levels (Figure 6.1-4 a,b). Acute stress did increase 
the expression of the adhesion receptor CD62L on classical monocytes in the placebo 
group, but not in participants that received PDX supplementation (Z = -2.803, p = 
0.005) (Figure 6.1-4 c). This increase in CD62L expression in the placebo group was 




Fig. 6.1-4 PDX supplementation lowers acute stress-induced increases in CD62L 
receptor expression on classical monocytes. Flow cytometric analysis was performed 
to quantify classical monocytes (CD14+, CD16-) (a, b), and their expression of the 
CD62L receptor (median fluorescent intensity (MFI)) (c, d). Individual dots represent 
participants (n = 10/group). **p < 0.01; data expressed as mean ± SEM; data was 
analysed using paired-sample Wilcoxon signed-rank test or t test (differences 




There was no difference in the inflammatory profile of plasma samples (Table 2) or 
in the TLR4 stimulated whole bloods (Table 3). In the TLR5 stimulated bloods, a trend 
for lower concentrations of IFN γ (t = -1.85, p = 0.087; 95%CI [-24.4, 1.89]) and IL-2 
(t=-1.9, p= 0.074; 95% CI [-3.46, 0.18]) post- PDX supplementation compared to 
placebo was observed (Table 3).  
 
6.1.3.4 Stress responses  
Neither cortisol awakening response or salivary cortisol concentrations after the 
acute stressor were affected by PDX supplementation (Figure 6.1-5). Likewise, the 
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galvanic skin response was not affected by the stressor or PDX administration (data 
not shown).  
 
Fig. 6.1-5 Salivary cortisol responses to acute stressor and morning awakening 
response did not change after PDX supplementation. Salivary cortisol for each visit as 
measured by the area under the curve with respect to ground (AUCg). Neither total 
salivary output in response to the socially evaluated cold pressor test (SECPT, (a)), nor 
cortisol awakening responses (CAR, b) were affected by PDX supplementation. Data 
analysed by Friedman test; data expressed as mean ± SEM 
 
6.1.3.5 Mood and Psychological Symptoms 
PDX supplementation did not affect levels of anxiety (HADS-A score), depression 
(HADS-D score, BDI-II score), perceived stress (PSS score) or psychopathological 
symptoms (SCL-90-R global severity index) (Table 4).  
 
6.1.3.6 Dietary intake 
Intake of total calories, macronutrient and dietary fibre intake as assessed by the FFQ 
was mostly consistent throughout the study period. There was a slight decrease in 
vitamin E (Z=-2.4, p=0.02), polyunsaturated fatty acids (Z=-2.4, p=0.02) and 
monounsaturated fatty acids (Z=-1.7, p=0.09) during the PDX period (Supplemental 




6.1.3.7 Compliance and tolerability  
Overall, participants showed good compliance to study product (>70%). One 
participant showed lower compliance at 60% during the PDX phase. No treatment 
related adverse events occurred during the PDX treatment arm.  
Overall, PDX supplementation was well tolerated as measured by the GI VAS at each 
visit. Only two people reported GI symptoms after PDX supplementation as assessed 
by the GI VAS, of which one reported abdominal pain. However, these symptoms 
were only present one out of every 10 days. Three participants reported 
development of bloating after the PDX intervention. However, these participants also 
reported bloating at other time points of the study, suggesting that bloating might 
be due to other causes.  
Generally, satisfaction with bowel habits was very high and GI symptoms did not 
interfere with life satisfaction in this cohort. PDX supplementation did not change GI 
symptom satisfaction and GI symptom life interference. Stool consistency as 
measured by the Bristol Stool chart did not change throughout the study period 






The expanding knowledge of the impact of the gut microbiota on cognition and brain 
function has led to a number of studies investigating potential avenues to manipulate 
the microbiota-gut-brain connection, including the use of probiotics, prebiotics or 
dietary fibre. While some benefits of prebiotic supplementation on host physiology 
have previously been illustrated in animals (Savignac et al., 2013; Mika et al., 2014) 
and humans (Hull et al., 2012; Holscher, 2017), evidence for the impact on mental 
health and cognition is limited. Thus, in this study we aimed to investigate the 
potential of a prebiotic fibre, PDX, on cognitive function, acute stress response and 
inflammation. Overall, PDX only had limited effects on the outcome measures 
assessed in this cohort. Contrary to our hypothesis, diversity of the gut microbiota 
did not change after PDX supplementation and only an increase in Ruminiclostridium 
5 was detected. While a modest improvement in cognitive flexibility and sustained 
attention of participants as well as attenuation of the increase in adhesion receptor 
CD62L on classical monocytes after the acute stressor was observed, PDX 
supplementation neither impacted the other measures of the inflammatory profile 
and stress responses nor mood or psychological outcomes.  
 
In animal models, combined with other pre- or probiotics, PDX affected cognitive 
function such as exploratory behaviour, recognition memory and neurochemistry 
(Fleming et al., 2019) and could attenuate the effects of early life stress on anxiety-
like behaviour and learning (McVey Neufeld et al., 2019). Here, a subtle improvement 
in cognitive flexibility as measured by the IED task and in sustained attention as 
shown by the increased number of total correct rejections in the RVP task after PDX 
supplementation was observed. Cognitive flexibility is an executive function that 
allows to switch from thinking about one concept to another or to alternate between 
tasks (Kim et al., 2011). The IED task specifically tests behavioural set shifting abilities 
involving visual discrimination and attentional set formation maintenance, shifting 
and flexibility of attention that depend on fronto-striatal areas. The RVP task, on the 
other hand, measures sustained attention and speed of processing. Sustained 
369 
 
attention is the ability to maintain attention through a set of stimuli over a long 
period of time which is mainly regulated by the right prefrontal and superior parietal 
cortex (Pardo et al., 1991). The present data indicating better performance in 
cognitive flexibility and sustained attention after PDX supplementation aligns with 
observations from other studies showing improved performance in these two 
cognitive processes after prebiotic consumption. For example, in the same 
attentional set shift task adapted for rodents as the one used in this study, rats 
consuming B-GOS required fewer trials shifting from an intra- to an extra-
dimensional set (Gronier et al., 2018). In human studies, B-GOS supplementation  
improved sustained attention measured as vigilance or tonic alertness in healthy 
volunteers (Schmidt et al., 2015) and enhanced cognitive performance, specifically 
executive functioning, in patients with psychosis (Kao et al., 2019). Taken together, 
results from the cognitive assessment in this study could provide evidence for a 
psychobiotic and cognitive-enhancing effect of PDX supplementation.  
 
Contrary to previous studies showing that PDX increases microbial diversity and 
supports the growth of beneficial bacteria (such as increases in Faecalibacterium, 
Akkermansia and Dialister (Roytio and Ouwehand, 2014), in this cohort no 
statistically significant changes in microbiota diversity and only minimal changes in 
composition were observed. However, it should be noted that the effect of PDX on 
the microbial composition varies greatly from study to study (Roytio and Ouwehand, 
2014), mainly due to different dosages of PDX (8g (Costabile et al., 2012) vs. 21g 
(Holscher et al., 2015; Holscher, 2017), differences in microbiota analysis (next 
generation sequencing (Holscher et al., 2015) vs. denaturing gradient gel 
electrophoresis (Costabile et al., 2012)) and difference in population characteristics 
(healthy vs. obese, age, gender etc.). Additionally, PDX has been shown to only 
impact outcome measures of weight management, gut barrier function and 
inflammation in combination with other probiotic supplementations (Stenman et al., 
2016) or elicited microbial changes in obese populations, in which an aberration in 
microbiota composition is commonly observed (Hibberd et al., 2019). It is also 
increasingly being established that the magnitude of response to prebiotic 
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supplementation and dietary interventions depends on factors such as baseline 
microbiota composition or dietary habits. Thereby, baseline microbial diversity, 
richness and prior stability could be predictors of the responsiveness of a participant 
to an intervention (Salonen et al., 2014; Tap et al., 2015). The lack of vast microbial 
changes observed herein could therefore be explained by the relatively low dose of 
the prebiotic fibre, an unresponsive baseline microbial community or the healthy 
status of the population. 
 
Interestingly, we found a significant increase in Ruminiclostridium 5 abundance after 
PDX supplementation. Little is known about the function of Ruminiclostridium 5 in 
humans. Lower levels of Ruminiclostridium 5 were found in patients with kidney 
stones (Tang et al., 2018) and in a rat model of acute necrotizing pancreatitis (Chen 
et al., 2017), potentially indicating an important role of this bacterium in 
inflammatory diseases. Additional studies are needed to decipher the potential 
function of Ruminiclostridium 5 in human physiology. It is worth mentioning that 
dietary intake over the study period did not change majorly, so that the increase in 
Ruminiclostridium 5 could mainly be attributed to the PDX.  
 
Monocytes have previously been described as a pathway for the microbiota-brain 
communication and levels of the murine counterpart of classical monocytes have 
been shown to change in response to acute stress (van de Wouw et al., 2019; van de 
Wouw et al., 2020). Previous research indicated that PDX could have immune 
modulatory effects (Schley and Field, 2002), such as increased secretion of IgA and 
decreased expression of cyclooxygenase-2 in rats and pigs (Peuranen et al., 2004; 
Fava et al., 2007). Here, we report that the increase in CD62L receptor expression on 
classical monocytes that was observed after the acute stressor during the placebo 
phase was attenuated by PDX supplementation. CD62L receptor expression can be 
used as a marker of acute stress-responsiveness, as it has been reported to be 
changed in response to acute stress in rats (Dhabhar et al., 2012). Based on the 
preliminary data presented herein, it could be hypothesized that potential anti-
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inflammatory effects of PDX may mediate the immune-to-brain communication. In 
animal models, classical monocytes have been implicated in microbiota-associated 
changes in cognition (Mohle et al., 2016). In obese individuals, low grade 
inflammation was reported as a mediator between obesity and performance in the 
IED task (Lasselin et al., 2016). These studies suggest that PDX supplementation 
controls the inflammatory response and might have potential health implications for 
patients with chronic inflammatory diseases, potentially including brain health. 
 
There are several limitations to this study. First, the sample size is relatively small.  
Although we acknowledge the exploratory nature of this study and the implications 
of a small sample size for uncertainty regarding type I and specifically type II error, 
the cross over design reduces confounding variables and provides statistical control 
for between-participant variation, thus allowing for a lower sample size to achieve 
similar power as non-crossover design studies. Nevertheless, we acknowledge that 
the current findings should be interpreted with caution due to the preliminary nature 
and should be used to inform larger clinical trials. Additionally, while a 4-week 
washout period and carryover design was applied to this study, the potential of 
carryover effects cannot be ruled out. The lack of effects of PDX on psychopathology, 
anxiety or stress could be partially explained by the healthy study cohort, showing 
low baseline depression, perceived stress or anxiety levels for which it would be 
difficult to observe significant changes. On the other hand, cognitive function in a 
healthy population might have more scope for improvement; however, larger studies 
are needed to investigate the specific benefits of PDX on cognition. The limited 
amount of changes observed in the microbiota composition could be due to the 
limitations of 16S rRNA sequencing. More detailed taxonomic classification using 
shot-gun metagenomic sequencing might be required to fully understand the impact 
of PDX on the microbiota composition and function. Nevertheless, while some 
studies observed more pronounced changes in the microbial profile after PDX 
supplementation, others report very subtle changes in the microbiome composition 
similar to the results observed herein (Roytio and Ouwehand, 2014). Lastly, although 
maltodextrin is frequently used as the placebo in various studies, it can readily be 
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digested and thus might have psychological and physiological effects (Kendig et al., 
2014), potentially impacting some outcomes measures of this study.  
 
Despite these limitations, to the best of our knowledge the data generated from this 
study is the first human study investigating the impact of PDX on brain health, 
thereby generating preliminary evidence to inform future clinical trials.. Previously, 
mechanisms by which PDX can exert beneficial effects on the host have been 
suggested to include microbial metabolites affecting hormonal concentrations in the 
blood (Tolhurst et al., 2012). Although the data provided from this study is 
insufficient to draw conclusions on underlying mechanisms, it could be hypothesized 
that the prebiotic PDX improved cognitive function through reducing inflammatory 
status, potentially mediated by Ruminiclostridium 5 abundance. However,  future 
larger studies using cognition as the primary outcome are warranted to fully 
understand whether PDX could be a potential psychobiotic candidate to support 
cognitive function and unravel underlying mechanisms.   
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The human gut microbiota has emerged as a key factor in the development of 
obesity. Certain probiotic strains have shown anti-obesity effects. The objective of 
this study was to investigate whether Bifidobacterium longum APC1472 has anti-
obesity effects in high-fat diet (HFD)-induced obese mice and whether B. longum 
APC1472 supplementation reduces body-mass index (BMI) in healthy 
overweight/obese individuals as the primary outcome. B. longum APC1472 effects 
on waist-to-hip ratio (W/H ratio) and on obesity-associated plasma biomarkers were 
analysed as secondary outcomes. 
6.2.1.2 Methods 
B. longum APC1472 was administered to HFD-fed C57BL/6 mice in drinking water for 
16 weeks. In the human intervention trial, participants received B. longum APC1472 
or placebo supplementation for 12 weeks, during which primary and secondary 
outcomes were measured at the beginning and end of the intervention. 
6.2.1.3 Findings 
B. longum APC1472 supplementation was associated with decreased bodyweight, fat 
depots accumulation and increased glucose tolerance in HFD-fed mice. While, in 
healthy overweight/obese adults, the supplementation of B. longum APC1472 strain 
did not change primary outcomes of BMI (0.03, 95% CI [-0.4, 0.3]) or W/H ratio 
(0.003, 95% CI [-0.01, 0.01]), a positive effect on the secondary outcome of fasting 
blood glucose levels was found (-0.299, 95% CI [-0.44, -0.09]). 
6.2.1.4 Interpretation 
This study shows a positive translational effect of B. longum APC1472 on fasting 
blood glucose from a preclinical mouse model of obesity to a human intervention 
study in otherwise healthy overweight and obese individuals. This highlights the 
promising potential of B. longum APC1472 to be developed as a valuable supplement 





Obesity is one of the most pervasive, chronic diseases globally, in both developed 
and developing countries, contributing to at least 2.8 million deaths annually and 
significantly impacting the healthcare system (WHO, 2018). The growing obesity 
epidemic is associated with increases in several comorbidities, such as cardiovascular 
disease, stroke, metabolic syndrome, type 2 diabetes and cancer (Tchernof and 
Despres, 2013; Narayanaswami and Dwoskin, 2017). Current available anti-obesity 
therapeutics are limited and associated with poor efficacy and adverse side effects 
(Bloom et al., 2008; Torres-Fuentes et al., 2014). Diet and exercise have been 
demonstrated to be the most potent in reducing obesity symptomatology (Fock and 
Khoo, 2013). In addition, natural compounds and their derivatives have been 
proposed as safer anti-obesity alternatives, either as functional foods or 
nutraceuticals (Torres-Fuentes et al., 2014).  
The gut microbiota has emerged as a key component in the development of obesity 
and modulates the host’s physiology and metabolism, including energy harvest, 
storage and expenditure (DiBaise et al., 2012; Torres-Fuentes et al., 2014; 
Rosenbaum et al., 2015; Patterson et al., 2016; Maruvada et al., 2017; Torres-Fuentes 
et al., 2017; van de Wouw et al., 2017; Cani et al., 2019). Preclinical and clinical 
evidence demonstrating the critical role of the gastrointestinal microbiota on host 
metabolism is steadily increasing. For example, germ-free mice are protected against 
obesity and are significantly leaner than normal control mice despite consuming 
more calories (Backhed et al., 2004). In addition, faecal transplantation from obese 
donors was shown to replicate the obese phenotype in lean germ-free mice 
independent of diet (Ley et al., 2005; Ley et al., 2006; Ridaura et al., 2013). Moreover, 
accelerated post-dieting weight regain is associated with a persistent intestinal 
microbiome signature after successful dieting in obese mice (Thaiss et al., 2016). 
However, the exact mechanisms of how diet-induced changes in gut microbiota 
affect gut-brain signalling, including host metabolism, appetite regulation and brain 
health, are currently still lacking (Adan et al., 2019; Ezra-Nevo et al., 2020). 
Interestingly, the obese-associated microbiota has been shown to have an increased 
376 
 
capability to harvest energy from food and contributes to host insulin resistance, gut 
permeability, low-grade inflammation, and fat deposition (Cani and Delzenne, 2009; 
Khan et al., 2016). Intestinal microbiota-derived metabolites have also been shown 
to impact the central regulation of appetite (Fetissov, 2017; Sandhu et al., 2017; 
Torres-Fuentes et al., 2017). For example, certain bacterial strains modify gut 
peptides secretion, such as glucagon-like peptide (GLP)-1, thus contributing to 
hypothalamic appetite and satiety signalling via afferent nerve fibres of the vagus 
nerve as well as by direct secretion into the circulatory system (Everard and Cani, 
2014; Sandhu et al., 2017). Furthermore, germ-free mice display marked decreases 
in expression of intestinal satiety peptides, including cholecystokinin (CCK), peptide 
tyrosine-tyrosine (PYY) and GLP-1 and also lower circulating levels of leptin and 
ghrelin (Duca et al., 2012). In addition, serum ghrelin levels are negatively correlated 
with the abundance of certain microbiota, including Bifidobacterium and 
Lactobacillus species (Queipo-Ortuno et al., 2013). And intake of the prebiotic 
oligofructose, which promotes the growth of Bifidobacterium and Lactobacillus, 
decreases the secretion of ghrelin in obese humans (Parnell and Reimer, 2009). 
Taken together, modulation of the gut microbiota is emerging as a promising strategy 
for the management of obesity and obesity-related disorders such as type-2 diabetes 
and cardiovascular disease (DiBaise et al., 2012; Torres-Fuentes et al., 2014; 
Patterson et al., 2016; Torres-Fuentes et al., 2017; Peng et al., 2018). 
Several probiotic strains with different anti-obesity effects in humans have been 
identified (Jung et al., 2013; Rajkumar et al., 2014; Torres-Fuentes et al., 2014; Zarrati 
et al., 2014; Stenman et al., 2016; Sabico et al., 2017; Kim et al., 2018; Hibberd et al., 
2019). The bacterial strain B. longum APC1472 has recently been shown to modulate 
ghrelinergic signalling in vitro (Torres-Fuentes et al., 2019), highlighting the 
therapeutic potential for host metabolism, appetite and obesity modulation. The 
ghrelin receptor (GHS-R1a) is activated by the endogenous hormone, ghrelin, the first 
and only known peripheral orexigenic peptide, which regulates peripheral 
metabolism and energy expenditure as well as centrally regulated homeostatic 
appetite and food-motivated reward signalling, governing eating behavior and food 
intake (Kojima et al., 1999; Tschop et al., 2000; Cummings et al., 2001; Nakazato et 
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al., 2001; Muller et al., 2015). Interestingly, obese individuals have attenuated 
postprandial suppression of ghrelin and a blunted nocturnal plasma ghrelin increase, 
reinforcing aberrant ghrelinergic signalling in obesity (Yildiz et al., 2004; le Roux et 
al., 2005). While the precise site of action of ghrelin is somewhat controversial 
(Abizaid, 2009; Abizaid and Horvath, 2012; Howick et al., 2017), the high prevalence 
of the ghrelin receptor throughout the small and large intestine, make it a likely 
target for interaction with the gut microbiota and thus may hold potential as a local 
therapeutic target (Takeshita et al., 2006).  
As such, we investigated B. longum APC1472 for its ability to ameliorate high-fat diet 
(HFD)-induced obesity in mice, and significant effects on adiposity and metabolism 
were observed. Based on these promising effects of B. longum in the preclinical 
model, we subsequently investigated whether it could improve obesity 
symptomatology in healthy overweight/obese adults. The primary objective of the 
human intervention study was to determine whether a 12-week daily 
supplementation of B. longum APC1472 decreases body-mass index (BMI), while the 
secondary objective was to investigate the effects on waist-to-hip ration (W/H ratio), 
and biomarkers associated with obesity, such as glucose, insulin, HbA1c and ghrelin 
levels. The exploratory objectives were to investigate the impact of B. longum 
APC1472 on the gut microbiota composition and diversity, peripheral inflammatory 






6.2.3.1 Animal study 
6.2.3.1.1 Animals, diets and ethical approval 
Five-week-old male C57BL/6 mice (Harlan Laboratories, UK) (40 mice, n=8-10 per 
group) were housed in groups of 2 mice per cage in standard holding cages with free 
access to food and water in the animal care facility of University College Cork. The 
holding room temperature (21 ± 1°C) and humidity (55 ± 10%) were controlled under 
a 12 h light/dark cycle (lights on 7.00 AM, lights off 7.00 PM). The mice were fed a 
low-fat diet (LFD) (10% fat (kcal/100 g), D12450B, Research Diet, USA) or a high-fat 
diet (HFD) (45% fat (kcal/100 g), D12451, Research Diet, USA) for 16 weeks. Food 
intake was recorded once per week and calculated on the basis of two mice per cage 
and five cages per group. The data were reported as cumulative food intake per 
mouse. Bodyweight was monitored weekly for 15 weeks.  Experiments were 
conducted in accordance with the European Directive 86/609/EEC and the 
Recommendation 2007/526/65/EC and were approved by the Animal 
Experimentation Ethics Committee of University College Cork.  
6.2.3.1.2 In vivo probiotic administration  
Bifidobacterium longum APC1472 was grown anaerobically in De Man, Rogosa and 
Sharpe (MRS) medium as previously described (Torres-Fuentes et al., 2019). The 
bacterial cell pellet was washed and concentrated in sterile phosphate buffered 
saline (PBS) containing 25% Glycerol (v/v) to an end concentration of 7.5x109 
CFU/mL, aliquoted and stored at -80°C. Aliquots were defrosted daily just prior to the 
start of the dark phase and diluted to 2x108 CFU/mL in drinking water for 
administration to LFD-fed and HFD-fed mice for 16 weeks. Water intake was 
monitored throughout the experiment. Drinking water containing an equivalent end 
concentration of sterile PBS (2% v/v) and glycerol (0.5% v/v) was administered to 
control mice. Water was replaced for probiotic/vehicle-free water every morning. B. 
longum APC1472 survival in drinking water (distilled water) in ambient temperature 
and oxygen content was tested over 24 h prior to the start of the experiment. 
Bacteria counts (CFU/mL) did not decrease over 1 log unit for the first 12 hours 
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suggesting adequate viability of the strain upon the time of consumption (Figure 
S1A). No significant changes in water intake were observed within the same diet 
groups (Figure S1B).  
6.2.3.1.3 In vivo Glucose tolerance test 
Glucose tolerance was assessed after 15 weeks of treatment as previously described 
(Suez et al., 2014), with minor modifications. Briefly, mice were fasted for 7 hours 
during the light phase, with free access to water. Glucose levels were measured in 
tail vein blood using a glucometer (Bayer, UK) immediately before and 15, 30, 60, 90 
and 120 min after intraperitoneal injection of glucose (1 g/kg of body weight in sterile 
saline).  
6.2.3.1.4 Murine tissue sampling 
Mice were euthanized by decapitation. Trunk blood was collected in tubes containing 
25 μM dipeptidyl peptidase IV (DPP-IV) inhibitor, 2x protease inhibitor cocktail 
(Roche) (diluted in PBS) and 0.1% Na2 EDTA for an expected blood volume of 400 µL, 
centrifuged at 3500 g for 15 min at 4°C and placed on dry ice until storage at −80°C 
for further analysis. Adipose depots (epididymal, subcutaneous, mesenteric and 
retroperitoneal) were dissected and weighed. Whole-brains were collected and 
placed for 8-10 sec into ice-cold isopentane. All tissues were frozen on dry ice and 
subsequently stored at −80°C for further analysis.  
6.2.3.1.5 Murine biochemical analysis 
Plasma insulin and leptin levels were analysed by ELISA using the MILLIPLEX® MAP 
Mouse Metabolic Hormone Magnetic Bead Panel (Millipore, MMHMAG-44K) 
accordingly to the manufacturer’s instructions. Plasma ghrelin levels were analysed 
using the Rat/Mouse Ghrelin (Total) ELISA Kits (Millipore, EZGRA-88K). Triglycerides 
levels were analysed with a Triglyceride Quantification Kit (Abcam Ltd, ab65336) 
following the to manufacturer’s instructions. Corticosterone levels were assayed 




6.2.3.1.6 Murine RNA Isolation and Quantitative Real-Time PCR 
Hypothalamus was dissected with a forceps (macropunch) from the frozen brain on 
dry ice and immediately processed for RNA extraction. Hypothalamus and epididymal 
adipose tissue total RNA were extracted using the mirVana™ miRNA Isolation kit 
(Ambion/Life Technologies, AM1560) and RNeasy® Lipid Tissue Mini Kit (Qiagen, 
74804), respectively with DNase treatment using Turbo DNA-free (Ambion/life 
Technologies, AM1907) according to the manufacturer’s recommendations. Equal 
amounts of RNA were first reverse transcribed to cDNA using High Capacity cDNA 
Reverse Transcription Kit (Applied Biosystems, 4368814). Real-time PCR was 
performed using TaqMan Universal Master Mix II, no Uracil-N glycoslyase (UNG) on 
a LightCycler®480  System (Roche). Mouse β-actin control mix Probe dye: VIC-MGB 
(Applied Biosystems, 4352341E) was used as an endogenous control. Target genes 
were amplified with probes designed by Integrated DNA Technologies (Table S1). 
Cycle threshold (Ct) values were recorded, normalized to its endogenous control and 
transformed to relative gene expression value using the 2−ΔΔCt method (Livak and 
Schmittgen, 2001). Each sample was analysed in triplicate for both target gene and 
endogenous control. The gene expression levels for each animal was calculated 
considering the mean from each of these triplicates. 
6.2.3.2 Human intervention study 
6.2.3.2.1 Human intervention study outline  
This study has a parallel-controlled design. In total, 150 individuals were screened, 
after which 124 were randomized into the treatment groups (Placebo: n = 50; 
Treatment: n = 74). The aim of the first visit of the participant was to assess 
participants for their eligibility to participate in the study and explain which 
procedures would be undertaken. Subjects were given an appointment for the next 
visit within a 3-week period. At the second visit, all baseline data and biologics were 
recorded, which was also done after 6 (visit 3) and 12 weeks (visit 4) of placebo or B. 
longum APC1472 treatment. Vital signs, anthropometric measurements and medical 
history were recorded. For women of childbearing age, a urine sample was collected 
for a pregnancy test. Fasting blood samples (20 mL) were collected to assess glucose, 
insulin, HbA1c, lipid profiles, satiety/appetite hormone profiles, and inflammatory 
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profiles. Saliva samples were collected for the assessment of the cortisol awakening 
response, as well as a stool sample for the microbiota analysis and short-chain fatty 
acid (SCFA) quantification. Questionnaires were administered to assess self-reported 
stress, anxiety, hunger/satiety, exercise and diet.  
Participants were asked to take one capsule per day, providing a daily dose of 1x1010 
CFU. Subjects, study facilitators, nurses and research analysts were kept blind as to 
in which group they belonged. The randomisation of treatment schedules was carried 
out by a computer-generated program. The remaining study product was collected 
to check for compliance following visits 3 and 4 (Haynes et al., 1980).  
6.2.3.2.2 Inclusion and exclusion criteria 
The inclusion criteria were as follows: subjects had to give written informed consent; 
had to be between 18-65 years of age; had a BMI between 28-34.9; had a W/H ratio 
≥0.88 for males and ≥0.83 for females; had to be willing to consume the 
investigational product daily for the duration of the study. Subjects were excluded if 
they were pregnant, lactating, or female and wish to become a parent during the 
study; regularly took probiotics; were hypersensitive to any of the components of the 
test product; were severely immune-compromised (i.e. HIV positive, transplant 
patient, antirejection medications, on a steroid for >30 days, or underwent 
chemotherapy or radiotherapy within the last year); had Type 1 or Type 2 Diabetes 
Mellitus; had a history of bariatric surgery; had taken anti-obesity medication in the 
previous 12-weeks; were actively, or has within the last 3 months, participating in a 
weight loss program or incurred a weight change of more than 3 kg during the past 
3 months; had a life-threatening illness; was on Metformin, anti-psychotic drugs or 
any medication that the investigator determined could impact the results of the 
study; had commenced use of anti-hypertensive drugs, anti-depressive drugs, statins 
or any other medication that the investigator determined could impact the results of 
the study within 3-months of randomisation date; had a history of co-existing 
gastrointestinal, and/or gynaecological, and/or urologic pathology (e.g. colon cancer, 
colitis, Crohn’s Disease, Celiac, Endometriosis, prostate cancer) or lactose 
intolerance; had a history of drug and/or alcohol abuse; was currently, or planning, 
to participate in another study during the study period; had a history of non-
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compliance; had been on antibiotics in the 12-weeks prior to randomisation; or 
consumed vitamin D supplements (>5000 IU/d). 17.3% of all screened participants 
were excluded due to these exclusion criteria.  
Subjects were removed from the study if they independently elected to withdraw; 
he/she developed any condition which contravened the original criteria; or was 
considered at any point to be unsuitable to continue the study, at the discretion of 
the investigator.  
6.2.3.2.3 Study setting and ethical approval  
The study was conducted in accordance with the ethical principles set forth in the 
current version of the Declaration of Helsinki (seventh version, October 2013), the 
International Conference on Harmonization E6 (R2) Good Clinical Practice (ICH GCP, 
November 2016) and all applicable local regulatory requirements (i.e. Clinical 
Research Ethics Committee of the Cork Teaching Hospitals). This study was registered 
with ClinicalTrials.gov (NCT04042181). The CONSORT diagram of this study is 
depicted in Figure 6.2-1, the study layout is depicted in Figure S2. This study was run 






6.2.3.2.4 Randomisation and blinding 
The investigational product arrived on site labelled with randomisation number. A 
randomisation list was generated by an independent statistician. Participants were 
assigned a randomisation number in chronological order from this randomisation list. 
The study team, participants and researchers were unaware which randomisation 
numbers were active or placebo. Blinding was undone after all data had been 
analyzed.  
6.2.3.2.5 Study recruitment 
Subjects were recruited through the database of Atlantia Food Clinical Research 
Trials, general practitioners’ offices and by posting adverts in local newspapers. 
Subjects underwent an initial phone screen. Eligible subjects were scheduled for a 
screening visit. Subjects received €300 upon completion of the study to cover costs 
and expenses incurred. 
Figure 7.21. Consort diagram. Number of healthy overweight/obese participants that were assessed for 
eligibility and excluded or allocated to the trial, treated, followed, and analysed. 
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6.2.3.2.6 Product formulation and dosage 
Bifidobacterium longum has been granted Qualified Presumption of Safety (QPS) 
status by the European Food Safety Authority (EFSA). B. longum APC1472 grown 
culture and the corresponding placebo were freeze-dried (Sacco SRI, Italy) and 
provided as hydroxypropylmethylcellulose (HPMC) capsules in PE bottles (Nutrilinea, 
Italy). The freeze-dried powder of the strain was blended with standard food-grade 
excipients to achieve the target dose of 1x1010 CFU. The excipients consisted of corn 
starch, magnesium stearate and silicon dioxide. The probiotic formulation consisted 
of B. longum APC1472, whereas the placebo contained maltodextrin. The product 
was stored at -20°C until distributed to the study participant and the participant was 
instructed to keep the product refrigerated. Participants returned any leftover 
product at their next visit, and the excess product was counted to check for 
compliance. 
6.2.3.2.7 Collection and analysis of blood samples 
Fasting blood samples were taken into EDTA tubes, fasting defined as refraining from 
food overnight (at least 10 hours), however drinking water was allowed throughout 
the duration of the fast. Samples for the analysis of active ghrelin were immediately 
treated with AEBSF (final concentration 1 mg/mL, Sigma, A8456), centrifuged and the 
resulting plasma was treated with HCl (final concentration 0.05N). Blood samples for 
the analysis using the U-PLEX assays were treated with DPP-IV inhibitor (final 
concentration 1%, Sigma, DPP4) and centrifuged. Blood plasma samples for other 
analyses did not undergo any additional processing, except for centrifugation. 
Centrifugation was performed at 1000g for 10 minutes at 4 °C, after which samples 
were aliquoted and either processed or stored at -80 °C for future analysis.  
Blood plasma from visit 1 was used to measure urea, creatinine, bilirubin, alanine 
aminotransferase, alkaline phosphatase, aspartate aminotransferase, gamma-
glutamyl transferase, total protein, albumin, globulin, calcium, magnesium, 
phosphate, uric acid, cholesterol, HDL cholesterol, LDL cholesterol, total triglycerides, 
glucose, full blood count + 5-part diff. Safety blood, haematology and biochemistry 
parameters were analysed by Biomnis-Eurofins Ireland.  
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Blood from visits 2, 3 and 4 was used to measure total cholesterol, LDL, HDL, 
triglycerides HbA1c, glucose and insulin by Biomnis-Eurofins Ireland. Furthermore, 
blood plasma was assessed for active ghrelin levels using an ELISA (EMD Millipore, 
EZGRA-88BK) which was performed according to the manufacturer’s instructions. 
Plates were read at 405 nm with a correction at 590 nm using the synergy HT plate 
reader (Biotek instruments). Blood plasma was also assessed for metabolic and 
inflammatory biomarkers using custom U-PLEX assays (MSD, K151ACM-2), which 
were also performed according to the manufacturer’s instructions. Blood plasma 
samples were diluted 1:3 for the U-PLEX assays. U-PLEX markers were linked as 
following; Plate 1: 1) Leptin, 2) PYY, 3) GLP-1 – total, 4) IFNγ, 5) Il-4, 7) TNF-α, 8) Il-10, 
9) C-peptide, 10) Ghrelin – total; Plate 2: 1) GLP-1 – active. The working solution was 
supplemented with DPP-IV inhibitor (final concentration 1%, Sigma, DPP4). Plates 
were read using the MESO QuickPlex SQ 120. Duplicates with ≥ 20% coefficient of 
variability were re-analysed. Samples did not undergo any additional freeze-thaw 
cycles. 
6.2.3.2.8 Collection and analysis of cortisol awakening response samples 
To monitor the cortisol awakening response, saliva from visits 2 and 4 was collected 
in Salivette devices (Sarstedt, 51.1534.500) immediately upon awakening, and after 
30, 45 and 60 minutes. Participants were instructed to keep samples in the fridge 
until delivery at the visit time, after which they were centrifuged at 1500 g for 5 min, 
the saliva was harvested and immediately stored at -80 °C. Salivary cortisol 
concentrations were quantified using ELISA kits (Enzo life sciences, ADI-901-071), 
which were performed according to the manufacturer’s instructions. Saliva samples 
were diluted 1:2. Plates were read at 405 nm with a correction at 580 nm using the 
synergy HT plate reader (Biotek instruments). Duplicates with ≥ 20% coefficient of 
variability were re-analysed. Samples did not undergo any additional freeze-thaw 
cycles. Cortisol awakening response was calculated using the area under the curve 
increase (AUCi). Briefly, data from the 30-, 45- and 60-minute time-points were 
normalized (delta) to the samples taken immediately upon awakening, after which 
the sum was taken of the 30-, 45- and 60-minute time-points (Stalder et al., 2016).  
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6.2.3.3 Murine and Human Microbiota 
6.2.3.3.1 Murine and Human Microbiota sequencing 
Murine cecal DNA was isolated using the QIAamp Fast DNA Stool Mini kit (Qiagen) as 
previously described and kept at -20°C until further analysis (Burokas et al., 2017). 
Isolated DNA was quantified on a NanoDrop ND2000 spectrophotometer (Thermo 
Scientific, DE) and used for 16S ribosomal RNA sequencing by Illumina MiSeq System 
(Illumina Inc., USA) according to the manufacturer’s instructions. Briefly, PCR 
amplicons (primers for V3-V4 hypervariable region of the 16S rRNA gene: F (5’-
TCGTCGGCAGCGTCAGATGTGTATAAGAGAC AGCCTACGGGNGGCWGCAG-3') and R 
(5’-GTCTCGTGGGCTCGGAGATGTGTATA AGAGACAGGACTACH VGGGTATCTAATCC-3') 
were purified and libraries prepared as previously described (Burokas et al., 2017). 
Briefly, the 16S V3-V4 amplicons were generated using Kapa HiFi HS ready mix and 
purified using the Agencourt AMPure XP system (Beckman Coulter Genomics, 
Takeley, UK). The Nextera XT Index Kit (Illumina Inc., USA) was used to barcode each 
sample. PCR products were cleaned using AMPure XP beads and a magnetic 96-well 
plate. Final barcoded amplicons were measured using the Qubit dsDNA High 
Sensitivity assay kit on the Qubit 3.0 fluorometer, diluted to 5 ng/µL and pooled. The 
PCR products from both PCR steps (Amplicon & Indexing) were visualised in agarose 
gels stained with SYBR Safe DNA gel stain (Invitrogen). Samples were sequenced at 
Clinical-Microbiomics, Denmark on the Illumina MiSeq platform using a 2 x 300 bp 
kit. After sequencing, reads were assembled, processed and analysed as previously 
described (Burokas et al., 2017). In the microbiota composition analysis, LDA Effect 
Size (LEfSe: Linear Discriminant Analysis Effect Size) was used as an algorithm with 
default settings on the interface Galaxy 
(http://huttenhower.sph.harvard.edu/lefse/) (Segata et al., 2011) to identify taxa 
with differentiating abundances. The differentially abundant features are ranked by 
effect size after undergoing linear discriminant analysis (LDA), using an effect size 
threshold of 2 (log10 scale). In non-technical terms, LEfSe pre-selects features that 
are different between groups and then tries to fit a model to see how well these 
features explain the groups. The score is an average between the effect size and how 
well the model fits, after which they are transformed to a value between -6 and 6. 
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Principal coordinates Analysis (PCoA) was performed based on Bray-Curtis beta 
diversity distances using the Adonis function in the “vegan” (2.4-3) package for R 
(version 3.3.1).  
For the human intervention study, faecal sample collection and DNA extraction was 
performed as previously described (see supplementary material for details) (Yu and 
Morrison, 2004). The DNA samples were processed according to the Illumina 16S 
Metagenomic Sequencing   Library Preparation instructions as described above for 
the murine DNA samples. Final barcoded amplicons were measured using the Qubit 
dsDNA High Sensitivity assay kit on the Qubit 3.0 fluorometer, diluted to 8.3 ng/µL, 
pooled and sent for sequencing. Microbiome analysis was carried out in R (version 
3.6.1) with Rstudio (version 1.2.1335). DADA2 was used to denoise and call amplicon 
sequence variants (ASVs). Taxonomy was assigned using the SILVA SSUREf database 
version 132. ASVs unknown on a genus level were excluded, as well as ASVs present 
in two or fewer samples. The ALDEx2 library used to compute the centered log-ratio 
transformed values of the remaining taxa (Fernandes et al., 2014). For principal 
components analysis (PCA), a pairwise implementation of the adonis() PERMANOVA 
function in the vegan library followed by the Bonferroni-Holm correction was used 
to test for difference in β-diversity in terms of Aitchison distance (source: Oksanen, 
Jari, et al. "Package ‘vegan’." Community ecology package, version 2.9 (2013): 1-295). 
Differential abundance was assessed using a pairwise implementation of the 
aldex.test() function, followed by Benjamini-Hochberg correction. In all cases, a q-
value < 0.1 was considered significant. α-diversity was computed using the iNEXT 
library (Hsieh and Chao, 2017). 
6.2.3.4 Faecal SCFA quantification 
Faecal samples were homogenised with acidified water (HCl pH 3) at a ratio of 1:7.5 
w/v and analyzed by gas chromatography flame ionisation detection (GC-FID) using 
a Varian 3800 GC system, fitted with an Agilent DB-FFAP column (30 mL x 0.32mm ID 
x 0.25 μm df; Agilent) and a flame ionisation detector with a CP-8400 auto-sampler. 
Helium was employed as the carrier gas at an initial flow rate of 1.3 mL/min. The 
initial oven temperature was 50 °C, was maintained for 30 seconds, raised to 140°C 
at 10 °C/min and held for 30 seconds, before being increased to 240°C at 20 °C/min, 
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and held for 5 minutes (total run time 20 minutes). The temperatures of the detector 
and the injection port were 300 °C and 240 °C, respectively. A split-less injection of 
0.2 µL was carried out for each sample or standard using a 10 µL syringe (Agilent) 
installed to a CP-8400 auto-sampler (Varian). A 5 m guard column was installed 
between the injector and analytical column (Restek). Peak integration was 
performed using Varian Star Chromatography Workstation version 6.0 software. 
Vials containing 1800 µL of water were run between each sample duplicates as blanks 
to control for any potential carryover. Standards were included in each run to 
maintain the calibration. For further details on sample and standards preparation see 
supplementary information. 
6.2.3.5 Questionnaires 
Using self-report scales, participants were assessed for perceived stress using 
Cohen’s Perceived Stress Scale and anxiety and depression using the Hospital Anxiety 
and Depression Scale (HADS) at baseline, after 6 and after 12 weeks, as previously 
described (Cohen et al., 1983; Zigmond and Snaith, 1983). In addition, satiety/hunger 
was determined using a visual analogue Hunger/Satiety scale, physical activity using 
the International Physical Activity Questionnaire (IPAQ) (Craig et al., 2003). Nutrient 
intake was assessed using a Food Frequency Questionnaire (FFQ), as previously 
described (Harrington et al., 2011).  
6.2.3.6 Statistical analysis 
Preclinical data were assessed for normality using the Shapiro-Wilk test. Normally 
distributed data were analysed using a two-way ANOVA, followed by Fisher’s least 
significant difference (LSD) post hoc test. Non-parametric datasets were analysed 
using the Kruskal-Wallis test, followed by the Mann-Whitney U test with Bonferroni 
adjustment of p-values. Body weight changes and glucose levels in glucose tolerance 
test were analysed with a two way repeated-measures ANOVA (with Diet and 
Probiotic as two independent factors and Time as a repeated-measured factor), 
followed by LSD post hoc test at each time point. Statistical analysis was performed 
using SPSS software (IBM SPSS statistics 22). Preclinical data are represented as mean 
± SEM.  
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For the human intervention study, differences between the treatment and placebo 
groups at the last visit (i.e. visit 4) were analysed using an analysis of covariance 
(ANCOVA), correcting for baseline variance (i.e. visit 2) and sex. Comparisons 
between baseline measurements (visit 2) and post-intervention measurements (visit 
4) were analysed using an unpaired student’s T-test. Analyses were performed on 
the intention to treat populations. Statistical analysis was performed using SPSS 
software version 26 (IBM Corp). Data in table are presented as mean ± SEM or 95% 
CI. P-Values <0.05 were considered statistically significant. Partial eta-squared (η2) 
was used to estimate effect size (Tabachnick and Fidell, 2012). Effect sizes were 
interpreted as following: η2 ≤ 0.06 was considered small, 0.06 > η2 ≤ 0.14 was 
considered moderate, η2 ≥ 0.14 was considered large. 
 
6.2.4 Results  
6.2.4.1 B. longum APC1472 decreases body weight gain and fat depots 
accumulation in obese mice 
B. longum APC1472 decreased body weight gain after 15 weeks of administration (F 
(1, 33) = 4.751, p = 0.037) (Figure 6.1-2A, 2B). HFD feeding increased caloric intake (F 
(1, 15) = 9.229, p = 0.008) (Figure S1C), body weight (F (1, 33) = 29.715, p < 0.001)  
(Figure 6.2-2A) and fat depot accumulation (mesenteric (F (1, 33) = 61.328, p < 
0.001), retroperitoneal (F (1, 32) = 128.409, p < 0.001), subcutaneous (F (1, 31) = 
124.091, p < 0.001) and epididymal (F (1, 33) = 81.673, p < 0.001)) (Figure 6.2-2C, D, 
E, F). Pairwise comparisons showed a significant decreased body weight effect of B. 
longum APC1472 in HFD-fed mice (p = 0.047) (Figure 6.2-2B), which was independent 
of caloric intake (Figure S1). Furthermore, the administration of B. longum APC1472 
significantly reduced fat depot accumulation (mesenteric (F (1, 33) = 5.908, p = 
0.021), and subcutaneous (F (1, 33) = 4.270, p = 0.047)) (Figure 6.2-2C, D, E, F). Finally, 
pairwise comparisons revealed a significant decreased fat depot accumation effect 
of B. longum APC1472 administration in HFD-fed mice (mesenteric p = 0.002, 




6.2.4.2 B. longum APC1472 administration improves glucose tolerance, circulating 
levels of leptin and corticosterone in obese mice 
Effect of HFD feeding (F (5, 155) = 3.321, p = 0.007) and a B. longum APC1472 
supplementation (F (5, 155) = 4.792, p < 0.001) effect were observed, as well as an 
interaction effect between these two factors and time (F (5, 155) = 3.307, p = 0.007) 
in the glucose tolerance test. Supplementation with B. longum APC1472 normalized 
glucose levels after 15 mins of glucose administration in HFD-fed obese mice (p = 
0.006) and also significantly decreased glucose after 90 (p = 0.019) and 120 min (p = 
0.018) respectively (Figure 6.2-3A) as determined by 2 way ANOVAs at each 
individual timepoint. Moreover, HFD feeding (F (1, 33) = 29.761, p < 0.001), B. longum 
APC1472 (F (1, 33) = 4.425, p = 0.043) and interaction effects between these two 
factors (F (1, 33) = 5.337, p = 0.027) were also observed when analyzing the area 
under the glucose levels curve (AUC) (Figure 6.2-3B), with B. longum APC1472 
administration  significantly reducing AUC in HFD-fed mice (p = 0.003) as determined 
by post-hoc comparison (Figure 6.2-3B). In addition, both a HFD feeding (F (1, 33) = 
9.167, p = 0.005) and a B. longum APC1472 effect  (F (1, 33) = 4.796, p = 0.036) were 
observed for non-fasting insulin levels (Figure 6.2-3C). Interestingly, B. longum 
Figure 6.2-2. Effects of Bifidobacterium longum APC1472 on body weight and fat depots accumulation in 
mice. (A) Weekly body weight gain, (B) total body weight gain and (C) mesenteric, (D) retroperitoneal, (E) 
subcutaneous and (F) epididymal fat depots accumulation (% of total body weight) in control mice treated 
with drinking water containing sterile PBS (2% v/v) and glycerol (0.5% v/v) and fed a control low-fat diet 
(LFD)  (n=10) or a high-fat diet (HFD) (n=9) and in mice treated with B. longum APC1472 in drinking water 
(2x108 CFU/mL) and fed a LFD (n=9 in A, B, C, E and F; n=8 in D) or a HFD (n=9 in A, B, C, D, and F; 
n=8 in E) for 15 (A, and B) or 16 weeks (C, D, E and F). Data are shown as mean ± SEM.. Data are significant 
different (p<0.05) accordingly to Repeated Measures ANOVA (A) or two-way ANOVA followed by LSD post-
hoc test (B, C, D, E and F). * indicates significant diet treatment effect (*p<0.05, **p<0.01, ***p<0.001) 




APC1472 reduced non-fasting insulin levels in LFD-fed mice (p = 0.054) but not in 
HFD-fed mice (Figure 6.2-3C). However, for fasting glucose levels, only a HFD feeding 
effect was observed (F (1, 32) = 29.153, p < 0.001) (Figure 6.2-3D). Moreover, both a 
HFD feeding (F (1, 31) = 30.926, p < 0.001) and a B. longum APC1472 effect (F (1, 31) 
= 17.917, p < 0.001) was observed for epididymal insulin receptor substrate 1 (IRS-1) 
expression  (Figure 6.2-3E). Post-hoc comparisons determined that interestingly, B. 
longum APC1472 significantly reduced IRS-1 expression in both LFD (p = 0.002) and 
HFD-fed mice (p = 0.011) (Figure 6.2-3E). Both a HFD feeding (F (1, 33) = 38.023, p < 
0.001) and a B. longum APC1472 (F (1, 33) = 5.340, p = 0.027) effect as well as an 
interaction effect (F (1, 33) = 4.237, p = 0.048) was observed for fasting leptin levels 
(Figure 6.2-3F). The effect of HFD on leptin levels  was attenuated by B. longum 
APC1472 treatment (p = 0.004). Finally, we found a significant B. longum APC1472 
treatment effect (F (1, 32) = 7.774, p = 0.009) for plasma corticosterone levels (Figure 
6.2-3G). Administration of B. longum APC1472 significantly decreased plasma 
corticosterone levels in HFD-fed mice (p = 0.011) (Figure 6.2-3G), which may have 




6.2.4.3 B.  longum APC1472 induces changes of hypothalamic neuropeptide 
expression in mice 
Analysis of the gene expression levels of hypothalamic neuropeptides involved in 
appetite modulation revealed a significant HFD effect on the gene expression of the 
orexigenic peptide agouti-related protein (AgRP) (F (1, 33) = 10.412, p = 0.003)  but a 
non-significant reduction in neuropeptide Y (NPY) expression (Figure S3). 
Interestingly, both a B. longum APC1472 effect (F (1, 33) = 7.820, p = 0.009) and an 
interaction effect (F (1, 33) = 5.881, p = 0.021) were observed for cocaine- and 
Figure 6.2-3. Bifidobacterium longum APC1472 improved glucose tolerance, leptin plasma levels and 
stress-induced corticosterone circulating levels in high-fat diet-induced obesity in mice. (A and B) Glucose 
tolerance test (GTT) glucose curve and area under the curve (AUC) after 1 g/kg glucose challenge, (C and 
D) non-fasting and fasting insulin plasma levels, (E) fasting leptin plasma levels, (F) epididymal fat insulin 
receptor substrate (IRS)-1 mRNA expression and (G) fasting-induced corticosterone plasma in control mice 
treated with drinking water containing sterile PBS (2% v/v) and glycerol (0.5% v/v) and fed a control low-fat 
diet (LFD)  (n=10 in A, B, C, E, F and G) or a high-fat diet (HFD) (n=9 in A, B, C, D, E and G; n=8 in F) 
and in mice treated with B. longum APC1472 in drinking water (2x108 CFU/mL) and fed a LFD (n=9 in A, 
B, C, D, E and F; n=8 in G) or a HFD (n=9 in A, B, C, D, E and F; n=8 in G) for 15 (A, B,C) or 16 weeks 
(D, E, F and G). Data are shown as mean ± SEM. Data are significant different (p<0.05) accordingly to 
Repeated Measures ANOVA (A) or two-way ANOVA followed by LSD post-hoc test (B, C, D, E, F and G). * 
indicates significant diet treatment effect (*p<0.05, **p<0.01, ***p<0.001) and # indicates significant B. 




amphetamine-regulated transcript (CART) expression (Figure S3). Indeed, B. longum 
APC1472 administration significantly reduced CART expression in HFD-fed mice (p = 
0.001). While a reduced expression was observed for the anorexigenic pro-
opiomelanocortin (POMC) gene expression in HFD-fed animals treated with B. 
longum APC1472 compared to HFD-fed, this did not reach statistical significance. 
Finally, no significant change in leptin (LEP-R) nor ghrelin (GHS-R1a) receptor 
expression was observed (Figure S3). 
6.2.4.4 Human Intervention Study population 
In the human study, no significant differences were observed in weight, BMI, W/H 
ratio, age, height, sex, ethnicity, mode of delivery, alcohol consumption, 
medical/surgical history and compliance at baseline between B. longum APC1472 
treatment and placebo groups (Table 1). We did observe an increased prevalence of 
concomitant medical or nutritional supplement consumption in the treatment group 
(48.6%) compared to the placebo group (33.3%). In addition, we also observed 
differences in the socioeconomic profile where there was a lower prevalence of 
employers and managers in the treatment group (2/74) compared to the placebo 
group (4/48). Similarly, we observed a lower prevalence of past smokers in the 
treatment group (28/74) compared to the placebo group (9/48). In conclusion, the 
baseline characteristics of our placebo group and B. longum APC1472 group are 
mostly the same. 
Physical activity and food intake patterns were also assessed, using self-report 
questionnaires, throughout the study (Table S2, S3). No differences in physical 
activity levels or calorie, macro- and micronutrient intake were observed over the 
12-week treatment period or between the placebo and B. longum APC1472 group. 
6.2.4.4.1 Adverse Events 
There were seven adverse events (6 placebo participants and 1 treatment 
participant) that were possibly related to the investigational product. The adverse 
event of the treatment participant was constipation. The remaining 6 adverse events 
were; gastro-intestinal discomfort and increased appetite; bloating; increased 
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flatulence; aches in joints and increased temperature; rash on knees, elbows, scalp 
and red blotches on chest & upper arm.  
Table 1. Baseline characteristics of subjects in the placebo and treatment arms at visit 






(n = 48, mean ± STD) 
B. longum APC1472 
(n = 74,  mean ± STD) 
Weight (kg) 87.9 ± 1.7 89.0 ± 1.3 
BMI 31.2 ± 0.3 30.8 ± 0.2 
W/H ratio 0.95 ± 0.01 0.96 ± 0.01 
Age (years) 46.3 ± 9.9 44.9 ± 11.4 
Height (m) 1.67 ± 0.10 1.70 ± 0.09 
Sex (no. of subject (%)) 
Male 19 (39.6 %) 34 (45.9 %) 
Female 29 (60.4 %) 40 (54.1 %) 
Race or ethnicity (no. of subject (%)) 
Caucasian 48 (100 %) 73 (98.6 %) 
Arabic 0 (0 %) 1 (1.4 %) 
Socioeconomic status (no. of subject (%)) 
Non-manual 15 (31.3 %) 21 (28.4 %) 
Lower Professional 14 (29.2 %) 19 (25.7 %) 
Manual skilled 4 (8.3 %) 8 (10.8 %) 
Semi-skilled 4 (8.3 %) 8 (10.8 %) 
Employers and managers 4 (8.3 %) 2 (2.7 %) 
Own account workers 3 (6.3 %) 7 (9.5 %) 
Higher Professional 3 (6.3 %) 5 (6.8 %) 
All others gainfully occupied and 
unknown 
1 (2.1 %) 2 (2.7 %) 
Farmer 0 (0 %) 1 (1.4 %) 
Unskilled 0 (0 %) 1 (1.4 %) 
Smoking status (no. of subject (%)) 
Non-smoker 22 (45.8 %) 40 (54.1 %) 
Past smoker 17 (35.4 %) 28 (37.8 %) 
Current smoker 9 (18.8 %) 6 (8.1 %) 
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6.2.4.5 B. longum APC1472 does not affect BMI and W/H ratio in humans 
The primary outcome of this study was to investigate whether B. longum APC1472 
supplementation could alter BMI, and a secondary outcome of change in W/H ratio 
was included to support the primary outcome. However, no differences were 
observed in BMI and W/H ratio over the 12-week treatment period, or between the 
placebo and B. longum APC1472 treatment groups (Figure 6.2-4). 
 
Alcohol consumption (mean ± SEM) 
Units per week 4.97 ± 0.68 4.31 ± 0.46 
Currently on concomitant medical or nutritional supplements (no. of subject (%)) 
Yes  16 (33.3 %) 36 (48.6 %) 
No 32 (66.7 %) 38 (51.4 %) 
Compliance (% product consumed) 
Week 6 95.8 ± 1.2 97.9 ± 0.8 





6.2.4.6 B. longum APC1472 improves fasting glucose levels independent of other 
blood markers of energy metabolism and satiety in humans 
We subsequently measured markers associated with host energy metabolism and 
satiety as part of the secondary and exploratory outcome measures (Figure 6.2-5 and 
Table S4 for full statistical results). Here we observed that both the B. longum 
APC1472 and the placebo arm reduced fasting glucose levels over the 12-week 
treatment period (Figure 6.2-5A). However, glucose levels were 0.266 mmol/L (95% 
CI [-0.44, -0.09]) lower in the B. longum APC1472 group compared with the placebo 
group (F(1,112) = 9.073, p = 0.003) (Figure 6.2-5B). The effect size of the B. longum 
APC1472-induced decrease was moderate (η2 = 0.075). We also observed that HbA1c 
levels decreased over the 12-week treatment period in both the placebo group 
(t(62.372) = 4.277, p < 0.001) and B. longum APC1472 treatment group (t(85.983) = 
5.787, p < 0.001) (Figure 6.2-5C). However, there were no differences between the 
groups, indicating that the decrease in HbA1c levels is most likely explained by the 
12-week treatment period or placebo effect. No changes were observed in other 
biomarkers of host metabolism such as insulin, C-peptide, ghrelin (active and total), 
Figure 6.2-4. B. longum APC1472 supplementation does not impact BMI and W/H ratio in overweight and 
obese individuals. Body mass index (BMI) (A, B) and waist-to-hip ratio (W/H ratio) (C, D) were measured as 
the beginning of the study (pre), after 6 weeks (mid) and after 12 weeks (post) of treatment. All BMI and W/H 
ratio data are depicted of all 3 timepoints (A, C), as well as the change after 12 weeks compared to at the 
beginning of the study (B, D). Data are depicted as boxplot or scatter dot plot, where the dots depict individual 
datapoints. N = 48 for the placebo group and n = 74 for the B. longum APC1472 treatment group. 
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GLP-1 (active and total), PYY and leptin levels (Figure 6.2-5 E-T). 
 
 
6.2.4.7 B. longum APC1472 does not influence human lipid and inflammatory 
profiles in humans 
It is well-known that obesity is associated with metabolic syndrome, hypertension 
and hyperlipidemia (Jarolimova et al., 2013). B. longum APC1472 did not impact lipid 
Figure 7.5-5. B. longum APC1472 supplementation reduces fasting blood glucose levels in overweight and 
obese individuals. Markers associated with host metabolism and satiety were measured as the beginning of 
the study (pre), after 6 weeks (mid) and after 12 weeks (post) of treatment. All data are depicted of all 3 
timepoints (A, C, E, G, I, K, M, O, Q, R), as well as the change after 12 weeks compared to at the beginning 
of the study (B, D, F, H, J, L, N, P, R, T). Data are depicted as boxplot or scatter dot plot, where the dots 
depict individual datapoints. N = 48 for the placebo group and n = 74 for the B. longum APC1472 treatment 




profiles (i.e. cholesterol, triglycerides and LDL), and inflammatory profiles (i.e. IL-10, 
TNF-α and IFNγ) compared to the placebo group (Table 2). In addition, vital signs 
remained unaltered throughout the study (Table S5). These results reveal that B. 
longum APC1472 did not evoke any negative effects on vital signs or induced any 
inflammation. Interestingly, even though no significant changes were observed in 
HDL levels over the 12-week treatment period, a small increase in HDL levels was 
observed in the B. longum APC1472 group (F(1,117) = 3.260, p = 0.074). The effect-
size of the increase in HDL levels was small (η2 = 0.027).  
6.2.4.8 B. longum APC1472 does not affect satiety, mood, perceived stress and 
cortisol awakening response in humans 
Considering that the gut microbiota has been implicated in the modulation of host 
mood and food intake behaviour (van de Wouw et al., 2017; Lach et al., 2018), we 
investigated whether B. longum APC1472 could improve levels of the stress hormone 
cortisol upon waking (i.e. cortisol awakening response), or self-reported measures of 
satiety, and self-reported measures of mood (i.e. perceived stress, anxiety and 
depression) (Table 3). B. longum APC1472 did not impact cortisol awakening 
response, or self-reported satiety, perceived stress, anxiety and depression 
measures. 
6.2.4.9 B. longum APC1472 improves fasting glucose levels, active ghrelin and 
cortisol awakening response in obese individuals 
Participants in this study were either overweight (n = 40; 28 ≥ BMI < 30) or obese (n 
= 82; 30 ≥ BMI < 35). It is possible that B. longum APC1472 could evoke a stronger 
effect in obese individuals as they have a stronger phenotype compared to 
overweight individuals. As such, we investigated whether any of the 
anthropomorphic measures, blood biomarkers and measures of mood were affected 
by B. longum APC1472 in the obese subpopulation only compared to placebo (Figure 
6.2-6 and Table S7-11 for population characteristics and full statistical results). 
Similar to the analysis on the entire study population, B. longum APC1472 and 
placebo reduced fasting glucose levels over the 12-week treatment period (Figure 
6.2-6A). However, glucose levels were 0.295 mmol/L (95% CI [-0.5, -0.1]) lower in the 
B. longum APC1472 group compared to the placebo group (F(1,75) = 7.566, p = 
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0.007), with a moderate effect size (η2 = 0.092) (Figure 6.2-6B). Furthermore, B. 
longum APC1472 increased active ghrelin levels (F(1,74) = 4.903, p = 0.030), with a 
moderate effect size (η2 = 0.062). B. longum APC1472 also reduced cortisol 
awakening response (F(1,51) = 4.415, p = 0.041), with a moderate effect size (η2 = 
0.080).  
Overall, these results show beneficial effects of B. longum APC1472 on fasting plasma 
glucose levels, active ghrelin levels and cortisol awakening response in obese 
individuals. It is also important to note that the effect size in the obese subpopulation 
(η2 = 0.092) was bigger than the effect size in the overall study population (η2 = 
0.075). This indicates that B. longum APC1472 has a more robust beneficial effect on 




Figure 6.2-6. B. longum APC1472 supplementation reduces fasting blood glucose levels and cortisol 
awakening response and increase active ghrelin in obese individuals. Fasting glucose and active ghrelin 
levels were measured at the beginning of the study (pre), after 6 weeks (mid) and after 12 weeks (post) of 
treatment. Cortisol awakening response was only assesed at the beginning of the stduy. All data are depicted 
of all 3 timepoints (A, C, E), as well as the change after 12 weeks compared to at the beginning of the study 
(B, D, F). Data are depicted as boxplot or scatter dot plot, where the dots depict individual datapoints. N = 
36 for the placebo group and n = 46 for the B. longum APC1472 treatment group. * indicates a significant 
effect (*p<0.05, **p<0.01) 
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6.2.4.10 B. longum APC1472 does not induce major rearrangements on the 
microbiota composition but increases the abundance of Bifidobacterium  
We subsequently investigated whether the observed changes induced by the B. 
longum APC1472 strain were mediated in part through modulation of the gut 
microbiota. Investigations into the cecal microbiota in the preclinical experiment 
revealed that there was a significant dissimilarity in beta diversity between LFD- and 
HFD-fed mice (p < 0.01) (Figure S5A), with a decreased relative abundances of 
Bacteroidetes phylum and increased relative abundances of Firmicutes class 
Clostridia, respectively (Figure S5B), which is in line with previous studies (Nadal et 
al., 2009; Clarke et al., 2012). Different phylotypes were responsible for the cecal 
microbiota differences among the treatment groups (Figure S5C), showing 
increments on different Firmicutes members in HFD-fed mice treated with B. longum 
APC1472. Moreover, B. longum APC1472 partially ameliorated the HFD-induced 
decrease in Bifidobacteriaceae relative abundance (p = 0.054, adjusted p = 0.170) 
(Figure S5D).  
Analysis of the faecal microbiota in the human intervention study revealed that B. 
longum APC1472 did not impact the alpha diversity indices (Shannon, Simpson and 
Chao1, Figure 6.2-7A-C). Furthermore, the overall composition of the microbiota 
remained unaffected as determined by the PCA analysis of the beta diversity (Figure 
6.2-7D). B. longum APC1472 did increase Bifidobacterium relative abundance over 
the 12-week intervention period (t(57) = -2.891, p = 0.005), which was not observed 
in the placebo group (Figure 6.2-7E). This resulted in a higher Bifidobacterium 
abundance in the treatment group compared to the placebo group post-intervention 
(F(3, 89) = 5.922, p = 0.017) (Figure 6.2-7F). Similar results were observed in the 





Short-chain fatty acids (SCFAs) are potentially one of the most investigated gut 
microbiota-derived metabolites implicated in host energy metabolism and obesity 
symptomatology (Torres-Fuentes et al., 2017; van de Wouw et al., 2017). Analysis of 
faecal SCFA levels in human samples revealed no differences in levels of acetate, 
propionate, butyrate and valerate (Table S6). Furthermore, isobutyrate and 
isovalerate levels remained unaffected (Table S6).  
6.2.5 Discussion  
There has been an increased emphasis on gut microbiota-targeted therapeutics for 
the amelioration of obesity (Torres-Fuentes et al., 2014; Cani et al., 2019; Muscogiuri 
et al., 2019; Sivamaruthi et al., 2019). For example, recent studies have identified 
several probiotic strains with different anti-obesity effects, including members of the 
genus Bifidobacterium (Jung et al., 2013; Rajkumar et al., 2014; Torres-Fuentes et al., 
Figure 6.2-7. B. longum APC1472 increases Bifidobacterium abundance without impacting the overall 
composition of the gut microbiota in humans. The gut microbiota was assesed at the beginning (pre) and 
end of the study (12 weeks, past). Alpha (A-C) and beta diversity (D) were investigated, as wel as the bacterial 
genera present (E-F). Microbial taxa were centre-log-transformed (CLR). Significant differences between pre 
and post were anlysed using the Mann-Whitney U test, whereas treatment differences were analysed using an 
ANCOVA controlling for sex and pre-intervention Bifidobacterium abundance. Data are depicted as boxplot 
or scatter dot plot, where the dots depict individual datapoints. N = 48 for the placebo group and n = 74 for 




2014; Zarrati et al., 2014; Stenman et al., 2016; Sabico et al., 2017; Kim et al., 2018; 
Hibberd et al., 2019), but the exact mechanisms of action are still lacking. In the 
present study, we demonstrate that a novel isolated B. longum APC1472 strain, 
which was previously shown to attenuate ghrelinergic signalling (Torres-Fuentes et 
al., 2019), reduces body weight gain, fat depot size, glucose tolerance and leptin 
levels in a preclinical mouse model of HFD-induced obesity. Furthermore, when the 
B. longum APC1472 strain was investigated in a human cohort of healthy overweight 
and obese individuals a reduced fasting blood glucose level was observed. 
Noteworthy, stratification and analysis of the obese human subpopulation revealed 
that B. longum APC1472 was able to normalize active ghrelin levels and the cortisol 
awakening response, which are both dysregulated in obesity (Tschop et al., 2001; 
Yildiz et al., 2004; Cummings, 2006; Wester et al., 2014; Zigman et al., 2016; Jackson 
et al., 2017). This highlights the translational value of this novel Bifidobacterium 
longum species, B. longum APC1472, from a preclinical mouse model to a human 
intervention study where this probiotic positively impacts markers of obesity, which 
may be linked to the ghrelinergic effects previously demonstrated (Torres-Fuentes et 
al., 2019). Specifically, we found that in the preclinical mouse model of obesity, the 
supplementation with B. longum APC1472 significantly reduced fat depots and body 
weight gain in HFD-fed mice independent of energy intake. Furthermore, B. longum 
APC1472 significantly reduced circulating leptin levels in HFD-fed mice, which is in 
line with the reduction in fat depot size as leptin is released into the bloodstream in 
proportion to body fat mass (Friedman and Halaas, 1998). Notably, circulating levels 
of leptin were increased in HFD-fed mice compared to LFD-fed mice with no 
alterations in leptin receptor hypothalamic expression, suggesting no alterations in 
leptin sensitivity, as has been previously reported in obesity (Cui et al., 2017). No 
changes were observed in the hypothalamic expression of the orexigenic peptides 
NPY and AgRP following B. longum APC1472 supplementation in mice. Both NPY and 
AgRP are orexigenic peptides that increase food intake when overexpressed or when 
administered centrally (Ilnytska and Argyropoulos, 2008; Zhang et al., 2014) and HFD-
fed mice demonstrate, as expected, a decrease in both of these orexigenic peptides. 
In contrast, increased hypothalamic expression of anorexigenic peptides such as 
POMC and CART in response to a high-fat diet has been suggested as a natural 
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feedback mechanism in order to maintain energy balance and body weight 
homeostasis (Bergen et al., 1999; Tian et al., 2004). The B. longum APC1472 was able 
to normalize the increased hypothalamic expression of the anorexigenic peptide 
CART in HFD-fed mice, suggesting a lower degree of energy imbalance and, therefore, 
a potential reduced metabolic dysfunction compared to HFD-fed mice. Moreover, 
CART is regulated by leptin and its expression is positively correlated with leptin 
levels (Wortley et al., 2004). Therefore, the decreased leptin levels observed in the 
B. longum APC1472-HFD group also support the observed decreased CART 
expression. This highlights the potential of B. longum APC1472 to modulate 
hypothalamic gene expression involved in energy homeostasis and appetite 
regulation, which warrants further investigation. 
In the human intervention study, no differences were observed in the primary 
outcome of BMI, even though the B. longum APC1472 supplementation was able to 
reduce body weight gain in HFD-induced obese mice. Similarly, no differences were 
observed in the supportive secondary outcome W/H ratio. This discrepancy might be 
explained by the fact that the majority of the human intervention cohort was non-
diabetic, whereas the HFD-induced obese mice had a decreased glucose tolerance, 
implying that host glucose metabolism may have been the main factor driving the 
reduction in body weight gain in the obese mice. It must also be noted that the 
treatment duration of the preclinical study was longer and, therefore, a longer 
treatment period in the human intervention study, or a higher treatment dosage, 
could have resulted in more significant differences and bigger effect-sizes. The 12-
week duration of the human study may have been too short of a time to see 
significant changes in BMI and W/H ration. Age has also been shown to affect body 
fat distribution and metabolism increasing both the risk and the severity of obesity 
development (Jura and Kozak, 2016). Therefore, some of the discrepancies and lack 
of translation between the mice study and humans could be explained by the 
relatively low age of the mice (adolescence to adulthood) versus the human cohort 
with an average age at midlife. A low age may facilitate a better response to changes 
in metabolic and physiologic responses and therefore a higher capacity to positively 
respond to therapeutic interventions. Moreover, the administration strategies were 
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differences between both studies. The mouse study followed a prevention strategy 
as B. longum APC1472 was administered before obesity was established, while in the 
human study the participants were already obese at the time of administration and, 
therefore, presented a more severe condition to ameliorate. 
Most notably, the B. longum APC1472 supplementation significantly improved 
glucose tolerance in HFD-induced obese mice. Similarly, B. longum APC1472 
decreased fasting blood glucose levels in overweight/obese individuals (-0.266 
mmol/L compared to placebo). It is important to note that the participants in this 
study had average fasting blood glucose levels of 5.0 mmol/L, which is considered 
healthy and non-diabetic (n = 11 were prediabetic). Above 5.6 mmol/L is considered 
prediabetic, whereas above 6.9 is considered diabetic (Emerging Risk Factors et al., 
2010; Chatterjee et al., 2017). The data indicate that B. longum APC1472 may have a 
bigger effect-size on fasting blood glucose levels in a prediabetic or diabetic 
population, which warrants further investigations. This is further reinforced by the 
obese subpopulation analysis of the obese individuals, rather than overweight and 
obese combined, which revealed a fasting blood glucose level (-0.295 mmol/L 
compared to placebo), which constitutes a bigger effect-size in fasting blood glucose 
levels (η2 = 0.092 vs 0.075), indicating a more potent treatment efficacy in obese 
individuals. This warrants further investigation into the effect of B. longum APC1472 
in a cohort of prediabetic or diabetic individuals. 
The underlying mechanisms for the decreased fasting blood glucose levels may be 
associated with the changes in ghrelinergic signalling, as B. longum APC1472 was 
found to attenuate ghrelinergic signalling in vitro (Torres-Fuentes et al., 2019) and 
ghrelin has been shown to be involved in glucose homeostasis via inhibition of insulin 
secretion (Ahima, 2006). Moreover, insulin receptor substrate 1 (IRS-1) has been 
reported to play a key role in glucose homeostasis being involved in glucose 
transporter 4 (GLUT-4) mobilization (Dong et al., 2006; Wang et al., 2009). Low IRS-1 
expression levels have been associated with glucose and insulin sensitivity 
impairments (Dong et al., 2006; Wang et al., 2009). Therefore, increased IRS-1 
expression in epididymal fat tissue of B. longum APC1472 treated mice may have also 
influenced glucose homeostasis. Nevertheless, glucose metabolism is multifactorial 
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and other mechanisms are likely also affected following the supplementation of the 
B. longum APC1472. However, while the biggest effect-size was observed on plasma 
glucose levels in both the preclinical and human intervention studies, it is also 
possible that the other observed effects are secondary to the decrease in plasma 
glucose levels. 
Notably, obesity is associated with decreased circulating levels of ghrelin (Tschop et 
al., 2001; Yildiz et al., 2004), which we also observed in the HFD-fed mice and the 
reason why the ghrelinergic system has been implicated as a promising therapeutic 
target to combat obesity (Schellekens et al., 2013; Howick et al., 2017). Indeed, the 
“hunger hormone” ghrelin was first described as a growth hormone secretagogue, 
but its key role in the regulation of appetite, food intake, adiposity and metabolism 
have directed the main therapeutic focus of ghrelin and its receptor towards obesity 
research with promising anti-obesity potential (Tschop et al., 2000; Wren et al., 2001; 
Horvath et al., 2003; Schellekens et al., 2012; Collden et al., 2017; Cui et al., 2017; 
Howick et al., 2017). Interestingly, B. longum APC1472 supplementation increased 
levels of active ghrelin, but not total ghrelin levels, in healthy obese individuals. The 
increase in active ghrelin may indicate an amelioration of the deficiencies in 
ghrelinergic signalling associated with obesity. It is also interesting to note that B. 
longum APC1472 was selected on its ability to modulate the ghrelinergic system in 
vitro (Torres-Fuentes et al., 2019). Future studies are warranted to investigate if 
administration of other bacterial strains and their metabolites, including SCFAs, 
which equally showed the ability to modulate ghrelin signaling in vitro (Torres-
Fuentes et al., 2019), have similar effects in obese individuals.  
Furthermore, our data reveal that B. longum APC1472 decreased fasting 
corticosterone levels in HFD-induced obese mice, indicating the downregulation of 
the hypothalamic-pituitary-adrenal (HPA) axis. In line with these results, B. longum 
APC1472 reduced cortisol awakening responses in obese individuals. Dysregulation 
of the HPA axis, which is colloquially seen as the “body’s stress system”, is a risk factor 
for obesity-related conditions such as cardiovascular disease, insulin resistance and 
type 2 diabetes (Incollingo Rodriguez et al., 2015). Hence, the stress hormone cortisol 
(corticosterone in rodents), which is central in the HPA axis, has been shown to 
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promote the accumulation of fat cells and weight gain (Incollingo Rodriguez et al., 
2015) and to regulate the function of pancreatic α and β cells affecting glucagon and 
insulin secretion (Kuo et al., 2015). As such, even though no changes were observed 
in insulin, the changes in cortisol awakening responses could indicate that the HPA 
axis has contributed to the B. longum APC1472-induced decrease in fasting blood 
glucose. Furthermore, the HPA axis is also affected by ghrelin, indicating that the 
observed changes in ghrelin could have also contributed to the changes in cortisol 
(Bali and Jaggi, 2016).  
Finally, we investigated the effects of B. longum APC1472 treatment on gut 
microbiota composition. Overall, B. longum APC1472 treatment did not have a major 
impact on microbiota composition other than the partial restoration of 
Bifidobacterium levels in HFD-fed mice. These findings are in line with the effects of 
B. longum APC1472 on healthy human overweight and obese individuals and with 
other investigations on obesity using different probiotics strains, where major 
rearrangements on microbiota composition were also not observed (Depommier et 
al., 2019; Everard et al., 2019). 
Of note, while the modulation of ghrelin receptor signalling by B. longum APC1472 
strain may have contributed to an improved metabolic profile, we cannot rule out 
other beneficial anti-obesity effects. As such, future studies are warranted further 
investigating the mechanisms and metabolites through which B. longum APC1472 
modulates host glucose homeostasis, with a focus on the ghrelinergic system.  
In conclusion, we have demonstrated positive anti-obesity effects of a novel B. 
longum APC1472 in HFD-induced obese mice and a partial translation of these 
positive effects of B. longum APC1472 supplementation in otherwise healthy 
overweight and obese individuals. In particular, we show the promising potential of 
B. longum APC1472 to be developed as a valuable supplement in reducing specific 
markers of obesity, possibly via the ghrelinergic system. Most notably, the decrease 
in fasting plasma glucose induced by B. longum APC1472 may have clinically 
significant health indications for prediabetic and type 2 diabetes mellitus populations 
in particular.   
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6.3.1 Abstract:  
6.3.1.1 Introduction:  
The gut microbiota plays a role in gut-brain communication and can influence 
psychological functioning. Diet is one of the major determinants of gut microbiota 
composition.  The impact of unpasteurized dairy products on the microbiota is 
unknown. In this observational study, we investigated the effect of a dietary change 
involving intake of unpasteurized dairy on gut microbiome composition and 
psychological status in participants undertaking a residential 12-week cookery course 
on an organic farm.  
6.3.1.2 Methods:  
Twenty-four participants completed the study. The majority of food consumed 
during their stay originated from the organic farm itself and included unpasteurized 
milk and dairy products. At the beginning and end of the course, participants 
provided faecal samples and completed self-report questionnaires on a variety of 
parameters including mood, anxiety and sleep. Nutrient intake was monitored with 
a food frequency questionnaire. Gut microbiota analysis with performed with 16S 
rRNA gene sequencing. Additionally, faecal short chain fatty acids (SCFAs) were 
measured.  
6.3.1.3 Results:  
Relative abundance of the genus Lactobacillus increased significantly between pre- 
and post-course time points. This increase was associated with participants intake of 
unpasteurized milk and dairy products. An increase in the faecal SCFA, valerate was 
observed along with an increase in the functional richness of the microbiome profile, 
as determined by measuring the predictive neuroactive potential using a gut-brain 
module approach.  
6.3.1.4 Conclusions:  
While concerns in relation to safety need to be considered, intake of unpasteurized 
milk and dairy products appear to be associated with the growth of the probiotic 
bacterial genus, Lactobacillus in the human gut. More research is needed on the 
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effect of dietary changes on gut microbiome composition, in particular in relation to 
the promotion of bacterial genera such as Lactobacillus, which are recognized as 
being beneficial for a range of physical and mental health outcomes. 
 
6.3.2 Introduction 
A growing body of evidence over the past decade has demonstrated the importance 
of the gut microbiome in all aspects of physical and mental health. While it is still 
unclear what exactly constitutes a ‘healthy’ gut microbiome, certain bacterial groups 
have been strongly associated with better health outcomes. Lactobacillus is one of 
the foremost genera considered to have probiotic properties (Di Cerbo et al., 2016). 
A probiotic is defined as a live microorganism which, when administered in adequate 
amounts, confers a health benefit on the host (Hill et al., 2014). The word 
‘psychobiotic’ is an expansion of this term and describes an organism which has been 
proven to be beneficial in relation to psychological functioning (Dinan et al., 2013). 
There have been a wide variety of studies undertaken in recent years which have 
demonstrated the benefit of a Lactobacillus probiotic, both mono- and multi-strain, 
for improving a range of health outcomes including obesity (John et al., 2018), 
diabetes (Hsieh et al., 2018), liver disease (Wong et al., 2013), cardiovascular disease 
(DiRienzo, 2014), gastrointestinal conditions (Wilkins and Sequoia, 2017) and 
neuropsychiatric disorders such as depression, anxiety and autism (Butler et al., 
2019). 
A key present-day challenge involves identifying the most effective ways of 
maintaining a healthy gut microbiome and promoting the growth of probiotic 
bacteria. While commercial probiotic products are widely available, there are 
concerns in relation to regulation, quality control, efficacy and cost (Kolacek et al., 
2017). Dietary intake is one of the main factors regulating gut microbiome 
composition and food-based interventions can be tailored to each individual to 
modify their bacterial profile (Johnson et al., 2019). While unravelling the diet-
microbiome relationship is a formidable task given the many confounding factors, 
attempts to do so have been made over the past decade. Gut microbiome profile has 
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been shown to be distinctly different in those living in rural areas with a traditional 
diet in comparison to urban-based westernized populations (De Filippo et al., 2010; 
Yatsunenko et al., 2012; Clemente et al., 2015). Even when one accounts for 
contributions of human genetic and geographical factors between populations, 
subsistence methods and diet significantly impact gut microbiota composition (Jha 
et al., 2018). It is hypothesized that a ‘microbiota insufficiency syndrome’ has 
resulted from modern lifestyle with its highly processed diets, overuse of antibiotics 
and increased sanitation and that the ‘industrialized’ microbiota may be a major 
contributing factor in the rise of many non-communicable chronic diseases in 
westernized societies (Sonnenburg and Sonnenburg, 2019). Even as one moves from 
looking at the early ancestral microbiota to more recent times, significant changes in 
lifestyle have continued until relatively recently. Ireland, as with many countries in 
the developed world, was a predominantly agrarian society up until the mid-late 20th 
century. In 1966, over 30% of the workforce were employed in agriculture with this 
figure estimated at less than 5% in 2016 (Office, 2016). Consumption of 
unpasteurized milk was a common part of the diet of those living on farms and 
epidemiological studies suggest that it may have played a protective role against the 
development of allergies and atopic diseases (Braun-Fahrlander and von Mutius, 
2011).  
Despite food safety concerns, the consumption of unpasteurized milk appears to be 
growing in popularity (Buzby et al., 2013; Fagnani et al., 2019). To our knowledge, 
there are no studies exploring the impact of unpasteurized milk intake on the gut 
microbiome. In this observational study, we investigated the effect of a dietary 
change involving the intake of unpasteurized milk on gut microbiota composition, 
metabolites and psychological status in 24 participants undertaking a residential, 
farm-based, 12-week cookery course. Our centre had previously published a study 
(Quigley et al., 2013) on the microbiota composition of unpasteurised milk taken 
from Irish cows which would thus be representative of the expected microbiota 
composition of the raw milk that would be consumed by participants in our study. 
Given the reported high proportion of viable probiotic bacteria such as Lactobacillus 
(and other lactic acid bacteria including Lactococcus and Leuconostoc), along with 
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the fact that Lactobacillus are considered intrinsically resistant to gastric acid 
(Tannock, 2004), we hypothesized that a dietary change involving raw milk 
consumption would alter the gut microbiome of participants with a potential 
differential increase in the relative abundance of these probiotic bacterial groups. 
6.3.3 Results 
6.3.3.1 Participant characteristics 
A total of 62 participants who were completing the 12-week course between May-
July 2018 were informed about the study. Twenty-eight participants volunteered and 
underwent screening. Two were excluded; one had a chronic gastrointestinal 
disorder and another had taken antibiotics in the previous month. Twenty-six 
participants were enrolled with 24 (13 females, 11 males) completing the study; 2 
failed to provide faecal samples. Of note, subject metadata and faecal samples were 
collected within the first three days of the course and again at week 11. The final 
week of the course (week 12) involved several examinations for students and thus, 
the associated increased stress during this week may have had the potential to 
influence findings. Our study sample comprised 24 participants; 13 females and 11 
males. Baseline characteristics of participants, including age, body mass index (BMI), 
smoking status, sleep quality and exercise levels are shown in Table 1.  
  
Table 1: Baseline Characteristics of participants 
 
  Pre-course Post-course P-value 
Number of participants 24   
Female; n (%) 13 (54%)   
Mean age; n (range) 30.25 (18-59)   
Smoking status; n (%) 7 (29)  
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 (BMI: Body Mass Index, IPAQ: International Physical Activity Questionnaire; PSQI: 
Pittsburgh Sleep Quality Index) 
6.3.3.2 Changes in diet 
Based on food frequency questionnaire (FFQ) analysis (Tables 2 and 3), there was no 
change in total calorie intake during the course. In terms of macronutrient intake, 
protein and carbohydrate intake remained unchanged and though total fat 
consumption increased, this change did not reach statistical significance (mean 
increase (g) from 94±35 to 128±66, p=0.08). With regards to micronutrients, Vitamin 
A (µg) intake increased significantly (715±577 to 1505±975, p=0.005)   as did Vitamin 
B12 (µg) (7.8±3.6 to 11±5.8, p=0.04). Although intake of fruit reduced slightly 
(2.02±1.2 to 1.38±0.84, p=0.04) consumption of vegetables and wholegrains did not 
change, nor did intake of alcohol or unhealthy foods such as sweets or snacks. 
 
 
Table 2: Changes in dietary components between pre-course and post-course time 
points, obtained from analysis of food frequency questionnaires. (P-values reaching 
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Cholesterol (mg) 300 mg 381±173 469±236 0.13 








Starch (g)  128±96 147±104 0.62 
Fibre (g) >25g 19±15 20±15 0.88 
Vitamin A (µg) 800 µg 715±577 1505±975 
0.005
* 
Thiamine (mg) 1.1 mg 1.8±1.2 1.9±1.2 0.87 
Riboflavin (mg) 1.4 mg 2.3±1.5 2.6±1.7 0.45 
Niacin (mg) 16 mg 27±15 29±19 1.00 
Vitamin B6 (mg) 1.4 mg 3.1±3.0 2.9±1.9 0.81 
Vitamin B12 (µg) 2.5 µg 7.8±3.6 11±5.8 0.04* 
Folate (µg) 200 µg 339±284 328±236 0.58 
Vitamin C (mg) 80 mg 104±60 79±41 0.16 
Vitamin D (µg) 5 µg 3.6±2.3 5.1±3.5 0.09 
Vitamin E (mg) 12 mg 14±7 16.6±9.7 0.41 
Phosphorous 
(mg) 
700 mg 1612±763 1787±942 0.64 
Calcium (mg) 1000 mg 914±387 1062±548 0.34 
Iron (mg) 7 mg 15±11 16±11 0.81 
Selenium (µg) 55 µg 67±30 79±43 0.49 
Zinc (mg) 10 mg 12±6 13±7 0.58 








Magnesium (mg) 375 mg 359±200 343±189 0.67 
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Copper (mg) 1 mg 1.2±0.6 1.5±0.8 0.31 




Manganese (mg) 2 mg 3.1±1.5 3.2±1.8 0.85 
Iodine (µg) 15 µg 169±76 201±100 0.28 
 
Table 3: Change in food group intake between pre-course and post-course time 
points, obtained from analysis of food frequency questionnaires. (P-values reaching 
statistical significance are in bold and accompanied by an asterix) 
Food Group Pre-course Post-course P-value 
Red meats 0.62±0.35 0.85±0.56 0.07 
Processed meats 0.58±0.77 0.33±0.27 0.08 
Poultry 0.31±0.26 0.25±0.22 0.73 
Organ meats 0.04±0.07 0.11±0.09 0.01* 
Fish 0.55±0.43 0.68±0.49 0.04* 
Fried foods 0.21±0.14 0.30±0.16 0.03* 
Refined 
carbohydrates 
0.84±0.56 1.28±1.17 0.26 
Whole grains 0.66±0.41 0.95±0.75 0.29 
Cereal 0.69±1.45 0.47±0.55 0.76 
Potatoes 0.34±0.26 0.49±0.34 0.06 
Pasta meals 0.42±0.31 0.34±0.25 0.66 
High-fat dairy 
products 





0.21±0.27 0.36±0.28 0.02* 
Egg dishes 0.61±0.49 0.43±0.29 0.34 
Fruit 2.02±1.2 1.38±0.84 0.04* 
Green leafy 
vegetables 
0.77±0.42 1.25±1.03 0.11 
Cruciferous 
vegetables 
0.68±0.61 0.44±0.32 0.34 
Starchy vegetables  0.42±0.56 0.37±0.24 0.16 
Other vegetables 3.98±2.17 3.72±2.03 0.66 
Legumes 0.30±0.24 0.22±0.25 0.10 
Sweets 1.77±1.29 2.45±2.00 0.31 
Snacks 0.48±1.00 0.37±0.66 0.40 
Soups  1.15±1.24 1.11±1.17 0.48 
Sauces 0.19±0.17 0.27±0.28 0.31 
Condiments 2.68±1.65 3.17±2.12 0.58 
Non-alcoholic 
beverages 
2.39±1.71 1.99±1.42 0.45 
Alcoholic beverages 1.43±1.21 1.42±1.29 0.91 
Fruit Juice 0.42±0.71 0.39±0.53 0.50 
Sweetened 
beverages 
0.81±1.03 0.78±0.74 0.56 
 
Participants intake of milk and dairy products are summarised in Table 4. In relation 
to participants overall intake of milk, this did not change during the course (mean 
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increase from 177mls±120 to 192mls±134, p=0.60).  However, a switch to 
unpasteurised milk was evident for most participants. Only one of 24 (4%) 
participants reported consuming unpasteurised milk prior to commencing the 
residential course while 23 participants (96%) reported its consumption during the 
course (mean increase from 23±116mls to 239±51mls, p<0.0001). Pre-course, 3 
participants consumed skimmed milk, 7 semi-skimmed, 11 whole and 3 non-specific 
and post-course only one participant consumed semi-skimmed while the remaining 
participants consumed whole milk, consistent with unpasteurized milk intake. Total 
intake of dairy products (cream, yoghurt, dairy desserts, cheese; salad cream or 
mayonnaise, butter, cottage cheese) did increase slightly though not to a statistically 
significant level (mean increase from 2.24±1.23 daily servings to 3.35±3.16, p=0.07). 
Two participants (8%) reported intake of unpasteurised dairy products prior to the 
course whereas 21 (87.5%) consumed these products during the course (mean 
increase from 0.01±0.04 servings per day to 1.2±1.4, p<0.0001).  
 
Table 4: Change in participants consumption of milk and dairy products between pre-
course and post-course time points, obtained from analysis of food frequency 
questionnaires. (P-values reaching statistical significance are in bold and 
accompanied by an asterix) 
Dairy intake Pre-course Post-course P-value 








0.21±0.27 0.36±0.28 0.02* 









0.01±0.04 1.2±1.4 <0.0001* 
 
6.3.3.3 Change in Microbiome composition 
 
We quantified the microbial diversity within each subject (α-diversity) before and 
after the course, and the difference between each subject’s pre-course and post-
course gut microbiota (β-diversity). No significant differences were found in either α-
diversity (simpson; p = 0.41, shannon; p = 0.26) or β-diversity (p= 0.998) (Figures 6.3-
1A and 6.3-1B). No differences were found between males and females.  
Analysis of the differential relative abundance of bacterial taxonomic groups 
revealed a total of 578 amplicon sequence variants (ASVs) within our samples (Figure 
1D). Undirected pairwise analysis of all ASVs, (Wilcoxon signed rank test, allowing for 
Storey's q-value post-hoc correction) revealed only one ASV which changed 
significantly between pre-course and post-course time points. This ASV 
corresponded to the genus, Lactobacillus which increased significantly 
(p=0.0003728; q = 0.0498) (Figure 6.3-1C). Identification of ASVs at a species level 
was not possible. We subsequently performed a directed search in relation to other 
lactic acid bacteria (LAB), a dominant population in bovine milk prior to 
pasteurization based on what was previously reported in the literature on the subject 
[21]. On the genus level, the relative abundance of Leuconostoc (p=0.09) and 
Enterococcus (p=0.14) did not change but that of Lactococcus increased significantly 
(p=0.01; q = 0.0108). Other major components of unpasteurized milk include 




We directly tested for associations between changes in dietary components and 
changes in microbiome composition within each subject over time. We observed a 
positive correlation between Lactobacillus abundance and combined intake of 
unpasteurized milk and dairy products (Spearman correlation, r=0.618, 
p=0.0000027) Upon closer inspection, Lactobacillus abundance appeared to fall into 
two groups based on the centred log-ratio (clr) transformation of relative abundance 
scores of >2.5 or <2.5, prompting us to dichotomize the data for Pearson’s Chi-
squared test. We defined these groups as low versus high Lactobacillus abundance 
and found a positive association between these two groups and the change in intake 
of unpasteurized milk and dairy products (combined score), binned into four groups 
based on the amount of portions consumed; 0-2, 3-4, 5-6 and 7-8. (Pearson's Chi-
squared, X-squared = 13.265, df = 3, p-value = 0.004096) (Figure 6.3-2). This 
association also held when looking at the relationship between Lactobacillus 
abundance and unpasteurized milk or unpasteurized dairy products individually. We 
analysed this Lactobacillus grouping against our other metadata (including age, sex, 
BMI, sleep, exercise and gastrointestinal parameters) but found no other factors 





Figure 6.3-1: A; Relative abundance of Lactobacillus at pre-course and post-course 
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time points. B; Alpha diversity of gut microbiome at pre-course and post-course time 
points. C Beta diversity of gut microbiome at pre-course and post-course time points. 
D; Relative abundance of genus-level taxa for each participant. Each column 
represents one participant with pre-course taxa on the left and post-course taxa on 
the right. (Box plots: Body represents median and interquartile range, whiskers 





Figure 2: Box plots showing the change in combined unpasteurised dairy score and 
Lactobacillus abundance between pre- and post-course time points. (Body represents 
median and interquartile range, whiskers represent the extremevalues; As some 




6.3.3.4 Functional Prediction and Application of Gut-Brain Modules 
Functional analysis of our microbiome data was performed using Piphillin (Iwai et al., 
2016) and further extended by subjecting our metagenomic data to a module-based 
analytical framework which targets microbial pathways involved in microbiota-gut-
brain communication, thus generating a predication of the neuroactive potential of 
a microbiome sample (Valles-Colomer et al., 2019). Within our sample, we observed 
43 of the 56 gut-brain modules (GBMs) described previously by the authors. In 
addition, we observed an increase in the functional richness of the microbiome 
profile, as determined by the number of gut-brain modules (GBMs) present 
(Wilcoxon signed rank test; mean increase of 1.79, p=0.00087), following the 12-
week course (Figure 6.3-3A). On analysis of the individual GBMs, one consistently 
increased significantly; GBM026: Nitric oxide synthesis II (nitrite reductase) (p = 
0.001; q = 0.061) (Figure 6.3-3B). Notably, GBM004: Kynurenine synthesis was never 
found in participants pre-course, but was detected in 6 out of 24 participants post-
course at very high levels. This observation did not pass the post-hoc correction (p = 
0.036, q = 0.361) (Figure 6.3-3C). Functional alpha diversity, measured here by 
calculating the alpha diversity of the floored KEGG Orthologue tables generated by 
Piphillin, did not differ between pre- and post-course time points (chao1; p = 0.14, 
simpson; p = 0.19,  shannon; p = 0.85).  
 
Figure 6.3-3: A: Functional richness of microbiome, as measured by observed number 
of gut-brain modules (GBM) at pre-course and post-course time points. B: Increase in 
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abundance of GBM 026: Nitric oxide synthesis II (nitrite reductase) between pre- and 
post-course time points. C: Increase in GBM 004: Kynurenine synthesis between pre- 
and post-course time points. (Box plots: Body represents median and interquartile 
range, whiskers represent the extreme values; As some scores overlap, each 
participant is not visible as an individual point on the graph) 
 
6.3.3.5 Change in microbiome metabolites 
Analysis of faecal short-chain fatty acids (SCFAs) revealed a significant increase in 
Valerate (p=0.04) over the 12 weeks. Propionate also increased, although not to a 
statistically significant level (p=0.08) while no change was observed in butyrate, iso-
butyrate, iso-valerate or acetate. (Table 5) 
 
 
Table 5: Short-chain-fatty-acid (SCFA) concentrations;  

































Iso-valerate 3.2 (1.9) 3.4 (1.7) 0.498 
Valerate 2.3 (0.8) 2.5 (0.8) 0.049 
* 
Total BCFA 5.6 (2.9) 6.0 (2.5) 0.44 





Figure 6.3-4: Concentration of Valerate at pre- and post-course time points. (Body 




6.3.3.6 Change in psychological measures  
 
There was no change in total scores on the Cohen’s Perceived Stress Scale (PSS), 
Hospital Anxiety and Depression Scale (HADS)-total score, HADS-anxiety subscale or 
HADS-depression subscale between pre- and post-course time points. However, 
because our study involved a healthy population, baseline anxiety and stress scores 
were low and mood scores were within the normal range (Table 6). Further analysis 
was considered taking into account baseline scores. The sample was dichotomized 
based on the median score of the above scales. Participants with higher baseline 
scores on the PSS showed a mean reduction of 4.42 points, whereas the rest of the 
participants reported a mean increase of 1 point (Wilcox test, p=0.026) between pre-
course and post course time points. Participants with higher anxiety scores than the 
median on the HADS-A also showed a statistically significant reduction compared to 
the rest of the participants (mean reduction of 2 vs a mean increase of 2, Wilcox test 
p=0.0043). We did not find any relationship between microbes and psychological 
scales. No differences were found between males and females. 
 




Pre-course Post-Course p-value 
PSS  14.96 (6.23) 13.13 (5.12) 0.149 
HADS-A 5.61 (3.72) 4.83 (3.21) 0.274 
HADS-D 3.04 (2.82) 3.83 (3.42) 0.198 
HADS-T 8.65 (5.37) 8.65 (5.93) 1 
HADS: Hamilton Anxiety and Depression Scale, HADS-D: HADS-Depression subscale, 
HADS-A:  




In this observational study, we investigated the effect of a dietary change on the gut 
microbiome of participants who undertook a 12-week residential cookery course on 
an organic farm, where the majority of food consumed and used for cooking, was 
locally-sourced, seasonal and produced using organic methods. Of particular interest 
was the use of unpasteurized milk and dairy products obtained from a small herd of 
Jersey cows on the farm. Most participants had not been using any unpasteurized 
dairy prior to the course and all used these products to some degree throughout their 
stay. We found that the main change in terms of microbiome composition was a 
dramatic increase in participants Lactobacilli between pre-course and post-course 
faecal samples. This increase was strongly associated with participants intake of 
unpasteurized milk and dairy products. In addition, a positive change was noted in 
relation to microbiome metabolites with an increase in valerate and, to a lesser 
extent not quite reaching statistical significance, propionate. 
While administration of probiotics in the form of conventional pharmaceutical agents 
such as tablets or capsules is a common method, the majority of probiotics 
commercially available are in the form of food-based delivery systems which use 
probiotic bacteria in their production or add these bacteria during the manufacturing 
process, e.g., cheese, yoghurt or fermented drinks (Govender et al., 2014). There are 
several problems associated with pharmaceutical and commercially-produced 
probiotic formulations. Firstly, the probiotic potential of bacteria is species and 
strain-specific but efficacy is often generalized across products in the current 
unregulated commercial probiotic market (de Simone, 2019). Secondly, there are 
many aspects of the manufacturing process of such products which can alter the 
delivery of viable functional probiotic bacteria (Sanders et al., 2014). Because 
probiotic products are generally categorized as food supplements, they are subject 
to less stringent regulatory criteria and quality control processes with regard to 
microorganism specification, their numbers and functional properties (Kolacek et al., 
2017). Thirdly, there is a cost consideration when it comes to commercial probiotic 
products, which may place daily probiotic supplements out of the reach of many.   
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An alternative to consuming commercially-produced probiotic supplements for the 
maintenance of a healthy gut microbiome is to alter one’s diet. It is increasingly 
accepted that the ‘Western-diet’, characterized by highly-processed, low-fibre, high-
sugar, high-fat foodstuffs has negative implications for health (Cordain et al., 2005) 
which may be mediated by an unfavourable impact on the gut microbiome (Zinocker 
and Lindseth, 2018). In contrast, adherence to a Mediterranean-style diet 
(characterized by high-level consumption of olive oil, fruit, nuts, vegetables, and 
cereals with moderate intake of fish and poultry) has been strongly associated with 
better physical (Estruch et al., 2018) and mental (Lassale et al., 2018) health 
outcomes, which again may be related to a beneficial impact on the gut microbiome 
and metabolome (De Filippis et al., 2016). Gut microbiome composition can be 
rapidly and significantly altered by introducing dietary change (David et al., 2014) 
with the impact of food choices on the microbiome being highly individualized 
(Johnson et al., 2019). In this study, the key change in relation to dietary intake during 
the 12-week residential course was an increase in dairy products, which in this 
context were unpasteurized. This was a major change for our subjects, the vast 
majority of whom did not consume unpasteurized milk or dairy products prior to the 
course.  
Cow’s milk is produced on a massive scale worldwide and has long played an 
important role in human nutrition (Haug et al., 2007). Cow’s milk harbours a rich 
microbiota and typically contains a significant population of lactic acid bacteria (LAB) 
that includes Lactococcus (8.2 x 101–1.4 x 104 CFU/ml), Streptococcus (1.41 x 101–1.5 
x 104 CFU/mL), Lactobacillus (1.0 x 102–3.2 x 104 CFU/ml), Leuconostoc (9.8 x 101–2.5 
x 103 CFU /mL) and Enterococcus spp. (2.57 x 101–1.58 x103 CFU/mL) (Quigley et al., 
2013). Other organisms present in substantial proportions are Pseudomonas and 
Acinetobacter, so-called psychrotrophs which can flourish during cold storage 
conditions and typically cause milk spoilage (Raats et al., 2011). Pasteurization of milk 
gained widespread popularity in the early 1900’s when cow’s milk was linked to the 
spread of disease epidemics such as tuberculosis, diphtheria, typhoid fever, scarlet 
fever, anthrax and cholera (Rankin et al., 2017). A recent Irish study, using molecular, 
culture-independent techniques, compared the microbial content of raw and 
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pasteurized cow’s milk (Quigley et al., 2013). Authors reported that, although the 
bacterial diversity of the raw and pasteurized milk were similar, raw milk contained 
mostly viable cells whereas the cell population in pasteurized milk were 
predominantly non-viable. Thus, while pasteurized milk appeared to have a 
somewhat similar microbiome composition to that of the raw milk, any potential 
probiotic LAB would have been in a nonviable state. In this study, Pseudomonas and 
Acinetobacter, two major genera found in unpasteurized milk, were not detected by 
16S rRNA analysis of the microbiomes of the participants, either pre or post 
treatment. This may be due to a selective filtering effect of the human immune 
system or physiological barriers such as gastric acid, which is known to act as such a 
filter  (Freedberg et al., 2015; Imhann et al., 2017).  
The consumption of raw milk is growing in popularity, although there is some debate 
in relation to its purported benefits and concern about the potential dangers of 
contracting milk-borne illnesses if the raw milk is contaminated with human 
pathogens (Lucey, 2015). There is a strong suggestion from epidemiological literature 
that the consumption of unpasteurized cow’s milk or yoghurt by children living on 
farms or rural areas has a protective effect against the development of asthma, 
allergies and atopy, a finding which seems to be independent of other farm-related 
exposures (Braun-Fahrlander and von Mutius, 2011). In addition, raw milk is 
anecdotally reported to be beneficial for people with lactose intolerance (Beals, 
2008). This is thought to be due to the fact that raw milk contains high counts of LAB 
that produce lactase enzymes, which would otherwise be destroyed during 
pasteurization. However, there is little research evidence to support these anecdotal 
claims and, in fact, one recent pilot randomized controlled trial (RCT) involving 16 
adults with lactose malabsorption, failed to find any benefit of raw milk over 
pasteurized milk for gastrointestinal symptoms (Mummah et al., 2014). Despite this, 
in a survey of raw-milk consumers (Mullin and Belkoff, 2014), over one-third of 
responders claimed to experience gastrointestinal discomfort from drinking 
pasteurized milk but no discomfort after drinking raw milk, although the vast 
majority of these people did not have a diagnosis of lactose intolerance. Another 
proposed benefit of raw milk is that it contains higher quantities of vitamins. A meta-
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analysis (Macdonald et al., 2011) reported that pasteurization reduced the 
concentrations of Vitamin E, Vitamin B12, Vitamin B2, Vitamin C and folate. Of these 
vitamins, B2 is of most importance as bovine milk contributes significantly to the 
recommended daily intake whereas in the case of all the others, milk is not typically 
an important source. In relation to the human gut microbiome, we are unaware of 
any studies specifically examining the effect of raw milk consumption. However, a 
few studies have investigated the impact of pasteurized milk on the human 
microbiome. One cross-sectional study reported a differential oral microbiome based 
on high versus low (pasteurized) milk intake (Johansson et al., 2018). Another 
investigated the impact of whole milk supplementation on the gut microbiota and 
cardiometabolic biomarkers between lactose malabsorbers (LM) and absorbers (LA) 
(Li et al., 2018). Authors found that whole milk supplementation significantly altered 
the intestinal microbiota composition in LM resulting in an increase in the phylum 
Actinobacteria along with increases in several genera; Bifidobacterium, Anaerostipes 
and Blautia. These changes occurred only in LM and not LA, suggesting that it was 
the increased lactose substrate reaching the colon which preferentially enhanced the 
growth of some micro-organisms. In addition to pasteurization, milk can be altered 
by skimming which is currently a widespread procedure. Prior to the course 10/24 of 
our participants reported consuming skimmed or semi-skimmed milk while post-
course 23/24 participants consumed whole milk, reflecting the unpasteurized milk 
intake. Skimmed milk contains less fat than whole milk and thus also less fat-soluble 
vitamins such as A and E. However, regular unfortified milk is not a major contributor 
to a person’s recommended daily allowance of these vitamins (Herrero et al., 2002) 
and despite the variable amounts in different milk types there does not appear to be 
significant difference in their bioavailability (Herrero-Barbudo et al., 2006). Other 
micronutrients such as calcium, sodium and choline do not differ between skimmed 
and whole milk (Manzi et al., 2013). Therefore, we considered the skimmed versus 
whole milk type to be of limited consequence. 
An obvious limitation of this study is the inherent potential for confounding given 
that, in addition to a change in diet, study participants experienced a change in 
environment. Disentangling the impact of diet and geographical environment on the 
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gut microbiome, however, is a very difficult task. Several large scale studies have 
attempted to explore the differences in microbiome composition between 
industrialised Western urban dwellers and those living in traditional rural 
communities in South America and Africa, such as the Hadza hunter-gatherers of 
Tanzania (Schnorr et al., 2014), rural Papua New Guineans (Martínez et al., 2015) 
children from the rural African village of Burkina Faso (De Filippo et al., 2010) and 
communities from Malawi and Amazonian Amerindians (Yatsunenko et al., 2012). 
Although a rural setting will likely contribute to gut microbiome differences, these 
farming environments are intrinsically linked to variation in diet and it is difficult to 
separate the impact of the farm environment itself and the farm-related dietary 
patterns. If a move to a rural farming environment were to account for the changes 
in microbiome seen in our study one could postulate that the changes would be 
consistent with the microbiome composition in rural dwellers from the above 
studies. This was not the case. While rural dwellers from PNG did have higher 
abundance of Lactobacillus than their urban counterparts (Martínez et al., 2015), 
those from the other rural farming communities did not (De Filippo et al., 2010; 
Schnorr et al., 2014). Obviously, the rural locations in the above studies were at the 
extreme end in relation to geographical location and traditional lifestyle and poorly 
comparable to the developed farm environment in which our participants were 
based. In a study more closely resembling our location, authors compared the 
microbiome of infants from farming and non-farming families in Wisconsin, United 
States, and again no differences in Lactobacillus or other LAB abundance were seen 
(Thorsen et al., 2019). Furthermore, the changes in bacterial taxa in the microbiome 
of our subjects were consistent with those species found in unpasteurized milk, 
supporting our conclusion that this specific dietary change was driving the 
microbiome differences between pre- and post-course time points.  
In this study we found that, during the 12-week course, the levels of the faecal SCFA 
valerate increased with a trend towards increase in proprionate. Straight-chain SCFAs 
(acetate, butyrate, propionate and valerate) are produced by the gut microbiota 
during the fermentation of partially and nondigestible polysaccharides whereas 
branched-chain SCFAs (isobutyrate and isovalerate) result from the metabolism of 
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proteins (He et al., 2018). SCFAs are thought to play a major role in the maintenance 
of gut and immune homeostasis (Tan et al., 2014) as well as in the gut-brain axis 
response to stress (van de Wouw et al., 2018). SCFA production can be stimulated by 
increasing dietary fibre intake (Francois et al., 2012) or protein consumption (Russell 
et al., 2011). However, in our study, participants intake of fibre or protein did not 
change and thus, it is proposed that increased valerate and propionate levels may 
have been secondary to increased abundance of Lactobacilli, which, along with other 
LAB, are known producers of SCFA (LeBlanc et al., 2017). Propionate has anti-
inflammatory properties and has been shown to be of potential benefit across a 
range of disorders, including hypertension and cardiovascular disease (Bartolomaeus 
et al., 2019), obesity (Chambers et al., 2015) and hypercholesterolemia (Demigne et 
al., 1995). Valerate is a less well-known SCFA with limited research to date into its 
therapeutic potential. However, a recent study revealed that it also appears to have 
an immunomodulatory effect (Luu et al., 2019). Interestingly, supplementation with 
Lactobacillus acidophilus increased the concentration of valerate in the caecum of 
chickens infected with Clostridium perfringens while reducing the infection-
associated gut dysbiosis (Li et al., 2017). Valerate may also hold some translatable 
therapeutic value in the context of Clostridium difficile infection (CDI). Valerate was 
shown to be significantly reduced in the faecal samples of patients with recurrent CDI 
and recovered following successful treatment with FMT (McDonald et al., 2018).  
Changes in the functionality of the microbiome were assessed in the context of a 
recent study which facilitates analysis of the neuroactive potential of a microbiome 
sample (Valles-Colomer et al., 2019). Authors achieved this using a gut-brain-module 
(GBM) framework which targets microbial pathways known to be involved in 
microbiota-gut-brain communication and have made this GBM catalogue available 
for use by other researchers (https://raeslab.org/software/gbms.html). When 
applying our predictive metagenomic data to this GBM catalogue we found an 
increase in the functional richness of the microbiome profile, as determined by the 
number of GBMs present, following the 12-week course (Figure 4). Such a consistent 
general increase in GBMs without a significant increase in microbial alpha diversity 
goes somewhat against the intuition that a more diverse microbial ecosystem will 
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necessarily display a higher functional diversity. More strikingly, the functional alpha 
diversity did not change during the course. GBMs represent a specific subset of 
microbiome function and are calculated using the values of specific KEGG 
Orthologues. A shift in microbial functions that specifically potentially impact the 
host brain without a corresponding general shift in microbial function detectible on 
the alpha diversity level shines light on the possibility that many more such specific 
shifts can occur undetected using current bioinformatics tools. Because of this, we 
call for a move away from general diversity and towards informed interrogation of 
specific functional changes in the microbiome as a readout.   
One GBM changed significantly after post-hoc correction; ‘GBM026; Nitric oxide 
synthesis II (nitrite reductase)’. Several studies have demonstrated the ability of 
various Lactobacillus species to synthesize nitric oxide by nitrate reductase activity 
(Xu and Verstraete, 2001; Liu et al., 2014). Nitric oxide is a complex and widespread 
signaling molecule which participates in virtually every organ system of the body. It 
is thought to play a role in the stress response and mood regulation (McLeod et al., 
2001) and may represent one mechanism by which Lactobacilli exert psychobiotic 
effects. The authors believe another GBM warrants discussing here, although its 
increase did not satisfy significance after post-hoc correction; ‘GBM004, Kynurenine 
synthesis’. This module was never detected in participants pre-course but was 
present in very high levels in 6 out of 24 participants post-course. This can be 
explained by the fact that the Kynurenine synthesis module requires two enzymatic 
steps. One of these was found in Lactobacillus, but the other one was not specific to 
a single microbe in this data set, but rather spread over several microbes and was 
only found in the 6 participants positive for MBG004. This finding conforms well with 
literature regarding emergent biosynthetic capacity of the microbiome (Chiu et al., 
2014; Perisin and Sund, 2018).  
Although we found no direct correlation between Lactobacillus abundance and 
psychological measures, it is notable that stress and anxiety levels reduced 
significantly in those with higher baseline scores on the PSS and HADS-A. This is 
consistent with probiotic interventional trials in healthy populations, whereby an 
impact is often only seen in those with higher anxiety or depression scores at baseline 
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(Ng et al., 2018; Liu et al., 2019). Of course, there are many possible confounding 
factors when it comes to interpreting this reduction. Participants in this course had 
varying reasons for completing the course; for some, the purpose was to enhance or 
change their career options and thus, possibly associated with stress; for others it 
was simply for leisure and viewed more as a holiday incorporating cookery classes. 
The change in environment and daily activity, the purpose of participation in the 
course and interaction with new people may all have contributed to psychological 
status. However, given the increasing evidence that the gut microbiome is an 
important node in gut-brain communication and that certain psychobiotics have 
anxiolytic effects, it is plausible to consider the possibility that the improvement in 
stress and anxiety may have been partially related to the increase in Lactobacillus. 
Lactobacillus rhamnosus (JB-1) has been shown to reduce anxiety behaviours in mice 
as well as altering central levels of gamma-aminobutyric acid (Bravo et al., 2011), a 
key neurotransmitter in anxiety regulation. Several species of Lactobacillus have 
demonstrated the ability to reduce anxiety and stress levels in healthy subjects 
(Messaoudi et al., 2011; Nishihira J.   et al., 2014; Takada et al., 2016) as well as in 
patients with chronic fatigue syndrome (Rao et al., 2009) or laryngeal cancer (Yang 
et al., 2016).  
There are several limitations to our study. Firstly, this was an observational study. 
While of course an RCT would be preferable, there are many challenges inherent in 
designing RCTs involving dietary interventions. It can be difficult to define 
appropriate control groups and effective blinding of participants and investigators is 
often extremely difficult (Weaver and Miller, 2017). In particular, it can be 
challenging to accomplish a high level of adherence with whole food, or dietary 
pattern, interventions. A major strength of our study in this regard was that our 
participants were based on-site for the entire duration of the study making it possible 
to ensure a consistency across individual diets which would be difficult to achieve 
outside a residential setting. The potential confounding effect of the farm 
environment as an independent modulator of microbiome composition is addressed 
earlier in the discussion. Secondly, our sample size was quite small. However, 
previously published studies investigating the diet-microbiome relationship have 
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involved participant numbers of ten or less (David et al., 2014; Ruggles et al., 2018) 
and have  generally been of much shorter duration (Johnson et al., 2019). Another 
factor which may limit the generalizability of our study was that participants 
undertaking this course were interested in food and cooking. Thus, they were likely 
to have good nutritional knowledge and possibly healthier than average diets at 
baseline. A specific limitation in this regard was an absence of any information on the 
use of non-nutritive sweeteners (NNS). These are being increasingly used due to the 
concern about the negative health impact of high-sugar diets and have been shown 
to significantly, and generally negatively, impact the gut microbiome (Suez et al., 
2015). Finally, given the limitations of 16S rRNA gene sequencing we were unable to 
characterize organisms beyond the genus level. More accurate taxonomic 
classification would have been useful had shotgun metagenomic sequencing been 
performed. Despite these limitations, this is, to our knowledge, the first study to 
report on the potential impact of unpasteurized milk and dairy products on the 
human gut microbiome. Given the growing popularity of consumption of raw milk 
and other probiotic-rich fermented foods, it is important that the effect of such 
products on the gut microbiome are investigated. 
While there are understandable concerns in relation to potential contamination and 
safety when it comes to unpasteurized milk, it is a rich source of probiotic bacteria. 
Abundances of Lactobacilli increased significantly following a 12-week dietary 
change which involved consumption of unpasteurized milk and dairy products. 
Lactococcus abundance, also increased, although to a lesser extent. These changes 
in microbiome composition were reflected by an increase in levels of the SCFA, 
valerate with an observed trend towards increase of propionate, along with an 
increase in the predicted functional richness of the microbiome. Given the growing 
appreciation of the importance of a healthy gut microbiome and the limitations of 
commercial probiotic products, there is a need for further research into the effect of 
different dietary changes on the microbiome. In particular, further studies 
investigating the probiotic potential of natural probiotic-containing foodstuffs such 




6.3.5.1 Study Site and Subjects  
Ballymaloe Cookery School, Organic Farm and Gardens is located in East Cork, Ireland 
and runs bi-annual 12-week residential courses where students live on-site, learn 
about organic farming methods and undertake intensive cookery classes. The 
majority of food consumed by participants during their stay originates from the 
organic farm itself or consists of high-quality, locally-sourced produce. The farm has 
a small herd of Jersey cows whose milk is used in its raw unpasteurized state for 
direct consumption, cooking and the production of other dairy products including 
cream, butter, cheese and yoghurt. There is an emphasis on eating, and cooking with, 
local seasonal fruit and vegetables, the vast majority of which is organic. Meat and 
fish are also locally sourced and, for the most part, organic.  
Approval of the study protocol was granted by the Clinical Research Ethics 
Committee of the Cork Teaching Hospitals (Protocol number DOP001) and conducted 
following the ICH Guidelines on Good Clinical Practice, and the Declaration of 
Helsinki. Written informed consent was obtained from all subjects before study 
procedures were conducted. Course participants were emailed in advance informing 
them of the study and a short talk on the gut microbiome was given at an 
introductory session prior to commencement of the course. In order to be eligible for 
the study, participants had to be between the age of 18-65 years and be generally 
healthy, with no chronic or current, physical or mental illness. Exclusion criteria 
included the use of medications which were likely to interfere with the objectives of 
the study (including any psychotropic medications) as well as intake of antibiotics, 
probiotics or prebiotics within the month prior to commencement of the study.   
6.3.5.2 Subject Metadata 
Demographic data was collected for each individual including information on age, sex 
and race. Weight and height were measured and used to calculate body mass index 
(BMI). Information in relation to medical and psychiatric history, along with 
medication use, was also obtained at interview. At the beginning and end of the 12-
week course participants completed self-report questionnaires on a variety of 
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parameters including mood, anxiety, sleep, exercise (PSS, HADS, PSQI, International 
Physical Activity Questionnaire (IPAQ)).  
6.3.5.3 Diet Quantification 
To monitor nutrient intake, participants completed the self-administered 152-item 
SLAN-06 (Survey of Lifestyle, Attitudes and Nutrition in Ireland) food frequency 
questionnaire (FFQ) (Harrington J, 2008) which is validated to be used in an Irish 
population. An additional eight food items as well as questions about type and 
frequency of milk, salt and fried food consumption were added. These items are 
included in the EPIC Norfolk questionnaire (Riboli and Kaaks, 1997) from which the 
SLAN-06 FFQ was adapted. An extra section was added to the FFQ by the authors to 
quantify intake of unpasteurized milk and dairy products before and during the 
course, as this information would not otherwise have been captured. These extra 
questions followed the same response format as the other food items.  
Participants were asked to estimate the frequency with which they consumed a 
specified portion size of each of the foods listed over the preceding month. The FFQ 
has nine possible responses ranging from “never or less than once per month” to “6+ 
per day”. Participants completed the FFQ before and after the stay at Ballymaloe. 
The FFQs were analysed for nutrient intake using the FETA software (Mulligan et al., 
2014).  
The 160 foods items were grouped into 29 food groups (e.g., fruits, vegetables, 
grains, sweets) using methods similar to those described in previous studies of 
dietary patterns (Arthur et al., 2013). To estimate the number of servings of any food 
group, each response was converted to the corresponding frequency factor and 
summed over all the food items to get the average servings of a specific food group 
per day. Intake of unpasteurised milk and dairy products was analysed in a similar 
way.  
6.3.5.4 Faecal sample collection and 16S rRNA gene sequencing and processing 
Faecal samples were collected at the beginning and end of the 12-week period in 
disposable plastic containers with a Thermo Scientific™ Oxoid AnaeroGen 2.5L Sachet 
in situ to generate anaerobic conditions within the container. Participants were 
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instructed to keep the sample containers in a refrigerator at 4oC. Samples were 
collected and transferred to a -80oC freezer within 12 hours.  
DNA was extracted using the DNA Fast Stool DNA extraction kit (Qiagen) using the 
protocol for Gram positive bacteria and including an additional bead beating step at 
the beginning of the procedure. DNA was quantified using the Qubit High Sensitivity 
Kit (Life Technologies), standardized and then used as a template for PCR. 16S 
metagenomic libraries were prepared using primers to amplify the V3-V4 region of 
the bacterial 16S rRNA gene, with Illumina adaptors incorporated as described in the 
Illumina 16 s Metagenomic Library Preparation guide. Following index PCR and 
purification, the products were quantified using the Qubit high sensitivity DNA kit 
(Life Technologies) and pooled equimolarly. The pooled libraries were assessed using 
an Agilent high sensitivity DNA kit and examined by quantitative PCR (qPCR) using 
the Kapa Quantification kit for Illumina (Kapa Biosystems, USA) according to the 
manufacturer’s guidelines. Libraries were then diluted and denatured following 
Illumina guidelines and sequenced (2 × 300 bp) on the Illumina MiSeq platform. 
6.3.5.5 Sequence table generation 
Three hundred base pair paired-end reads were prefiltered based on a quality score 
threshold of > 28 and trimmed, filtered for quality and chimeras using the DADA2 
library in R (Callahan et al., 2016). Taxonomy was assigned with DADA2 against the 
SILVA SSURef database release v132. Parameters as recommended in the DADA2 
manual were adhered to unless mentioned otherwise. ASVs were cut off at genus 
level, those that were unknown on the genus level were not considered in 
downstream analysis, as were genera that were only detected as non-zero in five 
percent or fewer of total samples. 
6.3.5.6 Short chain fatty acid (SCFA) measurements 
The concentration of SCFAs, acetate, propionate, Iso-butyrate, butyrate, Iso-valerate, 
and valerate were analyzed by gas chromatography flame ionization detection (GC-
FID) using a Varian 3800 GC system, fitted with a 5m guard column (Restek) 
connected to an Agilent DB-FFAP column (30 m L x 0.32mm ID x 0.25 μm df) and a 
flame ionization detector with a CP-8400 auto-sampler. 
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6.3.5.7 Statistical analysis  
Statistical analysis for changes in dietary measures was performed using SPSS 
Statistical Packages version 25 (SPSS, Inc., Chicago, IL, USA). Normality of outcome 
measures was assed using Shapiro Wilk’s test of normality. Differences in nutrient 
and food group intake pre- and post-course participation were analyzed using 
Student’s t-test or the non-parametric Wilcoxon Rank sum test. 
Microbiome data-handling was done in R (version 3.6) with the Rstudio GUI (version 
1.2.1555). In all cases, the iNEXT library was used to calculate alpha diversity (Hsieh 
et al., 2016).  
Principal component analysis (PCA) was performed on centered-log ratio 
transformed (clr) values using the ALDEx2 library (Fernandes et al., 2014). Number of 
permutations was always set to 1000. Aitchison distance was used as a distance 
metric for beta-diversity. Piphillin (Iwai et al., 2016) was used for functional inference 
from 16S rRNA gene sequences of stool samples in the form of Kyoto Encyclopedia 
of Genes and Genomes (KEGG) orthologues. Gut-brain modules were calculated 
using the R version of the Gomixer tool (Darzi et al., 2016). Differential abundance of 
microbes between groups was assessed using the ALDEx2 library. As part of testing 
for correlations between microbial abundance and metadata, skadi, an 
implementation of jackknifing and Grubb’s test, was used to assess the reliability of 
the data and detect outliers (R scripts avaliable online, 
https://github.com/thomazbastiaanssen/Tjazi; (Bastiaanssen T, 2018)). Correlation 
was assessed using Spearmans’s rank correlation coefficient. The relationship 
between categorical variables was assessed using Pearson's Chi-squared test. For 
datasets in which the condition of normality was violated the non-parametric 
Kruskal-Wallis test was used and post-hoc analysis was done using the Wilcoxon test. 
A p-value of < 0.05 was deemed significant. To correct for multiple testing in tests 
correlating volatility and specific microbiota, KEGG orthologues or pathways, the Q-





Chapter 7 Discussion 
7.1 In summary 
The microbiome-gut-brain axis field currently spans both clinical and animal 
research. This is reflected in the approaches used in this thesis, where the chapters 
were organised into three general categories. It is clear that diet is one of the main 
ways in which the microbiota can be modified. In chapter 2 of this thesis, which 
focuses on diet-based animal studies, we found that we were able to blunt the 
neuroinflammatory effects of ageing in the host by targeting the microbiome, using 
dietary prebiotic approaches. Similarly, we were able to show that the effects of 
stress could also be rescued by prebiotics or a dietary supplementation. Notably, not 
all stressors are created equal and the microbiome does not seem to hold the key in 
all cases. We were unable to find evidence of rescuing the effects of chronic hypoxia, 
which was previously shown to alter the microbiome, by prebiotics supplementation. 
In all cases, altering diet was shown to consistently change both microbiome 
composition and relative abundance of microbiome features. Importantly, in the last 
paper in this chapter, we show that is also possible for a poor quality diet such as a 
high-fat diet or even cafeteria diet to affect the microbiome and its host negatively.  
Chapter 3 features four papers and is themed around the effects of disrupting the 
normal microbiome colonization and homeostasis. It is clear that perturbing the 
microbiome can affect host brain and behaviour. First, we show that disrupting the 
microbiome with antibiotics in adolescence has persistent negative effects for host 
brain and behaviour in adulthood, even though the microbiome itself seems to 
recover. Then, we show that antibiotics perturbation can alter the permissivity to 
colonization of new species, potentially allowing the microbiome to develop in ways 
that would not occur without antibiotics administration, including on a functional 
level. Continuing this investigation of the effects of perturbing the microbiome, in 
the next paper we show that the microbiomes from mice delivered by caesarean 
section are distinct from those delivered vaginally. Like was the case with antibiotic-
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based perturbation, the microbiomes converge over time, making them 
indistinguishable by birth mode, but behavioural effect remain.  
Chapter 4 consists of a single paper where we show that deer mice, which naturally 
tend to compulsive-like behaviour in the form of building, have a different 
microbiome composition based on their behavioural phenotype.  
Then, in chapter 5 we discuss a single paper that not only reconfirms the microbiome-
gut-brain axis, but also sheds light on our findings regarding the importance of 
microbiome perturbation in the previous chapter of this thesis. We investigate the 
dynamics of microbiome change over time, which is termed volatility. First, we 
demonstrate how volatility can be measured. Then, we show that volatility is 
correlated to the severity of stress in both mice and humans. Finally, we show that 
there are consistent functional changes in the microbiomes of both humans and mice 
undergoing stress.  
In chapter 6 we make the step resolutely from animals to humans. While there are 
many differences between animal and human research, indeed, one of the many 
reasons why animal research is so important is the possibility to control for otherwise 
difficult to control factors like diet, genetics and environment, our findings in this 
chapter echo what we previously reported in animal work. While there are important 
differences between the rodent and human research described here, there are 
interesting patterns and commonalities in the findings worth discussing further. In 
these three subchapters, we show that we can improve host mood and behaviour by 
targeting the microbiome, by using a prebiotic in the first paper, a probiotic in the 
second and a diet rich in unpasteurized dairy products in the third. In order to help 
the reader link chapters to the sub-aims I introduces in chapter 1.3.3, I have provided 




Figure 7.1-1 summarising the aspects of the microbiota-gut-brain axis that have 
been investigated in the chapters in this thesis. Chapters are depicted in their 
respective bubbles.  
 
7.2 Identifying patterns in our microbiome-gut-brain 
axis studies 
7.2.1 Enduring effects of perturbations in the microbiome and 
its lasting effects on the host  
The perturbation of the host microbiome is a common pattern among the research 
described in this thesis. In chapter 2.5 we examined the effects of dietary 
perturbations in adolescence on microbiome composition in adulthood. Analogously, 
in chapter 3.2, we used antibiotics to perturb the microbiome in the same stage of 
life. In both cases we found that, while the microbiome is able to recover on a 
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compositional level to the extent where it is indistinguishable from controls, lasting 
effects remain in the host organism. In chapter 3.4, we again find that the differences 
animals delivered vaginally or by c-section are most clear on the level of the 
microbiome in early life, but that these differences resolve in adolescence. Again, we 
find that behavioural effects remain even after the microbiomes have converged. 
Interestingly, we were also able to show that the conditions of the microbiome can 
also be such that changes in the microbiome will be lasting. In chapter 3.3, we found 
that Blautia was only able to colonize animals that were given prebiotics in the case 
that their microbiome was first perturbed by antibiotics. This change was not 
detected in beta diversity as only a single genus was affected by it, though we were 
able to show that this increase in Blautia would also likely have functional 
consequences. As past states seem to matter for how a microbiome turns out even 
if the current environment is constant, one wonders whether the microbiome has a 
memory and, if so, how we could read it. This also reinforces that time is an important 
factor when it comes to the microbiome-gut-brain axis. There is evidence of critical 
windows in the developmental period where the host may be particularly vulnerable 
to perturbations in the microbiome. Interestingly, the development of the 
microbiome has recently been shown to follow some consistent and predictable 
trajectory (Chng et al., 2020; Gibbons, 2020). This taken together with the finding 
that the infant microbiome strongly selects for specific bacterial taxa from the 
mother  (Ferretti et al., 2018) suggests that the early-life microbiome may provide 
some metabolic function that is crucial for healthy development of the host. Indeed, 
as eukaryotes have never existed without prokaryotes, it makes sense from an 
evolutionary perspective that certain developmental processes in the host organism 
could rely on the presence of a microbiome with particular metabolic properties.  
7.2.2 There is disagreement between studies which specific 
genera react to stress interventions targeting the microbiota. 
Several studies discussed here examine the effects of stress on the microbiome. In 
all cases, we report changes in microbial genera after stress. However, perhaps 
surprisingly, the genera that were altered differ between studies. Indeed, chapter 
5.1, on volatility, features two cohorts of mice undergoing chronic social defeat 
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stress, but there is little to no agreement in what genera are affected by this stressor. 
Similarly, there was little agreement between the specific taxa that were altered in 
chapter 2.4, where we rescue the effects of chronic stress. In that study we also 
measured the microbiome in response to stress, albeit in rats this time rather than 
mice.  
There are several reasons for this disagreement, some of which lead to interesting 
hypotheses and points of discussion. First, we should acknowledge the consistent 
biases that are inherent to modern metagenomic analysis (McLaren et al., 2019). As 
sequencing efficiency has been shown to differ between  laboratories and even 
between researchers or individual plates to be sequenced, we cannot assume that 
the same microbiome perturbation will give the same signature between two 
experiments. Second, as is likely the case for the volatility study in chapter 5.1, the 
microbiome compositions at baseline can easily differ between cohorts of animals. It 
stands to reason that if conditions in the microbiome at baseline are different 
between two cohorts, one cannot expect the same treatment to have the same effect 
there.  
This makes the finding that there is indeed concordance in the stress response in the 
microbiome on an inferred functional level in these aforementioned animals from 
the volatility study in chapter 5.1 particularly striking. Indeed, it has been reported 
that there is more unexplained variance on the taxonomical level of the microbiome 
than on the functional level, suggesting that function is more strongly conserved than 
taxonomy in the microbiome (Eng and Borenstein, 2018; Mehta et al., 2018). This 
stands in contrast with the strict strain-level selection during early life development 
we discussed in the previous point. In both the cases of stress and development do 
we see an agreement on a functional level, but we only see agreement on the 
functional level in the case of early life development (Ferretti et al., 2018). This raises 
the question whether the mechanisms of selection differ between these two 
phenomena and, if so, how. In the case of the conserved functional shifts in the 
microbiome due to the stress-response, perhaps this can be explained by a conserved 
physiological stress response in the host. In contrast, the more preserved succession 
of microbiota during early life development may be more dependent on the infant 
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immune system, which is known to be influenced by the maternal microbiome 
(Mueller et al., 2015).  
7.2.3 Functional metagenomics analysis can provide more 
sensitivity and interpretability in microbiome-gut-brain axis 
studies. 
Functional metagenomics analysis is an increasingly common feature of microbiome-
gut-brain axis studies. We utilised functional metagenomics analysis next to 
taxonomical metagenomics analysis is several of  the pieces of research discussed 
above. It’s striking that the type of information we can gleam from functional analysis 
seems to differ depending on the research. In some cases, like in chapter 3.3, 
documenting the colonization of Blautia, functional analysis can contribute to the 
interpretation of ones findings by confirming that alterations in a given bacterial 
taxon indeed would have functional consequences. In chapter 2.4, regarding the 
effect of prebiotics on chronic hypoxia, the functional analysis echoed what we saw 
in the microbiome analysis, being a strong effect of prebiotics and only a weak effect 
of hypoxia. Interestingly, we tend to see a strong effect in the  capacity of the 
microbiome to metabolize substrates in studies where prebiotics are administered. 
In other cases, functional analysis is more sensitive than taxonomical level analysis. 
For instance, in chapter 2.3, the effects of polyphenols on the functional microbiome 
were more pronounced and numerous than on the taxonomical level. Another 
important example of an effect only visible on the functional level is the potential of 
the microbiome to metabolize levodopa (van Kessel et al., 2019). In chapter 6.3, 
which follows 24 participants on a diet high in unpasteurized dairy, we use the 
functional microbiome in a different manner. There, we show that after the course, 
the participants showed potential for a higher functional richness in regards to 
neuroactive functions.  
In general, it is clear that functional analysis can represent a useful complementary 
analysis next to the more traditional taxonomical analysis. Another advantage to 
functional analysis is that it can make interpretation more straightforward. Especially 
in the case of 16S analysis, where we are usually constrained to the genus level, is 
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can be hard to defend that an entire genus is either “good” or “bad” for host health. 
On the other hand, functional analysis provides the researcher with molecular 
pathways that in many cases can lead to more defensible and concrete molecular 
mechanistic understanding. In the case where both microbiome and gut 
metabolomics measurements were taken, it would even be possible to integrate the 
two approaches using a framework like KEGG to confirm which molecular pathways 
are differentially affected.  
7.2.4 There exists random drift in the microbiome over time, 
though intra-subject variance is smaller than inter-subject 
variance.  
The microbiome can be seen as a dynamic ecosystem, in constant flux. Compositional 
stability and variability of the microbiome are investigated in several of the reports 
presented above. Most clearly in chapter 5.1, where volatility, the degree of change 
in the microbiome over time, is shown to be correlated to severity of the stress 
response in both mice and a healthy human cohort. In human cohorts, such as the 
cohort of students undergoing academic stress featured in chapter 5.1 for volatility 
measurements, but also the human cohorts from chapters 6.2, and 6.3, on probiotic 
administration in an obese cohort and the consumption of unpasteurized dairy, 
respectively, which both feature samples at multiple time points per participant, 
intra-subject variance of the microbiome over time was smaller than inter-subject 
variance. Indeed, other research groups report this as well (Johnson et al., 2019).  
There are several important points to be made there. First, the fact that a previous 
composition of the microbiome holds some information on the next composition of 
the microbiome is an important confirmation that the microbiome is a consistent 
community with a drive towards homeostasis. Second, we can go further and say that 
this homeostasis is at least in part determined by function in relation to the host. 
Some interesting theoretical works has shown that different functions in a 
microbiome show different levels of robustness to perturbation, specifically, 
functions that were associated with a given biogeographical region were more robust 
in the microbiomes of that region (Eng and Borenstein, 2018). In many cases, the 
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reverse is also shown to be true. The microbiome compositions of healthy subjects 
are shown to be much more similar to each other than those of patients in numerous 
but not all microbiome-associated diseases, notably including Parkinson’s Disease 
and Schizophrenia (Ma, 2020). This phenomenon is referred to as the Anna Karenina 
principle and has been applied to a wide array of academic fields. In these cases, the 
microbiome-associated disease may rather be modulated by a dysregulated 
microbiome, a lack of stability, rather than a certain stable pathogenic state like in 
the case of a disease like Clostridium difficile infection.  
In the case of rodents, there have been reports of cage and litter effects in the 
microbiome. Indeed, as both rats and mice are known to be coprophagous, it stands 
to reason that the microbiomes of cage-mates would be converge towards each 
other. This is also reflected in the scientific literature (Ericsson et al., 2018; Miyoshi 
et al., 2018) and it is considered best practice to properly account for these effects 
during the experimental design. In humans, it has been reported that cohabitants 
have a more similar microbiome than average (Finnicum et al., 2019). The driving 
forces that determine in what way the microbiomes of cohabitants or cage-mates 
converge remains to be speculated on. 
7.3 Identifying Strengths in the analysis of our studies 
Limitations notwithstanding, there are several aspects that strengthened our 
understanding and yielded particularly informative or otherwise interesting results. 
It is worth discussing these so that future experiments can be tailored in such a way 
to ensure it can take advantage of these strengths.  
7.3.1 Specific functional modules over a general functional 
analysis 
As mentioned in the limitations, functional metagenomics analysis represents a 
valuable addition to taxonomical microbiome analysis, the two often complement 
each other. In several of our manuscripts, we went a step further and used the 
functional module framework. There are currently two types of functional modules, 
both introduced by the Flemish Raes group (Valles-Colomer et al., 2019). To reiterate, 
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first, there are Gut-Metabolic Modules (GMMs), which represent collections of the 
metabolic pathways and reactions that cover the genetic capacity of the microbiome 
to metabolise a given substrate. Next, there are Gut-Brain Modules (GBMs) which 
cover pathways and reactions that are known to synthesise or degrade neuroactive 
compounds, such as serotonin or GABA or histamine. There are many advantages to 
using these functional modules rather than a full non-curated list of all genes in a 
metagenome. First, functional modules represent a much shorter list than all genes 
or KEGG orthologues, making the results more practically feasible to interpret and 
reducing the risk of cherry-picking your favourite result from a long list of functions. 
Second, focusing on a shorter list of specific modules reduces the severity for post-
hoc correction of the false discovery rate. This way, changes that are relevant to the 
researcher are more likely to remain detectable as significantly altered without being 
drowned out by other functions that would not have been relevant to the research 
question anyway. Third, the functional modules represent a convenient common 
ground between different studies. The type of database or sequencing technique 
used during analysis determines the exact annotation and naming of taxa and may 
even determine what functional databases the researcher has access to. However, 
as the functional modules represent a small list of pre-defined processes, it is trivial 
to compare them between studies. This makes it easier to compare and contrast ones 
findings with that of other groups with similar questions or manipulations, without 
necessitating a complete concordance in bioinformatics pipelines. Especially the 
ability to calculate functional modules in both 16S, like we did in chapters 2.3, 3.1, 
5.1, and 6.3, as well as in whole genome shotgun sequencing, like we did in chapter 
2.4, on prebiotics and hypoxia and the microbiome, greatly improves our ability to 
compare effects in the microbiome between these to approaches. Moving forward  
with functional modules, the ability to assess how many taxa have the capacity to 
perform certain function as well the degree of contribution of each of those taxa to 
a function seems like an excellent point to expand on. In chapter 3.3, we were able 
to use this approach to show that Blautia was the main contributor to the functions 
that were altered in the group receiving prebiotics after antibiotics perturbation of 
the microbiome. We were not able to find a difference in the number of taxa capable 
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of performing those functions in that study, but it would be interesting to find cases 
where this division of labour, so to speak, is indeed altered.  
7.3.2 Volatility encapsulates the dynamic nature of the 
microbiome 
It is well-know that the microbiome is a complex dynamic ecosystem that spans all 
kingdoms of life. It is known to be in constant flux, yet, this dynamic nature is rarely 
considered in the context of host health. Volatility was shown to be related to host 
state, not only in chapter 5.1, on volatility specifically, where it was linked to stress, 
but also in chapter 3.1, where aged mice receiving young donor FMT showed a lower 
volatility than those who received FMT from aged donors. We argue for the inclusion 
of volatility in all future research that permits it, in a way similar to how alpha-
diversity is often considered. Further research on volatility itself should focus on the 
mechanisms determining what makes a microbiome volatile. In a longitudinal study 
following 34 participants over 17 consecutive days, the Knights group showed that 
stability of the microbiome was not related to stability of the diet, but that it was 
dependent on the diverseness of the diet (Johnson et al., 2019). This could mean that 
the host gut lumen metabolic environment regulates microbiome volatility.  
Volatility in the context of the microbiome-gut-brain axis aside, incorporating 
multiple measurements from different time points has several advantages from 
different points of view. First, from an ecological standpoint, taking several 
observations per sample reveals information about stability and robustness of an 
ecosystem. Currently, we are not able to estimate whether a community, like a 
microbiome, would be stable just from a single metagenomics sample. Indeed, in 
chapter 5.1, on volatility, we were unable to pin down any features of the 
microbiome at baseline that may reveal anything about the volatility that 
microbiome would display over the course of the experiment. However, this 
information may be quite relevant to the researchers. Not only would a less stable, 
more volatile microbiome be reason to suspect negative health outcomes, 
perturbing a microbiome may increase permissivity for new taxa, potentially 
pathogens, to colonize it as seen in chapter 3.3, where antibiotics perturbation was 
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necessary for Blautia to colonize. Blautia is typically seen as a commensal genus, but 
it is hard to imagine that this is the only genus that can colonize the microbiome after 
a perturbation. Second, from a statistical standpoint, taking multiple measurements 
allows the researcher to use more sensitive statistical models and tests, potentially 
reducing the required n-number to be able to detect the alterations taking place. The 
most simple example of this would be that a paired t-test is more sensitive than an 
unpaired t-test. We used this to our advantage in chapters 3.1, on FMT and ageing 
and 5.1, on volatility, but the approach paid off especially well in the human studies 
in chapter 6 where we had multiple timepoints available; 6.2 and 6.3. It is 
unsurprising that human microbiomes show more unexplained variance than 
laboratory murine microbiomes in general, given the larger variance in genetics, diet 
and environment for humans just to name a few factors.  Using the baseline 
microbiome, we were able to sidestep some of it, improving our power. Notably, The 
Knight group has recently released a tensor-based statistical model that takes intra-
subject variability into account, improving sensitivity compared other common 
methods (Martino et al., 2020). Notably, while the manuscript does describe it as a 
way to take advantage of longitudinal data, the model is completely invariant to the 
order of the measurements and can also be used if the repeated measurement range 
from different microbiota in from the same host, further increasing possibilities.  
 
7.4 Identifying Limitations of Microbiome Studies in 
the Microbiota-Gut-Brain Axis Field 
There are several key limitations that should be considered when it comes to 
microbiome studies, including the ones discussed here. Some of these limitations 
could be seen as features of metagenomics sequencing. It should also be noted here 
that any metagenomic analysis that involves database-assisted annotation is 
dependent on experimental work. We simply could not perform high-throughput 
microbiome analysis without the massive amount of work performed in the wet lab.  
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7.4.1 There are inherent hidden biases in all metagenomic 
sequencing data 
It is inherently problematic to compare microbiome between cohorts and, indeed, 
between plates within the same cohort. This phenomenon was thoroughly described 
and is invariant to 16S sequencing or whole genome shotgun metagenomics 
(McLaren et al., 2019). In a nutshell, it is not possible to infer abundance of a microbe 
or even the ratio between the abundance of two microbes in a single microbiome 
based on the amount of reads ascribed to said microbe. This is because hidden, often 
unknowable factors such as the ability of the microbial cell wall to withstand lysis or 
the resistance of the microbial genetic material to catalases will differentially affect 
the different microbes in a sample. Indeed, some of these biases are shown to be 
specific to a laboratory or even a sequencing plate, making it problematic to compare 
microbiome metagenomic sequencing data between batches or experiments. 
Fortunately, this does not impede our ability to investigate the microbiome outright. 
Within a batch, all biases are assumed to be equal. Furthermore, while the actual 
amounts of reads may differ based on these biases, the ratios of taxa can still be used 
to compare between cohorts. For example, if the proportion of, say, Lactobacillus in 
a sample increases based on the age of the host in a cohort, we would expect this to 
be the case in other cohorts as well, though the actual read count levels may vary to 
several orders of magnitude. Other metrics that don’t rely on singular taxa or 
features, such as volatility, have also been shown to be robust to this hidden bias 
effect as is indeed the case in chapter 5.1, on volatility.  
7.4.2 There are limitations specific to 16S amplicon 
sequencing 
With the exception of chapter 2.4 on hypoxia and prebiotics in rats, all studies 
presented here feature 16S sequencing rather than whole genome shotgun 
metagenomics. While there are several advantages to 16S sequencing such as the 
lower price, faster processing time and the need for less biomaterial, the microbiome 
field is moving towards whole genome shotgun metagenomics. There are arguably 
three main limitations of 16S sequencing. Firstly, the 16S ribosomal RNA is virtually 
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exclusively found in prokaryotes, making the technique unsuitable to investigate the 
eukaryote and otherwise non-prokaryote section of the microbiome, which includes 
fungi, archaea, protists, some animalia like helminths and viruses like bacteriophage. 
Secondly, 16S sequencing is typically thought of as only being reliably up to the genus 
level, whereas whole genome shotgun metagenomics have been used to go to the 
strain level and even single nucleotide variants (Zeevi et al., 2019). This worse 
resolution can and does lead to the conflation of different strains within a genus. For 
instance, there have been instances of researchers using 16S sequencing to assess 
colonization efficiency of certain probiotics without the ability to actually detect 
these bacteria in this probiotic (Zmora et al., 2018).Thirdly, as 16S only picks up (part 
of the) the 16S sequence, the technique does not provide a direct way to investigate 
the functional capacity of the microbiome. Rather, inferential tools such as PICRUSt2 
and Piphillin are necessary to take a best guess at the functional repertoire of the 
microbiome. Fortunately, both of these techniques perform reasonably well 
compared to whole genome shotgun sequencing, making this limitation generally not 
as limiting as the first two. In the case where a conclusion hinges on the presence or 
absence of a certain function, it is certainly recommended to verify the actual 
presence of a gene or functional pathway by sequencing it, be it by whole genome 
shotgun metagenomics or simply by targeted qPCR.  
 
7.4.3 Many microbiome studies lack a longitudinal 
component  
Longitudinal microbiome studies have several advantages over their single time point 
counterparts. As we discussed in chapter 5.1, on volatility, longitudinal studies enable 
us to investigate volatility, which has been shown to contain information on both the 
microbial ecosystem and on host health. Furthermore, as discussed in chapter 7.2.4, 
there is a large degree if intra-subject variance that can somewhat be accounted for 
by using a baseline measurement of each participant as its own control. Indeed, a 
framework to utilize multiple measurements per subject in order to reduce this intra-
subject variance was recently proposed by another group (Martino et al., 2020). 
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Arguably similarly, one would be able to drastically reduce this variance as well by 
harnessing the longitudinal nature of a data set, simply employing a linear mixed 
effects model, with the random factor being the subject (donor). Because of the 
dynamic state of the microbiome, not taking baseline measurements forces the 
researches to assume that all microbiomes have a similar state at baseline. 
Fortunately, this is often a reasonable and justifiable assumption, but it is important 
to consider nonetheless. For instance, in the case of chapter 5.1, on volatility, the 
two cohorts of mice had a completely different microbiome at baseline. Not taking 
this into account would have likely led to a drastically different outcome. When 
linking microbiome data to host behaviour, cognition or mental health, there is an 
added difficulty in that many of the tests that are performed to assess these factors 
are subject to a learning effect, meaning that these tests themselves cannot 
necessarily be performed at all the time points one intends to take microbiome 
samples.  
7.4.4 Many microbiome studies lack a functional component  
In many cases when reporting on microbiome-gut-brain axis experiments, the 
researchers will speculate on the effects of significantly affected microbial taxa on 
the host. While this is not problematic on itself, it often makes more sense to rather 
look at the potential functional changes in the microbiome. In certain cases, it is 
completely justified to use both approaches side by side. For instance, in chapter 6.3, 
which focuses on a diet enriched in unpasteurized dairy, it makes sense to look at 
genera that are typically seen as lactic acid bacteria. Still, in the same research, we 
would not have been able to find an increase in neuroactive potential in the 
microbiome after the course without looking at the functional level. Several of the 
papers presented above would have benefited from functional analysis. For instance, 
consider chapters 2.1 and 2.2, which both deal with a dietary intervention targeting 
the microbiome, the first being a prebiotic intervention to rescue the effects of 
ageing and the second showing that dietary supplementation of omega-3 fatty acids 
and vitamin A rescues the effects of stress. It would have been interesting to 
investigate whether changes in the microbiome could have been explained based on 
the metabolic potential of said microbiome, or whether the observed 
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neuroprotective and anxiolytic effects could be linked to a change in the neuroactive 
potential of the microbiome. While 16S sequencing is not optimal for this type of 
analysis, inferential methods can still give a reasonable indication of what may be 
taking place.  
 
7.5 Moving Forward 
The microbiome-gut-brain axis field has undergone rapid development in the past 
decades and it will likely continue to do so for some time. New technologies and 
resources as well as a growing scientific knowledge will lead to a more mechanistic 
understanding of the microbiota-gut-brain axis in health and disease. Based on the 
research discussed above, we will discuss and in some cases recommend how to 
move the field forward.  
7.5.1 Improving the bioinformatics 
Because of the high-dimensional data nature of microbiome sequencing data, 
bioinformatics have played an important role in the microbiome-gut-brain axis field. 
In recent years, reproducibility has vastly improved, which many prominent journal 
strongly recommending researchers to publish their bioinformatics analysis scripts 
alongside their work. Yet, there are still some points that stand out to us in particular 
when it comes to moving the field forward. First, there is no consensus in which 
bioinformatics approach to take. Numerous tools, frameworks, pipelines and 
platforms have been proposed over the years. While this rapid growth in the amount 
of available resources should be seen as a boon in many ways, there is one major 
downside to them. Often, it is problematic to compare between microbiome studies 
because of differences in bioinformatics methodology. For instance, reference 
databases can evolve rapidly, some even yearly, sometimes reassigning entire clades 
such as was the case for Lactobacillus (Salvetti et al., 2018). This difficulty to compare 
between studies makes it particularly problematic to perform meta-analyses. Often, 
reanalysing raw sequencing reads to is cumbersome and the quality of metadata is 
still insufficient. Besides the obvious solution of all using the same database, ways to 
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convert between databases, such is the case between many functional databases 
seems like the way forward. Another interesting approach could be meta-feature 
analysis with tools like the functional Gut-Brain Modules or Gut-Metabolic Modules. 
These tools are mostly agnostic to the upstream bioinformatics pipelines that were 
used, but still give outputs in the same format. Similar modules, be they related to 
function, taxonomy or something else, may enable us to converge on outcomes that 
are similar enough to compare without enforcing any one pipeline on researchers. In 
some cases like the use of the GreenGenes database, which was last updated in 2013, 
this type of reconciliation may still prove difficult. Second, microbiome 
metagenomics datasets are compositional in nature. This comes with a host of 
features not seen in classical datasets, such as an internal negative correlation 
between features within the data. In other words, if we know that one taxon takes 
up 10% of the population in one sample and 90% in the next sample, we already 
know as a result of this, that the rest of the taxa in the former sample encompass a 
lot more of the population than in the latter sample. The relative abundances are 
thus negatively correlated within the sample. Fortunately, compositional data 
analysis is a well-described field and there exist straightforward transformations, 
such as ALR, CLR and ILR, to essentially get rid of these effects and allow us to apply 
conventional statistical approaches (Aitchison, 1982; Aitchison et al., 2000). Recently, 
there have been some microbiome publications in high-impact journals that employ 
or even directly introduce adaptations of compositional data analysis effectively, 
thus improving the accuracy of their outcomes and improving the statistical 
approaches of the field as a whole (Johnson et al., 2019; Valles-Colomer et al., 2019; 
Martino et al., 2020).  
 
 
7.5.2 Integrating ecological understanding 
The microbiome-gut-brain axis field is a clear example of an interdisciplinary field, 
featuring aspects ranging ecology to molecular biology to gastroenterology to 
psychology, just to name a few. Notably, whereas many of these fields have other 
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areas of studies where they may overlap, it’s safe to say that generally ecologists 
don’t cross paths with the other fields as regularly. Microbe-microbe interactions are 
known to determine the behaviour of individual gut microbes and this is likely to also 
affect their neuroactive potential. There are several ecological subjects that we deem 
likely will be developed more deeply in terms of the microbiome. First, there is 
colonization. Indeed, during early life, the colonization of the microbiome is known 
to be important for normal development of the immune system and behaviour, like 
we also show in chapter 2.5, on the enduring effect of high fat and cafeteria diet, 
chapter 3.2, on the lingering effects of antibiotics during adolescence and chapter 
3.4, on the lingering effect of caesarean section. There are indications the host allies 
a selective pressure on the microbiome to control this colonization (Ferretti et al., 
2018). Furthermore, the microbiome has been shown to follow some patterns in how 
it recolonizes after antibiotics depletion (Chng et al., 2020). Understanding the 
factors determining healthy colonization, including that of psychobiotics, will 
undoubtedly prove beneficial to the microbiome-gut-brain axis field as a whole. 
Second, there are ecological guilds. Ecological guilds represent taxonomically 
unrelated but functionally related species that typically perform some sort of ‘task’ 
in the ecosystem, such as the degradation of a certain otherwise hard to process 
material (Simberloff and Dayan, 1991; Zhao et al., 2018). It is often of little 
consequence which members of a guild are present, but rather that there are some 
guild representation at all. In the microbiome, we are aware of two lines of research 
that try to elucidate the dynamics of guilds in the microbiome. First, Liping Zhao and 
colleagues have reported on the restoration of ecological guilds in patients with type 
2 diabetes and argue for the experimental identification of guild members in order 
to efficiently screen for host health risks (Lam et al., 2018). Second, there is the study 
of trophic levels in the microbiome (Wang et al., 2019). In short, rather than 
microbiome being a chaotic collection of microbes that randomly metabolize based 
on what genes they may possess, the trophic levels model describes a hierarchy of 
sub-consortia of the microbiome, each feeding on metabolites produced by the 
lower layer and producing metabolites for the next layer. Interestingly, this 
phenomenon leads back to the first point of colonization as a trophic layer can only 
develop if the necessary lower trophic layer is already present in the microbiome 
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(Gralka et al., 2020). It seems likely that early colonizers such as members of 
Lactobacillus or Bifidibacterium could represent the base trophic level in both 
humans and rodents, given their importance in early life development and 
colonization of the microbiome, as also discussed in chapter 3.4, documenting the 
effects of caesarean section on the microbiome and neurobehaviour. Moving 
forward, it would be beneficial to develop a framework to identify or recognise 
ecological guilds in a fashion similar to the framework used to detect functional 
modules. Thirdly, there are enterotypes and the core microbiome, two concepts that 
are deeply related. It remains a point of discussion in the microbiome field whether 
enterotypes exist in the human population. In a nutshell, enterotypes can be thought 
of as stereotypical microbiomes, perhaps related to ones diet and lifestyle. In 
contrast, the core microbiome could arguably be thought of as the single viable, 
healthy enterotype, if there indeed is such a thing. Typically, in research arguing for 
the existence of enterotypes, three or four different ones are distinguished. Typically, 
at least one enterotype is characterised by it’s high relative abundance of 
Bacteroides, while another one has a high proportion of Prevotella, though the 
difficulties in comparing between studies and cohorts that was discussed in chapter 
7.2.2 on commonalities between studies and chapter 7.4.1 in the limitations section 
make it problematic to make strong descriptive statements in this regard. In a 
seminal study, the Flemish group that also introduced functional modules showed 
that psychological quality of life scores are unevenly distributed between the four 
enterotypes they distinguished in their cohort of 1054 participants (Valles-Colomer 
et al., 2019). Going further, another study by a different group showed that certain 
intermediate states between two enterotypes are much less likely to occur than 
others, with metaphorical barriers preventing one enterotype to transition into a 
different enterotype, in addition to either enterotype being stable on itself (Levy et 
al., 2020).  Thus, it seems likely that the enterotype framework holds scientific merit 
and furthermore that it holds predictive power when it comes to the microbiome-
gut-brain axis. However, enterotypes are not considered when applying linear 
modelling approaches in the microbiome, which typically assume that all samples 
come from the same distribution. This stands in direct contrast with the concept of 
enterotypes. Looking forward, identifying enterotypes as part of microbiome 
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analysis, perhaps using some sort of reference tool or database, would enable 
bioinformaticians to take enterotypes into account in their statistical modelling 
approaches.  
 
All models are wrong, but some are useful  
George P.Box 
 
7.5.3 Advancing the microbiome-gut-brain axis field 
Throughout this text we have recommended numerous way in which to continue 
researching the microbiome-gut-brain axis field. Most notably, there is a lack of 
longitudinal studies. For instance, investigating microbiome stability and volatility in 
different types of stress or other psychiatric conditions such as major depressive 
disorder may lead to a deeper understanding of the mechanisms of gut-brain 
communication at play. Recently, more longitudinal studies have been published in 
the microbiome-gut-brain axis field. Psychotropic drugs were shown to affect the 
microbiome in a clinical population with anxiety and depressive disorder, including 
changes in neuroactive Gut-Brain Modules (Tomizawa et al., 2021). Another aspect 
of microbiome volatility that would be interesting to investigate is the interplay 
between volatility and other examples of stable changes, such as is the case in the 
circadian rhythm and the menstrual cycle.  Other ways to characterize the 
microbiome, such as through metabolomics, should also be considered for volatility. 
We have inferentially shown that microbiome function is affected as part of volatility, 
but whether, and to what degree, the metabolic environment is affected still remains 
to be answered. Another important goal is the integration of microbiome datasets 
with other ‘omics data, such as host transcriptomics or metabolomics. There are two 
main ways to approach this, one currently common than the other. First, there is 
naive integration. This involves simply correlating all features from the first data set 
to those of the other. Notably, the names of these features holds no weight in this 
analysis. Second, there is informed integration. This method is more rare and 
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typically relies on bioinformatics scripts rather than tools. Here, it matters which 
features are compared between datasets, drastically reducing possibility-space for 
correlations to occur and in turn increasing power. For example, metabolites from 
serum metabolomics may be compared to just the genes encoding for enzymes with 
said metabolites as known ligands. This approach is dependent on the quality of 
databases and was recently leveraged in a publication (Kim et al., 2020). Often, these 
methods are documented poorly or even unavailable altogether.  In the study where 
we investigated the potential of FMT form young mice to reverse the effects of 
ageing in mice, I ended up developing my own method to integrate metabolomics 
and functional microbiome metagenomics using a biologically informed framework, 
by leveraging the KEGG framework. This method allowed me to specifically 
investigate whether relevant functions in the microbiome were altered based on the 
metabolites whose levels were found to be altered by ageing and rescued by FMT 
from young animals. Integrating data from different ‘omics approaches can yield a 
clearer view of the metabolic pathways that play a role in microbiome-gut-brain 
communication, driving the field towards hypotheses that can lead to mechanistic 
understanding. Third, the effectiveness of the functional modules approach warrants 
an expansion of this type of framework. Rather than assessing the potential to 
metabolize neuroactive compounds, one could imagine a framework that assesses 
risk factors for mental health conditions. Furthermore, quantification of a 
microbiomes capacity to metabolize different psychobiotic drugs, its degree of 
antibiotic resistance and its permissivity to be colonized by new taxa, be they 
pathogenic or beneficial to the host come to mind as factors that would greatly 
improve interpretability of microbiome studies. Furthermore, as discussed in chapter 
7.3.1, in the strengths section, an overlaying framework of modules that are invariant 
to upstream bioinformatics pipelines will enable researchers to reliably and compare 





The microbiome is involved in regulating host health, including mental health. 
Furthermore, microbiome perturbation during critical windows of development can 
have lasting behavioural and neurophysiological consequences. The studies 
discussed here not only confirm this, but also build further upon previous studies 
investigating the microbiome-gut-brain axis. Furthermore, we have investigated and 
advanced our understanding of neglected features of the microbiome that we have 
shown to be informative in regard to the microbiome-gut-brain axis. Prime among 
these are volatility and functional modules. We have demonstrated how to measure 
these features and we have discussed how to leverage them in experiments. 
Additionally, we have argued for a stronger integration of ecological knowledge into 
our model of the gut microbiome, which we find to be essential in order to explain 
the results we find. Based on our findings, we have recommended new lines of 
questioning for future research. Future research incorporating volatility, functional 
markers and an ecological understanding from the design stage will enable us to 
move the field forward towards a deeper mechanistic understanding of microbiome-
gut-brain communication. With this mechanistic understanding, we will be able to 
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